Allowed Publications
Slot System
Featured Buckets
Featured Buckets Admin
Reverse Chronological Sort

Streamlining the Acute Care Pharmacy Consultation Process for Patients With Dysphagia or Enteral Feeding Tubes

Article Type
Changed
Display Headline

Streamlining the Acute Care Pharmacy Consultation Process for Patients With Dysphagia or Enteral Feeding Tubes

Medication regimens may require adjustment in acute care settings due to dysphagia and/or enteral feeding tubes. When a patient has dysphagia and/or a feeding tube, the health care team must review the pharmacotherapy regimen to assess the appropriateness of medication formulations. Patient anatomy, the type of feeding tube in place, pharmacokinetic and pharmacodynamic properties of medications, risk of feeding tube obstruction, and potential for interactions between enteral nutrition and medications should be considered when clinicians administer medications through feeding tubes. The risk of feeding tube obstruction and clogging rises with increasing tube length and decreasing tube lumen. Incidence of obstructed percutaneous endoscopic gastrotomy tubes is reported to be 23% to 35%.1

A coordinated effort by all members of the health care team is essential to provide safe and effective care to patients with dysphagia and/or enteral feeding tubes. To decrease the risk of feeding tube obstruction, medications should be dissolved in water or administered in liquid form, saline fluids should be avoided, and the tube should be flushed with water before and after administering medications.

The pharmacokinetics of medications can be altered when tablets are crushed or capsules are opened. The bioavailability of dabigatran, for example, increases by 75% when the capsules are opened and pellets are taken orally.2 Medications may become intolerable after manipulation due to taste.3 Others may also increase the risk of feeding tube obstruction, such as omeprazole granules that increase the risk of small-bore feeding tube obstruction.4

Prior assessments of drug administration for patients with dysphagia and/or enteral feeding tubes has shown medication errors are prevalent.5-7 The Institute for Safe Medication Practices (ISMP) issued a Medication Safety Alert that provides a framework for preventing medication errors when preparing and administering medications via enteral feeding tubes.8 Other resources, such as monographs, are also available to guide pharmacotherapy decisions when oral medications require manipulation for administration to patients with dysphagia and/or enteral feeding tubes.9-11

In 2021, the Kansas City Veterans Affairs Medical Center (KCVAMC) was recognized as a Veterans Health Administration (VHA) Shark Tank finalist for improving the safety of medication administration for patients with enteral feeding tubes.12 This involved the addition of a Computerized Patient Record System (CPRS), clinical reminder order check (CROC), and a comprehensive medication review by a pharmacist. After implementing the CROC alert and pharmacy e-consultation workflow, the KCVAMC team reported that the number of inappropriate medications (ie, drugs on the ISMP do not crush list) was reduced from 41 to 6 in 1 year, resulting in an 85.4% reduction in potential medication errors.13

In 2014, the Richard L. Roudebush VAMC (RLRVAMC) created a pharmacy consultation process for patients with dysphagia and/or enteral feeding tubes. Any clinician could place a pharmacy consultation in CPRS. A pharmacist then reviewed patient charts, medication information resources, the VA formulary, and RLRVAMC pharmacy inventory. The pharmacist conferred with the patient’s care team to adjust pharmacotherapy, completed a consultation note, and updated medication order comments in Veterans Health Information Systems and Technology Architecture (VistA). These comments interfaced with the barcode medication administration software for the health care professional administering medications.

Despite the 2014 quality improvement (QI) process, medication errors involving the inappropriate ordering, preparation, and administration of medications for patients with dysphagia and/or enteral feeding tubes continued to be reported. Additionally, anonymous feedback revealed that only 3 of 10 responding pharmacists were satisfied with the existing medication use process for patients with dysphagia and/or enteral feeding tubes. Pharmacists expressed concerns that (1) clinicians were inappropriately crushing and/or manipulating new medications that were ordered after pharmacy consultations; (2) there was a lack of comprehensive documentation in CPRS; and (3) there were too many manual steps in the process. In response, RLRVAMC initiated a new QI initiative to improve the medication use process for patients with dysphagia and/or enteral feeding tubes in the acute care setting.

Quality Improvement Project

This multidisciplinary RLRVAMC QI project began November 2024 to improve pharmacotherapy care for patients with dysphagia and/or enteral feeding tubes in acute care. It was approved by the RLRVAMC Pharmacy Service. This intervention addressed the pharmacy consultation template, standardization of equipment, standardization of language, creation of clinical alerts, and sustainment (Table 1).

eAcute-Care-T1

RLRVAMC has about 8600 annual inpatient admissions and 159 acute care beds.14 The project charter was drafted, and local stakeholders were identified including pharmacy technicians, pharmacists, nurses, speech language pathologists, and acute care clinicians. Pharmacy consultation workload was retrospectively reviewed to describe the scope of the existing state.

A workshop with 12 QI project stakeholders in December 2024 used A3 methodology to define the current process and the target state, barriers and solutions, prioritize interventions on an impact-effort matrix, perform a gap analysis, identify rapid plan-do-study-act (PDSA) experiments, and develop a completion plan (Figure). Five postworkshop PDSA experiments engaged additional stakeholders, clinical application coordinators, and medical supply representatives to ascertain the feasibility of the tools implemented.

eAcute-Care-F1
FIGURE. Process Maps of Current State and Target State
Abbreviations: BCMA, barcode medication administration; CDSS, clinical decision support system; CPRS, Computerized Patient Record System;
EHR, electronic health record; SOP, standard operating procedure; VistA, Veterans Health Information Systems and Technology Architecture.

About 3% of RLRVAMC admissions involve a pharmacy consultation to review medications for dysphagia and/or enteral feeding tubes. Clinicians reviewed 30 preimplementation inpatient pharmacy consultations involving 200 oral medications. Pharmacists were more frequently consulted for inpatients with dysphagia (19 [63%]) than for patients with enteral feeding tubes (11 [37%]) (Table 2).

eAcute-Care-T2
Pharmacy Consultation Template

The pharmacy consultation was updated in CPRS. Prior to this QI project, the ordering clinician was prompted to select 1 option for the indication: dysphagia or enteral feeding tube. The type of enteral feeding tube was not prompted by the consultation text nor required to be specified in the consultation. The ordering clinician could provide free-text comments. Of 11 preimplementation consultations, the type of enteral feeding tube was specified in 5 (45%). The consultation template entry was updated to include an option to check a box for the consultation indication from 3 options: dysphagia, enteral feeding, or other patient- specific condition/request. If enteral feeding tube is selected, then the clinician is prompted to select the type of enteral feeding tube. Since the completion of the project, there have been no patient safety reports concerning an erroneous or incomplete consultation entry (Supplemental Material).

The note template was updated to import the list of active inpatient medications and provide sections for the adjudicating pharmacist to document which medications can be crushed (or opened), which require adjustment, and which are hazardous and require special handling. Additionally, the revised template added a statement clarifying that the documented recommendations apply only to the medication regimen at the time of the consultation (Supplemental Material).

Standardizations

There are multiple pill-crushing devices used at RLRVAMC that vary in crushing mechanism, corresponding medication pouches, and degree of protection when manipulating hazardous medications. Prior to this QI project, RLRVAMC used 3 pill-crushing devices (about 30 total devices in inpatient care areas). Only 1 device with corresponding closed pouches for preparation of hazardous medications was available, which was stored in the RLRVAMC inpatient pharmacy. This workflow resulted in waste and posed potential risks for delays in care. This project incorporated a standard pill-crushing system with the corresponding medication pouches in all inpatient care areas, which provided safeguards for clinicians to prepare and administer hazardous medications (Supplemental Material).

Patients requiring medications to be crushed or opened on discharge should receive education, written instruction, and have care plans documented in CPRS. RLRVAMC patients receive education and a printed medication list. Prior to this QI project, the instructions for crushing or opening medications could only be entered by free text in the electronic medication reconciliation tool, allowing for the potential for inconsistent language or omissions.

This QI project included an update to the electronic medication reconciliation tool. An optional checkbox selection was added for patients requiring medications to be manipulated. When checked, a radial selection for individual medications is displayed, prompting the clinician and pharmacist to indicate either do not crush tablet or OK to crush tablet. These selections appear in clinical care notes and on the printed medication list provided to the patient (Supplemental Material).

Clinical Alerts

As part of the RLRVAMC QI initiative, a CROC alert was implemented, based on the KCVAMC intervention for patients with enteral feeding tubes.13 The RLRVAMC CROC alert also included patients with dysphagia. A nursing text order was made available in CPRS for patients requiring medications and remains active throughout the duration of the patient’s admission or until discontinued. It generates CROC alerts in CPRS and VistA when new medication orders are entered and reviewed by pharmacists.

Clinicians used clinical decision support systems to create daily lists of patients receiving medications by feeding tube and patients receiving crushed/opened medications due to dysphagia. This allows pharmacists to perform a census review of all inpatients to confirm appropriateness of medication orders. Clinical alerts for patients with enteral feeding tubes are advised by the ISMP and have data demonstrating a reduction in medication errors (Supplemental Material).14,15

Sustainment

During the sustainment phase, process owners were identified and a Pharmacy Service standard operating procedure (SOP) was written. The development of an institutional do not crush medication list was discussed; however, it was determined to be difficult to develop and maintain. An institutional tertiary resource list was selected in favor of a locally developed resource. These resources include the Handbook of Drug Administration via Enteral Feeding Tubes, Third Edition, the Pharmacist’s Letter list, “Meds that Should Not be Crushed,” and the Up- ToDate Lexidrug list, “Oral Medications That Should Not Be Crushed or Altered.”9-11 Links to the resources were added to the RLRVAMC pharmacy service SharePoint. In addition to defining the preferred tertiary resources, the SOP defined the process for reviewing inventory and the process for reviewing medication orders for hazard risk.

Discussion

Continued patient safety reports and low satisfaction rates among pharmacists prompted this QI project to improve safety for patients with dysphagia and/or enteral feeding tubes at RLRVAMC. The project engaged stakeholders and also identified and addressed gaps with potential for patient harm.

The tools implemented by this initiative drew from previous work by the KCVAMC and from framework provided by the ISMP.8,13 We expanded the QI intervention to include acute care patients with dysphagia.

RLRVAMC did not take steps to track the impact of the interventions on medication errors. However, no patient safety reports concerning an erroneous or incomplete pharmacy consultation entry have been reported. We also think that it is reasonable to assume that the adoption of the safety tools described here will have a positive impact on patient safety. RLRVAMC pharmacists have noted an increased appreciation for medication safety when processing medication orders for patients with dysphagia and/or enteral feeding tubes. While the workflow took time to adopt and integrate, clinical pharmacists perceived it as an improvement in patient safety. Our future focus is aimed at translating the process improvement into the Oracle/Cerner electronic health record, which is scheduled to be deployed at the RLRVAMC in August 2026.

Limitations

This QI project did not aim to quantify or compare medication errors before and after the intervention. An accurate number of unreported errors in the medication use process for patients with dysphagia and/or enteral feeding tubes would be challenging to quantify without direct observation. Multiple clinicians are engaged in the medication use process and individual steps may not be documented at all, or documented properly. In addition, medication errors are often underreported and may not reflect the total number of errors and/or potential for errors. That said, reported medication errors in the medication use process for patients with dysphagia and/or enteral feeding tubes are reviewed on a monthly basis by the RLRVAMC Multidisciplinary Medication Safety committee to continuously improve patient safety.

Another potential limitation is the extent to which the project can be adapted at other VHA sites. For example, RLRVAMC uses CPRS; the framework and tools to improve medication safety may not translate to sites using the Oracle/Cerner electronic health record. Furthermore, this QI project included a pharmacy consultation workflow that relied on pharmacists who are available at any hour. Other facilities may not have continuous consultation coverage to review medications for patients with dysphagia and/or enteral feeding tubes.

Conclusions

This QI project drew from ISMP recommendations, previous work within the VHA, local practice, and insight from multiple disciplines on the health care team to revise and create tools to improve medication safety for patients with dysphagia and/or enteral feeding tubes in the acute care setting. These tools included a revised pharmacy consultation workflow with improvements to the pharmacy consultation template, standardization of the pill-crushing devices and language used for patient medication lists, implementation of CROC alerts within the EHR, and development of an SOP.

The RLRVAMC Pharmacy Service intends to continue reviewing patient safety reports, assessing staff perspectives, and refining (and potentially adding) tools for medication safety. Future QI initiatives may focus on improving medication safety for outpatients with dysphagia and/or enteral feeding tubes. We also hope that these tools can be adapted at other VAMCs to promote medication safety for patients with dysphagia and/or enteral feeding tubes.

References
  1. Blumenstein I, Shastri YM, Stein J. Gastroenteric tube feeding: techniques, problems and solutions. World J Gastroenterol. 2014;20:8505-8524. doi:10.3748/wjg.v20.i26.8505
  2. Pradaxa (dabigatran etexilate). Prescribing information. Boehringer Ingelheim Pharmaceuticals, Inc; 2025. https:// pro.boehringer-ingelheim.com/us/products/pradaxa/bipdf /pradaxa-capsules-us-pi
  3. Lovell AG, Protus BM, Dickman JR, et al. Palatability of crushed over-the-counter medications. J Pain Symptom Manage. 2021;61:755-762. doi:10.1016/j.jpainsymman.2020.09.020
  4. Messaouik D, Sautou-Miranda V, Bagel-Boithias S, et al. Comparative study and optimisation of the administration mode of three proton pump inhibitors by nasogastric tube. Int J Pharm. 2005;299:65-72. doi:10.1016/j.ijpharm.2005.04.034
  5. Demirkan K, Bayraktar-Ekincioglu A, Gulhan-Halil M, et al. Assessment of drug administration via feeding tube and the knowledge of health-care professionals in a university hospital. Eur J Clin Nutr. 2017;71:164-168. doi:10.1038/ejcn.2016.147
  6. Fodil M, Nghiem D, Colas M, et al. Assessment of clinical practices for crushing medication in geriatric units. J Nutr Health Aging. 2017;21:904-908. doi:10.1007/s12603-017-0886-3
  7. Zhu LL, Xu LC, Wang HQ, et al. Appropriateness of administration of nasogastric medication and preliminary intervention. Ther Clin Risk Manag. 2012;8:393-401. doi:10.2147/TCRM.S37785
  8. Institute for Safe Medication Practices (ISMP). Preventing errors when preparing and administering medications via enteral feeding tubes. Acute Care ISMP Medication Safety Alert. November 17, 2022. Accessed March 17, 2026. https://nutritioncare.org/wp-content/uploads/2025/02 /ISMP-Safety-Alert_Medications-and-Enteral-Feeding -Tubes.pdf
  9. White R, Bradnam V. Handbook of Drug Administration via Enteral Feeding Tubes. 3rd ed. Pharmaceutical Press; 2015.
  10. Clinical resource, meds that should not be crushed. Pharmacist’s Letter/Pharmacy Technician’s Letter/Prescriber Insights. Updated April 2025. Accessed March 17, 2026. https://pharmacist.therapeuticresearch.com/en/Content /Segments/PRL/2014/Aug/Meds-That-Should-Not-Be -Crushed-7309
  11. Oral medications that should not be crushed or altered. In: Lexidrug. UpToDate, Inc. https://online.lexi.com/lco /action/doc/retrieve/docid/patch_f/4227
  12. Uttaro E, Zhao F, Schweighardt A. Filling the gaps on the Institute for Safe Medication Practices (ISMP) do not crush list for immediate-release products. Int J Pharm Compd. 2021;25:364-371.
  13. US Dept of Veterans Affairs. VA Diffusion Marketplace. Improved safety of enteral tube medication administration. Updated 2024. Accessed March 17, 2026. https:// marketplace.va.gov/innovations/improved-safety-of -enteral-tube-medication-administration
  14. US Dept of Veterans Affairs. About us. VA Indiana Healthcare System. Updated October 17, 2024. Accessed March 2, 2026. https://www.va.gov/indiana-health-care/about-us/
  15. Wasylewicz ATM, van Grinsven RJB, Bikker JMW, et al. Clinical decision support system-assisted pharmacy intervention reduces feeding tube-related medication errors in hospitalized patients: a focus on medication suitable for feeding-tube administration. JPEN J Parenter Enteral Nutr. 2021;45:625-632. doi:10.1002/jpen.1869
Article PDF
Author and Disclosure Information

Garrett Garver, PharmD, BCPSa,b; Tiffany Boelke, PharmD, BCACPa; William Ifeachor, PharmD, MBA, BCPSa; Tamra Pierce, PharmD, BCPSa; Stacey Johnston, BSPSa; Rebeca Beight, CPhTa; Gabrielle Newhouse, PharmDa; Megan Routh, PharmDa; Kylie Sellers, PharmDa; Yasmin Siwy, PharmDa,c; Edward Stoll, PharmDa; Ethan Wahl, PharmD, BCPSa

Author affiliations
aVeterans Affairs Indiana Healthcare System, Indianapolis
bCincinnati Veterans Affairs Medical Center, Ohio
cDurham Veterans Affairs Medical Center, North Carolina

Author disclosures The authors report no actual or potential conflicts of interest with regard to this article.

Disclaimer The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing information for specific drugs or drug combinations— including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.

Ethics and consent This process improvement project was approved as an operational, nonresearch quality improvement project by institutional service leadership. Therefore, this project was not reviewed by an institutional review board or research and development committee.

Correspondence: Garrett Garver (garrett.garver@va.gov)

Fed Pract. 2026;43(5)e0703. Published online June 2. doi:10.12788/fp.0703

Issue
Federal Practitioner - 43(5)
Publications
Topics
Page Number
1-7
Sections
Author and Disclosure Information

Garrett Garver, PharmD, BCPSa,b; Tiffany Boelke, PharmD, BCACPa; William Ifeachor, PharmD, MBA, BCPSa; Tamra Pierce, PharmD, BCPSa; Stacey Johnston, BSPSa; Rebeca Beight, CPhTa; Gabrielle Newhouse, PharmDa; Megan Routh, PharmDa; Kylie Sellers, PharmDa; Yasmin Siwy, PharmDa,c; Edward Stoll, PharmDa; Ethan Wahl, PharmD, BCPSa

Author affiliations
aVeterans Affairs Indiana Healthcare System, Indianapolis
bCincinnati Veterans Affairs Medical Center, Ohio
cDurham Veterans Affairs Medical Center, North Carolina

Author disclosures The authors report no actual or potential conflicts of interest with regard to this article.

Disclaimer The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing information for specific drugs or drug combinations— including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.

Ethics and consent This process improvement project was approved as an operational, nonresearch quality improvement project by institutional service leadership. Therefore, this project was not reviewed by an institutional review board or research and development committee.

Correspondence: Garrett Garver (garrett.garver@va.gov)

Fed Pract. 2026;43(5)e0703. Published online June 2. doi:10.12788/fp.0703

Author and Disclosure Information

Garrett Garver, PharmD, BCPSa,b; Tiffany Boelke, PharmD, BCACPa; William Ifeachor, PharmD, MBA, BCPSa; Tamra Pierce, PharmD, BCPSa; Stacey Johnston, BSPSa; Rebeca Beight, CPhTa; Gabrielle Newhouse, PharmDa; Megan Routh, PharmDa; Kylie Sellers, PharmDa; Yasmin Siwy, PharmDa,c; Edward Stoll, PharmDa; Ethan Wahl, PharmD, BCPSa

Author affiliations
aVeterans Affairs Indiana Healthcare System, Indianapolis
bCincinnati Veterans Affairs Medical Center, Ohio
cDurham Veterans Affairs Medical Center, North Carolina

Author disclosures The authors report no actual or potential conflicts of interest with regard to this article.

Disclaimer The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing information for specific drugs or drug combinations— including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.

Ethics and consent This process improvement project was approved as an operational, nonresearch quality improvement project by institutional service leadership. Therefore, this project was not reviewed by an institutional review board or research and development committee.

Correspondence: Garrett Garver (garrett.garver@va.gov)

Fed Pract. 2026;43(5)e0703. Published online June 2. doi:10.12788/fp.0703

Article PDF
Article PDF

Medication regimens may require adjustment in acute care settings due to dysphagia and/or enteral feeding tubes. When a patient has dysphagia and/or a feeding tube, the health care team must review the pharmacotherapy regimen to assess the appropriateness of medication formulations. Patient anatomy, the type of feeding tube in place, pharmacokinetic and pharmacodynamic properties of medications, risk of feeding tube obstruction, and potential for interactions between enteral nutrition and medications should be considered when clinicians administer medications through feeding tubes. The risk of feeding tube obstruction and clogging rises with increasing tube length and decreasing tube lumen. Incidence of obstructed percutaneous endoscopic gastrotomy tubes is reported to be 23% to 35%.1

A coordinated effort by all members of the health care team is essential to provide safe and effective care to patients with dysphagia and/or enteral feeding tubes. To decrease the risk of feeding tube obstruction, medications should be dissolved in water or administered in liquid form, saline fluids should be avoided, and the tube should be flushed with water before and after administering medications.

The pharmacokinetics of medications can be altered when tablets are crushed or capsules are opened. The bioavailability of dabigatran, for example, increases by 75% when the capsules are opened and pellets are taken orally.2 Medications may become intolerable after manipulation due to taste.3 Others may also increase the risk of feeding tube obstruction, such as omeprazole granules that increase the risk of small-bore feeding tube obstruction.4

Prior assessments of drug administration for patients with dysphagia and/or enteral feeding tubes has shown medication errors are prevalent.5-7 The Institute for Safe Medication Practices (ISMP) issued a Medication Safety Alert that provides a framework for preventing medication errors when preparing and administering medications via enteral feeding tubes.8 Other resources, such as monographs, are also available to guide pharmacotherapy decisions when oral medications require manipulation for administration to patients with dysphagia and/or enteral feeding tubes.9-11

In 2021, the Kansas City Veterans Affairs Medical Center (KCVAMC) was recognized as a Veterans Health Administration (VHA) Shark Tank finalist for improving the safety of medication administration for patients with enteral feeding tubes.12 This involved the addition of a Computerized Patient Record System (CPRS), clinical reminder order check (CROC), and a comprehensive medication review by a pharmacist. After implementing the CROC alert and pharmacy e-consultation workflow, the KCVAMC team reported that the number of inappropriate medications (ie, drugs on the ISMP do not crush list) was reduced from 41 to 6 in 1 year, resulting in an 85.4% reduction in potential medication errors.13

In 2014, the Richard L. Roudebush VAMC (RLRVAMC) created a pharmacy consultation process for patients with dysphagia and/or enteral feeding tubes. Any clinician could place a pharmacy consultation in CPRS. A pharmacist then reviewed patient charts, medication information resources, the VA formulary, and RLRVAMC pharmacy inventory. The pharmacist conferred with the patient’s care team to adjust pharmacotherapy, completed a consultation note, and updated medication order comments in Veterans Health Information Systems and Technology Architecture (VistA). These comments interfaced with the barcode medication administration software for the health care professional administering medications.

Despite the 2014 quality improvement (QI) process, medication errors involving the inappropriate ordering, preparation, and administration of medications for patients with dysphagia and/or enteral feeding tubes continued to be reported. Additionally, anonymous feedback revealed that only 3 of 10 responding pharmacists were satisfied with the existing medication use process for patients with dysphagia and/or enteral feeding tubes. Pharmacists expressed concerns that (1) clinicians were inappropriately crushing and/or manipulating new medications that were ordered after pharmacy consultations; (2) there was a lack of comprehensive documentation in CPRS; and (3) there were too many manual steps in the process. In response, RLRVAMC initiated a new QI initiative to improve the medication use process for patients with dysphagia and/or enteral feeding tubes in the acute care setting.

Quality Improvement Project

This multidisciplinary RLRVAMC QI project began November 2024 to improve pharmacotherapy care for patients with dysphagia and/or enteral feeding tubes in acute care. It was approved by the RLRVAMC Pharmacy Service. This intervention addressed the pharmacy consultation template, standardization of equipment, standardization of language, creation of clinical alerts, and sustainment (Table 1).

eAcute-Care-T1

RLRVAMC has about 8600 annual inpatient admissions and 159 acute care beds.14 The project charter was drafted, and local stakeholders were identified including pharmacy technicians, pharmacists, nurses, speech language pathologists, and acute care clinicians. Pharmacy consultation workload was retrospectively reviewed to describe the scope of the existing state.

A workshop with 12 QI project stakeholders in December 2024 used A3 methodology to define the current process and the target state, barriers and solutions, prioritize interventions on an impact-effort matrix, perform a gap analysis, identify rapid plan-do-study-act (PDSA) experiments, and develop a completion plan (Figure). Five postworkshop PDSA experiments engaged additional stakeholders, clinical application coordinators, and medical supply representatives to ascertain the feasibility of the tools implemented.

eAcute-Care-F1
FIGURE. Process Maps of Current State and Target State
Abbreviations: BCMA, barcode medication administration; CDSS, clinical decision support system; CPRS, Computerized Patient Record System;
EHR, electronic health record; SOP, standard operating procedure; VistA, Veterans Health Information Systems and Technology Architecture.

About 3% of RLRVAMC admissions involve a pharmacy consultation to review medications for dysphagia and/or enteral feeding tubes. Clinicians reviewed 30 preimplementation inpatient pharmacy consultations involving 200 oral medications. Pharmacists were more frequently consulted for inpatients with dysphagia (19 [63%]) than for patients with enteral feeding tubes (11 [37%]) (Table 2).

eAcute-Care-T2
Pharmacy Consultation Template

The pharmacy consultation was updated in CPRS. Prior to this QI project, the ordering clinician was prompted to select 1 option for the indication: dysphagia or enteral feeding tube. The type of enteral feeding tube was not prompted by the consultation text nor required to be specified in the consultation. The ordering clinician could provide free-text comments. Of 11 preimplementation consultations, the type of enteral feeding tube was specified in 5 (45%). The consultation template entry was updated to include an option to check a box for the consultation indication from 3 options: dysphagia, enteral feeding, or other patient- specific condition/request. If enteral feeding tube is selected, then the clinician is prompted to select the type of enteral feeding tube. Since the completion of the project, there have been no patient safety reports concerning an erroneous or incomplete consultation entry (Supplemental Material).

The note template was updated to import the list of active inpatient medications and provide sections for the adjudicating pharmacist to document which medications can be crushed (or opened), which require adjustment, and which are hazardous and require special handling. Additionally, the revised template added a statement clarifying that the documented recommendations apply only to the medication regimen at the time of the consultation (Supplemental Material).

Standardizations

There are multiple pill-crushing devices used at RLRVAMC that vary in crushing mechanism, corresponding medication pouches, and degree of protection when manipulating hazardous medications. Prior to this QI project, RLRVAMC used 3 pill-crushing devices (about 30 total devices in inpatient care areas). Only 1 device with corresponding closed pouches for preparation of hazardous medications was available, which was stored in the RLRVAMC inpatient pharmacy. This workflow resulted in waste and posed potential risks for delays in care. This project incorporated a standard pill-crushing system with the corresponding medication pouches in all inpatient care areas, which provided safeguards for clinicians to prepare and administer hazardous medications (Supplemental Material).

Patients requiring medications to be crushed or opened on discharge should receive education, written instruction, and have care plans documented in CPRS. RLRVAMC patients receive education and a printed medication list. Prior to this QI project, the instructions for crushing or opening medications could only be entered by free text in the electronic medication reconciliation tool, allowing for the potential for inconsistent language or omissions.

This QI project included an update to the electronic medication reconciliation tool. An optional checkbox selection was added for patients requiring medications to be manipulated. When checked, a radial selection for individual medications is displayed, prompting the clinician and pharmacist to indicate either do not crush tablet or OK to crush tablet. These selections appear in clinical care notes and on the printed medication list provided to the patient (Supplemental Material).

Clinical Alerts

As part of the RLRVAMC QI initiative, a CROC alert was implemented, based on the KCVAMC intervention for patients with enteral feeding tubes.13 The RLRVAMC CROC alert also included patients with dysphagia. A nursing text order was made available in CPRS for patients requiring medications and remains active throughout the duration of the patient’s admission or until discontinued. It generates CROC alerts in CPRS and VistA when new medication orders are entered and reviewed by pharmacists.

Clinicians used clinical decision support systems to create daily lists of patients receiving medications by feeding tube and patients receiving crushed/opened medications due to dysphagia. This allows pharmacists to perform a census review of all inpatients to confirm appropriateness of medication orders. Clinical alerts for patients with enteral feeding tubes are advised by the ISMP and have data demonstrating a reduction in medication errors (Supplemental Material).14,15

Sustainment

During the sustainment phase, process owners were identified and a Pharmacy Service standard operating procedure (SOP) was written. The development of an institutional do not crush medication list was discussed; however, it was determined to be difficult to develop and maintain. An institutional tertiary resource list was selected in favor of a locally developed resource. These resources include the Handbook of Drug Administration via Enteral Feeding Tubes, Third Edition, the Pharmacist’s Letter list, “Meds that Should Not be Crushed,” and the Up- ToDate Lexidrug list, “Oral Medications That Should Not Be Crushed or Altered.”9-11 Links to the resources were added to the RLRVAMC pharmacy service SharePoint. In addition to defining the preferred tertiary resources, the SOP defined the process for reviewing inventory and the process for reviewing medication orders for hazard risk.

Discussion

Continued patient safety reports and low satisfaction rates among pharmacists prompted this QI project to improve safety for patients with dysphagia and/or enteral feeding tubes at RLRVAMC. The project engaged stakeholders and also identified and addressed gaps with potential for patient harm.

The tools implemented by this initiative drew from previous work by the KCVAMC and from framework provided by the ISMP.8,13 We expanded the QI intervention to include acute care patients with dysphagia.

RLRVAMC did not take steps to track the impact of the interventions on medication errors. However, no patient safety reports concerning an erroneous or incomplete pharmacy consultation entry have been reported. We also think that it is reasonable to assume that the adoption of the safety tools described here will have a positive impact on patient safety. RLRVAMC pharmacists have noted an increased appreciation for medication safety when processing medication orders for patients with dysphagia and/or enteral feeding tubes. While the workflow took time to adopt and integrate, clinical pharmacists perceived it as an improvement in patient safety. Our future focus is aimed at translating the process improvement into the Oracle/Cerner electronic health record, which is scheduled to be deployed at the RLRVAMC in August 2026.

Limitations

This QI project did not aim to quantify or compare medication errors before and after the intervention. An accurate number of unreported errors in the medication use process for patients with dysphagia and/or enteral feeding tubes would be challenging to quantify without direct observation. Multiple clinicians are engaged in the medication use process and individual steps may not be documented at all, or documented properly. In addition, medication errors are often underreported and may not reflect the total number of errors and/or potential for errors. That said, reported medication errors in the medication use process for patients with dysphagia and/or enteral feeding tubes are reviewed on a monthly basis by the RLRVAMC Multidisciplinary Medication Safety committee to continuously improve patient safety.

Another potential limitation is the extent to which the project can be adapted at other VHA sites. For example, RLRVAMC uses CPRS; the framework and tools to improve medication safety may not translate to sites using the Oracle/Cerner electronic health record. Furthermore, this QI project included a pharmacy consultation workflow that relied on pharmacists who are available at any hour. Other facilities may not have continuous consultation coverage to review medications for patients with dysphagia and/or enteral feeding tubes.

Conclusions

This QI project drew from ISMP recommendations, previous work within the VHA, local practice, and insight from multiple disciplines on the health care team to revise and create tools to improve medication safety for patients with dysphagia and/or enteral feeding tubes in the acute care setting. These tools included a revised pharmacy consultation workflow with improvements to the pharmacy consultation template, standardization of the pill-crushing devices and language used for patient medication lists, implementation of CROC alerts within the EHR, and development of an SOP.

The RLRVAMC Pharmacy Service intends to continue reviewing patient safety reports, assessing staff perspectives, and refining (and potentially adding) tools for medication safety. Future QI initiatives may focus on improving medication safety for outpatients with dysphagia and/or enteral feeding tubes. We also hope that these tools can be adapted at other VAMCs to promote medication safety for patients with dysphagia and/or enteral feeding tubes.

Medication regimens may require adjustment in acute care settings due to dysphagia and/or enteral feeding tubes. When a patient has dysphagia and/or a feeding tube, the health care team must review the pharmacotherapy regimen to assess the appropriateness of medication formulations. Patient anatomy, the type of feeding tube in place, pharmacokinetic and pharmacodynamic properties of medications, risk of feeding tube obstruction, and potential for interactions between enteral nutrition and medications should be considered when clinicians administer medications through feeding tubes. The risk of feeding tube obstruction and clogging rises with increasing tube length and decreasing tube lumen. Incidence of obstructed percutaneous endoscopic gastrotomy tubes is reported to be 23% to 35%.1

A coordinated effort by all members of the health care team is essential to provide safe and effective care to patients with dysphagia and/or enteral feeding tubes. To decrease the risk of feeding tube obstruction, medications should be dissolved in water or administered in liquid form, saline fluids should be avoided, and the tube should be flushed with water before and after administering medications.

The pharmacokinetics of medications can be altered when tablets are crushed or capsules are opened. The bioavailability of dabigatran, for example, increases by 75% when the capsules are opened and pellets are taken orally.2 Medications may become intolerable after manipulation due to taste.3 Others may also increase the risk of feeding tube obstruction, such as omeprazole granules that increase the risk of small-bore feeding tube obstruction.4

Prior assessments of drug administration for patients with dysphagia and/or enteral feeding tubes has shown medication errors are prevalent.5-7 The Institute for Safe Medication Practices (ISMP) issued a Medication Safety Alert that provides a framework for preventing medication errors when preparing and administering medications via enteral feeding tubes.8 Other resources, such as monographs, are also available to guide pharmacotherapy decisions when oral medications require manipulation for administration to patients with dysphagia and/or enteral feeding tubes.9-11

In 2021, the Kansas City Veterans Affairs Medical Center (KCVAMC) was recognized as a Veterans Health Administration (VHA) Shark Tank finalist for improving the safety of medication administration for patients with enteral feeding tubes.12 This involved the addition of a Computerized Patient Record System (CPRS), clinical reminder order check (CROC), and a comprehensive medication review by a pharmacist. After implementing the CROC alert and pharmacy e-consultation workflow, the KCVAMC team reported that the number of inappropriate medications (ie, drugs on the ISMP do not crush list) was reduced from 41 to 6 in 1 year, resulting in an 85.4% reduction in potential medication errors.13

In 2014, the Richard L. Roudebush VAMC (RLRVAMC) created a pharmacy consultation process for patients with dysphagia and/or enteral feeding tubes. Any clinician could place a pharmacy consultation in CPRS. A pharmacist then reviewed patient charts, medication information resources, the VA formulary, and RLRVAMC pharmacy inventory. The pharmacist conferred with the patient’s care team to adjust pharmacotherapy, completed a consultation note, and updated medication order comments in Veterans Health Information Systems and Technology Architecture (VistA). These comments interfaced with the barcode medication administration software for the health care professional administering medications.

Despite the 2014 quality improvement (QI) process, medication errors involving the inappropriate ordering, preparation, and administration of medications for patients with dysphagia and/or enteral feeding tubes continued to be reported. Additionally, anonymous feedback revealed that only 3 of 10 responding pharmacists were satisfied with the existing medication use process for patients with dysphagia and/or enteral feeding tubes. Pharmacists expressed concerns that (1) clinicians were inappropriately crushing and/or manipulating new medications that were ordered after pharmacy consultations; (2) there was a lack of comprehensive documentation in CPRS; and (3) there were too many manual steps in the process. In response, RLRVAMC initiated a new QI initiative to improve the medication use process for patients with dysphagia and/or enteral feeding tubes in the acute care setting.

Quality Improvement Project

This multidisciplinary RLRVAMC QI project began November 2024 to improve pharmacotherapy care for patients with dysphagia and/or enteral feeding tubes in acute care. It was approved by the RLRVAMC Pharmacy Service. This intervention addressed the pharmacy consultation template, standardization of equipment, standardization of language, creation of clinical alerts, and sustainment (Table 1).

eAcute-Care-T1

RLRVAMC has about 8600 annual inpatient admissions and 159 acute care beds.14 The project charter was drafted, and local stakeholders were identified including pharmacy technicians, pharmacists, nurses, speech language pathologists, and acute care clinicians. Pharmacy consultation workload was retrospectively reviewed to describe the scope of the existing state.

A workshop with 12 QI project stakeholders in December 2024 used A3 methodology to define the current process and the target state, barriers and solutions, prioritize interventions on an impact-effort matrix, perform a gap analysis, identify rapid plan-do-study-act (PDSA) experiments, and develop a completion plan (Figure). Five postworkshop PDSA experiments engaged additional stakeholders, clinical application coordinators, and medical supply representatives to ascertain the feasibility of the tools implemented.

eAcute-Care-F1
FIGURE. Process Maps of Current State and Target State
Abbreviations: BCMA, barcode medication administration; CDSS, clinical decision support system; CPRS, Computerized Patient Record System;
EHR, electronic health record; SOP, standard operating procedure; VistA, Veterans Health Information Systems and Technology Architecture.

About 3% of RLRVAMC admissions involve a pharmacy consultation to review medications for dysphagia and/or enteral feeding tubes. Clinicians reviewed 30 preimplementation inpatient pharmacy consultations involving 200 oral medications. Pharmacists were more frequently consulted for inpatients with dysphagia (19 [63%]) than for patients with enteral feeding tubes (11 [37%]) (Table 2).

eAcute-Care-T2
Pharmacy Consultation Template

The pharmacy consultation was updated in CPRS. Prior to this QI project, the ordering clinician was prompted to select 1 option for the indication: dysphagia or enteral feeding tube. The type of enteral feeding tube was not prompted by the consultation text nor required to be specified in the consultation. The ordering clinician could provide free-text comments. Of 11 preimplementation consultations, the type of enteral feeding tube was specified in 5 (45%). The consultation template entry was updated to include an option to check a box for the consultation indication from 3 options: dysphagia, enteral feeding, or other patient- specific condition/request. If enteral feeding tube is selected, then the clinician is prompted to select the type of enteral feeding tube. Since the completion of the project, there have been no patient safety reports concerning an erroneous or incomplete consultation entry (Supplemental Material).

The note template was updated to import the list of active inpatient medications and provide sections for the adjudicating pharmacist to document which medications can be crushed (or opened), which require adjustment, and which are hazardous and require special handling. Additionally, the revised template added a statement clarifying that the documented recommendations apply only to the medication regimen at the time of the consultation (Supplemental Material).

Standardizations

There are multiple pill-crushing devices used at RLRVAMC that vary in crushing mechanism, corresponding medication pouches, and degree of protection when manipulating hazardous medications. Prior to this QI project, RLRVAMC used 3 pill-crushing devices (about 30 total devices in inpatient care areas). Only 1 device with corresponding closed pouches for preparation of hazardous medications was available, which was stored in the RLRVAMC inpatient pharmacy. This workflow resulted in waste and posed potential risks for delays in care. This project incorporated a standard pill-crushing system with the corresponding medication pouches in all inpatient care areas, which provided safeguards for clinicians to prepare and administer hazardous medications (Supplemental Material).

Patients requiring medications to be crushed or opened on discharge should receive education, written instruction, and have care plans documented in CPRS. RLRVAMC patients receive education and a printed medication list. Prior to this QI project, the instructions for crushing or opening medications could only be entered by free text in the electronic medication reconciliation tool, allowing for the potential for inconsistent language or omissions.

This QI project included an update to the electronic medication reconciliation tool. An optional checkbox selection was added for patients requiring medications to be manipulated. When checked, a radial selection for individual medications is displayed, prompting the clinician and pharmacist to indicate either do not crush tablet or OK to crush tablet. These selections appear in clinical care notes and on the printed medication list provided to the patient (Supplemental Material).

Clinical Alerts

As part of the RLRVAMC QI initiative, a CROC alert was implemented, based on the KCVAMC intervention for patients with enteral feeding tubes.13 The RLRVAMC CROC alert also included patients with dysphagia. A nursing text order was made available in CPRS for patients requiring medications and remains active throughout the duration of the patient’s admission or until discontinued. It generates CROC alerts in CPRS and VistA when new medication orders are entered and reviewed by pharmacists.

Clinicians used clinical decision support systems to create daily lists of patients receiving medications by feeding tube and patients receiving crushed/opened medications due to dysphagia. This allows pharmacists to perform a census review of all inpatients to confirm appropriateness of medication orders. Clinical alerts for patients with enteral feeding tubes are advised by the ISMP and have data demonstrating a reduction in medication errors (Supplemental Material).14,15

Sustainment

During the sustainment phase, process owners were identified and a Pharmacy Service standard operating procedure (SOP) was written. The development of an institutional do not crush medication list was discussed; however, it was determined to be difficult to develop and maintain. An institutional tertiary resource list was selected in favor of a locally developed resource. These resources include the Handbook of Drug Administration via Enteral Feeding Tubes, Third Edition, the Pharmacist’s Letter list, “Meds that Should Not be Crushed,” and the Up- ToDate Lexidrug list, “Oral Medications That Should Not Be Crushed or Altered.”9-11 Links to the resources were added to the RLRVAMC pharmacy service SharePoint. In addition to defining the preferred tertiary resources, the SOP defined the process for reviewing inventory and the process for reviewing medication orders for hazard risk.

Discussion

Continued patient safety reports and low satisfaction rates among pharmacists prompted this QI project to improve safety for patients with dysphagia and/or enteral feeding tubes at RLRVAMC. The project engaged stakeholders and also identified and addressed gaps with potential for patient harm.

The tools implemented by this initiative drew from previous work by the KCVAMC and from framework provided by the ISMP.8,13 We expanded the QI intervention to include acute care patients with dysphagia.

RLRVAMC did not take steps to track the impact of the interventions on medication errors. However, no patient safety reports concerning an erroneous or incomplete pharmacy consultation entry have been reported. We also think that it is reasonable to assume that the adoption of the safety tools described here will have a positive impact on patient safety. RLRVAMC pharmacists have noted an increased appreciation for medication safety when processing medication orders for patients with dysphagia and/or enteral feeding tubes. While the workflow took time to adopt and integrate, clinical pharmacists perceived it as an improvement in patient safety. Our future focus is aimed at translating the process improvement into the Oracle/Cerner electronic health record, which is scheduled to be deployed at the RLRVAMC in August 2026.

Limitations

This QI project did not aim to quantify or compare medication errors before and after the intervention. An accurate number of unreported errors in the medication use process for patients with dysphagia and/or enteral feeding tubes would be challenging to quantify without direct observation. Multiple clinicians are engaged in the medication use process and individual steps may not be documented at all, or documented properly. In addition, medication errors are often underreported and may not reflect the total number of errors and/or potential for errors. That said, reported medication errors in the medication use process for patients with dysphagia and/or enteral feeding tubes are reviewed on a monthly basis by the RLRVAMC Multidisciplinary Medication Safety committee to continuously improve patient safety.

Another potential limitation is the extent to which the project can be adapted at other VHA sites. For example, RLRVAMC uses CPRS; the framework and tools to improve medication safety may not translate to sites using the Oracle/Cerner electronic health record. Furthermore, this QI project included a pharmacy consultation workflow that relied on pharmacists who are available at any hour. Other facilities may not have continuous consultation coverage to review medications for patients with dysphagia and/or enteral feeding tubes.

Conclusions

This QI project drew from ISMP recommendations, previous work within the VHA, local practice, and insight from multiple disciplines on the health care team to revise and create tools to improve medication safety for patients with dysphagia and/or enteral feeding tubes in the acute care setting. These tools included a revised pharmacy consultation workflow with improvements to the pharmacy consultation template, standardization of the pill-crushing devices and language used for patient medication lists, implementation of CROC alerts within the EHR, and development of an SOP.

The RLRVAMC Pharmacy Service intends to continue reviewing patient safety reports, assessing staff perspectives, and refining (and potentially adding) tools for medication safety. Future QI initiatives may focus on improving medication safety for outpatients with dysphagia and/or enteral feeding tubes. We also hope that these tools can be adapted at other VAMCs to promote medication safety for patients with dysphagia and/or enteral feeding tubes.

References
  1. Blumenstein I, Shastri YM, Stein J. Gastroenteric tube feeding: techniques, problems and solutions. World J Gastroenterol. 2014;20:8505-8524. doi:10.3748/wjg.v20.i26.8505
  2. Pradaxa (dabigatran etexilate). Prescribing information. Boehringer Ingelheim Pharmaceuticals, Inc; 2025. https:// pro.boehringer-ingelheim.com/us/products/pradaxa/bipdf /pradaxa-capsules-us-pi
  3. Lovell AG, Protus BM, Dickman JR, et al. Palatability of crushed over-the-counter medications. J Pain Symptom Manage. 2021;61:755-762. doi:10.1016/j.jpainsymman.2020.09.020
  4. Messaouik D, Sautou-Miranda V, Bagel-Boithias S, et al. Comparative study and optimisation of the administration mode of three proton pump inhibitors by nasogastric tube. Int J Pharm. 2005;299:65-72. doi:10.1016/j.ijpharm.2005.04.034
  5. Demirkan K, Bayraktar-Ekincioglu A, Gulhan-Halil M, et al. Assessment of drug administration via feeding tube and the knowledge of health-care professionals in a university hospital. Eur J Clin Nutr. 2017;71:164-168. doi:10.1038/ejcn.2016.147
  6. Fodil M, Nghiem D, Colas M, et al. Assessment of clinical practices for crushing medication in geriatric units. J Nutr Health Aging. 2017;21:904-908. doi:10.1007/s12603-017-0886-3
  7. Zhu LL, Xu LC, Wang HQ, et al. Appropriateness of administration of nasogastric medication and preliminary intervention. Ther Clin Risk Manag. 2012;8:393-401. doi:10.2147/TCRM.S37785
  8. Institute for Safe Medication Practices (ISMP). Preventing errors when preparing and administering medications via enteral feeding tubes. Acute Care ISMP Medication Safety Alert. November 17, 2022. Accessed March 17, 2026. https://nutritioncare.org/wp-content/uploads/2025/02 /ISMP-Safety-Alert_Medications-and-Enteral-Feeding -Tubes.pdf
  9. White R, Bradnam V. Handbook of Drug Administration via Enteral Feeding Tubes. 3rd ed. Pharmaceutical Press; 2015.
  10. Clinical resource, meds that should not be crushed. Pharmacist’s Letter/Pharmacy Technician’s Letter/Prescriber Insights. Updated April 2025. Accessed March 17, 2026. https://pharmacist.therapeuticresearch.com/en/Content /Segments/PRL/2014/Aug/Meds-That-Should-Not-Be -Crushed-7309
  11. Oral medications that should not be crushed or altered. In: Lexidrug. UpToDate, Inc. https://online.lexi.com/lco /action/doc/retrieve/docid/patch_f/4227
  12. Uttaro E, Zhao F, Schweighardt A. Filling the gaps on the Institute for Safe Medication Practices (ISMP) do not crush list for immediate-release products. Int J Pharm Compd. 2021;25:364-371.
  13. US Dept of Veterans Affairs. VA Diffusion Marketplace. Improved safety of enteral tube medication administration. Updated 2024. Accessed March 17, 2026. https:// marketplace.va.gov/innovations/improved-safety-of -enteral-tube-medication-administration
  14. US Dept of Veterans Affairs. About us. VA Indiana Healthcare System. Updated October 17, 2024. Accessed March 2, 2026. https://www.va.gov/indiana-health-care/about-us/
  15. Wasylewicz ATM, van Grinsven RJB, Bikker JMW, et al. Clinical decision support system-assisted pharmacy intervention reduces feeding tube-related medication errors in hospitalized patients: a focus on medication suitable for feeding-tube administration. JPEN J Parenter Enteral Nutr. 2021;45:625-632. doi:10.1002/jpen.1869
References
  1. Blumenstein I, Shastri YM, Stein J. Gastroenteric tube feeding: techniques, problems and solutions. World J Gastroenterol. 2014;20:8505-8524. doi:10.3748/wjg.v20.i26.8505
  2. Pradaxa (dabigatran etexilate). Prescribing information. Boehringer Ingelheim Pharmaceuticals, Inc; 2025. https:// pro.boehringer-ingelheim.com/us/products/pradaxa/bipdf /pradaxa-capsules-us-pi
  3. Lovell AG, Protus BM, Dickman JR, et al. Palatability of crushed over-the-counter medications. J Pain Symptom Manage. 2021;61:755-762. doi:10.1016/j.jpainsymman.2020.09.020
  4. Messaouik D, Sautou-Miranda V, Bagel-Boithias S, et al. Comparative study and optimisation of the administration mode of three proton pump inhibitors by nasogastric tube. Int J Pharm. 2005;299:65-72. doi:10.1016/j.ijpharm.2005.04.034
  5. Demirkan K, Bayraktar-Ekincioglu A, Gulhan-Halil M, et al. Assessment of drug administration via feeding tube and the knowledge of health-care professionals in a university hospital. Eur J Clin Nutr. 2017;71:164-168. doi:10.1038/ejcn.2016.147
  6. Fodil M, Nghiem D, Colas M, et al. Assessment of clinical practices for crushing medication in geriatric units. J Nutr Health Aging. 2017;21:904-908. doi:10.1007/s12603-017-0886-3
  7. Zhu LL, Xu LC, Wang HQ, et al. Appropriateness of administration of nasogastric medication and preliminary intervention. Ther Clin Risk Manag. 2012;8:393-401. doi:10.2147/TCRM.S37785
  8. Institute for Safe Medication Practices (ISMP). Preventing errors when preparing and administering medications via enteral feeding tubes. Acute Care ISMP Medication Safety Alert. November 17, 2022. Accessed March 17, 2026. https://nutritioncare.org/wp-content/uploads/2025/02 /ISMP-Safety-Alert_Medications-and-Enteral-Feeding -Tubes.pdf
  9. White R, Bradnam V. Handbook of Drug Administration via Enteral Feeding Tubes. 3rd ed. Pharmaceutical Press; 2015.
  10. Clinical resource, meds that should not be crushed. Pharmacist’s Letter/Pharmacy Technician’s Letter/Prescriber Insights. Updated April 2025. Accessed March 17, 2026. https://pharmacist.therapeuticresearch.com/en/Content /Segments/PRL/2014/Aug/Meds-That-Should-Not-Be -Crushed-7309
  11. Oral medications that should not be crushed or altered. In: Lexidrug. UpToDate, Inc. https://online.lexi.com/lco /action/doc/retrieve/docid/patch_f/4227
  12. Uttaro E, Zhao F, Schweighardt A. Filling the gaps on the Institute for Safe Medication Practices (ISMP) do not crush list for immediate-release products. Int J Pharm Compd. 2021;25:364-371.
  13. US Dept of Veterans Affairs. VA Diffusion Marketplace. Improved safety of enteral tube medication administration. Updated 2024. Accessed March 17, 2026. https:// marketplace.va.gov/innovations/improved-safety-of -enteral-tube-medication-administration
  14. US Dept of Veterans Affairs. About us. VA Indiana Healthcare System. Updated October 17, 2024. Accessed March 2, 2026. https://www.va.gov/indiana-health-care/about-us/
  15. Wasylewicz ATM, van Grinsven RJB, Bikker JMW, et al. Clinical decision support system-assisted pharmacy intervention reduces feeding tube-related medication errors in hospitalized patients: a focus on medication suitable for feeding-tube administration. JPEN J Parenter Enteral Nutr. 2021;45:625-632. doi:10.1002/jpen.1869
Issue
Federal Practitioner - 43(5)
Issue
Federal Practitioner - 43(5)
Page Number
1-7
Page Number
1-7
Publications
Publications
Topics
Article Type
Display Headline

Streamlining the Acute Care Pharmacy Consultation Process for Patients With Dysphagia or Enteral Feeding Tubes

Display Headline

Streamlining the Acute Care Pharmacy Consultation Process for Patients With Dysphagia or Enteral Feeding Tubes

Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
survey writer start date

Total Brain Diagnostics: Advancing Precision Brain and Mental Health at the Department of Veterans Affairs

Article Type
Changed
Display Headline

Total Brain Diagnostics: Advancing Precision Brain and Mental Health at the Department of Veterans Affairs

In leveraging existing, readily available evidence-based health care information (eg, systematic reviews, clinical practice guidelines), clinicians have historically made recommendations based on treatment responses of the average patient.1 Recently, this approach has been expanded into data-driven, evidence-based precision medical care for individuals across a wide range of disciplines and care settings. These precision medicine approaches use information related to an individual’s genes, environment, and lifestyle to tailor recommendations regarding prevention, diagnosis, and treatment.

Applying precision medicine approaches to the unique exposures and experiences of service members and veterans—particularly those who served in combat environments—through the incorporation of biopsychosocial factors into medical decision-making may be even more pertinent. This sentiment is reflected in Section 305 of the Commander John Scott Hannon Veterans Mental Health Care Improvement Act of 2019, which outlines the Precision Medicine Initiative of the US Department of Veterans Affairs (VA) to identify and validate brain and mental health biomarkers.2 Despite widespread consensus regarding the promise of precision medicine, large, rich datasets with elements pertaining to common military exposures such as traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) are limited.

Existing datasets, most of which are relatively small or focus on specific cohorts (eg, older veterans, transitioning veterans), continue to create barriers to advancing precision medicine. For example, in classically designed clinical trials, analyses are generally conducted in a manner that may obfuscate efficacy among subcohorts of individuals, thereby underscoring the need to explore alternative strategies to unify existing datasets capable of revealing such heterogeneity.3 The evidence base for precision medical care is limited, drawing from published trials with relatively small sample sizes and even larger cohort studies have limited biomarker data. Additionally, these models are often exploratory during development, and to avoid statistical overfitting of an exploratory model, validation in similar datasets is needed—an added burden when data sources are small or underpowered to begin with.

A promising approach is to combine and harmonize the largest, most deeply characterized data sources from similar samples. Although combining such datasets may appear to require minimal time and effort, harmonizing similar variables in an evidence-based and replicable manner requires time and expertise, even when participant characteristics and outcomes are similar.4-7

Challenges related to harmonization are related to the wide range of strategies (eg, self-report questionnaires, clinical interviews, electronic health record review) used to measure common brain and mental health constructs, such as depression. Even when similar methods (eg, self-report measures) are implemented, challenges persist. For example, if a study used a depression measure that focused primarily on cognitive symptoms (eg, pessimism, self-dislike, suicidal ideation) and another study used a depression measure composed of items more heavily weighted towards somatic symptoms (eg, insomnia, loss of appetite, weight loss, decreased libido), combining their data could be challenging, particularly if researchers, clinicians, or administrators are interested in more than dichotomous outcomes (eg, depression vs no depression).8,9

To address this knowledge gap and harmonize multimodal data from varied sources, well-planned and reproducible curation is needed. Longitudinal cohort studies of service members and veterans with military combat and training exposure histories provide researchers and other stakeholders access to extant biopsychosocial data shown to affect risk for adverse health outcomes; however, efforts to facilitate individually tailored treatment or other precision medicine approaches would benefit from the synthesis of such datasets.10

Members of the VA Total Brain Diagnostics (TBD) team are engaged in harmonizing variables from the Long-Term Impact of Military-Relevant Brain Injury Consortium–Chronic Effects of Neurotrauma Consortium (LIMBIC-CENC)11 and the Translational Research Center for TBI and Stress Disorders (TRACTS).12-21 While there is overlap across LIMBIC-CENC and TRACTS with respect to data domains, considerable data harmonization is needed to allow for future valid and meaningful analyses, particularly those involving multivariable predictors.

Data Sources

Both data sources for the TBD harmonization project, LIMBIC-CENC and TRACTS, include extensive, longitudinal data collected from relatively large cohorts of veterans and service members with combat exposure. Both studies collect detailed data related to potential brain injury history and include participants with and without a history of TBI. Similarly, both include extensive collection of fluid biomarkers and imaging data, as well as measures of biopsychosocial functioning.

Data collection sites for LIMBIC-CENC include 16 recruitment sites, 9 at VA medical centers (Richmond, Houston, Tampa, San Antonio, Portland, Minneapolis, Boston, Salisbury, San Diego) and 7 at military treatment sites (Alexandria, San Diego, Tampa, Tacoma, Columbia, Coronado, Hinesville), in addition to 11 assessment sites (Richmond, Houston, Tampa, San Antonio, Portland, Minneapolis, Boston, Salisbury, San Diego, Alexandria, Augusta). Data for TRACTS are collected at sites in Boston and Houston.

LIMBIC-CENC is a 12-year, 17-site cohort of service members and veteran participants with combat exposure who are well characterized at baseline and undergo annual reassessments. As of December 2025, > 3100 participants have been recruited, and nearly 90% remain in follow-up. Data collection includes > 6200 annual follow-up evaluations and > 1550 5-year re-evaluations, with 400 enrolled participants followed up annually.

TRACTS is a 16-year, 2-site cohort of veterans with combat exposure who complete comprehensive assessments at enrollment, undergo annual reassessments, and complete comprehensive reassessment every 5 years thereafter. As of December 2025, > 1075 participants have completed baseline (Time 1) assessments, > 600 have completed the 2-year re-evaluation (Time 2), > 175 have completed the 5-year re-evaluation (Time 3), and > 35 have completed 10-year evaluations (Time 4), with about 50 new participants added and 100 enrolled participants followed up annually. More data on participant characteristics are available for both LIMBIC-CENC and TRACTS in previous publications.11,22These 2 ongoing, prospective, longitudinal cohorts of service members and veterans offer access to a wide range of potential risk factors that can affect response to care and outcomes, including demographics (eg, age, sex), injury characteristics (eg, pre-exposure factors, exposure factors), biomarkers (eg, serum, saliva, brain imaging, evoked potentials), and functional measures (eg, computerized posturography, computerized eye tracking, sensory testing, clinical examination, neuropsychological assessments, symptom questionnaires).

Harmonization Strategy

Pooling and harmonizing data from large studies evaluating similar participant cohorts and conditions involves numerous steps to appropriately handle a variety of measurements and disparate variable names. The TBD team adapted a model data harmonization system developed by O’Neil et al through initial work harmonizing the Federal Interagency Traumatic Brain Injury Research Informatics System (FITBIR).4-7 This process was expanded and generalized by the research team to combine data from LIMBIC-CENC and TRACTS to create a single pooled dataset for analysis (Figure).

FDP04302056_F1
FIGURE. Data pooling and harmonization system for the Federal Interagency Traumatic Brain
Injury Research database.

This approach was selected because it accommodates heterogeneous study designs (eg, cross-sectional, longitudinal, case-control), data collection methods (eg, clinical assessment, self-reported, objective blood, and imaging biomarkers), and various assessments of the same construct (ie, different measures of brain injury). While exact matches for data collection methods and measures may be easily harmonized, the timing of assessment, number of assessments, assessment tool version, and other factors must be considered. The goal was to harmonize data from LIMBIC-CENC and TRACTS to allow additional data sources to be harmonized and incorporated in the future.

Original data files from each study were reshaped to represent participant-level observations with 1 unique measurement per row. The measurement represents what information was collected and the value recorded represents the unique observation. These data are linked to metadata from the original study, which includes the study’s definition of each measurement, how it was collected, and any available information regarding when it was collected in reference to study enrollment or injury. Additional information on the file source, row, and column position of each data point was added to enable recreation of the original data as needed.

The resulting dataset was used to harmonize measurements from LIMBIC-CENC and TRACTS into a priori-defined schemas for brain- and mental health-relevant concepts, including TBI severity, PTSD, substance use, depression, suicidal ideation, and functioning (including cognitive, physical, and social functioning). This process was facilitated using natural language processing (NLP). Each study uniquely defines all measurements and provides written definitions with the data. Measurement definitions serve as records describing what was collected, how it was collected, and how the study may have uniquely defined information for its purposes. For example, definitions of exposure to brain injury and severity of brain injury may differ between studies, and the study-provided definition defines these differences.

Definitions were converted into numeric vectors through sentence embedding, a process that preserves the semantic meaning of the definition.23 Cosine similarity was used as the primary metric to compare the semantic textual similarity between pairs of measurement definitions. Cosine similarity ranges from 0 to 1, where 0 indicates no meaningful similarity and 1 indicates they have identical meanings.24 This approach leverages the relationship between the definitions of each measurement provided by a study and enables quick comparison of all pairwise combinations of measurement definitions between studies.

Subsets of similar measurements across studies were organized into a priori-defined schema. Clinical experts then reviewed each schema and further refined them into domains, (eg, mechanism of injury, clinical signs, acute symptoms) and subdomains (children), such as loss of consciousness, amnesia, and alteration of consciousness. This approach allows efficient handling of 2 specific cases that commonly occur when pooling and harmonizing datasets: (1) identifying the same measurement with differing names; and (2) identifying different measurements with definitions that each relate to the same domain.

The Table provides a general example of the schema for TBI severity. This was an iterative process in which clinical experts reviewed study-defined measurement definitions to develop general harmonized domains, and NLP techniques facilitated and accelerated identification and organization of measurements within these domains.

FDP04302056_T1

Expected Impact

Harmonization combining LIMBIC-CENC and TRACTS datasets is ongoing. Preliminary descriptive analyses of baseline cohort data indicate that harmonization across data sources is appropriate, given the lack of significant heterogeneity across sites and studies for most domains. Work by members of the TBD team is expected to lay the foundation for the use of existing and ongoing prospective, longitudinal datasets (eg, LIMBIC-CENC, TRACTS) and linked large datasets (eg, VA Informatics and Computing Infrastructure including electronic health records, VA Million Veteran Program, DaVINCI [US Department of Defense and VA Infrastructure for Clinical Intelligence]) to generate generalizable, clinically relevant information to advance precision brain and mental health care among service members and veterans.

By enhancing existing practice, this synthesized dataset has the potential to inform tailored and personalized medicine approaches designed to meet the needs of veterans and service members. These data will serve as the starting point for multivariable models examining the intersection of physiologic, behavioral, and environmental factors. The goal of this data harmonization effort is to better elucidate how clinicians and researchers can select optimal approaches for veterans and service members with TBI histories by accounting for a comprehensive set of physiologic, behavioral, and environmental factors in an individually tailored manner. These data may further extend existing clinical practice guideline approaches, inform shared decision-making, and enhance functional outcomes beyond those currently available.

Conclusions

Individuals who have served in the military have unique biopsychosocial exposures that are associated with brain and mental health disorders. To address these needs, the nationwide TBD team has initiated the creation of a unified, longitudinal dataset that includes harmonized measures from existing LIMBIC-CENC and TRACTS protocols. Initial data harmonization efforts are required to facilitate precision prognostics, diagnostics, and tailored interventions, with the goal of improving veterans’ brain and mental health and psychosocial functioning and enabling tailored and evidence-informed, individualized clinical care.

References
  1. The Promise of Precision Medicine. National Institutes of Health (NIH). Updated January 21, 2025. Accessed January 5, 2026. https://www.nih.gov/about-nih/nih-turning-discovery-into-health/promise-precision-medicine.
  2. Commander John Scott Hannon Veterans Mental Health Care Improvement Act of 2019, S 785, 116th Cong (2019-2020) Accessed January 5, 2026. https://www.congress.gov/bill/116th-congress/senate-bill/785
  3. Cheng C, Messerschmidt L, Bravo I, et al. A general primer for data harmonization. Sci Data. 2024;11:152. doi:10.1038/s41597-024-02956-3
  4. Neil M, Cameron D, Clauss K, et al. A proof-of-concept study demonstrating how FITBIR datasets can be harmonized to examine posttraumatic stress disorder-traumatic brain injury associations. J Behav Data Sci. 2024;4:45-62. doi:10.35566/jbds/oneil
  5. O’Neil ME, Cameron D, Krushnic D, et al. Using harmonized FITBIR datasets to examine associations between TBI history and cognitive functioning. Appl Neuropsychol Adult. doi:10.1080/23279095.2024.2401974
  6. O’Neil ME, Krushnic D, Clauss K, et al. Harmonizing federal interagency traumatic brain injury research data to examine depression and suicide-related outcomes. Rehabil Psychol. 2024;69:159-170. doi:10.1037/rep0000547
  7. O’Neil ME, Krushnic D, Walker WC, et al. Increased risk for clinically significant sleep disturbances in mild traumatic brain injury: an approach to leveraging the federal interagency traumatic brain injury research database. Brain Sci. 2024;14:921. doi:10.3390/brainsci14090921
  8. Uher R, Perlis RH, Placentino A, et al. Self-report and clinician-rated measures of depression severity: can one replace the other? Depress Anxiety. 2012;29:1043-1049. doi:10.1002/da.21993
  9. Hung CI, Weng LJ, Su YJ, et al. Depression and somatic symptoms scale: a new scale with both depression and somatic symptoms emphasized. Psychiatry Clin Neurosci. 2006;60:700-708. doi:10.1111/j.1440-1819.2006.01585.x
  10. Stewart IJ, Howard JT, Amuan ME, et al. Traumatic brain injury is associated with the subsequent risk of atrial fibrillation or atrial flutter. Heart Rhythm. 2025;22:661-667. doi:10.1016/j.hrthm.2024.09.019
  11. Cifu DX. Clinical research findings from the long-term impact of military-relevant brain injury consortium-chronic effects of neurotrauma consortium (LIMBIC-CENC) 2013-2021. Brain Inj. 2022;36:587-597.doi:10.1080/02699052.2022.2033843
  12. Fonda JR, Fredman L, Brogly SB, et al. Traumatic brain injury and attempted suicide among veterans of the wars in Iraq and Afghanistan. Am J Epidemiol. 2017;186:220-226. doi:10.1093/aje/kwx044
  13. Fortier CB, Amick MM, Kenna A, et al. Correspondence of the Boston Assessment of Traumatic Brain Injury-Lifetime (BAT-L) clinical interview and the VA TBI screen. J Head Trauma Rehabil. 2015;30:E1-7. doi:10.1097/htr.0000000000000008
  14. Grande LJ, Robinson ME, Radigan LJ, et al. Verbal memory deficits in OEF/OIF/OND veterans exposed to blasts at close range. J Int Neuropsychol Soc. 2018;24:466-475. doi:10.1017/S1355617717001242
  15. Hayes JP, Logue MW, Sadeh N, et al. Mild traumatic brain injury is associated with reduced cortical thickness in those at risk for Alzheimer’s disease. Brain. 2017;140:813-825. doi:10.1093/brain/aww344
  16. Lippa SM, Fonda JR, Fortier CB, et al. Deployment-related psychiatric and behavioral conditions and their association with functional disability in OEF/OIF/OND veterans. J Trauma Stress. 2015;28:25-33. doi:10.1002/jts.21979
  17. McGlinchey RE, Milberg WP, Fonda JR, et al. A methodology for assessing deployment trauma and its consequences in OEF/OIF/OND veterans: the TRACTS longitudinal prospective cohort study. Int J Methods Psychiatr Res. 2017;26:e1556. doi:10.1002/mpr.1556
  18. Radigan LJ, McGlinchey RE, Milberg WP, et al. Correspondence of the Boston Assessment of Traumatic Brain Injury-Lifetime and the VA Comprehensive TBI Evaluation. J Head Trauma Rehabil. 2018;33:E51-E55. doi:10.1097/htr.0000000000000361
  19. Sydnor VJ, Bouix S, Pasternak O, et al. Mild traumatic brain injury impacts associations between limbic system microstructure and post-traumatic stress disorder symptomatology. Neuroimage Clin. 2020;26:102190. doi:10.1016/j.nicl.2020.102190
  20. Van Etten EJ, Knight AR, Colaizzi TA, et al. Peritraumatic context and long-term outcomes of concussion. JAMA Netw Open. 2025;8:e2455622. doi:10.1001/jamanetworkopen.2024.55622
  21. Andrews RJ, Fonda JR, Levin LK, et al. Comprehensive analysis of the predictors of neurobehavioral symptom reporting in veterans. Neurology. 2018;91:e732-e745. doi:10.1212/wnl.0000000000006034
  22. McGlinchey RE, Milberg WP, Fonda JR, Fortier CB. A methodology for assessing deployment trauma and its consequences in OEF/OIF/OND veterans: the TRACTS longitudional prospective cohort study. Int J Methods Psychiatr Res. 2017;26:e1556. doi:10.1002/mpr.1556
  23. Reimers N, Gurevych I. Sentence-BERT: Sentence embeddings using Siamese BERT-Networks. 2019. Conference on Empirical Methods in Natural Language Processing.
  24. Singhal A. Modern information retrieval: a brief overview. IEEE Data Eng Bull. 2001;24:34-43.
Article PDF
Author and Disclosure Information

Maya O’Neil, PhDa,b; David Cameron, MPHa,b; David X. Cifu, MDc,d; Molly Sullan, PhDe,f; Kate Clauss, PhDa,b; William P. Milberg, PhDg,h; Catherine B. Fortier, PhDg,h; Elisabeth A. Wilde, PhDi,j; Ryan Holliday, PhD, OTR/Le,f,k; Adam Kinney, PhD, OTR/Le,f; Lisa A. Brenner, PhDe,f

Author affiliations
aVeterans Affairs Portland Health Care System, Oregon
bOregon Health & Science University, Portland
cCentral Virginia Veteran Healthcare System, Richmond
dVirginia Commonwealth University, Richmond
eVeterans Affairs Rocky Mountain Regional Medical Center, Aurora, Colorado
fUniversity of Colorado, Aurora
gVeterans Affairs Boston Healthcare System, Massachusetts
hHarvard Medical School, Boston, Massachusetts
iVeterans Affairs Salt Lake City Healthcare System, Utah
jUniversity of Utah, Salt Lake City
kVeterans Affairs Pacific Island Health Care System, Honolulu, Hawaii

Author disclosures Maya O’Neil, Catherine Fortier, and William Milberg report grants from the US Department of Veterans Affairs (VA) and US Department of Defense (DoD). Lisa Brenner reports grants from the VA, DoD, National Institutes of Health (NIH), Face the Fight, and the State of Colorado, editorial remuneration from Wolters Kluwer and the RAND Corporation, and royalties from the American Psychological Association (APA) and Oxford University Press. David Cifu reports grants from the VA, DoD, NIH, and the National Institute on Disability, Independent Living, and Rehabilitation Research Agency, and royalties from Elsevier. Ryan Holliday reports grants from VA, DoD, and the State of Colorado. Elisabeth Wilde reports grants from the VA, DoD, and NIH and editorial remuneration from APA. Adam Kinney reports grants from the VA, State of Colorado, and American Occupational Therapy Foundation.

Disclaimer The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies.

Ethics and consent This research was reviewed by the Institutional Review Board and approved as a science only project by the Research and Development committee at Portland Veterans Affairs Health Care System.

Funding This project was funded by US Department of Veterans Affairs (VA) Rehabilitation Research and Development (RR&D) Grant (No. RX004911) to Maya O’Neil, Lisa Brenner, David Cifu, and Elisabeth Wilde. It was also supported by the Translational Research Center for TBI and Stress Disorders, a VA RR&D National Research Center for Traumatic Brain Injury (B3001-C), Psychological Health/Traumatic Brain Injury Research Program Long-Term Impact of Military-Relevant Brain Injury Consortium (LIMBIC) Award/W81XWH-18-PH/TBIRP-LIMBIC under Awards No. W81XWH1920067 and W81XWH-13-2-0095, and by the U.S. Department of Veterans Affairs Awards No. I01 CX002097, I01 CX002096, I01 HX003155, I01 RX003444, I01 RX003443, I01 RX003442, I01 CX001135, I01 CX001246, I01 RX001774, I01 RX 001135, I01 RX 002076, I01 RX 001880, I01 RX 002172, I01 RX 002173, I01 RX 002171, I01 RX 002174, and I01 RX 002170.

Correspondence: Maya O’Neil (maya.oneil@va.gov)

Fed Pract. 2026;43(2). Published online February 16. doi:10.12788/fp.0676

Issue
Federal Practitioner - 43(2)
Publications
Topics
Page Number
56-61
Sections
Author and Disclosure Information

Maya O’Neil, PhDa,b; David Cameron, MPHa,b; David X. Cifu, MDc,d; Molly Sullan, PhDe,f; Kate Clauss, PhDa,b; William P. Milberg, PhDg,h; Catherine B. Fortier, PhDg,h; Elisabeth A. Wilde, PhDi,j; Ryan Holliday, PhD, OTR/Le,f,k; Adam Kinney, PhD, OTR/Le,f; Lisa A. Brenner, PhDe,f

Author affiliations
aVeterans Affairs Portland Health Care System, Oregon
bOregon Health & Science University, Portland
cCentral Virginia Veteran Healthcare System, Richmond
dVirginia Commonwealth University, Richmond
eVeterans Affairs Rocky Mountain Regional Medical Center, Aurora, Colorado
fUniversity of Colorado, Aurora
gVeterans Affairs Boston Healthcare System, Massachusetts
hHarvard Medical School, Boston, Massachusetts
iVeterans Affairs Salt Lake City Healthcare System, Utah
jUniversity of Utah, Salt Lake City
kVeterans Affairs Pacific Island Health Care System, Honolulu, Hawaii

Author disclosures Maya O’Neil, Catherine Fortier, and William Milberg report grants from the US Department of Veterans Affairs (VA) and US Department of Defense (DoD). Lisa Brenner reports grants from the VA, DoD, National Institutes of Health (NIH), Face the Fight, and the State of Colorado, editorial remuneration from Wolters Kluwer and the RAND Corporation, and royalties from the American Psychological Association (APA) and Oxford University Press. David Cifu reports grants from the VA, DoD, NIH, and the National Institute on Disability, Independent Living, and Rehabilitation Research Agency, and royalties from Elsevier. Ryan Holliday reports grants from VA, DoD, and the State of Colorado. Elisabeth Wilde reports grants from the VA, DoD, and NIH and editorial remuneration from APA. Adam Kinney reports grants from the VA, State of Colorado, and American Occupational Therapy Foundation.

Disclaimer The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies.

Ethics and consent This research was reviewed by the Institutional Review Board and approved as a science only project by the Research and Development committee at Portland Veterans Affairs Health Care System.

Funding This project was funded by US Department of Veterans Affairs (VA) Rehabilitation Research and Development (RR&D) Grant (No. RX004911) to Maya O’Neil, Lisa Brenner, David Cifu, and Elisabeth Wilde. It was also supported by the Translational Research Center for TBI and Stress Disorders, a VA RR&D National Research Center for Traumatic Brain Injury (B3001-C), Psychological Health/Traumatic Brain Injury Research Program Long-Term Impact of Military-Relevant Brain Injury Consortium (LIMBIC) Award/W81XWH-18-PH/TBIRP-LIMBIC under Awards No. W81XWH1920067 and W81XWH-13-2-0095, and by the U.S. Department of Veterans Affairs Awards No. I01 CX002097, I01 CX002096, I01 HX003155, I01 RX003444, I01 RX003443, I01 RX003442, I01 CX001135, I01 CX001246, I01 RX001774, I01 RX 001135, I01 RX 002076, I01 RX 001880, I01 RX 002172, I01 RX 002173, I01 RX 002171, I01 RX 002174, and I01 RX 002170.

Correspondence: Maya O’Neil (maya.oneil@va.gov)

Fed Pract. 2026;43(2). Published online February 16. doi:10.12788/fp.0676

Author and Disclosure Information

Maya O’Neil, PhDa,b; David Cameron, MPHa,b; David X. Cifu, MDc,d; Molly Sullan, PhDe,f; Kate Clauss, PhDa,b; William P. Milberg, PhDg,h; Catherine B. Fortier, PhDg,h; Elisabeth A. Wilde, PhDi,j; Ryan Holliday, PhD, OTR/Le,f,k; Adam Kinney, PhD, OTR/Le,f; Lisa A. Brenner, PhDe,f

Author affiliations
aVeterans Affairs Portland Health Care System, Oregon
bOregon Health & Science University, Portland
cCentral Virginia Veteran Healthcare System, Richmond
dVirginia Commonwealth University, Richmond
eVeterans Affairs Rocky Mountain Regional Medical Center, Aurora, Colorado
fUniversity of Colorado, Aurora
gVeterans Affairs Boston Healthcare System, Massachusetts
hHarvard Medical School, Boston, Massachusetts
iVeterans Affairs Salt Lake City Healthcare System, Utah
jUniversity of Utah, Salt Lake City
kVeterans Affairs Pacific Island Health Care System, Honolulu, Hawaii

Author disclosures Maya O’Neil, Catherine Fortier, and William Milberg report grants from the US Department of Veterans Affairs (VA) and US Department of Defense (DoD). Lisa Brenner reports grants from the VA, DoD, National Institutes of Health (NIH), Face the Fight, and the State of Colorado, editorial remuneration from Wolters Kluwer and the RAND Corporation, and royalties from the American Psychological Association (APA) and Oxford University Press. David Cifu reports grants from the VA, DoD, NIH, and the National Institute on Disability, Independent Living, and Rehabilitation Research Agency, and royalties from Elsevier. Ryan Holliday reports grants from VA, DoD, and the State of Colorado. Elisabeth Wilde reports grants from the VA, DoD, and NIH and editorial remuneration from APA. Adam Kinney reports grants from the VA, State of Colorado, and American Occupational Therapy Foundation.

Disclaimer The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies.

Ethics and consent This research was reviewed by the Institutional Review Board and approved as a science only project by the Research and Development committee at Portland Veterans Affairs Health Care System.

Funding This project was funded by US Department of Veterans Affairs (VA) Rehabilitation Research and Development (RR&D) Grant (No. RX004911) to Maya O’Neil, Lisa Brenner, David Cifu, and Elisabeth Wilde. It was also supported by the Translational Research Center for TBI and Stress Disorders, a VA RR&D National Research Center for Traumatic Brain Injury (B3001-C), Psychological Health/Traumatic Brain Injury Research Program Long-Term Impact of Military-Relevant Brain Injury Consortium (LIMBIC) Award/W81XWH-18-PH/TBIRP-LIMBIC under Awards No. W81XWH1920067 and W81XWH-13-2-0095, and by the U.S. Department of Veterans Affairs Awards No. I01 CX002097, I01 CX002096, I01 HX003155, I01 RX003444, I01 RX003443, I01 RX003442, I01 CX001135, I01 CX001246, I01 RX001774, I01 RX 001135, I01 RX 002076, I01 RX 001880, I01 RX 002172, I01 RX 002173, I01 RX 002171, I01 RX 002174, and I01 RX 002170.

Correspondence: Maya O’Neil (maya.oneil@va.gov)

Fed Pract. 2026;43(2). Published online February 16. doi:10.12788/fp.0676

Article PDF
Article PDF

In leveraging existing, readily available evidence-based health care information (eg, systematic reviews, clinical practice guidelines), clinicians have historically made recommendations based on treatment responses of the average patient.1 Recently, this approach has been expanded into data-driven, evidence-based precision medical care for individuals across a wide range of disciplines and care settings. These precision medicine approaches use information related to an individual’s genes, environment, and lifestyle to tailor recommendations regarding prevention, diagnosis, and treatment.

Applying precision medicine approaches to the unique exposures and experiences of service members and veterans—particularly those who served in combat environments—through the incorporation of biopsychosocial factors into medical decision-making may be even more pertinent. This sentiment is reflected in Section 305 of the Commander John Scott Hannon Veterans Mental Health Care Improvement Act of 2019, which outlines the Precision Medicine Initiative of the US Department of Veterans Affairs (VA) to identify and validate brain and mental health biomarkers.2 Despite widespread consensus regarding the promise of precision medicine, large, rich datasets with elements pertaining to common military exposures such as traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) are limited.

Existing datasets, most of which are relatively small or focus on specific cohorts (eg, older veterans, transitioning veterans), continue to create barriers to advancing precision medicine. For example, in classically designed clinical trials, analyses are generally conducted in a manner that may obfuscate efficacy among subcohorts of individuals, thereby underscoring the need to explore alternative strategies to unify existing datasets capable of revealing such heterogeneity.3 The evidence base for precision medical care is limited, drawing from published trials with relatively small sample sizes and even larger cohort studies have limited biomarker data. Additionally, these models are often exploratory during development, and to avoid statistical overfitting of an exploratory model, validation in similar datasets is needed—an added burden when data sources are small or underpowered to begin with.

A promising approach is to combine and harmonize the largest, most deeply characterized data sources from similar samples. Although combining such datasets may appear to require minimal time and effort, harmonizing similar variables in an evidence-based and replicable manner requires time and expertise, even when participant characteristics and outcomes are similar.4-7

Challenges related to harmonization are related to the wide range of strategies (eg, self-report questionnaires, clinical interviews, electronic health record review) used to measure common brain and mental health constructs, such as depression. Even when similar methods (eg, self-report measures) are implemented, challenges persist. For example, if a study used a depression measure that focused primarily on cognitive symptoms (eg, pessimism, self-dislike, suicidal ideation) and another study used a depression measure composed of items more heavily weighted towards somatic symptoms (eg, insomnia, loss of appetite, weight loss, decreased libido), combining their data could be challenging, particularly if researchers, clinicians, or administrators are interested in more than dichotomous outcomes (eg, depression vs no depression).8,9

To address this knowledge gap and harmonize multimodal data from varied sources, well-planned and reproducible curation is needed. Longitudinal cohort studies of service members and veterans with military combat and training exposure histories provide researchers and other stakeholders access to extant biopsychosocial data shown to affect risk for adverse health outcomes; however, efforts to facilitate individually tailored treatment or other precision medicine approaches would benefit from the synthesis of such datasets.10

Members of the VA Total Brain Diagnostics (TBD) team are engaged in harmonizing variables from the Long-Term Impact of Military-Relevant Brain Injury Consortium–Chronic Effects of Neurotrauma Consortium (LIMBIC-CENC)11 and the Translational Research Center for TBI and Stress Disorders (TRACTS).12-21 While there is overlap across LIMBIC-CENC and TRACTS with respect to data domains, considerable data harmonization is needed to allow for future valid and meaningful analyses, particularly those involving multivariable predictors.

Data Sources

Both data sources for the TBD harmonization project, LIMBIC-CENC and TRACTS, include extensive, longitudinal data collected from relatively large cohorts of veterans and service members with combat exposure. Both studies collect detailed data related to potential brain injury history and include participants with and without a history of TBI. Similarly, both include extensive collection of fluid biomarkers and imaging data, as well as measures of biopsychosocial functioning.

Data collection sites for LIMBIC-CENC include 16 recruitment sites, 9 at VA medical centers (Richmond, Houston, Tampa, San Antonio, Portland, Minneapolis, Boston, Salisbury, San Diego) and 7 at military treatment sites (Alexandria, San Diego, Tampa, Tacoma, Columbia, Coronado, Hinesville), in addition to 11 assessment sites (Richmond, Houston, Tampa, San Antonio, Portland, Minneapolis, Boston, Salisbury, San Diego, Alexandria, Augusta). Data for TRACTS are collected at sites in Boston and Houston.

LIMBIC-CENC is a 12-year, 17-site cohort of service members and veteran participants with combat exposure who are well characterized at baseline and undergo annual reassessments. As of December 2025, > 3100 participants have been recruited, and nearly 90% remain in follow-up. Data collection includes > 6200 annual follow-up evaluations and > 1550 5-year re-evaluations, with 400 enrolled participants followed up annually.

TRACTS is a 16-year, 2-site cohort of veterans with combat exposure who complete comprehensive assessments at enrollment, undergo annual reassessments, and complete comprehensive reassessment every 5 years thereafter. As of December 2025, > 1075 participants have completed baseline (Time 1) assessments, > 600 have completed the 2-year re-evaluation (Time 2), > 175 have completed the 5-year re-evaluation (Time 3), and > 35 have completed 10-year evaluations (Time 4), with about 50 new participants added and 100 enrolled participants followed up annually. More data on participant characteristics are available for both LIMBIC-CENC and TRACTS in previous publications.11,22These 2 ongoing, prospective, longitudinal cohorts of service members and veterans offer access to a wide range of potential risk factors that can affect response to care and outcomes, including demographics (eg, age, sex), injury characteristics (eg, pre-exposure factors, exposure factors), biomarkers (eg, serum, saliva, brain imaging, evoked potentials), and functional measures (eg, computerized posturography, computerized eye tracking, sensory testing, clinical examination, neuropsychological assessments, symptom questionnaires).

Harmonization Strategy

Pooling and harmonizing data from large studies evaluating similar participant cohorts and conditions involves numerous steps to appropriately handle a variety of measurements and disparate variable names. The TBD team adapted a model data harmonization system developed by O’Neil et al through initial work harmonizing the Federal Interagency Traumatic Brain Injury Research Informatics System (FITBIR).4-7 This process was expanded and generalized by the research team to combine data from LIMBIC-CENC and TRACTS to create a single pooled dataset for analysis (Figure).

FDP04302056_F1
FIGURE. Data pooling and harmonization system for the Federal Interagency Traumatic Brain
Injury Research database.

This approach was selected because it accommodates heterogeneous study designs (eg, cross-sectional, longitudinal, case-control), data collection methods (eg, clinical assessment, self-reported, objective blood, and imaging biomarkers), and various assessments of the same construct (ie, different measures of brain injury). While exact matches for data collection methods and measures may be easily harmonized, the timing of assessment, number of assessments, assessment tool version, and other factors must be considered. The goal was to harmonize data from LIMBIC-CENC and TRACTS to allow additional data sources to be harmonized and incorporated in the future.

Original data files from each study were reshaped to represent participant-level observations with 1 unique measurement per row. The measurement represents what information was collected and the value recorded represents the unique observation. These data are linked to metadata from the original study, which includes the study’s definition of each measurement, how it was collected, and any available information regarding when it was collected in reference to study enrollment or injury. Additional information on the file source, row, and column position of each data point was added to enable recreation of the original data as needed.

The resulting dataset was used to harmonize measurements from LIMBIC-CENC and TRACTS into a priori-defined schemas for brain- and mental health-relevant concepts, including TBI severity, PTSD, substance use, depression, suicidal ideation, and functioning (including cognitive, physical, and social functioning). This process was facilitated using natural language processing (NLP). Each study uniquely defines all measurements and provides written definitions with the data. Measurement definitions serve as records describing what was collected, how it was collected, and how the study may have uniquely defined information for its purposes. For example, definitions of exposure to brain injury and severity of brain injury may differ between studies, and the study-provided definition defines these differences.

Definitions were converted into numeric vectors through sentence embedding, a process that preserves the semantic meaning of the definition.23 Cosine similarity was used as the primary metric to compare the semantic textual similarity between pairs of measurement definitions. Cosine similarity ranges from 0 to 1, where 0 indicates no meaningful similarity and 1 indicates they have identical meanings.24 This approach leverages the relationship between the definitions of each measurement provided by a study and enables quick comparison of all pairwise combinations of measurement definitions between studies.

Subsets of similar measurements across studies were organized into a priori-defined schema. Clinical experts then reviewed each schema and further refined them into domains, (eg, mechanism of injury, clinical signs, acute symptoms) and subdomains (children), such as loss of consciousness, amnesia, and alteration of consciousness. This approach allows efficient handling of 2 specific cases that commonly occur when pooling and harmonizing datasets: (1) identifying the same measurement with differing names; and (2) identifying different measurements with definitions that each relate to the same domain.

The Table provides a general example of the schema for TBI severity. This was an iterative process in which clinical experts reviewed study-defined measurement definitions to develop general harmonized domains, and NLP techniques facilitated and accelerated identification and organization of measurements within these domains.

FDP04302056_T1

Expected Impact

Harmonization combining LIMBIC-CENC and TRACTS datasets is ongoing. Preliminary descriptive analyses of baseline cohort data indicate that harmonization across data sources is appropriate, given the lack of significant heterogeneity across sites and studies for most domains. Work by members of the TBD team is expected to lay the foundation for the use of existing and ongoing prospective, longitudinal datasets (eg, LIMBIC-CENC, TRACTS) and linked large datasets (eg, VA Informatics and Computing Infrastructure including electronic health records, VA Million Veteran Program, DaVINCI [US Department of Defense and VA Infrastructure for Clinical Intelligence]) to generate generalizable, clinically relevant information to advance precision brain and mental health care among service members and veterans.

By enhancing existing practice, this synthesized dataset has the potential to inform tailored and personalized medicine approaches designed to meet the needs of veterans and service members. These data will serve as the starting point for multivariable models examining the intersection of physiologic, behavioral, and environmental factors. The goal of this data harmonization effort is to better elucidate how clinicians and researchers can select optimal approaches for veterans and service members with TBI histories by accounting for a comprehensive set of physiologic, behavioral, and environmental factors in an individually tailored manner. These data may further extend existing clinical practice guideline approaches, inform shared decision-making, and enhance functional outcomes beyond those currently available.

Conclusions

Individuals who have served in the military have unique biopsychosocial exposures that are associated with brain and mental health disorders. To address these needs, the nationwide TBD team has initiated the creation of a unified, longitudinal dataset that includes harmonized measures from existing LIMBIC-CENC and TRACTS protocols. Initial data harmonization efforts are required to facilitate precision prognostics, diagnostics, and tailored interventions, with the goal of improving veterans’ brain and mental health and psychosocial functioning and enabling tailored and evidence-informed, individualized clinical care.

In leveraging existing, readily available evidence-based health care information (eg, systematic reviews, clinical practice guidelines), clinicians have historically made recommendations based on treatment responses of the average patient.1 Recently, this approach has been expanded into data-driven, evidence-based precision medical care for individuals across a wide range of disciplines and care settings. These precision medicine approaches use information related to an individual’s genes, environment, and lifestyle to tailor recommendations regarding prevention, diagnosis, and treatment.

Applying precision medicine approaches to the unique exposures and experiences of service members and veterans—particularly those who served in combat environments—through the incorporation of biopsychosocial factors into medical decision-making may be even more pertinent. This sentiment is reflected in Section 305 of the Commander John Scott Hannon Veterans Mental Health Care Improvement Act of 2019, which outlines the Precision Medicine Initiative of the US Department of Veterans Affairs (VA) to identify and validate brain and mental health biomarkers.2 Despite widespread consensus regarding the promise of precision medicine, large, rich datasets with elements pertaining to common military exposures such as traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) are limited.

Existing datasets, most of which are relatively small or focus on specific cohorts (eg, older veterans, transitioning veterans), continue to create barriers to advancing precision medicine. For example, in classically designed clinical trials, analyses are generally conducted in a manner that may obfuscate efficacy among subcohorts of individuals, thereby underscoring the need to explore alternative strategies to unify existing datasets capable of revealing such heterogeneity.3 The evidence base for precision medical care is limited, drawing from published trials with relatively small sample sizes and even larger cohort studies have limited biomarker data. Additionally, these models are often exploratory during development, and to avoid statistical overfitting of an exploratory model, validation in similar datasets is needed—an added burden when data sources are small or underpowered to begin with.

A promising approach is to combine and harmonize the largest, most deeply characterized data sources from similar samples. Although combining such datasets may appear to require minimal time and effort, harmonizing similar variables in an evidence-based and replicable manner requires time and expertise, even when participant characteristics and outcomes are similar.4-7

Challenges related to harmonization are related to the wide range of strategies (eg, self-report questionnaires, clinical interviews, electronic health record review) used to measure common brain and mental health constructs, such as depression. Even when similar methods (eg, self-report measures) are implemented, challenges persist. For example, if a study used a depression measure that focused primarily on cognitive symptoms (eg, pessimism, self-dislike, suicidal ideation) and another study used a depression measure composed of items more heavily weighted towards somatic symptoms (eg, insomnia, loss of appetite, weight loss, decreased libido), combining their data could be challenging, particularly if researchers, clinicians, or administrators are interested in more than dichotomous outcomes (eg, depression vs no depression).8,9

To address this knowledge gap and harmonize multimodal data from varied sources, well-planned and reproducible curation is needed. Longitudinal cohort studies of service members and veterans with military combat and training exposure histories provide researchers and other stakeholders access to extant biopsychosocial data shown to affect risk for adverse health outcomes; however, efforts to facilitate individually tailored treatment or other precision medicine approaches would benefit from the synthesis of such datasets.10

Members of the VA Total Brain Diagnostics (TBD) team are engaged in harmonizing variables from the Long-Term Impact of Military-Relevant Brain Injury Consortium–Chronic Effects of Neurotrauma Consortium (LIMBIC-CENC)11 and the Translational Research Center for TBI and Stress Disorders (TRACTS).12-21 While there is overlap across LIMBIC-CENC and TRACTS with respect to data domains, considerable data harmonization is needed to allow for future valid and meaningful analyses, particularly those involving multivariable predictors.

Data Sources

Both data sources for the TBD harmonization project, LIMBIC-CENC and TRACTS, include extensive, longitudinal data collected from relatively large cohorts of veterans and service members with combat exposure. Both studies collect detailed data related to potential brain injury history and include participants with and without a history of TBI. Similarly, both include extensive collection of fluid biomarkers and imaging data, as well as measures of biopsychosocial functioning.

Data collection sites for LIMBIC-CENC include 16 recruitment sites, 9 at VA medical centers (Richmond, Houston, Tampa, San Antonio, Portland, Minneapolis, Boston, Salisbury, San Diego) and 7 at military treatment sites (Alexandria, San Diego, Tampa, Tacoma, Columbia, Coronado, Hinesville), in addition to 11 assessment sites (Richmond, Houston, Tampa, San Antonio, Portland, Minneapolis, Boston, Salisbury, San Diego, Alexandria, Augusta). Data for TRACTS are collected at sites in Boston and Houston.

LIMBIC-CENC is a 12-year, 17-site cohort of service members and veteran participants with combat exposure who are well characterized at baseline and undergo annual reassessments. As of December 2025, > 3100 participants have been recruited, and nearly 90% remain in follow-up. Data collection includes > 6200 annual follow-up evaluations and > 1550 5-year re-evaluations, with 400 enrolled participants followed up annually.

TRACTS is a 16-year, 2-site cohort of veterans with combat exposure who complete comprehensive assessments at enrollment, undergo annual reassessments, and complete comprehensive reassessment every 5 years thereafter. As of December 2025, > 1075 participants have completed baseline (Time 1) assessments, > 600 have completed the 2-year re-evaluation (Time 2), > 175 have completed the 5-year re-evaluation (Time 3), and > 35 have completed 10-year evaluations (Time 4), with about 50 new participants added and 100 enrolled participants followed up annually. More data on participant characteristics are available for both LIMBIC-CENC and TRACTS in previous publications.11,22These 2 ongoing, prospective, longitudinal cohorts of service members and veterans offer access to a wide range of potential risk factors that can affect response to care and outcomes, including demographics (eg, age, sex), injury characteristics (eg, pre-exposure factors, exposure factors), biomarkers (eg, serum, saliva, brain imaging, evoked potentials), and functional measures (eg, computerized posturography, computerized eye tracking, sensory testing, clinical examination, neuropsychological assessments, symptom questionnaires).

Harmonization Strategy

Pooling and harmonizing data from large studies evaluating similar participant cohorts and conditions involves numerous steps to appropriately handle a variety of measurements and disparate variable names. The TBD team adapted a model data harmonization system developed by O’Neil et al through initial work harmonizing the Federal Interagency Traumatic Brain Injury Research Informatics System (FITBIR).4-7 This process was expanded and generalized by the research team to combine data from LIMBIC-CENC and TRACTS to create a single pooled dataset for analysis (Figure).

FDP04302056_F1
FIGURE. Data pooling and harmonization system for the Federal Interagency Traumatic Brain
Injury Research database.

This approach was selected because it accommodates heterogeneous study designs (eg, cross-sectional, longitudinal, case-control), data collection methods (eg, clinical assessment, self-reported, objective blood, and imaging biomarkers), and various assessments of the same construct (ie, different measures of brain injury). While exact matches for data collection methods and measures may be easily harmonized, the timing of assessment, number of assessments, assessment tool version, and other factors must be considered. The goal was to harmonize data from LIMBIC-CENC and TRACTS to allow additional data sources to be harmonized and incorporated in the future.

Original data files from each study were reshaped to represent participant-level observations with 1 unique measurement per row. The measurement represents what information was collected and the value recorded represents the unique observation. These data are linked to metadata from the original study, which includes the study’s definition of each measurement, how it was collected, and any available information regarding when it was collected in reference to study enrollment or injury. Additional information on the file source, row, and column position of each data point was added to enable recreation of the original data as needed.

The resulting dataset was used to harmonize measurements from LIMBIC-CENC and TRACTS into a priori-defined schemas for brain- and mental health-relevant concepts, including TBI severity, PTSD, substance use, depression, suicidal ideation, and functioning (including cognitive, physical, and social functioning). This process was facilitated using natural language processing (NLP). Each study uniquely defines all measurements and provides written definitions with the data. Measurement definitions serve as records describing what was collected, how it was collected, and how the study may have uniquely defined information for its purposes. For example, definitions of exposure to brain injury and severity of brain injury may differ between studies, and the study-provided definition defines these differences.

Definitions were converted into numeric vectors through sentence embedding, a process that preserves the semantic meaning of the definition.23 Cosine similarity was used as the primary metric to compare the semantic textual similarity between pairs of measurement definitions. Cosine similarity ranges from 0 to 1, where 0 indicates no meaningful similarity and 1 indicates they have identical meanings.24 This approach leverages the relationship between the definitions of each measurement provided by a study and enables quick comparison of all pairwise combinations of measurement definitions between studies.

Subsets of similar measurements across studies were organized into a priori-defined schema. Clinical experts then reviewed each schema and further refined them into domains, (eg, mechanism of injury, clinical signs, acute symptoms) and subdomains (children), such as loss of consciousness, amnesia, and alteration of consciousness. This approach allows efficient handling of 2 specific cases that commonly occur when pooling and harmonizing datasets: (1) identifying the same measurement with differing names; and (2) identifying different measurements with definitions that each relate to the same domain.

The Table provides a general example of the schema for TBI severity. This was an iterative process in which clinical experts reviewed study-defined measurement definitions to develop general harmonized domains, and NLP techniques facilitated and accelerated identification and organization of measurements within these domains.

FDP04302056_T1

Expected Impact

Harmonization combining LIMBIC-CENC and TRACTS datasets is ongoing. Preliminary descriptive analyses of baseline cohort data indicate that harmonization across data sources is appropriate, given the lack of significant heterogeneity across sites and studies for most domains. Work by members of the TBD team is expected to lay the foundation for the use of existing and ongoing prospective, longitudinal datasets (eg, LIMBIC-CENC, TRACTS) and linked large datasets (eg, VA Informatics and Computing Infrastructure including electronic health records, VA Million Veteran Program, DaVINCI [US Department of Defense and VA Infrastructure for Clinical Intelligence]) to generate generalizable, clinically relevant information to advance precision brain and mental health care among service members and veterans.

By enhancing existing practice, this synthesized dataset has the potential to inform tailored and personalized medicine approaches designed to meet the needs of veterans and service members. These data will serve as the starting point for multivariable models examining the intersection of physiologic, behavioral, and environmental factors. The goal of this data harmonization effort is to better elucidate how clinicians and researchers can select optimal approaches for veterans and service members with TBI histories by accounting for a comprehensive set of physiologic, behavioral, and environmental factors in an individually tailored manner. These data may further extend existing clinical practice guideline approaches, inform shared decision-making, and enhance functional outcomes beyond those currently available.

Conclusions

Individuals who have served in the military have unique biopsychosocial exposures that are associated with brain and mental health disorders. To address these needs, the nationwide TBD team has initiated the creation of a unified, longitudinal dataset that includes harmonized measures from existing LIMBIC-CENC and TRACTS protocols. Initial data harmonization efforts are required to facilitate precision prognostics, diagnostics, and tailored interventions, with the goal of improving veterans’ brain and mental health and psychosocial functioning and enabling tailored and evidence-informed, individualized clinical care.

References
  1. The Promise of Precision Medicine. National Institutes of Health (NIH). Updated January 21, 2025. Accessed January 5, 2026. https://www.nih.gov/about-nih/nih-turning-discovery-into-health/promise-precision-medicine.
  2. Commander John Scott Hannon Veterans Mental Health Care Improvement Act of 2019, S 785, 116th Cong (2019-2020) Accessed January 5, 2026. https://www.congress.gov/bill/116th-congress/senate-bill/785
  3. Cheng C, Messerschmidt L, Bravo I, et al. A general primer for data harmonization. Sci Data. 2024;11:152. doi:10.1038/s41597-024-02956-3
  4. Neil M, Cameron D, Clauss K, et al. A proof-of-concept study demonstrating how FITBIR datasets can be harmonized to examine posttraumatic stress disorder-traumatic brain injury associations. J Behav Data Sci. 2024;4:45-62. doi:10.35566/jbds/oneil
  5. O’Neil ME, Cameron D, Krushnic D, et al. Using harmonized FITBIR datasets to examine associations between TBI history and cognitive functioning. Appl Neuropsychol Adult. doi:10.1080/23279095.2024.2401974
  6. O’Neil ME, Krushnic D, Clauss K, et al. Harmonizing federal interagency traumatic brain injury research data to examine depression and suicide-related outcomes. Rehabil Psychol. 2024;69:159-170. doi:10.1037/rep0000547
  7. O’Neil ME, Krushnic D, Walker WC, et al. Increased risk for clinically significant sleep disturbances in mild traumatic brain injury: an approach to leveraging the federal interagency traumatic brain injury research database. Brain Sci. 2024;14:921. doi:10.3390/brainsci14090921
  8. Uher R, Perlis RH, Placentino A, et al. Self-report and clinician-rated measures of depression severity: can one replace the other? Depress Anxiety. 2012;29:1043-1049. doi:10.1002/da.21993
  9. Hung CI, Weng LJ, Su YJ, et al. Depression and somatic symptoms scale: a new scale with both depression and somatic symptoms emphasized. Psychiatry Clin Neurosci. 2006;60:700-708. doi:10.1111/j.1440-1819.2006.01585.x
  10. Stewart IJ, Howard JT, Amuan ME, et al. Traumatic brain injury is associated with the subsequent risk of atrial fibrillation or atrial flutter. Heart Rhythm. 2025;22:661-667. doi:10.1016/j.hrthm.2024.09.019
  11. Cifu DX. Clinical research findings from the long-term impact of military-relevant brain injury consortium-chronic effects of neurotrauma consortium (LIMBIC-CENC) 2013-2021. Brain Inj. 2022;36:587-597.doi:10.1080/02699052.2022.2033843
  12. Fonda JR, Fredman L, Brogly SB, et al. Traumatic brain injury and attempted suicide among veterans of the wars in Iraq and Afghanistan. Am J Epidemiol. 2017;186:220-226. doi:10.1093/aje/kwx044
  13. Fortier CB, Amick MM, Kenna A, et al. Correspondence of the Boston Assessment of Traumatic Brain Injury-Lifetime (BAT-L) clinical interview and the VA TBI screen. J Head Trauma Rehabil. 2015;30:E1-7. doi:10.1097/htr.0000000000000008
  14. Grande LJ, Robinson ME, Radigan LJ, et al. Verbal memory deficits in OEF/OIF/OND veterans exposed to blasts at close range. J Int Neuropsychol Soc. 2018;24:466-475. doi:10.1017/S1355617717001242
  15. Hayes JP, Logue MW, Sadeh N, et al. Mild traumatic brain injury is associated with reduced cortical thickness in those at risk for Alzheimer’s disease. Brain. 2017;140:813-825. doi:10.1093/brain/aww344
  16. Lippa SM, Fonda JR, Fortier CB, et al. Deployment-related psychiatric and behavioral conditions and their association with functional disability in OEF/OIF/OND veterans. J Trauma Stress. 2015;28:25-33. doi:10.1002/jts.21979
  17. McGlinchey RE, Milberg WP, Fonda JR, et al. A methodology for assessing deployment trauma and its consequences in OEF/OIF/OND veterans: the TRACTS longitudinal prospective cohort study. Int J Methods Psychiatr Res. 2017;26:e1556. doi:10.1002/mpr.1556
  18. Radigan LJ, McGlinchey RE, Milberg WP, et al. Correspondence of the Boston Assessment of Traumatic Brain Injury-Lifetime and the VA Comprehensive TBI Evaluation. J Head Trauma Rehabil. 2018;33:E51-E55. doi:10.1097/htr.0000000000000361
  19. Sydnor VJ, Bouix S, Pasternak O, et al. Mild traumatic brain injury impacts associations between limbic system microstructure and post-traumatic stress disorder symptomatology. Neuroimage Clin. 2020;26:102190. doi:10.1016/j.nicl.2020.102190
  20. Van Etten EJ, Knight AR, Colaizzi TA, et al. Peritraumatic context and long-term outcomes of concussion. JAMA Netw Open. 2025;8:e2455622. doi:10.1001/jamanetworkopen.2024.55622
  21. Andrews RJ, Fonda JR, Levin LK, et al. Comprehensive analysis of the predictors of neurobehavioral symptom reporting in veterans. Neurology. 2018;91:e732-e745. doi:10.1212/wnl.0000000000006034
  22. McGlinchey RE, Milberg WP, Fonda JR, Fortier CB. A methodology for assessing deployment trauma and its consequences in OEF/OIF/OND veterans: the TRACTS longitudional prospective cohort study. Int J Methods Psychiatr Res. 2017;26:e1556. doi:10.1002/mpr.1556
  23. Reimers N, Gurevych I. Sentence-BERT: Sentence embeddings using Siamese BERT-Networks. 2019. Conference on Empirical Methods in Natural Language Processing.
  24. Singhal A. Modern information retrieval: a brief overview. IEEE Data Eng Bull. 2001;24:34-43.
References
  1. The Promise of Precision Medicine. National Institutes of Health (NIH). Updated January 21, 2025. Accessed January 5, 2026. https://www.nih.gov/about-nih/nih-turning-discovery-into-health/promise-precision-medicine.
  2. Commander John Scott Hannon Veterans Mental Health Care Improvement Act of 2019, S 785, 116th Cong (2019-2020) Accessed January 5, 2026. https://www.congress.gov/bill/116th-congress/senate-bill/785
  3. Cheng C, Messerschmidt L, Bravo I, et al. A general primer for data harmonization. Sci Data. 2024;11:152. doi:10.1038/s41597-024-02956-3
  4. Neil M, Cameron D, Clauss K, et al. A proof-of-concept study demonstrating how FITBIR datasets can be harmonized to examine posttraumatic stress disorder-traumatic brain injury associations. J Behav Data Sci. 2024;4:45-62. doi:10.35566/jbds/oneil
  5. O’Neil ME, Cameron D, Krushnic D, et al. Using harmonized FITBIR datasets to examine associations between TBI history and cognitive functioning. Appl Neuropsychol Adult. doi:10.1080/23279095.2024.2401974
  6. O’Neil ME, Krushnic D, Clauss K, et al. Harmonizing federal interagency traumatic brain injury research data to examine depression and suicide-related outcomes. Rehabil Psychol. 2024;69:159-170. doi:10.1037/rep0000547
  7. O’Neil ME, Krushnic D, Walker WC, et al. Increased risk for clinically significant sleep disturbances in mild traumatic brain injury: an approach to leveraging the federal interagency traumatic brain injury research database. Brain Sci. 2024;14:921. doi:10.3390/brainsci14090921
  8. Uher R, Perlis RH, Placentino A, et al. Self-report and clinician-rated measures of depression severity: can one replace the other? Depress Anxiety. 2012;29:1043-1049. doi:10.1002/da.21993
  9. Hung CI, Weng LJ, Su YJ, et al. Depression and somatic symptoms scale: a new scale with both depression and somatic symptoms emphasized. Psychiatry Clin Neurosci. 2006;60:700-708. doi:10.1111/j.1440-1819.2006.01585.x
  10. Stewart IJ, Howard JT, Amuan ME, et al. Traumatic brain injury is associated with the subsequent risk of atrial fibrillation or atrial flutter. Heart Rhythm. 2025;22:661-667. doi:10.1016/j.hrthm.2024.09.019
  11. Cifu DX. Clinical research findings from the long-term impact of military-relevant brain injury consortium-chronic effects of neurotrauma consortium (LIMBIC-CENC) 2013-2021. Brain Inj. 2022;36:587-597.doi:10.1080/02699052.2022.2033843
  12. Fonda JR, Fredman L, Brogly SB, et al. Traumatic brain injury and attempted suicide among veterans of the wars in Iraq and Afghanistan. Am J Epidemiol. 2017;186:220-226. doi:10.1093/aje/kwx044
  13. Fortier CB, Amick MM, Kenna A, et al. Correspondence of the Boston Assessment of Traumatic Brain Injury-Lifetime (BAT-L) clinical interview and the VA TBI screen. J Head Trauma Rehabil. 2015;30:E1-7. doi:10.1097/htr.0000000000000008
  14. Grande LJ, Robinson ME, Radigan LJ, et al. Verbal memory deficits in OEF/OIF/OND veterans exposed to blasts at close range. J Int Neuropsychol Soc. 2018;24:466-475. doi:10.1017/S1355617717001242
  15. Hayes JP, Logue MW, Sadeh N, et al. Mild traumatic brain injury is associated with reduced cortical thickness in those at risk for Alzheimer’s disease. Brain. 2017;140:813-825. doi:10.1093/brain/aww344
  16. Lippa SM, Fonda JR, Fortier CB, et al. Deployment-related psychiatric and behavioral conditions and their association with functional disability in OEF/OIF/OND veterans. J Trauma Stress. 2015;28:25-33. doi:10.1002/jts.21979
  17. McGlinchey RE, Milberg WP, Fonda JR, et al. A methodology for assessing deployment trauma and its consequences in OEF/OIF/OND veterans: the TRACTS longitudinal prospective cohort study. Int J Methods Psychiatr Res. 2017;26:e1556. doi:10.1002/mpr.1556
  18. Radigan LJ, McGlinchey RE, Milberg WP, et al. Correspondence of the Boston Assessment of Traumatic Brain Injury-Lifetime and the VA Comprehensive TBI Evaluation. J Head Trauma Rehabil. 2018;33:E51-E55. doi:10.1097/htr.0000000000000361
  19. Sydnor VJ, Bouix S, Pasternak O, et al. Mild traumatic brain injury impacts associations between limbic system microstructure and post-traumatic stress disorder symptomatology. Neuroimage Clin. 2020;26:102190. doi:10.1016/j.nicl.2020.102190
  20. Van Etten EJ, Knight AR, Colaizzi TA, et al. Peritraumatic context and long-term outcomes of concussion. JAMA Netw Open. 2025;8:e2455622. doi:10.1001/jamanetworkopen.2024.55622
  21. Andrews RJ, Fonda JR, Levin LK, et al. Comprehensive analysis of the predictors of neurobehavioral symptom reporting in veterans. Neurology. 2018;91:e732-e745. doi:10.1212/wnl.0000000000006034
  22. McGlinchey RE, Milberg WP, Fonda JR, Fortier CB. A methodology for assessing deployment trauma and its consequences in OEF/OIF/OND veterans: the TRACTS longitudional prospective cohort study. Int J Methods Psychiatr Res. 2017;26:e1556. doi:10.1002/mpr.1556
  23. Reimers N, Gurevych I. Sentence-BERT: Sentence embeddings using Siamese BERT-Networks. 2019. Conference on Empirical Methods in Natural Language Processing.
  24. Singhal A. Modern information retrieval: a brief overview. IEEE Data Eng Bull. 2001;24:34-43.
Issue
Federal Practitioner - 43(2)
Issue
Federal Practitioner - 43(2)
Page Number
56-61
Page Number
56-61
Publications
Publications
Topics
Article Type
Display Headline

Total Brain Diagnostics: Advancing Precision Brain and Mental Health at the Department of Veterans Affairs

Display Headline

Total Brain Diagnostics: Advancing Precision Brain and Mental Health at the Department of Veterans Affairs

Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
survey writer start date

Implementation of Harm Reduction Syringe Services Programs at 2 Veterans Affairs Medical Centers

Article Type
Changed
Display Headline

Implementation of Harm Reduction Syringe Services Programs at 2 Veterans Affairs Medical Centers

A syringe services program (SSP) is a harm reduction strategy designed to improve the quality of care provided to people who use drugs (PWUD). SSPs not only provide sterile syringes but establish a connection to medical services and resources for the safe disposal of syringes. By engaging with an SSP, patients may receive naloxone, condoms, fentanyl test strips, opioid use disorder medications, vaccinations, or testing for infectious diseases such as HIV and hepatitis C virus (HCV). Patients may also be connected to housing or social work services.

SSPs do not lead to increased drug use,1 increased improperly disposed supplies needed for drug use in the community, or increased crime.2,3 New users of SSPs are 5 times more likely to enter treatment for drug use than those who do not use SSPs.4-8 Further, SSPs have been found to reduce HIV and HCV transmission and are cost-effective in HIV prevention.9-11

Syringe Services Program

SSPs were implemented at the US Department of Veterans Affairs (VA) Alaska VA Healthcare System (AVAHCS) and VA Southern Oregon Healthcare System (VASOHCS). AVAHCS provides outpatient care across Alaska, with sites in Anchorage, Fairbanks, Homer, Juneau, Wasilla, and Soldotna. VASOHCS provides outpatient care to Southern Oregon and Northern California, with sites in White City, Grants Pass, and Klamath Falls, Oregon. Both are part of Veterans Integrated Service Network 20

Workgroups at AVAHCS and VASOHCS developed SSPs to reduce risks associated with drug use, promote positive outcomes for PWUD, and increase availability of harm reduction resources. During the July 2023 to June 2024 pharmacy residency cycle, an ambulatory care pharmacy resident from the Veterans Integrated Services Network 20 Clinical Resource Hub—a regional resource for clinical services—joined the workgroups. The workgroups established a goal that SSP resources would be made available to enrolled patients without any exclusions, prioritizing health equity.

SSP implementation needed buy-in from AVAHCS and VASOHCS leadership and key stakeholders who could participate in the workgroups. Following AVAHCS and VASOHCS leadership approval, each facility workgroup drafted standard operating procedures (SOPs). Both facilities planned to implement the program using prepackaged kits (sterile syringes, alcohol pads, cotton swabs, a sharps container, and an educational brochure on safe injection practices) supplied by the VA National Harm Reduction Program.

Each SSP offered patients direct links to additional care options at the time of kit distribution, including information regarding medications/supplies (ie, hepatitis A/B vaccines, HIV preexposure prophylaxis, substance use disorder pharmacotherapy, naloxone, and condoms), laboratory tests for infectious and sexually transmitted diseases, and referrals to substance use disorder treatment, social work, suicide prevention, mental health, and primary care.

The goal was to implement both SSPs during the July 2023 to June 2024 residency year. Other goals included tracking the quantity of supplies distributed, the number of patients reached, the impact of clinician education on the distribution of supplies, and comparing the implementation of the SSPs in the electronic health record (EHR) systems.

Alaska VA Healthcare System

An SOP was approved on December 20, 2023, and national supply kits were stocked in collaboration with the logistics department at the Anchorage AVAHCS campus. Social and behavioral health teams, primary care social workers, primary care clinicians, and nursing staff received training on the resources available through the SSP. A local adaptation of a template was created in the Computerized Patient Records System (CPRS) EHR. The template facilitates SSP kit distribution and patient screening for additional resources. Patients can engage with the SSP through any trained staff member. The staff member then completes the template and helps to distribute the SSP kit, in collaboration with the logistics department. The SSP does not operate in a dedicated physical space. The behavioral health team is most actively engaged in the SSP. The goal of SSP is to have resources available anywhere a patient requests services, including primary care and specialty clinics and to empower staff to meet patients’ needs. One patient has utilized the SSP as of June 2025.

Southern Oregon Healthcare System

Kits were ordered and stocked as pharmacy items in preparation for dispensing while awaiting medical center policy approval. Education began with the primary care mental health integration team. After initial education, an interdisciplinary presentation was given to VASOHCS clinicians to increase knowledge of the SSP. To enable documentation of SSP engagement, a local template was developed in the Cerner EHR to be shared among care team members at the facility. Similar to AVAHCS, the SSP does not have a physical space. All trained facility staff may engage in the SSP and distribute SSP kits. The workgroup that implemented this program remains available to support staff. Five patients have accessed the SSP since November 2024 and 7 SSP kits have been distributed as of June 2025.

Discussion

The SSP workgroups sought to expand the program through additional education. A number of factors should be considered when implementing an SSP. Across facilities, program implementation can be time-consuming and the timeline for administrative processes may be long. The workgroups met weekly or monthly depending on the status of the program and the administrative processes. Materials developed included SOP and MCP documents, a 1-page educational handout on SSP offerings, and a PowerPoint presentation for initial clinician education. Involving a pharmacy resident supported professional development and accelerated implementation timelines.

The facilities differed in implementation. AVAHCS collaborated with the logistics department to distribute kits, while VASOHCS worked with the Pharmacy service. A benefit of collaborating with logistics is that patients can receive a kit at the point of contact with the health care system, receiving it directly from the clinic the patient is visiting while eliminating the need to make an additional stop at the pharmacy. Conversely, partnering with the Pharmacy service allowed supply kits to be distributed by mail, enabling patients direct access to kits without having to present in-person. This is particularly valuable considering the large geographical area and remote care services available at VASOHCS.

Implementation varied significantly because AVAHCS operated on CPRS while VASOHCS used Cerner, a newer EHR. AVAHCS adapted a national template produced for CPRS sites, while VASOHCS had to prepare a local template (auto-text) for SSP documentation. Future plans at AVAHCS may include adding fentanyl test strips as an orderable item in the EHR given that AVAHCS has a local instance of CPRS; however, VASOHCS cannot order fentanyl test strips through the Pharmacy service due to legal restrictions. While Oregon permits fentanyl test strip use, the Cerner instance used by VA is a national program, and therefore the addition of fentanyl test strips as an orderable item in the EHR would carry national implications, including for VA health care systems in states where fentanyl test strip legality is variable. Despite the challenges, efforts to include fentanyl test strips in both SSPs are ongoing.

No significant EHR changes were needed to make the national supply kits available in the Cerner EHR through the VASOHCS Pharmacy service. To have national supply kits available through the AVAHCS Pharmacy service, the EHR would need to be manipulated by adding a local drug file in CPRS. Differences between the EHRs often facilitated the need for adaptation from existing models of SSPs within VA, which were all based in CPRS.

Conclusions

The implementation of SSPs at AVAHCS and VASOHCS enable clinicians to provide quality harm reduction services to PWUD. Despite variations in EHR systems, AVAHCS and VASOHCS implemented SSP within 1 year. Tracking of program engagement via the number of patients interacting with the program and the number of SSP kits distributed will continue. SSP implementation in states where it is permitted may help provide optimal patient care for PWUD.

References
  1. Hagan H, McGough JP, Thiede H, Hopkins S, Duchin J, Alexander ER. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. J Subst Abuse Treat. 2000;19(3):247-252. doi:10.1016/s0740-5472(00)00104-5
  2. Marx MA, Crape B, Brookmeyer RS, et al. Trends in crime and the introduction of a needle exchange program. Am J Public Health. 2000;90(12):1933-1936. doi:10.2105/ajph.90.12.1933
  3. Galea S, Ahern J, Fuller C, Freudenberg N, Vlahov D. Needle exchange programs and experience of violence in an inner city neighborhood. J Acquir Immune Defic Syndr. 2001;28(3):282-288. doi:10.1097/00042560-200111010-00014
  4. Des Jarlais DC, Nugent A, Solberg A, Feelemyer J, Mermin J, Holtzman D. Syringe service programs for persons who inject drugs in urban, suburban, and rural areas — United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(48):1337-1341. doi:10.15585/ mmwr.mm6448a3
  5. Tookes HE, Kral AH, Wenger LD, et al. A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs. Drug Alcohol Depend. 2012;123(1-3):255-259. doi:10.1016/j.drugalcdep.2011.12.001
  6. Klein SJ, Candelas AR, Cooper JG, et al. Increasing safe syringe collection sites in New York State. Public Health Rep. 2008;123(4):433-440. doi:10.1177/003335490812300404
  7. de Montigny L, Vernez Moudon A, Leigh B, Kim SY. Assessing a drop box programme: a spatial analysis of discarded needles. Int J Drug Policy. 2010;21(3):208-214. doi:10.1016/j.drugpo.2009.07.003
  8. Bluthenthal RN, Anderson R, Flynn NM, Kral AH. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug Alcohol Depend. 2007;89(2-3):214-222. doi:10.1016/j.drugalcdep.2006.12.035
  9. Platt L, Minozzi S, Reed J, et al. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs. Cochrane Database Syst Rev. 2017;9(9):CD012021. doi:10.1002/14651858.CD012021.pub2
  10. Fernandes RM, Cary M, Duarte G, et al. Effectiveness of needle and syringe programmes in people who inject drugs — an overview of systematic reviews. BMC Public Health. 2017;17(1):309. doi:10.1186/s12889-017-4210-2
  11. Bernard CL, Owens DK, Goldhaber-Fiebert JD, Brandeau ML. Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: a model-based analysis. PLoS Med. 2017;14(5):e1002312. doi:10.1371/journal.pmed.1002312
Article PDF
Author and Disclosure Information

Michael Burkett, PharmD, BCACPa; Jessica Litke, PharmD, BCPSa; Annette Percy, PharmD, BCPPb; Katherine Plank, PharmDb; Korin Richardson, PharmD, BCPPb; Matthew Kirkland, PharmD, BCGPc

Correspondence: Michael Burkett (michael.burkett@va.gov)

Author affiliations
aVeterans Affairs Northwest Health Network/Veterans Integrated Service Network 20, Boise, Idaho
bVeterans Affairs Southern Oregon Healthcare System, White City
cAlaska Veterans Affairs Healthcare System, Anchorage

Author disclosures
The authors report no actual or potential conflicts of interest or outside sources of funding with regard to this article.

Fed Pract. 2025;42(7). Published online July 19. doi:10.12788/fp.0598

Issue
Federal Practitioner - 42(7)
Publications
Topics
Page Number
261-263
Sections
Author and Disclosure Information

Michael Burkett, PharmD, BCACPa; Jessica Litke, PharmD, BCPSa; Annette Percy, PharmD, BCPPb; Katherine Plank, PharmDb; Korin Richardson, PharmD, BCPPb; Matthew Kirkland, PharmD, BCGPc

Correspondence: Michael Burkett (michael.burkett@va.gov)

Author affiliations
aVeterans Affairs Northwest Health Network/Veterans Integrated Service Network 20, Boise, Idaho
bVeterans Affairs Southern Oregon Healthcare System, White City
cAlaska Veterans Affairs Healthcare System, Anchorage

Author disclosures
The authors report no actual or potential conflicts of interest or outside sources of funding with regard to this article.

Fed Pract. 2025;42(7). Published online July 19. doi:10.12788/fp.0598

Author and Disclosure Information

Michael Burkett, PharmD, BCACPa; Jessica Litke, PharmD, BCPSa; Annette Percy, PharmD, BCPPb; Katherine Plank, PharmDb; Korin Richardson, PharmD, BCPPb; Matthew Kirkland, PharmD, BCGPc

Correspondence: Michael Burkett (michael.burkett@va.gov)

Author affiliations
aVeterans Affairs Northwest Health Network/Veterans Integrated Service Network 20, Boise, Idaho
bVeterans Affairs Southern Oregon Healthcare System, White City
cAlaska Veterans Affairs Healthcare System, Anchorage

Author disclosures
The authors report no actual or potential conflicts of interest or outside sources of funding with regard to this article.

Fed Pract. 2025;42(7). Published online July 19. doi:10.12788/fp.0598

Article PDF
Article PDF

A syringe services program (SSP) is a harm reduction strategy designed to improve the quality of care provided to people who use drugs (PWUD). SSPs not only provide sterile syringes but establish a connection to medical services and resources for the safe disposal of syringes. By engaging with an SSP, patients may receive naloxone, condoms, fentanyl test strips, opioid use disorder medications, vaccinations, or testing for infectious diseases such as HIV and hepatitis C virus (HCV). Patients may also be connected to housing or social work services.

SSPs do not lead to increased drug use,1 increased improperly disposed supplies needed for drug use in the community, or increased crime.2,3 New users of SSPs are 5 times more likely to enter treatment for drug use than those who do not use SSPs.4-8 Further, SSPs have been found to reduce HIV and HCV transmission and are cost-effective in HIV prevention.9-11

Syringe Services Program

SSPs were implemented at the US Department of Veterans Affairs (VA) Alaska VA Healthcare System (AVAHCS) and VA Southern Oregon Healthcare System (VASOHCS). AVAHCS provides outpatient care across Alaska, with sites in Anchorage, Fairbanks, Homer, Juneau, Wasilla, and Soldotna. VASOHCS provides outpatient care to Southern Oregon and Northern California, with sites in White City, Grants Pass, and Klamath Falls, Oregon. Both are part of Veterans Integrated Service Network 20

Workgroups at AVAHCS and VASOHCS developed SSPs to reduce risks associated with drug use, promote positive outcomes for PWUD, and increase availability of harm reduction resources. During the July 2023 to June 2024 pharmacy residency cycle, an ambulatory care pharmacy resident from the Veterans Integrated Services Network 20 Clinical Resource Hub—a regional resource for clinical services—joined the workgroups. The workgroups established a goal that SSP resources would be made available to enrolled patients without any exclusions, prioritizing health equity.

SSP implementation needed buy-in from AVAHCS and VASOHCS leadership and key stakeholders who could participate in the workgroups. Following AVAHCS and VASOHCS leadership approval, each facility workgroup drafted standard operating procedures (SOPs). Both facilities planned to implement the program using prepackaged kits (sterile syringes, alcohol pads, cotton swabs, a sharps container, and an educational brochure on safe injection practices) supplied by the VA National Harm Reduction Program.

Each SSP offered patients direct links to additional care options at the time of kit distribution, including information regarding medications/supplies (ie, hepatitis A/B vaccines, HIV preexposure prophylaxis, substance use disorder pharmacotherapy, naloxone, and condoms), laboratory tests for infectious and sexually transmitted diseases, and referrals to substance use disorder treatment, social work, suicide prevention, mental health, and primary care.

The goal was to implement both SSPs during the July 2023 to June 2024 residency year. Other goals included tracking the quantity of supplies distributed, the number of patients reached, the impact of clinician education on the distribution of supplies, and comparing the implementation of the SSPs in the electronic health record (EHR) systems.

Alaska VA Healthcare System

An SOP was approved on December 20, 2023, and national supply kits were stocked in collaboration with the logistics department at the Anchorage AVAHCS campus. Social and behavioral health teams, primary care social workers, primary care clinicians, and nursing staff received training on the resources available through the SSP. A local adaptation of a template was created in the Computerized Patient Records System (CPRS) EHR. The template facilitates SSP kit distribution and patient screening for additional resources. Patients can engage with the SSP through any trained staff member. The staff member then completes the template and helps to distribute the SSP kit, in collaboration with the logistics department. The SSP does not operate in a dedicated physical space. The behavioral health team is most actively engaged in the SSP. The goal of SSP is to have resources available anywhere a patient requests services, including primary care and specialty clinics and to empower staff to meet patients’ needs. One patient has utilized the SSP as of June 2025.

Southern Oregon Healthcare System

Kits were ordered and stocked as pharmacy items in preparation for dispensing while awaiting medical center policy approval. Education began with the primary care mental health integration team. After initial education, an interdisciplinary presentation was given to VASOHCS clinicians to increase knowledge of the SSP. To enable documentation of SSP engagement, a local template was developed in the Cerner EHR to be shared among care team members at the facility. Similar to AVAHCS, the SSP does not have a physical space. All trained facility staff may engage in the SSP and distribute SSP kits. The workgroup that implemented this program remains available to support staff. Five patients have accessed the SSP since November 2024 and 7 SSP kits have been distributed as of June 2025.

Discussion

The SSP workgroups sought to expand the program through additional education. A number of factors should be considered when implementing an SSP. Across facilities, program implementation can be time-consuming and the timeline for administrative processes may be long. The workgroups met weekly or monthly depending on the status of the program and the administrative processes. Materials developed included SOP and MCP documents, a 1-page educational handout on SSP offerings, and a PowerPoint presentation for initial clinician education. Involving a pharmacy resident supported professional development and accelerated implementation timelines.

The facilities differed in implementation. AVAHCS collaborated with the logistics department to distribute kits, while VASOHCS worked with the Pharmacy service. A benefit of collaborating with logistics is that patients can receive a kit at the point of contact with the health care system, receiving it directly from the clinic the patient is visiting while eliminating the need to make an additional stop at the pharmacy. Conversely, partnering with the Pharmacy service allowed supply kits to be distributed by mail, enabling patients direct access to kits without having to present in-person. This is particularly valuable considering the large geographical area and remote care services available at VASOHCS.

Implementation varied significantly because AVAHCS operated on CPRS while VASOHCS used Cerner, a newer EHR. AVAHCS adapted a national template produced for CPRS sites, while VASOHCS had to prepare a local template (auto-text) for SSP documentation. Future plans at AVAHCS may include adding fentanyl test strips as an orderable item in the EHR given that AVAHCS has a local instance of CPRS; however, VASOHCS cannot order fentanyl test strips through the Pharmacy service due to legal restrictions. While Oregon permits fentanyl test strip use, the Cerner instance used by VA is a national program, and therefore the addition of fentanyl test strips as an orderable item in the EHR would carry national implications, including for VA health care systems in states where fentanyl test strip legality is variable. Despite the challenges, efforts to include fentanyl test strips in both SSPs are ongoing.

No significant EHR changes were needed to make the national supply kits available in the Cerner EHR through the VASOHCS Pharmacy service. To have national supply kits available through the AVAHCS Pharmacy service, the EHR would need to be manipulated by adding a local drug file in CPRS. Differences between the EHRs often facilitated the need for adaptation from existing models of SSPs within VA, which were all based in CPRS.

Conclusions

The implementation of SSPs at AVAHCS and VASOHCS enable clinicians to provide quality harm reduction services to PWUD. Despite variations in EHR systems, AVAHCS and VASOHCS implemented SSP within 1 year. Tracking of program engagement via the number of patients interacting with the program and the number of SSP kits distributed will continue. SSP implementation in states where it is permitted may help provide optimal patient care for PWUD.

A syringe services program (SSP) is a harm reduction strategy designed to improve the quality of care provided to people who use drugs (PWUD). SSPs not only provide sterile syringes but establish a connection to medical services and resources for the safe disposal of syringes. By engaging with an SSP, patients may receive naloxone, condoms, fentanyl test strips, opioid use disorder medications, vaccinations, or testing for infectious diseases such as HIV and hepatitis C virus (HCV). Patients may also be connected to housing or social work services.

SSPs do not lead to increased drug use,1 increased improperly disposed supplies needed for drug use in the community, or increased crime.2,3 New users of SSPs are 5 times more likely to enter treatment for drug use than those who do not use SSPs.4-8 Further, SSPs have been found to reduce HIV and HCV transmission and are cost-effective in HIV prevention.9-11

Syringe Services Program

SSPs were implemented at the US Department of Veterans Affairs (VA) Alaska VA Healthcare System (AVAHCS) and VA Southern Oregon Healthcare System (VASOHCS). AVAHCS provides outpatient care across Alaska, with sites in Anchorage, Fairbanks, Homer, Juneau, Wasilla, and Soldotna. VASOHCS provides outpatient care to Southern Oregon and Northern California, with sites in White City, Grants Pass, and Klamath Falls, Oregon. Both are part of Veterans Integrated Service Network 20

Workgroups at AVAHCS and VASOHCS developed SSPs to reduce risks associated with drug use, promote positive outcomes for PWUD, and increase availability of harm reduction resources. During the July 2023 to June 2024 pharmacy residency cycle, an ambulatory care pharmacy resident from the Veterans Integrated Services Network 20 Clinical Resource Hub—a regional resource for clinical services—joined the workgroups. The workgroups established a goal that SSP resources would be made available to enrolled patients without any exclusions, prioritizing health equity.

SSP implementation needed buy-in from AVAHCS and VASOHCS leadership and key stakeholders who could participate in the workgroups. Following AVAHCS and VASOHCS leadership approval, each facility workgroup drafted standard operating procedures (SOPs). Both facilities planned to implement the program using prepackaged kits (sterile syringes, alcohol pads, cotton swabs, a sharps container, and an educational brochure on safe injection practices) supplied by the VA National Harm Reduction Program.

Each SSP offered patients direct links to additional care options at the time of kit distribution, including information regarding medications/supplies (ie, hepatitis A/B vaccines, HIV preexposure prophylaxis, substance use disorder pharmacotherapy, naloxone, and condoms), laboratory tests for infectious and sexually transmitted diseases, and referrals to substance use disorder treatment, social work, suicide prevention, mental health, and primary care.

The goal was to implement both SSPs during the July 2023 to June 2024 residency year. Other goals included tracking the quantity of supplies distributed, the number of patients reached, the impact of clinician education on the distribution of supplies, and comparing the implementation of the SSPs in the electronic health record (EHR) systems.

Alaska VA Healthcare System

An SOP was approved on December 20, 2023, and national supply kits were stocked in collaboration with the logistics department at the Anchorage AVAHCS campus. Social and behavioral health teams, primary care social workers, primary care clinicians, and nursing staff received training on the resources available through the SSP. A local adaptation of a template was created in the Computerized Patient Records System (CPRS) EHR. The template facilitates SSP kit distribution and patient screening for additional resources. Patients can engage with the SSP through any trained staff member. The staff member then completes the template and helps to distribute the SSP kit, in collaboration with the logistics department. The SSP does not operate in a dedicated physical space. The behavioral health team is most actively engaged in the SSP. The goal of SSP is to have resources available anywhere a patient requests services, including primary care and specialty clinics and to empower staff to meet patients’ needs. One patient has utilized the SSP as of June 2025.

Southern Oregon Healthcare System

Kits were ordered and stocked as pharmacy items in preparation for dispensing while awaiting medical center policy approval. Education began with the primary care mental health integration team. After initial education, an interdisciplinary presentation was given to VASOHCS clinicians to increase knowledge of the SSP. To enable documentation of SSP engagement, a local template was developed in the Cerner EHR to be shared among care team members at the facility. Similar to AVAHCS, the SSP does not have a physical space. All trained facility staff may engage in the SSP and distribute SSP kits. The workgroup that implemented this program remains available to support staff. Five patients have accessed the SSP since November 2024 and 7 SSP kits have been distributed as of June 2025.

Discussion

The SSP workgroups sought to expand the program through additional education. A number of factors should be considered when implementing an SSP. Across facilities, program implementation can be time-consuming and the timeline for administrative processes may be long. The workgroups met weekly or monthly depending on the status of the program and the administrative processes. Materials developed included SOP and MCP documents, a 1-page educational handout on SSP offerings, and a PowerPoint presentation for initial clinician education. Involving a pharmacy resident supported professional development and accelerated implementation timelines.

The facilities differed in implementation. AVAHCS collaborated with the logistics department to distribute kits, while VASOHCS worked with the Pharmacy service. A benefit of collaborating with logistics is that patients can receive a kit at the point of contact with the health care system, receiving it directly from the clinic the patient is visiting while eliminating the need to make an additional stop at the pharmacy. Conversely, partnering with the Pharmacy service allowed supply kits to be distributed by mail, enabling patients direct access to kits without having to present in-person. This is particularly valuable considering the large geographical area and remote care services available at VASOHCS.

Implementation varied significantly because AVAHCS operated on CPRS while VASOHCS used Cerner, a newer EHR. AVAHCS adapted a national template produced for CPRS sites, while VASOHCS had to prepare a local template (auto-text) for SSP documentation. Future plans at AVAHCS may include adding fentanyl test strips as an orderable item in the EHR given that AVAHCS has a local instance of CPRS; however, VASOHCS cannot order fentanyl test strips through the Pharmacy service due to legal restrictions. While Oregon permits fentanyl test strip use, the Cerner instance used by VA is a national program, and therefore the addition of fentanyl test strips as an orderable item in the EHR would carry national implications, including for VA health care systems in states where fentanyl test strip legality is variable. Despite the challenges, efforts to include fentanyl test strips in both SSPs are ongoing.

No significant EHR changes were needed to make the national supply kits available in the Cerner EHR through the VASOHCS Pharmacy service. To have national supply kits available through the AVAHCS Pharmacy service, the EHR would need to be manipulated by adding a local drug file in CPRS. Differences between the EHRs often facilitated the need for adaptation from existing models of SSPs within VA, which were all based in CPRS.

Conclusions

The implementation of SSPs at AVAHCS and VASOHCS enable clinicians to provide quality harm reduction services to PWUD. Despite variations in EHR systems, AVAHCS and VASOHCS implemented SSP within 1 year. Tracking of program engagement via the number of patients interacting with the program and the number of SSP kits distributed will continue. SSP implementation in states where it is permitted may help provide optimal patient care for PWUD.

References
  1. Hagan H, McGough JP, Thiede H, Hopkins S, Duchin J, Alexander ER. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. J Subst Abuse Treat. 2000;19(3):247-252. doi:10.1016/s0740-5472(00)00104-5
  2. Marx MA, Crape B, Brookmeyer RS, et al. Trends in crime and the introduction of a needle exchange program. Am J Public Health. 2000;90(12):1933-1936. doi:10.2105/ajph.90.12.1933
  3. Galea S, Ahern J, Fuller C, Freudenberg N, Vlahov D. Needle exchange programs and experience of violence in an inner city neighborhood. J Acquir Immune Defic Syndr. 2001;28(3):282-288. doi:10.1097/00042560-200111010-00014
  4. Des Jarlais DC, Nugent A, Solberg A, Feelemyer J, Mermin J, Holtzman D. Syringe service programs for persons who inject drugs in urban, suburban, and rural areas — United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(48):1337-1341. doi:10.15585/ mmwr.mm6448a3
  5. Tookes HE, Kral AH, Wenger LD, et al. A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs. Drug Alcohol Depend. 2012;123(1-3):255-259. doi:10.1016/j.drugalcdep.2011.12.001
  6. Klein SJ, Candelas AR, Cooper JG, et al. Increasing safe syringe collection sites in New York State. Public Health Rep. 2008;123(4):433-440. doi:10.1177/003335490812300404
  7. de Montigny L, Vernez Moudon A, Leigh B, Kim SY. Assessing a drop box programme: a spatial analysis of discarded needles. Int J Drug Policy. 2010;21(3):208-214. doi:10.1016/j.drugpo.2009.07.003
  8. Bluthenthal RN, Anderson R, Flynn NM, Kral AH. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug Alcohol Depend. 2007;89(2-3):214-222. doi:10.1016/j.drugalcdep.2006.12.035
  9. Platt L, Minozzi S, Reed J, et al. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs. Cochrane Database Syst Rev. 2017;9(9):CD012021. doi:10.1002/14651858.CD012021.pub2
  10. Fernandes RM, Cary M, Duarte G, et al. Effectiveness of needle and syringe programmes in people who inject drugs — an overview of systematic reviews. BMC Public Health. 2017;17(1):309. doi:10.1186/s12889-017-4210-2
  11. Bernard CL, Owens DK, Goldhaber-Fiebert JD, Brandeau ML. Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: a model-based analysis. PLoS Med. 2017;14(5):e1002312. doi:10.1371/journal.pmed.1002312
References
  1. Hagan H, McGough JP, Thiede H, Hopkins S, Duchin J, Alexander ER. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. J Subst Abuse Treat. 2000;19(3):247-252. doi:10.1016/s0740-5472(00)00104-5
  2. Marx MA, Crape B, Brookmeyer RS, et al. Trends in crime and the introduction of a needle exchange program. Am J Public Health. 2000;90(12):1933-1936. doi:10.2105/ajph.90.12.1933
  3. Galea S, Ahern J, Fuller C, Freudenberg N, Vlahov D. Needle exchange programs and experience of violence in an inner city neighborhood. J Acquir Immune Defic Syndr. 2001;28(3):282-288. doi:10.1097/00042560-200111010-00014
  4. Des Jarlais DC, Nugent A, Solberg A, Feelemyer J, Mermin J, Holtzman D. Syringe service programs for persons who inject drugs in urban, suburban, and rural areas — United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(48):1337-1341. doi:10.15585/ mmwr.mm6448a3
  5. Tookes HE, Kral AH, Wenger LD, et al. A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs. Drug Alcohol Depend. 2012;123(1-3):255-259. doi:10.1016/j.drugalcdep.2011.12.001
  6. Klein SJ, Candelas AR, Cooper JG, et al. Increasing safe syringe collection sites in New York State. Public Health Rep. 2008;123(4):433-440. doi:10.1177/003335490812300404
  7. de Montigny L, Vernez Moudon A, Leigh B, Kim SY. Assessing a drop box programme: a spatial analysis of discarded needles. Int J Drug Policy. 2010;21(3):208-214. doi:10.1016/j.drugpo.2009.07.003
  8. Bluthenthal RN, Anderson R, Flynn NM, Kral AH. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug Alcohol Depend. 2007;89(2-3):214-222. doi:10.1016/j.drugalcdep.2006.12.035
  9. Platt L, Minozzi S, Reed J, et al. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs. Cochrane Database Syst Rev. 2017;9(9):CD012021. doi:10.1002/14651858.CD012021.pub2
  10. Fernandes RM, Cary M, Duarte G, et al. Effectiveness of needle and syringe programmes in people who inject drugs — an overview of systematic reviews. BMC Public Health. 2017;17(1):309. doi:10.1186/s12889-017-4210-2
  11. Bernard CL, Owens DK, Goldhaber-Fiebert JD, Brandeau ML. Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: a model-based analysis. PLoS Med. 2017;14(5):e1002312. doi:10.1371/journal.pmed.1002312
Issue
Federal Practitioner - 42(7)
Issue
Federal Practitioner - 42(7)
Page Number
261-263
Page Number
261-263
Publications
Publications
Topics
Article Type
Display Headline

Implementation of Harm Reduction Syringe Services Programs at 2 Veterans Affairs Medical Centers

Display Headline

Implementation of Harm Reduction Syringe Services Programs at 2 Veterans Affairs Medical Centers

Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
survey writer start date

VA Cancer Clinical Trials as a Strategy for Increasing Accrual of Racial and Ethnic Underrepresented Groups

Article Type
Changed

Background

Cancer clinical trials (CCTs) are central to improving cancer care. However, generalizability of findings from CCTs is difficult due to the lack of diversity in most United States CCTs. Clinical trial accrual of underrepresented groups, is low throughout the United States and is approximately 4-5% in most CCTs. Reasons for low accrual in this population are multifactorial. Despite numerous factors related to accruing racial and ethnic underrepresented groups, many institutions have sought to address these barriers. We conducted a scoping review to identify evidence-based approaches to increase participation in cancer treatment clinical trials.

Methods

We reviewed the Salisbury VA Medical Center Oncology clinical trial database from October 2019 to June 2024. The participants in these clinical trials required consent. These clinical trials included treatment interventional as well as non-treatment interventional. Fifteen studies were included and over 260 Veterans participated.

Results

Key themes emerged that included a focus on patient education, cultural competency, and building capacity in the clinics to care for the Veteran population at three separate sites in the Salisbury VA system. The Black Veteran accrual rate of 29% was achieved. This accrual rate is representative of our VA catchment population of 33% for Black Veterans, and is five times the national average.

Conclusions

The research team’s success in enrolling Black Veterans in clinical trials is attributed to several factors. The demographic composition of Veterans served by the Salisbury, Charlotte, and Kernersville VA provided a diverse population that included a 33% Black group. The type of clinical trials focused on patients who were most impacted by the disease. The VA did afford less barriers to access to health care.

Issue
Federal Practitioner - 41(suppl 4)
Publications
Topics
Page Number
S43
Sections

Background

Cancer clinical trials (CCTs) are central to improving cancer care. However, generalizability of findings from CCTs is difficult due to the lack of diversity in most United States CCTs. Clinical trial accrual of underrepresented groups, is low throughout the United States and is approximately 4-5% in most CCTs. Reasons for low accrual in this population are multifactorial. Despite numerous factors related to accruing racial and ethnic underrepresented groups, many institutions have sought to address these barriers. We conducted a scoping review to identify evidence-based approaches to increase participation in cancer treatment clinical trials.

Methods

We reviewed the Salisbury VA Medical Center Oncology clinical trial database from October 2019 to June 2024. The participants in these clinical trials required consent. These clinical trials included treatment interventional as well as non-treatment interventional. Fifteen studies were included and over 260 Veterans participated.

Results

Key themes emerged that included a focus on patient education, cultural competency, and building capacity in the clinics to care for the Veteran population at three separate sites in the Salisbury VA system. The Black Veteran accrual rate of 29% was achieved. This accrual rate is representative of our VA catchment population of 33% for Black Veterans, and is five times the national average.

Conclusions

The research team’s success in enrolling Black Veterans in clinical trials is attributed to several factors. The demographic composition of Veterans served by the Salisbury, Charlotte, and Kernersville VA provided a diverse population that included a 33% Black group. The type of clinical trials focused on patients who were most impacted by the disease. The VA did afford less barriers to access to health care.

Background

Cancer clinical trials (CCTs) are central to improving cancer care. However, generalizability of findings from CCTs is difficult due to the lack of diversity in most United States CCTs. Clinical trial accrual of underrepresented groups, is low throughout the United States and is approximately 4-5% in most CCTs. Reasons for low accrual in this population are multifactorial. Despite numerous factors related to accruing racial and ethnic underrepresented groups, many institutions have sought to address these barriers. We conducted a scoping review to identify evidence-based approaches to increase participation in cancer treatment clinical trials.

Methods

We reviewed the Salisbury VA Medical Center Oncology clinical trial database from October 2019 to June 2024. The participants in these clinical trials required consent. These clinical trials included treatment interventional as well as non-treatment interventional. Fifteen studies were included and over 260 Veterans participated.

Results

Key themes emerged that included a focus on patient education, cultural competency, and building capacity in the clinics to care for the Veteran population at three separate sites in the Salisbury VA system. The Black Veteran accrual rate of 29% was achieved. This accrual rate is representative of our VA catchment population of 33% for Black Veterans, and is five times the national average.

Conclusions

The research team’s success in enrolling Black Veterans in clinical trials is attributed to several factors. The demographic composition of Veterans served by the Salisbury, Charlotte, and Kernersville VA provided a diverse population that included a 33% Black group. The type of clinical trials focused on patients who were most impacted by the disease. The VA did afford less barriers to access to health care.

Issue
Federal Practitioner - 41(suppl 4)
Issue
Federal Practitioner - 41(suppl 4)
Page Number
S43
Page Number
S43
Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Eyebrow Default
Research
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
survey writer start date

Improving Colorectal Cancer Screening via Mailed Fecal Immunochemical Testing in a Veterans Affairs Health System

Article Type
Changed

Colorectal cancer (CRC) is among the most common cancers and causes of cancer-related deaths in the United States.1 Reflective of a nationwide trend, CRC screening rates at the Veterans Affairs Connecticut Healthcare System (VACHS) decreased during the COVID-19 pandemic.2-5 Contributing factors to this decrease included cancellations of elective colonoscopies during the initial phase of the pandemic and concurrent turnover of endoscopists. In 2021, the US Preventive Services Task Force lowered the recommended initial CRC screening age from 50 years to 45 years, further increasing the backlog of unscreened patients.6

Fecal immunochemical testing (FIT) is a noninvasive screening method in which antibodies are used to detect hemoglobin in the stool. The sensitivity and specificity of 1-time FIT are 79% to 80% and 94%, respectively, for the detection of CRC, with sensitivity improving with successive testing.7,8 Annual FIT is recognized as a tier 1 preferred screening method by the US Multi-Society Task Force on Colorectal Cancer.7,9 Programs that mail FIT kits to eligible patients outside of physician visits have been successfully implemented in health care systems.10,11

The VACHS designed and implemented a mailed FIT program using existing infrastructure and staffing.

 

Program Description

A team of local stakeholders comprised of VACHS leadership, primary care, nursing, and gastroenterology staff, as well as representatives from laboratory, informatics, mail services, and group practice management, was established to execute the project. The team met monthly to plan the project.

The team developed a dataset consisting of patients aged 45 to 75 years who were at average risk for CRC and due for CRC screening. Patients were defined as due for CRC screening if they had not had a colonoscopy in the previous 9 years or a FIT or fecal occult blood test in the previous 11 months. Average risk for CRC was defined by excluding patients with associated diagnosis codes for CRC, colectomy, inflammatory bowel disease, and anemia. The program also excluded patients with diagnosis codes associated with dementia, deferring discussions about cancer screening to their primary care practitioners (PCPs). Patients with invalid mailing addresses were also excluded, as well as those whose PCPs had indicated in the electronic health record that the patient received CRC screening outside the US Department of Veterans Affairs (VA) system.

 

 

Letter Templates

Two patient letter electronic health record templates were developed. The first was a primer letter, which was mailed to patients 2 to 3 weeks before the mailed FIT kit as an introduction to the program.12 The purpose of the primer letter was to give advance notice to patients that they could expect a FIT kit to arrive in the mail. The goal was to prepare patients to complete FIT when the kit arrived and prompt them to call the VA to opt out of the mailed FIT program if they were up to date with CRC screening or if they had a condition which made them at high risk for CRC.

The second FIT letter arrived with the FIT kit, introduced FIT and described the importance of CRC screening. The letter detailed instructions for completing FIT and automatically created a FIT order. It also included a list of common conditions that may exclude patients, with a recommendation for patients to contact their medical team if they felt they were not candidates for FIT.

Staff Education

A previous VACHS pilot project demonstrated the success of a mailed FIT program to increase FIT use. Implemented as part of the pilot program, staff education consisted of a session for clinicians about the role of FIT in CRC screening and an all-staff education session. An additional education session about CRC and FIT for all staff was repeated with the program launch.

 

Program Launch

The mailed FIT program was introduced during a VACHS primary care all-staff meeting. After the meeting, each patient aligned care team (PACT) received an encrypted email that included a list of the patients on their team who were candidates for the program, a patient-facing FIT instruction sheet, detailed instructions on how to send the FIT primer letter, and a FIT package consisting of the labeled FIT kit, FIT letter, and patient instruction sheet. A reminder letter was sent to each patient 3 weeks after the FIT package was mailed. The patient lists were populated into a shared, encrypted Microsoft Teams folder that was edited in real time by PACT teams and viewed by VACHS leadership to track progress.

Program Metrics

At program launch, the VACHS had 4642 patients due for CRC screening who were eligible for the mailed FIT program. On March 7, 2023, the data consisting of FIT tests ordered between December 2022 and May 2023—3 months before and after the launch of the program—were reviewed and categorized. In the 3 months before program launch, 1528 FIT were ordered and 714 were returned (46.7%). In the 3 months after the launch of the program, 4383 FIT were ordered and 1712 were returned (39.1%) (Figure). Test orders increased 287% from the preintervention to the postintervention period. The mean (SD) number of monthly FIT tests prelaunch was 509 (32.7), which increased to 1461 (331.6) postlaunch.

At the VACHS, 61.4% of patients aged 45 to 75 years were up to date with CRC screening before the program launch. In the 3 months after program launch, the rate increased to 63.8% among patients aged 45 to 75 years, the highest rate in our Veterans Integrated Services Network and exceeding the VA national average CRC screening rate, according to unpublished VA Monthly Management Report data.

In the 3 months following the program launch, 139 FIT kits tested positive for potential CRC. Of these, 79 (56.8%) patients had completed a diagnostic colonoscopy. PACT PCPs and nurses received reports on patients with positive FIT tests and those with no colonoscopy scheduled or completed and were asked to follow up.

 

 

Discussion

Through a proactive, population-based CRC screening program centered on mailed FIT kits outside of the traditional patient visit, the VACHS increased the use of FIT and rates of CRC screening. The numbers of FIT kits ordered and completed substantially increased in the 3 months after program launch.

Compared to mailed FIT programs described in the literature that rely on centralized processes in that a separate team operates the mailed FIT program for the entire organization, this program used existing PACT infrastructure and staff.10,11 This strategy allowed VACHS to design and implement the program in several months. Not needing to hire new staff or create a central team for the sole purpose of implementing the program allowed us to save on any organizational funding and efforts that would have accompanied the additional staff. The program described in this article may be more attainable for primary care practices or smaller health systems that do not have the capacity for the creation of a centralized process.

Limitations

Although the total number of FIT completions substantially increased during the program, the rate of FIT completion during the mailed FIT program was lower than the rate of completion prior to program launch. This decreased rate of FIT kit completion may be related to separation from a patient visit and potential loss of real-time education with a clinician. The program’s decentralized design increased the existing workload for primary care staff, and as a result, consideration must be given to local staffing levels. Additionally, the report of eligible patients depended on diagnosis codes and may have captured patients with higher-than-average risk of CRC, such as patients with prior history of adenomatous polyps, family history of CRC, or other medical or genetic conditions. We attempted to mitigate this by including a list of conditions that would exclude patients from FIT eligibility in the FIT letter and giving them the option to opt out.

Conclusions

CRC screening rates improved following implementation of a primary care team-centered quality improvement process to proactively identify patients appropriate for FIT and mail them FIT kits. This project highlights that population-health interventions around CRC screening via use of FIT can be successful within a primary care patient-centered medical home model, considering the increases in both CRC screening rates and increase in FIT tests ordered.

References

1. American Cancer Society. Key statistics for colorectal cancer. Revised January 29, 2024. Accessed June 11, 2024. https://www.cancer.org/cancer/types/colon-rectal-cancer/about/key-statistics.html

2. Chen RC, Haynes K, Du S, Barron J, Katz AJ. Association of cancer screening deficit in the United States with the COVID-19 pandemic. JAMA Oncol. 2021;7(6):878-884. doi:10.1001/jamaoncol.2021.0884

3. Mazidimoradi A, Tiznobaik A, Salehiniya H. Impact of the COVID-19 pandemic on colorectal cancer screening: a systematic review. J Gastrointest Cancer. 2022;53(3):730-744. doi:10.1007/s12029-021-00679-x

4. Adams MA, Kurlander JE, Gao Y, Yankey N, Saini SD. Impact of coronavirus disease 2019 on screening colonoscopy utilization in a large integrated health system. Gastroenterology. 2022;162(7):2098-2100.e2. doi:10.1053/j.gastro.2022.02.034

5. Sundaram S, Olson S, Sharma P, Rajendra S. A review of the impact of the COVID-19 pandemic on colorectal cancer screening: implications and solutions. Pathogens. 2021;10(11):558. doi:10.3390/pathogens10111508

6. US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(19):1965-1977. doi:10.1001/jama.2021.6238

7. Robertson DJ, Lee JK, Boland CR, et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2017;85(1):2-21.e3. doi:10.1016/j.gie.2016.09.025

8. Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160(3):171. doi:10.7326/M13-1484

9. Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017;153(1):307-323. doi:10.1053/j.gastro.2017.05.013

10. Deeds SA, Moore CB, Gunnink EJ, et al. Implementation of a mailed faecal immunochemical test programme for colorectal cancer screening among veterans. BMJ Open Qual. 2022;11(4):e001927. doi:10.1136/bmjoq-2022-001927

11. Selby K, Jensen CD, Levin TR, et al. Program components and results from an organized colorectal cancer screening program using annual fecal immunochemical testing. Clin Gastroenterol Hepatol. 2022;20(1):145-152. doi:10.1016/j.cgh.2020.09.042

12. Deeds S, Liu T, Schuttner L, et al. A postcard primer prior to mailed fecal immunochemical test among veterans: a randomized controlled trial. J Gen Intern Med. 2023:38(14):3235-3241. doi:10.1007/s11606-023-08248-7

Article PDF
Author and Disclosure Information

Jin Xu, MDa,b; Jeffrey Kravetz, MDa,b; Juliette Spelman, MDa,b; Kimberley Roy, MSNa; Vincent Lilly, RNa; Danielle Cosentinoa;  Christopher Ruser, MDa,b

Correspondence:  Jin Xu  (jin.xu@yale.edu)

aVeterans Affairs Connecticut Healthcare System, West Haven

bYale University School of Medicine, New Haven, Connecticut

Author disclosures

The authors report no actual or potential conflicts of interest or outside sources of funding with regard to this article.

Disclaimer

The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies.

Ethics and consent

This quality improvement project was not reviewed by an institutional review board.

Issue
Federal Practitioner - 41(suppl 3)
Publications
Topics
Page Number
S39-S42
Sections
Author and Disclosure Information

Jin Xu, MDa,b; Jeffrey Kravetz, MDa,b; Juliette Spelman, MDa,b; Kimberley Roy, MSNa; Vincent Lilly, RNa; Danielle Cosentinoa;  Christopher Ruser, MDa,b

Correspondence:  Jin Xu  (jin.xu@yale.edu)

aVeterans Affairs Connecticut Healthcare System, West Haven

bYale University School of Medicine, New Haven, Connecticut

Author disclosures

The authors report no actual or potential conflicts of interest or outside sources of funding with regard to this article.

Disclaimer

The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies.

Ethics and consent

This quality improvement project was not reviewed by an institutional review board.

Author and Disclosure Information

Jin Xu, MDa,b; Jeffrey Kravetz, MDa,b; Juliette Spelman, MDa,b; Kimberley Roy, MSNa; Vincent Lilly, RNa; Danielle Cosentinoa;  Christopher Ruser, MDa,b

Correspondence:  Jin Xu  (jin.xu@yale.edu)

aVeterans Affairs Connecticut Healthcare System, West Haven

bYale University School of Medicine, New Haven, Connecticut

Author disclosures

The authors report no actual or potential conflicts of interest or outside sources of funding with regard to this article.

Disclaimer

The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies.

Ethics and consent

This quality improvement project was not reviewed by an institutional review board.

Article PDF
Article PDF

Colorectal cancer (CRC) is among the most common cancers and causes of cancer-related deaths in the United States.1 Reflective of a nationwide trend, CRC screening rates at the Veterans Affairs Connecticut Healthcare System (VACHS) decreased during the COVID-19 pandemic.2-5 Contributing factors to this decrease included cancellations of elective colonoscopies during the initial phase of the pandemic and concurrent turnover of endoscopists. In 2021, the US Preventive Services Task Force lowered the recommended initial CRC screening age from 50 years to 45 years, further increasing the backlog of unscreened patients.6

Fecal immunochemical testing (FIT) is a noninvasive screening method in which antibodies are used to detect hemoglobin in the stool. The sensitivity and specificity of 1-time FIT are 79% to 80% and 94%, respectively, for the detection of CRC, with sensitivity improving with successive testing.7,8 Annual FIT is recognized as a tier 1 preferred screening method by the US Multi-Society Task Force on Colorectal Cancer.7,9 Programs that mail FIT kits to eligible patients outside of physician visits have been successfully implemented in health care systems.10,11

The VACHS designed and implemented a mailed FIT program using existing infrastructure and staffing.

 

Program Description

A team of local stakeholders comprised of VACHS leadership, primary care, nursing, and gastroenterology staff, as well as representatives from laboratory, informatics, mail services, and group practice management, was established to execute the project. The team met monthly to plan the project.

The team developed a dataset consisting of patients aged 45 to 75 years who were at average risk for CRC and due for CRC screening. Patients were defined as due for CRC screening if they had not had a colonoscopy in the previous 9 years or a FIT or fecal occult blood test in the previous 11 months. Average risk for CRC was defined by excluding patients with associated diagnosis codes for CRC, colectomy, inflammatory bowel disease, and anemia. The program also excluded patients with diagnosis codes associated with dementia, deferring discussions about cancer screening to their primary care practitioners (PCPs). Patients with invalid mailing addresses were also excluded, as well as those whose PCPs had indicated in the electronic health record that the patient received CRC screening outside the US Department of Veterans Affairs (VA) system.

 

 

Letter Templates

Two patient letter electronic health record templates were developed. The first was a primer letter, which was mailed to patients 2 to 3 weeks before the mailed FIT kit as an introduction to the program.12 The purpose of the primer letter was to give advance notice to patients that they could expect a FIT kit to arrive in the mail. The goal was to prepare patients to complete FIT when the kit arrived and prompt them to call the VA to opt out of the mailed FIT program if they were up to date with CRC screening or if they had a condition which made them at high risk for CRC.

The second FIT letter arrived with the FIT kit, introduced FIT and described the importance of CRC screening. The letter detailed instructions for completing FIT and automatically created a FIT order. It also included a list of common conditions that may exclude patients, with a recommendation for patients to contact their medical team if they felt they were not candidates for FIT.

Staff Education

A previous VACHS pilot project demonstrated the success of a mailed FIT program to increase FIT use. Implemented as part of the pilot program, staff education consisted of a session for clinicians about the role of FIT in CRC screening and an all-staff education session. An additional education session about CRC and FIT for all staff was repeated with the program launch.

 

Program Launch

The mailed FIT program was introduced during a VACHS primary care all-staff meeting. After the meeting, each patient aligned care team (PACT) received an encrypted email that included a list of the patients on their team who were candidates for the program, a patient-facing FIT instruction sheet, detailed instructions on how to send the FIT primer letter, and a FIT package consisting of the labeled FIT kit, FIT letter, and patient instruction sheet. A reminder letter was sent to each patient 3 weeks after the FIT package was mailed. The patient lists were populated into a shared, encrypted Microsoft Teams folder that was edited in real time by PACT teams and viewed by VACHS leadership to track progress.

Program Metrics

At program launch, the VACHS had 4642 patients due for CRC screening who were eligible for the mailed FIT program. On March 7, 2023, the data consisting of FIT tests ordered between December 2022 and May 2023—3 months before and after the launch of the program—were reviewed and categorized. In the 3 months before program launch, 1528 FIT were ordered and 714 were returned (46.7%). In the 3 months after the launch of the program, 4383 FIT were ordered and 1712 were returned (39.1%) (Figure). Test orders increased 287% from the preintervention to the postintervention period. The mean (SD) number of monthly FIT tests prelaunch was 509 (32.7), which increased to 1461 (331.6) postlaunch.

At the VACHS, 61.4% of patients aged 45 to 75 years were up to date with CRC screening before the program launch. In the 3 months after program launch, the rate increased to 63.8% among patients aged 45 to 75 years, the highest rate in our Veterans Integrated Services Network and exceeding the VA national average CRC screening rate, according to unpublished VA Monthly Management Report data.

In the 3 months following the program launch, 139 FIT kits tested positive for potential CRC. Of these, 79 (56.8%) patients had completed a diagnostic colonoscopy. PACT PCPs and nurses received reports on patients with positive FIT tests and those with no colonoscopy scheduled or completed and were asked to follow up.

 

 

Discussion

Through a proactive, population-based CRC screening program centered on mailed FIT kits outside of the traditional patient visit, the VACHS increased the use of FIT and rates of CRC screening. The numbers of FIT kits ordered and completed substantially increased in the 3 months after program launch.

Compared to mailed FIT programs described in the literature that rely on centralized processes in that a separate team operates the mailed FIT program for the entire organization, this program used existing PACT infrastructure and staff.10,11 This strategy allowed VACHS to design and implement the program in several months. Not needing to hire new staff or create a central team for the sole purpose of implementing the program allowed us to save on any organizational funding and efforts that would have accompanied the additional staff. The program described in this article may be more attainable for primary care practices or smaller health systems that do not have the capacity for the creation of a centralized process.

Limitations

Although the total number of FIT completions substantially increased during the program, the rate of FIT completion during the mailed FIT program was lower than the rate of completion prior to program launch. This decreased rate of FIT kit completion may be related to separation from a patient visit and potential loss of real-time education with a clinician. The program’s decentralized design increased the existing workload for primary care staff, and as a result, consideration must be given to local staffing levels. Additionally, the report of eligible patients depended on diagnosis codes and may have captured patients with higher-than-average risk of CRC, such as patients with prior history of adenomatous polyps, family history of CRC, or other medical or genetic conditions. We attempted to mitigate this by including a list of conditions that would exclude patients from FIT eligibility in the FIT letter and giving them the option to opt out.

Conclusions

CRC screening rates improved following implementation of a primary care team-centered quality improvement process to proactively identify patients appropriate for FIT and mail them FIT kits. This project highlights that population-health interventions around CRC screening via use of FIT can be successful within a primary care patient-centered medical home model, considering the increases in both CRC screening rates and increase in FIT tests ordered.

Colorectal cancer (CRC) is among the most common cancers and causes of cancer-related deaths in the United States.1 Reflective of a nationwide trend, CRC screening rates at the Veterans Affairs Connecticut Healthcare System (VACHS) decreased during the COVID-19 pandemic.2-5 Contributing factors to this decrease included cancellations of elective colonoscopies during the initial phase of the pandemic and concurrent turnover of endoscopists. In 2021, the US Preventive Services Task Force lowered the recommended initial CRC screening age from 50 years to 45 years, further increasing the backlog of unscreened patients.6

Fecal immunochemical testing (FIT) is a noninvasive screening method in which antibodies are used to detect hemoglobin in the stool. The sensitivity and specificity of 1-time FIT are 79% to 80% and 94%, respectively, for the detection of CRC, with sensitivity improving with successive testing.7,8 Annual FIT is recognized as a tier 1 preferred screening method by the US Multi-Society Task Force on Colorectal Cancer.7,9 Programs that mail FIT kits to eligible patients outside of physician visits have been successfully implemented in health care systems.10,11

The VACHS designed and implemented a mailed FIT program using existing infrastructure and staffing.

 

Program Description

A team of local stakeholders comprised of VACHS leadership, primary care, nursing, and gastroenterology staff, as well as representatives from laboratory, informatics, mail services, and group practice management, was established to execute the project. The team met monthly to plan the project.

The team developed a dataset consisting of patients aged 45 to 75 years who were at average risk for CRC and due for CRC screening. Patients were defined as due for CRC screening if they had not had a colonoscopy in the previous 9 years or a FIT or fecal occult blood test in the previous 11 months. Average risk for CRC was defined by excluding patients with associated diagnosis codes for CRC, colectomy, inflammatory bowel disease, and anemia. The program also excluded patients with diagnosis codes associated with dementia, deferring discussions about cancer screening to their primary care practitioners (PCPs). Patients with invalid mailing addresses were also excluded, as well as those whose PCPs had indicated in the electronic health record that the patient received CRC screening outside the US Department of Veterans Affairs (VA) system.

 

 

Letter Templates

Two patient letter electronic health record templates were developed. The first was a primer letter, which was mailed to patients 2 to 3 weeks before the mailed FIT kit as an introduction to the program.12 The purpose of the primer letter was to give advance notice to patients that they could expect a FIT kit to arrive in the mail. The goal was to prepare patients to complete FIT when the kit arrived and prompt them to call the VA to opt out of the mailed FIT program if they were up to date with CRC screening or if they had a condition which made them at high risk for CRC.

The second FIT letter arrived with the FIT kit, introduced FIT and described the importance of CRC screening. The letter detailed instructions for completing FIT and automatically created a FIT order. It also included a list of common conditions that may exclude patients, with a recommendation for patients to contact their medical team if they felt they were not candidates for FIT.

Staff Education

A previous VACHS pilot project demonstrated the success of a mailed FIT program to increase FIT use. Implemented as part of the pilot program, staff education consisted of a session for clinicians about the role of FIT in CRC screening and an all-staff education session. An additional education session about CRC and FIT for all staff was repeated with the program launch.

 

Program Launch

The mailed FIT program was introduced during a VACHS primary care all-staff meeting. After the meeting, each patient aligned care team (PACT) received an encrypted email that included a list of the patients on their team who were candidates for the program, a patient-facing FIT instruction sheet, detailed instructions on how to send the FIT primer letter, and a FIT package consisting of the labeled FIT kit, FIT letter, and patient instruction sheet. A reminder letter was sent to each patient 3 weeks after the FIT package was mailed. The patient lists were populated into a shared, encrypted Microsoft Teams folder that was edited in real time by PACT teams and viewed by VACHS leadership to track progress.

Program Metrics

At program launch, the VACHS had 4642 patients due for CRC screening who were eligible for the mailed FIT program. On March 7, 2023, the data consisting of FIT tests ordered between December 2022 and May 2023—3 months before and after the launch of the program—were reviewed and categorized. In the 3 months before program launch, 1528 FIT were ordered and 714 were returned (46.7%). In the 3 months after the launch of the program, 4383 FIT were ordered and 1712 were returned (39.1%) (Figure). Test orders increased 287% from the preintervention to the postintervention period. The mean (SD) number of monthly FIT tests prelaunch was 509 (32.7), which increased to 1461 (331.6) postlaunch.

At the VACHS, 61.4% of patients aged 45 to 75 years were up to date with CRC screening before the program launch. In the 3 months after program launch, the rate increased to 63.8% among patients aged 45 to 75 years, the highest rate in our Veterans Integrated Services Network and exceeding the VA national average CRC screening rate, according to unpublished VA Monthly Management Report data.

In the 3 months following the program launch, 139 FIT kits tested positive for potential CRC. Of these, 79 (56.8%) patients had completed a diagnostic colonoscopy. PACT PCPs and nurses received reports on patients with positive FIT tests and those with no colonoscopy scheduled or completed and were asked to follow up.

 

 

Discussion

Through a proactive, population-based CRC screening program centered on mailed FIT kits outside of the traditional patient visit, the VACHS increased the use of FIT and rates of CRC screening. The numbers of FIT kits ordered and completed substantially increased in the 3 months after program launch.

Compared to mailed FIT programs described in the literature that rely on centralized processes in that a separate team operates the mailed FIT program for the entire organization, this program used existing PACT infrastructure and staff.10,11 This strategy allowed VACHS to design and implement the program in several months. Not needing to hire new staff or create a central team for the sole purpose of implementing the program allowed us to save on any organizational funding and efforts that would have accompanied the additional staff. The program described in this article may be more attainable for primary care practices or smaller health systems that do not have the capacity for the creation of a centralized process.

Limitations

Although the total number of FIT completions substantially increased during the program, the rate of FIT completion during the mailed FIT program was lower than the rate of completion prior to program launch. This decreased rate of FIT kit completion may be related to separation from a patient visit and potential loss of real-time education with a clinician. The program’s decentralized design increased the existing workload for primary care staff, and as a result, consideration must be given to local staffing levels. Additionally, the report of eligible patients depended on diagnosis codes and may have captured patients with higher-than-average risk of CRC, such as patients with prior history of adenomatous polyps, family history of CRC, or other medical or genetic conditions. We attempted to mitigate this by including a list of conditions that would exclude patients from FIT eligibility in the FIT letter and giving them the option to opt out.

Conclusions

CRC screening rates improved following implementation of a primary care team-centered quality improvement process to proactively identify patients appropriate for FIT and mail them FIT kits. This project highlights that population-health interventions around CRC screening via use of FIT can be successful within a primary care patient-centered medical home model, considering the increases in both CRC screening rates and increase in FIT tests ordered.

References

1. American Cancer Society. Key statistics for colorectal cancer. Revised January 29, 2024. Accessed June 11, 2024. https://www.cancer.org/cancer/types/colon-rectal-cancer/about/key-statistics.html

2. Chen RC, Haynes K, Du S, Barron J, Katz AJ. Association of cancer screening deficit in the United States with the COVID-19 pandemic. JAMA Oncol. 2021;7(6):878-884. doi:10.1001/jamaoncol.2021.0884

3. Mazidimoradi A, Tiznobaik A, Salehiniya H. Impact of the COVID-19 pandemic on colorectal cancer screening: a systematic review. J Gastrointest Cancer. 2022;53(3):730-744. doi:10.1007/s12029-021-00679-x

4. Adams MA, Kurlander JE, Gao Y, Yankey N, Saini SD. Impact of coronavirus disease 2019 on screening colonoscopy utilization in a large integrated health system. Gastroenterology. 2022;162(7):2098-2100.e2. doi:10.1053/j.gastro.2022.02.034

5. Sundaram S, Olson S, Sharma P, Rajendra S. A review of the impact of the COVID-19 pandemic on colorectal cancer screening: implications and solutions. Pathogens. 2021;10(11):558. doi:10.3390/pathogens10111508

6. US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(19):1965-1977. doi:10.1001/jama.2021.6238

7. Robertson DJ, Lee JK, Boland CR, et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2017;85(1):2-21.e3. doi:10.1016/j.gie.2016.09.025

8. Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160(3):171. doi:10.7326/M13-1484

9. Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017;153(1):307-323. doi:10.1053/j.gastro.2017.05.013

10. Deeds SA, Moore CB, Gunnink EJ, et al. Implementation of a mailed faecal immunochemical test programme for colorectal cancer screening among veterans. BMJ Open Qual. 2022;11(4):e001927. doi:10.1136/bmjoq-2022-001927

11. Selby K, Jensen CD, Levin TR, et al. Program components and results from an organized colorectal cancer screening program using annual fecal immunochemical testing. Clin Gastroenterol Hepatol. 2022;20(1):145-152. doi:10.1016/j.cgh.2020.09.042

12. Deeds S, Liu T, Schuttner L, et al. A postcard primer prior to mailed fecal immunochemical test among veterans: a randomized controlled trial. J Gen Intern Med. 2023:38(14):3235-3241. doi:10.1007/s11606-023-08248-7

References

1. American Cancer Society. Key statistics for colorectal cancer. Revised January 29, 2024. Accessed June 11, 2024. https://www.cancer.org/cancer/types/colon-rectal-cancer/about/key-statistics.html

2. Chen RC, Haynes K, Du S, Barron J, Katz AJ. Association of cancer screening deficit in the United States with the COVID-19 pandemic. JAMA Oncol. 2021;7(6):878-884. doi:10.1001/jamaoncol.2021.0884

3. Mazidimoradi A, Tiznobaik A, Salehiniya H. Impact of the COVID-19 pandemic on colorectal cancer screening: a systematic review. J Gastrointest Cancer. 2022;53(3):730-744. doi:10.1007/s12029-021-00679-x

4. Adams MA, Kurlander JE, Gao Y, Yankey N, Saini SD. Impact of coronavirus disease 2019 on screening colonoscopy utilization in a large integrated health system. Gastroenterology. 2022;162(7):2098-2100.e2. doi:10.1053/j.gastro.2022.02.034

5. Sundaram S, Olson S, Sharma P, Rajendra S. A review of the impact of the COVID-19 pandemic on colorectal cancer screening: implications and solutions. Pathogens. 2021;10(11):558. doi:10.3390/pathogens10111508

6. US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(19):1965-1977. doi:10.1001/jama.2021.6238

7. Robertson DJ, Lee JK, Boland CR, et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2017;85(1):2-21.e3. doi:10.1016/j.gie.2016.09.025

8. Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160(3):171. doi:10.7326/M13-1484

9. Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017;153(1):307-323. doi:10.1053/j.gastro.2017.05.013

10. Deeds SA, Moore CB, Gunnink EJ, et al. Implementation of a mailed faecal immunochemical test programme for colorectal cancer screening among veterans. BMJ Open Qual. 2022;11(4):e001927. doi:10.1136/bmjoq-2022-001927

11. Selby K, Jensen CD, Levin TR, et al. Program components and results from an organized colorectal cancer screening program using annual fecal immunochemical testing. Clin Gastroenterol Hepatol. 2022;20(1):145-152. doi:10.1016/j.cgh.2020.09.042

12. Deeds S, Liu T, Schuttner L, et al. A postcard primer prior to mailed fecal immunochemical test among veterans: a randomized controlled trial. J Gen Intern Med. 2023:38(14):3235-3241. doi:10.1007/s11606-023-08248-7

Issue
Federal Practitioner - 41(suppl 3)
Issue
Federal Practitioner - 41(suppl 3)
Page Number
S39-S42
Page Number
S39-S42
Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
survey writer start date
Article PDF Media

An Opportunity to Provide High-Quality Training and Care: Use of Telesupervision and Reflection on Practices

Article Type
Changed
Display Headline

An Opportunity to Provide High-Quality Training and Care: Use of Telesupervision and Reflection on Practices

Rural populations experience more health care disparities than urban populations, including a greater proportion of adults aged ≥ 65 years, higher poverty, and a higher prevalence of chronic comorbidities. Reported rates vary by study methodology and over time.1 These disparities are further exacerbated by reduced access to health care practitioners (HCPs), particularly physical and mental health specialty services, and a lack of rural health care facilities.1 HCP training programs are primarily located in urban settings and may heavily influence the geographical location and population focus of newly trained HCPs’ first positions.2 As the largest provider of health professions training, the US Department of Veterans Affairs (VA) can innovate to improve the quality of education and training while supporting rural health care sustainability and health care workforce retention.3,4 

One such innovation is expanding the implementation of telesupervision (ie, clinical supervision delivered via synchronous audio and video formats) for health professions trainees. During the COVID-19 pandemic, the literature documenting telesupervision substantially expanded across health care disciplines. These findings support telesupervision as a feasible alternative to traditional in-person supervision and suggest increased trainee comfort with telehealth use.5,6 The literature also provides insight into considerations for the use of telesupervision, including being more intentional in the development of the supervisory relationship,6-8 and enabling appropriate access to supervisors to support quality patient care and experiential learning.9,10 

This quality improvement examination of telesupervision in 11 rural VA psychology training programs spanned 3 years and included 3197 monthly surveys completed by supervisors and trainees. It supported the use of telesupervision compared with in-person or mixed modality supervision across a wide range of outcomes in upholding patient safety and maintaining the quality of supervision while also expanding trainees’ comfort in implementing telehealth care. The Table summarizes how frequently supervisors observed trainees providing clinical care via live observation, video or tape reviews, or conducting cotherapy. The clinical sessions for most trainees (70.3%) were directly observed by supervisors at least monthly across all methods. We also reviewed differences in Supervisory Working Alliance Inventory (SWAI) scores, which quantify the strength of the working relationship between trainees and supervisors, across 458 rotations by position (trainee vs supervisor) and rurality (rural vs urban sites). Overall, alliance was high with mean scores of 5.5 to 6.7 on a 7-point scale. While trainees tended to report higher alliance (P < .001), there were no differences by rurality (P = .06) or the rurality × position interaction (P = .08), and the marginally significant effects were small, indicating that rurality tended to attenuate position effects (Figure). Additional analyses of modality (in-person, telesupervision, or mixed modalities) indicated no differences. Thus, trainee and supervisor data from this project identified safe, high-quality, and consistent supervisory practices. Finally, additional data highlighted the potential benefits of a mixed-modality supervision, including both in-person supervision and telesupervision.11,12 

The expanded use of telesupervision provides several new opportunities for rural health care clinical supervisors, trainees, and veterans. Clinical supervisors who would otherwise operate as the sole HCP within their discipline or specialty at a remote clinic can increase their professional connection to a main facility and/or larger professional organization by serving as a clinical supervisor within a training program via telesupervision. This creates a greater connection to the larger mission, thereby supporting the clinical supervisor’s potential retention in their work setting.10 

FIGURE. Mean Supervisory Working Alliance Inventory Scores and 95% CIs, based on 458 rotations by position and rurality. 

Telesupervision expands the opportunity for health professions trainees to be clinically supervised by individuals with the cultural knowledge specific to the patient population served (ie, those individuals working within or knowledgeable about the particular rural setting). This supports higher quality training and patient care, even if the trainee’s primary physical location is not colocated with the clinical supervisor. 

Telesupervision can expand the number of clinical supervisors and rotations available within a health care system or clinic, particularly for specialty services (eg, psychological testing, dermatology) that are not otherwise available within specific geographic regions. Thus, telesupervision enables a supervisor with the needed expertise, specialty, or advanced training at one clinic to supervise a trainee located hundreds to thousands of miles away while serving a veteran who may or may not be colocated with either HCP. For example, the supervisor may be located in American Samoa, supervising a trainee physically residing in Hawaii who provides telehealth patient care to a veteran in Saipan. This also enables health care systems serving rural patient populations to bolster their offerings to support future trainee recruitment. 

The more trainees increase their connection to caring for rural veterans, the greater the likelihood they will develop knowledge and contribute to these communities after completing their training. Consequently, telesupervision may be fundamental to improving rural population health, contributing to the sustainability of rural health training programs and workforce retention, increasing access to needed health care in geographical areas of shortage, and allowing trainees to receive supervision from those who are most competent in the specific needs of patients living in rural communities. 

The evolving landscape of telesupervision and associated opportunities underscores the need to bolster overall clinical supervision practices. Clinical supervision is more than assuming liability, cosigning notes, and ensuring that the standard of care is met. The provision of clinical supervision is a distinct competency separate from the delivery of clinical care. However, only a small portion of those providing clinical supervision have had formal training in supervision and the development of supervision competencies.13,14 Thus, an HCP can be a highly proficient clinician while still being deficient in the skills needed to be a competent clinical supervisor, with a lack of training in supervision skills undermining engagement in effective supervision.15 

Research supports the following as essential components of effective clinical supervision: a working alliance between supervisor and supervisee, inclusive of resolution of strains/ruptures, consistent provision of evaluative feedback, consistent supervision meetings, direct observation of clinical work, and opportunities for trainees to see skills modeled through experiential supervision.13 These elements enable investment in the long-term development of the trainee through deep and nuanced feedback provided, the supervisory relationship, access to mentoring, and assistance with articulating case formulations to enable future health care professionals to provide even better care. Engaging in effective supervision requires both the development of supervision competencies and the time allocation needed to uphold these essential elements. Although vital to quality health care, clinical supervision is not consistently reflected in labor mapping or productivity metrics. Consequently, limited dedicated time for supervision (eg, direct observation of trainees’ clinical care, reflection, and preparation to address trainees’ developmental needs) and heavy workloads remain major barriers to effective supervision.14 The continued expansion of technology-assisted supervision highlights the need for HCP duties and associated clinical supervisory skills (whether in person or via telesupervision) to become more integrated into their roles within health care settings. 

Upholding effective supervision practices within telesupervision requires thoughtful implementation. Supervisors should engage in direct observation of clinical work in a manner that enables timely correction of trainees and supplemental clinical care as needed, including interventions that assist trainees. In addition, it is essential that the supervisor provides trainees with access to scheduled, ad hoc, and emergent supervision. Furthermore, the supervisor needs to ensure that, regardless of modality, the supervisor can uphold the competency/learning goal development of the trainee (ie, meet learning needs), effectively deliver and receive constructive feedback, and model critical clinical skills relevant to the clinical training area. Of utmost importance, the supervisory oversight and type of supervision required should match the setting to ensure effective supervision. 

In some clinical settings, telesupervision may be less appropriate for upholding all elements of effective supervision while matching the needs of the clinical intervention and the trainee. Thus, supervisors need to engage in the supervisory modality that enables them to effectively intervene in clinical care according to the oversight needed. For example, a physical health care intervention may require the supervisor to provide hands-on guidance for a skill or procedure, whereas the dynamics of an inpatient mental health care setting may have patient care interactions that are not fully met by the use of telesupervision, such as complex patients’ needs, acuity, and crisis management. As telesupervision research continues to expand to better understand these applied complexities, there will be an evolving knowledge of the nuances in the application of telesupervision that best capture the benefits of telesupervision without compromising the quality of training and patient care. 

CONCLUSIONS 

Clinicians working with HCP trainees have the opportunity to use telesupervision to create a dynamic and rich learning environment while maintaining the quality of training and potentially reducing health disparities experienced by rural veterans. With this opportunity also comes the need to recognize clinical supervision as a competency and an essential role of an HCP. In doing so, a thoughtful approach to supervision will enable the powerful tool of telesupervision to be used to its highest potential in a responsible manner that does not overextend its reach. 

References
  1. National Healthcare Quality and Disparities Report Chartbook on Rural Healthcare. Agency for Healthcare Research and Quality; November 2021. Accessed January 26, 2026. https://www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/chartbooks/2019-qdr-rural-chartbook.pdf
  2. PHYSICIAN WORKFORCE: Caps on Medicare-Funded Graduate Medical Education at Teaching Hospitals. US Government Accountability Office; May 2021. Accessed January 26, 2026. https://www.gao.gov/assets/gao-21-391.pdf
  3. Passion to Learn, Power to Heal. US Dept of Veterans Affairs, Office of Academic Affiliations; 2021. Accessed January 26, 2026. https://content.yudu.com/web/448fx/0A448g9/75thAnniversary2021/html/index.html?origin=reader
  4. US Department of Veterans Affairs. Impact of VACAA (Choice ACT) on training at VA. 2018. Accessed January 26, 2026. https://www.va.gov/OAA/VACAA_Impact.asp
  5. Frye WS, Feldman M, Katzenstein J, et al. Modified training experiences for psychology interns and fellows during COVID-19: use of telepsychology and telesupervision by child and adolescent training programs. J Clin Psychol Med Settings. 2022;29:840-848. doi:10.1007/s10880-021-09839-4
  6. Bernhard PA, Camins JS. Supervision from afar: trainees’ perspectives on telesupervision. Couns Psychol Q. 2021;34:377-386. doi:10.1080/09515070.2020.1770697
  7. Schmittel EM, Lettenberger-Klein C, Oliver T, et al. Intentionality in academic telesupervision: a phenomenological study of faculty telesupervisors’ experiences. Contemp Fam Ther. 2023;45:61-74. doi:10.1007/s10591-021-09601-w
  8. Hames JL, Bell DJ, Perez-Lima LM, et al. Navigating uncharted waters: considerations for training clinics in the rapid transition to telepsychology and telesupervision during COVID-19. J Psychother Integr. 2020;30:348-365. doi:10.1037/int0000224
  9. Hausman C, Vescera K, Bacigalupi R, et al. Remote supervision and training in suicide prevention during the time of the coronavirus pandemic: recommendations for training programs and supervisors. Train Educ Prof Psychol. 2021;15:290-297. doi:10.1037/tep0000379
  10. Shearer EM, Jordan SE, Eliason KD, et al. Perspectives of psychology supervisors and trainees: implications for supervision and telesupervision. J Technol Behav Sci. 2024;9:68-82. doi:10.1007/s41347-024-00387-w
  11. Shearer EM, Jordan SE, Mackintosh M. Strategies to facilitate and assess effective supervision across in-person and virtual modalities. Presented at: Annual Meeting of the American Psychological Association; August 3, 2023; Washington, DC.
  12. Shearer EM, Mackintosh M, Jordan SE, et al. Using technology to enhance the supervisory relationship: A review of the data. Presented at: Annual Meeting of the American Psychological Association; August 8, 2024; Seattle, WA.
  13. Falender CA, Shafranske EP. Clinical Supervision: A Competency-Based Approach. 2nd ed. American Psychological Association; 2021.
  14. Hutman H, Enyedy K, Ellis M, et al. Training public sector clinicians in competency-based clinical supervision: methods, curriculum, and lessons learned. J Contemp Psychother. 2021;51:227-237. doi:10.1007/s10879-021-09499-3
  15. Rothwell C, Kehoe A, Farook SF, et al. Enablers and barriers to effective clinical supervision in the workplace: a rapid evidence review. BMJ Open. 2021;11:e052929. doi:10.1136/bmjopen-2021-052929
Article PDF
Author and Disclosure Information

Shiloh E. Jordan, PhDa,b; Margaret-Anne Mackintosh, PhDb,c

Author affiliations 

aVeterans Affairs Pacific Islands Health Care System, Honolulu, Hawaii 

bVeterans Rural Health Resource Center, Salt Lake City, Utah 

cNational Center for PTSD, Dissemination and Training Division, Veterans Affairs Palo Alto Health Care System, Menlo Park, California 

Author disclosures 

This work was supported by the US Department of Veterans Affairs, Veterans Health Administration, Office of Rural Health NOMAD #PRFY-008768, and support and resources from the National Center for PTSD. 

Disclaimer 

The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies, including the Department of Veterans Affairs. 

Ethics and consent 

The US Department of Veterans Affairs (VA) Office of Research and Development and the VA Portland Health Care System Research Office designated this project as quality improvement and not subject to institutional review board oversight. 

Correspondence: Shiloh Jordan (shiloh.jordan@va.gov) 

Fed Pract. 2026;43(5). Published May 15. doi:10.12788/fp.0692

Issue
Federal Practitioner - 43(5)
Publications
Topics
Page Number
176-179
Sections
Author and Disclosure Information

Shiloh E. Jordan, PhDa,b; Margaret-Anne Mackintosh, PhDb,c

Author affiliations 

aVeterans Affairs Pacific Islands Health Care System, Honolulu, Hawaii 

bVeterans Rural Health Resource Center, Salt Lake City, Utah 

cNational Center for PTSD, Dissemination and Training Division, Veterans Affairs Palo Alto Health Care System, Menlo Park, California 

Author disclosures 

This work was supported by the US Department of Veterans Affairs, Veterans Health Administration, Office of Rural Health NOMAD #PRFY-008768, and support and resources from the National Center for PTSD. 

Disclaimer 

The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies, including the Department of Veterans Affairs. 

Ethics and consent 

The US Department of Veterans Affairs (VA) Office of Research and Development and the VA Portland Health Care System Research Office designated this project as quality improvement and not subject to institutional review board oversight. 

Correspondence: Shiloh Jordan (shiloh.jordan@va.gov) 

Fed Pract. 2026;43(5). Published May 15. doi:10.12788/fp.0692

Author and Disclosure Information

Shiloh E. Jordan, PhDa,b; Margaret-Anne Mackintosh, PhDb,c

Author affiliations 

aVeterans Affairs Pacific Islands Health Care System, Honolulu, Hawaii 

bVeterans Rural Health Resource Center, Salt Lake City, Utah 

cNational Center for PTSD, Dissemination and Training Division, Veterans Affairs Palo Alto Health Care System, Menlo Park, California 

Author disclosures 

This work was supported by the US Department of Veterans Affairs, Veterans Health Administration, Office of Rural Health NOMAD #PRFY-008768, and support and resources from the National Center for PTSD. 

Disclaimer 

The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies, including the Department of Veterans Affairs. 

Ethics and consent 

The US Department of Veterans Affairs (VA) Office of Research and Development and the VA Portland Health Care System Research Office designated this project as quality improvement and not subject to institutional review board oversight. 

Correspondence: Shiloh Jordan (shiloh.jordan@va.gov) 

Fed Pract. 2026;43(5). Published May 15. doi:10.12788/fp.0692

Article PDF
Article PDF

Rural populations experience more health care disparities than urban populations, including a greater proportion of adults aged ≥ 65 years, higher poverty, and a higher prevalence of chronic comorbidities. Reported rates vary by study methodology and over time.1 These disparities are further exacerbated by reduced access to health care practitioners (HCPs), particularly physical and mental health specialty services, and a lack of rural health care facilities.1 HCP training programs are primarily located in urban settings and may heavily influence the geographical location and population focus of newly trained HCPs’ first positions.2 As the largest provider of health professions training, the US Department of Veterans Affairs (VA) can innovate to improve the quality of education and training while supporting rural health care sustainability and health care workforce retention.3,4 

One such innovation is expanding the implementation of telesupervision (ie, clinical supervision delivered via synchronous audio and video formats) for health professions trainees. During the COVID-19 pandemic, the literature documenting telesupervision substantially expanded across health care disciplines. These findings support telesupervision as a feasible alternative to traditional in-person supervision and suggest increased trainee comfort with telehealth use.5,6 The literature also provides insight into considerations for the use of telesupervision, including being more intentional in the development of the supervisory relationship,6-8 and enabling appropriate access to supervisors to support quality patient care and experiential learning.9,10 

This quality improvement examination of telesupervision in 11 rural VA psychology training programs spanned 3 years and included 3197 monthly surveys completed by supervisors and trainees. It supported the use of telesupervision compared with in-person or mixed modality supervision across a wide range of outcomes in upholding patient safety and maintaining the quality of supervision while also expanding trainees’ comfort in implementing telehealth care. The Table summarizes how frequently supervisors observed trainees providing clinical care via live observation, video or tape reviews, or conducting cotherapy. The clinical sessions for most trainees (70.3%) were directly observed by supervisors at least monthly across all methods. We also reviewed differences in Supervisory Working Alliance Inventory (SWAI) scores, which quantify the strength of the working relationship between trainees and supervisors, across 458 rotations by position (trainee vs supervisor) and rurality (rural vs urban sites). Overall, alliance was high with mean scores of 5.5 to 6.7 on a 7-point scale. While trainees tended to report higher alliance (P < .001), there were no differences by rurality (P = .06) or the rurality × position interaction (P = .08), and the marginally significant effects were small, indicating that rurality tended to attenuate position effects (Figure). Additional analyses of modality (in-person, telesupervision, or mixed modalities) indicated no differences. Thus, trainee and supervisor data from this project identified safe, high-quality, and consistent supervisory practices. Finally, additional data highlighted the potential benefits of a mixed-modality supervision, including both in-person supervision and telesupervision.11,12 

The expanded use of telesupervision provides several new opportunities for rural health care clinical supervisors, trainees, and veterans. Clinical supervisors who would otherwise operate as the sole HCP within their discipline or specialty at a remote clinic can increase their professional connection to a main facility and/or larger professional organization by serving as a clinical supervisor within a training program via telesupervision. This creates a greater connection to the larger mission, thereby supporting the clinical supervisor’s potential retention in their work setting.10 

FIGURE. Mean Supervisory Working Alliance Inventory Scores and 95% CIs, based on 458 rotations by position and rurality. 

Telesupervision expands the opportunity for health professions trainees to be clinically supervised by individuals with the cultural knowledge specific to the patient population served (ie, those individuals working within or knowledgeable about the particular rural setting). This supports higher quality training and patient care, even if the trainee’s primary physical location is not colocated with the clinical supervisor. 

Telesupervision can expand the number of clinical supervisors and rotations available within a health care system or clinic, particularly for specialty services (eg, psychological testing, dermatology) that are not otherwise available within specific geographic regions. Thus, telesupervision enables a supervisor with the needed expertise, specialty, or advanced training at one clinic to supervise a trainee located hundreds to thousands of miles away while serving a veteran who may or may not be colocated with either HCP. For example, the supervisor may be located in American Samoa, supervising a trainee physically residing in Hawaii who provides telehealth patient care to a veteran in Saipan. This also enables health care systems serving rural patient populations to bolster their offerings to support future trainee recruitment. 

The more trainees increase their connection to caring for rural veterans, the greater the likelihood they will develop knowledge and contribute to these communities after completing their training. Consequently, telesupervision may be fundamental to improving rural population health, contributing to the sustainability of rural health training programs and workforce retention, increasing access to needed health care in geographical areas of shortage, and allowing trainees to receive supervision from those who are most competent in the specific needs of patients living in rural communities. 

The evolving landscape of telesupervision and associated opportunities underscores the need to bolster overall clinical supervision practices. Clinical supervision is more than assuming liability, cosigning notes, and ensuring that the standard of care is met. The provision of clinical supervision is a distinct competency separate from the delivery of clinical care. However, only a small portion of those providing clinical supervision have had formal training in supervision and the development of supervision competencies.13,14 Thus, an HCP can be a highly proficient clinician while still being deficient in the skills needed to be a competent clinical supervisor, with a lack of training in supervision skills undermining engagement in effective supervision.15 

Research supports the following as essential components of effective clinical supervision: a working alliance between supervisor and supervisee, inclusive of resolution of strains/ruptures, consistent provision of evaluative feedback, consistent supervision meetings, direct observation of clinical work, and opportunities for trainees to see skills modeled through experiential supervision.13 These elements enable investment in the long-term development of the trainee through deep and nuanced feedback provided, the supervisory relationship, access to mentoring, and assistance with articulating case formulations to enable future health care professionals to provide even better care. Engaging in effective supervision requires both the development of supervision competencies and the time allocation needed to uphold these essential elements. Although vital to quality health care, clinical supervision is not consistently reflected in labor mapping or productivity metrics. Consequently, limited dedicated time for supervision (eg, direct observation of trainees’ clinical care, reflection, and preparation to address trainees’ developmental needs) and heavy workloads remain major barriers to effective supervision.14 The continued expansion of technology-assisted supervision highlights the need for HCP duties and associated clinical supervisory skills (whether in person or via telesupervision) to become more integrated into their roles within health care settings. 

Upholding effective supervision practices within telesupervision requires thoughtful implementation. Supervisors should engage in direct observation of clinical work in a manner that enables timely correction of trainees and supplemental clinical care as needed, including interventions that assist trainees. In addition, it is essential that the supervisor provides trainees with access to scheduled, ad hoc, and emergent supervision. Furthermore, the supervisor needs to ensure that, regardless of modality, the supervisor can uphold the competency/learning goal development of the trainee (ie, meet learning needs), effectively deliver and receive constructive feedback, and model critical clinical skills relevant to the clinical training area. Of utmost importance, the supervisory oversight and type of supervision required should match the setting to ensure effective supervision. 

In some clinical settings, telesupervision may be less appropriate for upholding all elements of effective supervision while matching the needs of the clinical intervention and the trainee. Thus, supervisors need to engage in the supervisory modality that enables them to effectively intervene in clinical care according to the oversight needed. For example, a physical health care intervention may require the supervisor to provide hands-on guidance for a skill or procedure, whereas the dynamics of an inpatient mental health care setting may have patient care interactions that are not fully met by the use of telesupervision, such as complex patients’ needs, acuity, and crisis management. As telesupervision research continues to expand to better understand these applied complexities, there will be an evolving knowledge of the nuances in the application of telesupervision that best capture the benefits of telesupervision without compromising the quality of training and patient care. 

CONCLUSIONS 

Clinicians working with HCP trainees have the opportunity to use telesupervision to create a dynamic and rich learning environment while maintaining the quality of training and potentially reducing health disparities experienced by rural veterans. With this opportunity also comes the need to recognize clinical supervision as a competency and an essential role of an HCP. In doing so, a thoughtful approach to supervision will enable the powerful tool of telesupervision to be used to its highest potential in a responsible manner that does not overextend its reach. 

Rural populations experience more health care disparities than urban populations, including a greater proportion of adults aged ≥ 65 years, higher poverty, and a higher prevalence of chronic comorbidities. Reported rates vary by study methodology and over time.1 These disparities are further exacerbated by reduced access to health care practitioners (HCPs), particularly physical and mental health specialty services, and a lack of rural health care facilities.1 HCP training programs are primarily located in urban settings and may heavily influence the geographical location and population focus of newly trained HCPs’ first positions.2 As the largest provider of health professions training, the US Department of Veterans Affairs (VA) can innovate to improve the quality of education and training while supporting rural health care sustainability and health care workforce retention.3,4 

One such innovation is expanding the implementation of telesupervision (ie, clinical supervision delivered via synchronous audio and video formats) for health professions trainees. During the COVID-19 pandemic, the literature documenting telesupervision substantially expanded across health care disciplines. These findings support telesupervision as a feasible alternative to traditional in-person supervision and suggest increased trainee comfort with telehealth use.5,6 The literature also provides insight into considerations for the use of telesupervision, including being more intentional in the development of the supervisory relationship,6-8 and enabling appropriate access to supervisors to support quality patient care and experiential learning.9,10 

This quality improvement examination of telesupervision in 11 rural VA psychology training programs spanned 3 years and included 3197 monthly surveys completed by supervisors and trainees. It supported the use of telesupervision compared with in-person or mixed modality supervision across a wide range of outcomes in upholding patient safety and maintaining the quality of supervision while also expanding trainees’ comfort in implementing telehealth care. The Table summarizes how frequently supervisors observed trainees providing clinical care via live observation, video or tape reviews, or conducting cotherapy. The clinical sessions for most trainees (70.3%) were directly observed by supervisors at least monthly across all methods. We also reviewed differences in Supervisory Working Alliance Inventory (SWAI) scores, which quantify the strength of the working relationship between trainees and supervisors, across 458 rotations by position (trainee vs supervisor) and rurality (rural vs urban sites). Overall, alliance was high with mean scores of 5.5 to 6.7 on a 7-point scale. While trainees tended to report higher alliance (P < .001), there were no differences by rurality (P = .06) or the rurality × position interaction (P = .08), and the marginally significant effects were small, indicating that rurality tended to attenuate position effects (Figure). Additional analyses of modality (in-person, telesupervision, or mixed modalities) indicated no differences. Thus, trainee and supervisor data from this project identified safe, high-quality, and consistent supervisory practices. Finally, additional data highlighted the potential benefits of a mixed-modality supervision, including both in-person supervision and telesupervision.11,12 

The expanded use of telesupervision provides several new opportunities for rural health care clinical supervisors, trainees, and veterans. Clinical supervisors who would otherwise operate as the sole HCP within their discipline or specialty at a remote clinic can increase their professional connection to a main facility and/or larger professional organization by serving as a clinical supervisor within a training program via telesupervision. This creates a greater connection to the larger mission, thereby supporting the clinical supervisor’s potential retention in their work setting.10 

FIGURE. Mean Supervisory Working Alliance Inventory Scores and 95% CIs, based on 458 rotations by position and rurality. 

Telesupervision expands the opportunity for health professions trainees to be clinically supervised by individuals with the cultural knowledge specific to the patient population served (ie, those individuals working within or knowledgeable about the particular rural setting). This supports higher quality training and patient care, even if the trainee’s primary physical location is not colocated with the clinical supervisor. 

Telesupervision can expand the number of clinical supervisors and rotations available within a health care system or clinic, particularly for specialty services (eg, psychological testing, dermatology) that are not otherwise available within specific geographic regions. Thus, telesupervision enables a supervisor with the needed expertise, specialty, or advanced training at one clinic to supervise a trainee located hundreds to thousands of miles away while serving a veteran who may or may not be colocated with either HCP. For example, the supervisor may be located in American Samoa, supervising a trainee physically residing in Hawaii who provides telehealth patient care to a veteran in Saipan. This also enables health care systems serving rural patient populations to bolster their offerings to support future trainee recruitment. 

The more trainees increase their connection to caring for rural veterans, the greater the likelihood they will develop knowledge and contribute to these communities after completing their training. Consequently, telesupervision may be fundamental to improving rural population health, contributing to the sustainability of rural health training programs and workforce retention, increasing access to needed health care in geographical areas of shortage, and allowing trainees to receive supervision from those who are most competent in the specific needs of patients living in rural communities. 

The evolving landscape of telesupervision and associated opportunities underscores the need to bolster overall clinical supervision practices. Clinical supervision is more than assuming liability, cosigning notes, and ensuring that the standard of care is met. The provision of clinical supervision is a distinct competency separate from the delivery of clinical care. However, only a small portion of those providing clinical supervision have had formal training in supervision and the development of supervision competencies.13,14 Thus, an HCP can be a highly proficient clinician while still being deficient in the skills needed to be a competent clinical supervisor, with a lack of training in supervision skills undermining engagement in effective supervision.15 

Research supports the following as essential components of effective clinical supervision: a working alliance between supervisor and supervisee, inclusive of resolution of strains/ruptures, consistent provision of evaluative feedback, consistent supervision meetings, direct observation of clinical work, and opportunities for trainees to see skills modeled through experiential supervision.13 These elements enable investment in the long-term development of the trainee through deep and nuanced feedback provided, the supervisory relationship, access to mentoring, and assistance with articulating case formulations to enable future health care professionals to provide even better care. Engaging in effective supervision requires both the development of supervision competencies and the time allocation needed to uphold these essential elements. Although vital to quality health care, clinical supervision is not consistently reflected in labor mapping or productivity metrics. Consequently, limited dedicated time for supervision (eg, direct observation of trainees’ clinical care, reflection, and preparation to address trainees’ developmental needs) and heavy workloads remain major barriers to effective supervision.14 The continued expansion of technology-assisted supervision highlights the need for HCP duties and associated clinical supervisory skills (whether in person or via telesupervision) to become more integrated into their roles within health care settings. 

Upholding effective supervision practices within telesupervision requires thoughtful implementation. Supervisors should engage in direct observation of clinical work in a manner that enables timely correction of trainees and supplemental clinical care as needed, including interventions that assist trainees. In addition, it is essential that the supervisor provides trainees with access to scheduled, ad hoc, and emergent supervision. Furthermore, the supervisor needs to ensure that, regardless of modality, the supervisor can uphold the competency/learning goal development of the trainee (ie, meet learning needs), effectively deliver and receive constructive feedback, and model critical clinical skills relevant to the clinical training area. Of utmost importance, the supervisory oversight and type of supervision required should match the setting to ensure effective supervision. 

In some clinical settings, telesupervision may be less appropriate for upholding all elements of effective supervision while matching the needs of the clinical intervention and the trainee. Thus, supervisors need to engage in the supervisory modality that enables them to effectively intervene in clinical care according to the oversight needed. For example, a physical health care intervention may require the supervisor to provide hands-on guidance for a skill or procedure, whereas the dynamics of an inpatient mental health care setting may have patient care interactions that are not fully met by the use of telesupervision, such as complex patients’ needs, acuity, and crisis management. As telesupervision research continues to expand to better understand these applied complexities, there will be an evolving knowledge of the nuances in the application of telesupervision that best capture the benefits of telesupervision without compromising the quality of training and patient care. 

CONCLUSIONS 

Clinicians working with HCP trainees have the opportunity to use telesupervision to create a dynamic and rich learning environment while maintaining the quality of training and potentially reducing health disparities experienced by rural veterans. With this opportunity also comes the need to recognize clinical supervision as a competency and an essential role of an HCP. In doing so, a thoughtful approach to supervision will enable the powerful tool of telesupervision to be used to its highest potential in a responsible manner that does not overextend its reach. 

References
  1. National Healthcare Quality and Disparities Report Chartbook on Rural Healthcare. Agency for Healthcare Research and Quality; November 2021. Accessed January 26, 2026. https://www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/chartbooks/2019-qdr-rural-chartbook.pdf
  2. PHYSICIAN WORKFORCE: Caps on Medicare-Funded Graduate Medical Education at Teaching Hospitals. US Government Accountability Office; May 2021. Accessed January 26, 2026. https://www.gao.gov/assets/gao-21-391.pdf
  3. Passion to Learn, Power to Heal. US Dept of Veterans Affairs, Office of Academic Affiliations; 2021. Accessed January 26, 2026. https://content.yudu.com/web/448fx/0A448g9/75thAnniversary2021/html/index.html?origin=reader
  4. US Department of Veterans Affairs. Impact of VACAA (Choice ACT) on training at VA. 2018. Accessed January 26, 2026. https://www.va.gov/OAA/VACAA_Impact.asp
  5. Frye WS, Feldman M, Katzenstein J, et al. Modified training experiences for psychology interns and fellows during COVID-19: use of telepsychology and telesupervision by child and adolescent training programs. J Clin Psychol Med Settings. 2022;29:840-848. doi:10.1007/s10880-021-09839-4
  6. Bernhard PA, Camins JS. Supervision from afar: trainees’ perspectives on telesupervision. Couns Psychol Q. 2021;34:377-386. doi:10.1080/09515070.2020.1770697
  7. Schmittel EM, Lettenberger-Klein C, Oliver T, et al. Intentionality in academic telesupervision: a phenomenological study of faculty telesupervisors’ experiences. Contemp Fam Ther. 2023;45:61-74. doi:10.1007/s10591-021-09601-w
  8. Hames JL, Bell DJ, Perez-Lima LM, et al. Navigating uncharted waters: considerations for training clinics in the rapid transition to telepsychology and telesupervision during COVID-19. J Psychother Integr. 2020;30:348-365. doi:10.1037/int0000224
  9. Hausman C, Vescera K, Bacigalupi R, et al. Remote supervision and training in suicide prevention during the time of the coronavirus pandemic: recommendations for training programs and supervisors. Train Educ Prof Psychol. 2021;15:290-297. doi:10.1037/tep0000379
  10. Shearer EM, Jordan SE, Eliason KD, et al. Perspectives of psychology supervisors and trainees: implications for supervision and telesupervision. J Technol Behav Sci. 2024;9:68-82. doi:10.1007/s41347-024-00387-w
  11. Shearer EM, Jordan SE, Mackintosh M. Strategies to facilitate and assess effective supervision across in-person and virtual modalities. Presented at: Annual Meeting of the American Psychological Association; August 3, 2023; Washington, DC.
  12. Shearer EM, Mackintosh M, Jordan SE, et al. Using technology to enhance the supervisory relationship: A review of the data. Presented at: Annual Meeting of the American Psychological Association; August 8, 2024; Seattle, WA.
  13. Falender CA, Shafranske EP. Clinical Supervision: A Competency-Based Approach. 2nd ed. American Psychological Association; 2021.
  14. Hutman H, Enyedy K, Ellis M, et al. Training public sector clinicians in competency-based clinical supervision: methods, curriculum, and lessons learned. J Contemp Psychother. 2021;51:227-237. doi:10.1007/s10879-021-09499-3
  15. Rothwell C, Kehoe A, Farook SF, et al. Enablers and barriers to effective clinical supervision in the workplace: a rapid evidence review. BMJ Open. 2021;11:e052929. doi:10.1136/bmjopen-2021-052929
References
  1. National Healthcare Quality and Disparities Report Chartbook on Rural Healthcare. Agency for Healthcare Research and Quality; November 2021. Accessed January 26, 2026. https://www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/chartbooks/2019-qdr-rural-chartbook.pdf
  2. PHYSICIAN WORKFORCE: Caps on Medicare-Funded Graduate Medical Education at Teaching Hospitals. US Government Accountability Office; May 2021. Accessed January 26, 2026. https://www.gao.gov/assets/gao-21-391.pdf
  3. Passion to Learn, Power to Heal. US Dept of Veterans Affairs, Office of Academic Affiliations; 2021. Accessed January 26, 2026. https://content.yudu.com/web/448fx/0A448g9/75thAnniversary2021/html/index.html?origin=reader
  4. US Department of Veterans Affairs. Impact of VACAA (Choice ACT) on training at VA. 2018. Accessed January 26, 2026. https://www.va.gov/OAA/VACAA_Impact.asp
  5. Frye WS, Feldman M, Katzenstein J, et al. Modified training experiences for psychology interns and fellows during COVID-19: use of telepsychology and telesupervision by child and adolescent training programs. J Clin Psychol Med Settings. 2022;29:840-848. doi:10.1007/s10880-021-09839-4
  6. Bernhard PA, Camins JS. Supervision from afar: trainees’ perspectives on telesupervision. Couns Psychol Q. 2021;34:377-386. doi:10.1080/09515070.2020.1770697
  7. Schmittel EM, Lettenberger-Klein C, Oliver T, et al. Intentionality in academic telesupervision: a phenomenological study of faculty telesupervisors’ experiences. Contemp Fam Ther. 2023;45:61-74. doi:10.1007/s10591-021-09601-w
  8. Hames JL, Bell DJ, Perez-Lima LM, et al. Navigating uncharted waters: considerations for training clinics in the rapid transition to telepsychology and telesupervision during COVID-19. J Psychother Integr. 2020;30:348-365. doi:10.1037/int0000224
  9. Hausman C, Vescera K, Bacigalupi R, et al. Remote supervision and training in suicide prevention during the time of the coronavirus pandemic: recommendations for training programs and supervisors. Train Educ Prof Psychol. 2021;15:290-297. doi:10.1037/tep0000379
  10. Shearer EM, Jordan SE, Eliason KD, et al. Perspectives of psychology supervisors and trainees: implications for supervision and telesupervision. J Technol Behav Sci. 2024;9:68-82. doi:10.1007/s41347-024-00387-w
  11. Shearer EM, Jordan SE, Mackintosh M. Strategies to facilitate and assess effective supervision across in-person and virtual modalities. Presented at: Annual Meeting of the American Psychological Association; August 3, 2023; Washington, DC.
  12. Shearer EM, Mackintosh M, Jordan SE, et al. Using technology to enhance the supervisory relationship: A review of the data. Presented at: Annual Meeting of the American Psychological Association; August 8, 2024; Seattle, WA.
  13. Falender CA, Shafranske EP. Clinical Supervision: A Competency-Based Approach. 2nd ed. American Psychological Association; 2021.
  14. Hutman H, Enyedy K, Ellis M, et al. Training public sector clinicians in competency-based clinical supervision: methods, curriculum, and lessons learned. J Contemp Psychother. 2021;51:227-237. doi:10.1007/s10879-021-09499-3
  15. Rothwell C, Kehoe A, Farook SF, et al. Enablers and barriers to effective clinical supervision in the workplace: a rapid evidence review. BMJ Open. 2021;11:e052929. doi:10.1136/bmjopen-2021-052929
Issue
Federal Practitioner - 43(5)
Issue
Federal Practitioner - 43(5)
Page Number
176-179
Page Number
176-179
Publications
Publications
Topics
Article Type
Display Headline

An Opportunity to Provide High-Quality Training and Care: Use of Telesupervision and Reflection on Practices

Display Headline

An Opportunity to Provide High-Quality Training and Care: Use of Telesupervision and Reflection on Practices

Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
survey writer start date

Potential Tyrosine Kinase Inhibitor Therapy Discontinuation for Patients With Chronic Myeloid Leukemia in a VA Regional Network

Article Type
Changed
Display Headline

Potential Tyrosine Kinase Inhibitor Therapy Discontinuation for Patients With Chronic Myeloid Leukemia in a VA Regional Network

Chronic myeloid leukemia (CML) is a hematologic malignancy resulting from an acquired mutation. The mutation results in a reciprocal translocation between the long arms of chromosomes 9 and 22 and is known as the Philadelphia chromosome (Ph), or Ph-positive (Ph+) when present. The translocation results in the formation of a BCR-ABL fusion oncogene, which leads to continuous cell cycling and proliferation, altered differentiation, and a loss of apoptosis.1,2

Until the 1980s, CML was considered fatal.3 The mainstay of treatment consisted of 2 oral chemotherapeutic agents, busulfan and hydroxyurea. These medications did not prevent blast crisis, a fatal form of leukemia.4,5 The introduction of tyrosine kinase inhibitors (TKIs) transformed CML management and improved 10-year overall survival from about 20% to > 80% by delaying the transition to blast crisis. Now, the risk of death from general health conditions or comorbidities is higher than that of CML.6

TKIs target the root cause of CML through inhibition of the BCR-ABL oncoprotein.1,2 For CML, the goals of treatment include maintaining hematologic, cytogenetic, and molecular remission; preventing progression to accelerated phase or blast crisis; minimizing toxicity; and enabling potential cessation of therapy in carefully selected patients.7,8

Small cohort studies suggest that dose reduction of TKIs in patients who achieve optimal responses may reduce the risk of long-term adverse effects (AEs). However, optimal dose-reduction and minimum effective dose of each agent are unknown.7 The ability to maintain undetectable minimal residual disease or disease detectable at a stable low level after TKI discontinuation has been called treatment-free remission. Studies suggest that about 40% to 50% of patients who have achieved a stable deep molecular response remain in treatment-free remission after stopping first-line treatment.9,10 Of the patients who relapse following TKI discontinuation, 80% relapse within the first 6 months of treatment cessation. Molecular response is regained in almost all patients when treatment is resumed with the same TKI.11

The National Comprehensive Cancer Network (NCCN) recommends considering discontinuation of TKI therapy only outside the setting of a clinical trial and only in patients who consent to discontinuation after a thorough discussion of the potential risks and benefits. The NCCN criteria for patients who may be eligible for discontinuation are listed in Table 1. The Life After Stopping TKIs study reported that 80% of patients with well-controlled chronic phase CML who discontinued TKIs had a clinically meaningful improvement in fatigue. Patients also reported clinically meaningful improvements in depression, diarrhea, sleep disturbance, and pain interference. These symptoms worsened after restarting TKI therapy.12

0526FED-AVAHO-TKI_T1

TKI DISCONTINUATION

Electronic health record data were extracted using structured query language from the US Department of Veterans Affairs (VA) Corporate Data Warehouse (CDW). To be eligible for discontinuation, veterans had to be aged > 18 years, receive oncology care within a Veterans Integrated Services Network (VISN) 21 health care system (HCS) (VA Sierra Nevada HCS, VA Southern Nevada HCS, VA Central California HCS, VA Palo Alto HCS, VA Northern California HCS, and VA San Francisco HCS) or be a veteran referred to a community-based oncology practitioner. Patients had to have a documented diagnosis of chronic phase CML, have an active order for a TKI, be on TKI therapy for ≥ 3 years, and have a stable molecular response (BCR-ABL1 ≤ 0.01% on the International Scale for ≥ 2 years with ≥ 4 tests done ≥ 3 months apart) as of October 1, 2024. Veterans were excluded if they had a history of advanced accelerated phase CML, previous TKI discontinuation trials, nonadherence to the TKI, or if they did not want to consider TKI discontinuation.

This analysis evaluated the potential cost avoidance associated with TKI discontinuation. Cost avoidance was calculated using the average wholesale price of each TKI. Secondary objectives evaluated health outcomes of TKI discontinuation including CML relapse, reported AEs, long-term remission, and TKI withdrawal syndrome. Health outcomes were determined through chart review of AEs and clinic notes documented in the electronic health record during the study time frame.

Baseline information for eligible patients was collected, including age, sex, and race, and chart reviews were completed to evaluate reported AEs associated with therapy. Oncology clinical pharmacy practitioners (CPPs) at each VISN 21 facility were notified of eligible patients to facilitate discussion with oncologists and establish monitoring if therapy was discontinued. Following TKI discontinuation, health outcomes were evaluated, including CML relapse, changes in reported AEs, long-term remission, and TKI withdrawal syndrome. Descriptive statistics were used to analyze the baseline characteristics. Cost avoidance was calculated using the average wholesale price for each TKI. The number of tablets required to reach each patient’s individual dose was taken into consideration when determining the cost avoidance. A dashboard was created using the query from the CDW and was developed in Microsoft Power BI.

Preliminary Results

In FY 2024, VISN 21 had 3819 oncology patients. Twenty-four patients had taken a TKI for ≥ 3 years, 20 had a stable molecular response, and 15 had not previously attempted to discontinue their TKI (Figure 1). Fifteen veterans were eligible for therapy discontinuation for a total potential annual cost avoidance of $1.2 million (Figure 2). Most of the cost avoidance, $935,057 (78%), was attributed to 3 patients on nilotinib. The mean age of the population was 74 years. All patients were male, and 12 (80%) were White. (Table 2). At baseline, 11 patients (73%) were taking imatinib. One patient received oncology care from a community care clinician. All 15 patients decided to remain on therapy.

0526FED-AVAHO-TKI_F1
FIGURE 1. Flow Diagram for Study Participants
Abbreviations: CML, chronic myeloid leukemia; TKI, tyrosine kinase inhibitor;
VISN, Veterans Integrated Service Network.
0526FED-AVAHO-TKI_F2
FIGURE 2. Potential average yearly wholesale cost avoidance
for 15 patients at Veterans Integrated Services Network 21.
0526FED-AVAHO-TKI_T2

DISCUSSION

As a multisite quality improvement initiative, this project raised awareness of TKI therapy discontinuation in select patients with CML. It also sparked collaboration among oncology CPPs and clinicians and stimulated conversations about CML treatment. The development of the TKI discontinuation dashboard provides a population health management tool for CPPs and clinicians to identify eligible patients in the future.

Adherence to TKIs is crucial for disease control and survival in patients with CML. Patients are counseled that poor adherence to therapy may contribute to worsening disease or suboptimal response, the development of resistance, and greater health care costs.13 Therefore, it was a challenge for patients to understand and accept that they could stop TKI therapy after achieving a stable deep molecular response. Discussions with patients about the goal of therapy—suppressing the BCR-ABL oncogene, which they have achieved—could encourage patients to trial therapy discontinuation.

Only small cohort studies have been completed to evaluate the outcomes of therapy discontinuation. Much remains unknown regarding the optimal dose-reduction strategy and the minimum effective dose of each agent. Additionally, understanding the qualities of a good candidate for TKI discontinuation remains a barrier. A similar project was conducted in VISN 17. Five patients were counseled on TKI discontinuation; however, only 1 discontinued TKI therapy. Unfortunately, soon after discontinuing treatment, the patient had to restart therapy. Additional literature will enhance understanding of therapy discontinuation.

An unexpected finding of TKI discontinuation trials has been a reversible phenomenon known as TKI withdrawal syndrome.9 It can occur regardless of the TKI used and results in pruritus and new or worsening musculoskeletal pain within several weeks of TKI discontinuation in about 30% of patients. Symptoms may last several months and may require acetaminophen or nonsteroidal anti-inflammatory drugs for pain control.9,10,14

The potential cost avoidance of $1.2 million is an underestimation because VA contracts allow for greater cost savings. However, that information is confidential and therefore average wholesale price had to be used for this project. Most of the cost avoidance was due to 4 patients who could not tolerate imatinib and used nilotinib, which is more expensive.

Limitations

The small sample size presented some limitations. Of the 3819 oncology patients within VISN 21 in FY 2024, 186 received a TKI and only 15 were eligible for discontinuation. Additionally, challenges emerged when discussing discontinuation with community care clinicians and patients. Community care clinicians were difficult to contact, making it challenging to discuss the project with them. CPPs noted hesitancy among VA clinicians and patients to discontinue a medication for which adherence was continually emphasized.

Conclusions

Discussions about CML TKI discontinuation led to collaboration with the oncology care team and could lead to significant cost avoidance. Barriers to TKI discontinuation included patients’ concern for relapse, risk of discontinuation syndrome, the requirement for close monitoring, and clinician buy-in. Outcome studies are needed to gain a greater understanding of the benefits and risks of therapy discontinuation. In the future, evaluation of possible clinical and biological predictors of successful TKI discontinuation may be beneficial.

References
  1. Schiffer CA. BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia. N Engl J Med. 2007;357:258-265. doi:10.1056/NEJMct071828
  2. Hehlmann R, Hochhaus A, Baccarani M; European LeukemiaNet. Chronic myeloid leukaemia. Lancet. 2007;370:342-350. doi:10.1016/S0140-6736(07)61165-9
  3. Goldman JM, Melo JV. Chronic myeloid leukemia--advances in biology and new approaches to treatment. N Engl J Med. 2003;349:1451-1464. doi:10.1056/NEJMra020777
  4. Pasic I, Lipton JH. Current approach to the treatment of chronic myeloid leukaemia. Leuk Res. 2017;55:65-78. doi:10.1016/j.leukres.2017.01.005
  5. Rao KV, Iannucci A, Jabbour E. Current and future clinical strategies in the management of chronic myeloid leukemia. Pharmacotherapy. 2010;30:77S-101S. doi:10.1592/phco.30.pt2.77S
  6. Cortes J, Pavlovsky C, Saußele S. Chronic myeloid leukaemia. Lancet. 2021;398:1914-1926. doi:10.1016/S0140-6736(21)01204-6
  7. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Chronic myeloid leukemia. Version 1.2026. July 16, 2025. Accessed February 8, 2026. https://www.nccn.org /guidelines/guidelines-detail?id=1427
  8. Hochhaus A, Baccarani M, Silver RT, et al. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia. 2020;34:966-984. doi:10.1038/s41375-020-0776-2
  9. Saußele S, Richter J, Hochhaus A, Mahon F-X. The concept of treatment-free remission in chronic myeloid leukemia. Leukemia. 2016;30:1638-1647. doi:10.1038/leu.2016.115
  10. Atallah E, Sweet K. Treatment-free remission: the new goal in CML therapy. Curr Hematol Malig Rep. 2021;16:433-439. doi:10.1007/s11899-021-00653-1
  11. Hehlmann R. The new ELN recommendations for treating CML. J Clin Med. 2020;9:3671. doi:10.3390/jcm9113671
  12. Atallah E, Schiffer CA, Radich JP , et al. Assessment of outcomes after stopping tyrosine kinase inhibitors among patients with chronic myeloid leukemia: a non-randomized clinical trial. JAMA Oncol. 2021;7:42-50. doi:10.1001/jamaoncol.2020.5774
  13. Breccia M, Efficace F, Alimena G. Imatinib treatment in chronic myelogenous leukemia: what have we learned so far? Cancer Lett. 2011;300:115-121. doi:10.1016/j.canlet.2010.10.018
  14. Berman E. How I treat chronic-phase chronic myelogenous leukemia. Blood. 2022;139:3138-3147. doi:10.1182/blood.2021011722
Article PDF
Author and Disclosure Information

Kirsten Werner, PharmDa; Jenna Carmichael, PharmDb; Steve Flynn, PharmD, BCPSb; David Huberman, PhDc; Robert Malmstrom, PharmDb; Diana T. Higgins, PharmDb; Janice M. Taylor, PharmD, BCPSd

Author affiliations
aVeterans Affairs Sierra Nevada Health Care System, Reno
bVeterans Integrated Service Network 21, Pleasant Hill, California
cVeterans Affairs Palo Alto Health Care System, California
dVeterans Integrated Services Network 9, Nashville, Tennessee

Author disclosures The authors report no actual or potential conflicts of interest in regard to this article.

Correspondence: Kirsten Werner (kirsten.werner@va.gov)

Disclaimer The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.

Ethics and consent The Veterans Affairs Sierra Nevada Health Care System Research and Development Committee approved this project and determined that it was exempt from institutional review board oversight.

Acknowledgments The authors thank the oncology clinical pharmacy practitioners and clinicians at the Veterans Integrated Services Network 21 facilities for their collaboration and support.

Fed Pract. 2026;43(suppl 2). Published online May 15. doi:10.12788/fp.0714

Issue
Federal Practitioner - 43(suppl 2)
Publications
Topics
Page Number
S14-S17
Sections
Author and Disclosure Information

Kirsten Werner, PharmDa; Jenna Carmichael, PharmDb; Steve Flynn, PharmD, BCPSb; David Huberman, PhDc; Robert Malmstrom, PharmDb; Diana T. Higgins, PharmDb; Janice M. Taylor, PharmD, BCPSd

Author affiliations
aVeterans Affairs Sierra Nevada Health Care System, Reno
bVeterans Integrated Service Network 21, Pleasant Hill, California
cVeterans Affairs Palo Alto Health Care System, California
dVeterans Integrated Services Network 9, Nashville, Tennessee

Author disclosures The authors report no actual or potential conflicts of interest in regard to this article.

Correspondence: Kirsten Werner (kirsten.werner@va.gov)

Disclaimer The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.

Ethics and consent The Veterans Affairs Sierra Nevada Health Care System Research and Development Committee approved this project and determined that it was exempt from institutional review board oversight.

Acknowledgments The authors thank the oncology clinical pharmacy practitioners and clinicians at the Veterans Integrated Services Network 21 facilities for their collaboration and support.

Fed Pract. 2026;43(suppl 2). Published online May 15. doi:10.12788/fp.0714

Author and Disclosure Information

Kirsten Werner, PharmDa; Jenna Carmichael, PharmDb; Steve Flynn, PharmD, BCPSb; David Huberman, PhDc; Robert Malmstrom, PharmDb; Diana T. Higgins, PharmDb; Janice M. Taylor, PharmD, BCPSd

Author affiliations
aVeterans Affairs Sierra Nevada Health Care System, Reno
bVeterans Integrated Service Network 21, Pleasant Hill, California
cVeterans Affairs Palo Alto Health Care System, California
dVeterans Integrated Services Network 9, Nashville, Tennessee

Author disclosures The authors report no actual or potential conflicts of interest in regard to this article.

Correspondence: Kirsten Werner (kirsten.werner@va.gov)

Disclaimer The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.

Ethics and consent The Veterans Affairs Sierra Nevada Health Care System Research and Development Committee approved this project and determined that it was exempt from institutional review board oversight.

Acknowledgments The authors thank the oncology clinical pharmacy practitioners and clinicians at the Veterans Integrated Services Network 21 facilities for their collaboration and support.

Fed Pract. 2026;43(suppl 2). Published online May 15. doi:10.12788/fp.0714

Article PDF
Article PDF

Chronic myeloid leukemia (CML) is a hematologic malignancy resulting from an acquired mutation. The mutation results in a reciprocal translocation between the long arms of chromosomes 9 and 22 and is known as the Philadelphia chromosome (Ph), or Ph-positive (Ph+) when present. The translocation results in the formation of a BCR-ABL fusion oncogene, which leads to continuous cell cycling and proliferation, altered differentiation, and a loss of apoptosis.1,2

Until the 1980s, CML was considered fatal.3 The mainstay of treatment consisted of 2 oral chemotherapeutic agents, busulfan and hydroxyurea. These medications did not prevent blast crisis, a fatal form of leukemia.4,5 The introduction of tyrosine kinase inhibitors (TKIs) transformed CML management and improved 10-year overall survival from about 20% to > 80% by delaying the transition to blast crisis. Now, the risk of death from general health conditions or comorbidities is higher than that of CML.6

TKIs target the root cause of CML through inhibition of the BCR-ABL oncoprotein.1,2 For CML, the goals of treatment include maintaining hematologic, cytogenetic, and molecular remission; preventing progression to accelerated phase or blast crisis; minimizing toxicity; and enabling potential cessation of therapy in carefully selected patients.7,8

Small cohort studies suggest that dose reduction of TKIs in patients who achieve optimal responses may reduce the risk of long-term adverse effects (AEs). However, optimal dose-reduction and minimum effective dose of each agent are unknown.7 The ability to maintain undetectable minimal residual disease or disease detectable at a stable low level after TKI discontinuation has been called treatment-free remission. Studies suggest that about 40% to 50% of patients who have achieved a stable deep molecular response remain in treatment-free remission after stopping first-line treatment.9,10 Of the patients who relapse following TKI discontinuation, 80% relapse within the first 6 months of treatment cessation. Molecular response is regained in almost all patients when treatment is resumed with the same TKI.11

The National Comprehensive Cancer Network (NCCN) recommends considering discontinuation of TKI therapy only outside the setting of a clinical trial and only in patients who consent to discontinuation after a thorough discussion of the potential risks and benefits. The NCCN criteria for patients who may be eligible for discontinuation are listed in Table 1. The Life After Stopping TKIs study reported that 80% of patients with well-controlled chronic phase CML who discontinued TKIs had a clinically meaningful improvement in fatigue. Patients also reported clinically meaningful improvements in depression, diarrhea, sleep disturbance, and pain interference. These symptoms worsened after restarting TKI therapy.12

0526FED-AVAHO-TKI_T1

TKI DISCONTINUATION

Electronic health record data were extracted using structured query language from the US Department of Veterans Affairs (VA) Corporate Data Warehouse (CDW). To be eligible for discontinuation, veterans had to be aged > 18 years, receive oncology care within a Veterans Integrated Services Network (VISN) 21 health care system (HCS) (VA Sierra Nevada HCS, VA Southern Nevada HCS, VA Central California HCS, VA Palo Alto HCS, VA Northern California HCS, and VA San Francisco HCS) or be a veteran referred to a community-based oncology practitioner. Patients had to have a documented diagnosis of chronic phase CML, have an active order for a TKI, be on TKI therapy for ≥ 3 years, and have a stable molecular response (BCR-ABL1 ≤ 0.01% on the International Scale for ≥ 2 years with ≥ 4 tests done ≥ 3 months apart) as of October 1, 2024. Veterans were excluded if they had a history of advanced accelerated phase CML, previous TKI discontinuation trials, nonadherence to the TKI, or if they did not want to consider TKI discontinuation.

This analysis evaluated the potential cost avoidance associated with TKI discontinuation. Cost avoidance was calculated using the average wholesale price of each TKI. Secondary objectives evaluated health outcomes of TKI discontinuation including CML relapse, reported AEs, long-term remission, and TKI withdrawal syndrome. Health outcomes were determined through chart review of AEs and clinic notes documented in the electronic health record during the study time frame.

Baseline information for eligible patients was collected, including age, sex, and race, and chart reviews were completed to evaluate reported AEs associated with therapy. Oncology clinical pharmacy practitioners (CPPs) at each VISN 21 facility were notified of eligible patients to facilitate discussion with oncologists and establish monitoring if therapy was discontinued. Following TKI discontinuation, health outcomes were evaluated, including CML relapse, changes in reported AEs, long-term remission, and TKI withdrawal syndrome. Descriptive statistics were used to analyze the baseline characteristics. Cost avoidance was calculated using the average wholesale price for each TKI. The number of tablets required to reach each patient’s individual dose was taken into consideration when determining the cost avoidance. A dashboard was created using the query from the CDW and was developed in Microsoft Power BI.

Preliminary Results

In FY 2024, VISN 21 had 3819 oncology patients. Twenty-four patients had taken a TKI for ≥ 3 years, 20 had a stable molecular response, and 15 had not previously attempted to discontinue their TKI (Figure 1). Fifteen veterans were eligible for therapy discontinuation for a total potential annual cost avoidance of $1.2 million (Figure 2). Most of the cost avoidance, $935,057 (78%), was attributed to 3 patients on nilotinib. The mean age of the population was 74 years. All patients were male, and 12 (80%) were White. (Table 2). At baseline, 11 patients (73%) were taking imatinib. One patient received oncology care from a community care clinician. All 15 patients decided to remain on therapy.

0526FED-AVAHO-TKI_F1
FIGURE 1. Flow Diagram for Study Participants
Abbreviations: CML, chronic myeloid leukemia; TKI, tyrosine kinase inhibitor;
VISN, Veterans Integrated Service Network.
0526FED-AVAHO-TKI_F2
FIGURE 2. Potential average yearly wholesale cost avoidance
for 15 patients at Veterans Integrated Services Network 21.
0526FED-AVAHO-TKI_T2

DISCUSSION

As a multisite quality improvement initiative, this project raised awareness of TKI therapy discontinuation in select patients with CML. It also sparked collaboration among oncology CPPs and clinicians and stimulated conversations about CML treatment. The development of the TKI discontinuation dashboard provides a population health management tool for CPPs and clinicians to identify eligible patients in the future.

Adherence to TKIs is crucial for disease control and survival in patients with CML. Patients are counseled that poor adherence to therapy may contribute to worsening disease or suboptimal response, the development of resistance, and greater health care costs.13 Therefore, it was a challenge for patients to understand and accept that they could stop TKI therapy after achieving a stable deep molecular response. Discussions with patients about the goal of therapy—suppressing the BCR-ABL oncogene, which they have achieved—could encourage patients to trial therapy discontinuation.

Only small cohort studies have been completed to evaluate the outcomes of therapy discontinuation. Much remains unknown regarding the optimal dose-reduction strategy and the minimum effective dose of each agent. Additionally, understanding the qualities of a good candidate for TKI discontinuation remains a barrier. A similar project was conducted in VISN 17. Five patients were counseled on TKI discontinuation; however, only 1 discontinued TKI therapy. Unfortunately, soon after discontinuing treatment, the patient had to restart therapy. Additional literature will enhance understanding of therapy discontinuation.

An unexpected finding of TKI discontinuation trials has been a reversible phenomenon known as TKI withdrawal syndrome.9 It can occur regardless of the TKI used and results in pruritus and new or worsening musculoskeletal pain within several weeks of TKI discontinuation in about 30% of patients. Symptoms may last several months and may require acetaminophen or nonsteroidal anti-inflammatory drugs for pain control.9,10,14

The potential cost avoidance of $1.2 million is an underestimation because VA contracts allow for greater cost savings. However, that information is confidential and therefore average wholesale price had to be used for this project. Most of the cost avoidance was due to 4 patients who could not tolerate imatinib and used nilotinib, which is more expensive.

Limitations

The small sample size presented some limitations. Of the 3819 oncology patients within VISN 21 in FY 2024, 186 received a TKI and only 15 were eligible for discontinuation. Additionally, challenges emerged when discussing discontinuation with community care clinicians and patients. Community care clinicians were difficult to contact, making it challenging to discuss the project with them. CPPs noted hesitancy among VA clinicians and patients to discontinue a medication for which adherence was continually emphasized.

Conclusions

Discussions about CML TKI discontinuation led to collaboration with the oncology care team and could lead to significant cost avoidance. Barriers to TKI discontinuation included patients’ concern for relapse, risk of discontinuation syndrome, the requirement for close monitoring, and clinician buy-in. Outcome studies are needed to gain a greater understanding of the benefits and risks of therapy discontinuation. In the future, evaluation of possible clinical and biological predictors of successful TKI discontinuation may be beneficial.

Chronic myeloid leukemia (CML) is a hematologic malignancy resulting from an acquired mutation. The mutation results in a reciprocal translocation between the long arms of chromosomes 9 and 22 and is known as the Philadelphia chromosome (Ph), or Ph-positive (Ph+) when present. The translocation results in the formation of a BCR-ABL fusion oncogene, which leads to continuous cell cycling and proliferation, altered differentiation, and a loss of apoptosis.1,2

Until the 1980s, CML was considered fatal.3 The mainstay of treatment consisted of 2 oral chemotherapeutic agents, busulfan and hydroxyurea. These medications did not prevent blast crisis, a fatal form of leukemia.4,5 The introduction of tyrosine kinase inhibitors (TKIs) transformed CML management and improved 10-year overall survival from about 20% to > 80% by delaying the transition to blast crisis. Now, the risk of death from general health conditions or comorbidities is higher than that of CML.6

TKIs target the root cause of CML through inhibition of the BCR-ABL oncoprotein.1,2 For CML, the goals of treatment include maintaining hematologic, cytogenetic, and molecular remission; preventing progression to accelerated phase or blast crisis; minimizing toxicity; and enabling potential cessation of therapy in carefully selected patients.7,8

Small cohort studies suggest that dose reduction of TKIs in patients who achieve optimal responses may reduce the risk of long-term adverse effects (AEs). However, optimal dose-reduction and minimum effective dose of each agent are unknown.7 The ability to maintain undetectable minimal residual disease or disease detectable at a stable low level after TKI discontinuation has been called treatment-free remission. Studies suggest that about 40% to 50% of patients who have achieved a stable deep molecular response remain in treatment-free remission after stopping first-line treatment.9,10 Of the patients who relapse following TKI discontinuation, 80% relapse within the first 6 months of treatment cessation. Molecular response is regained in almost all patients when treatment is resumed with the same TKI.11

The National Comprehensive Cancer Network (NCCN) recommends considering discontinuation of TKI therapy only outside the setting of a clinical trial and only in patients who consent to discontinuation after a thorough discussion of the potential risks and benefits. The NCCN criteria for patients who may be eligible for discontinuation are listed in Table 1. The Life After Stopping TKIs study reported that 80% of patients with well-controlled chronic phase CML who discontinued TKIs had a clinically meaningful improvement in fatigue. Patients also reported clinically meaningful improvements in depression, diarrhea, sleep disturbance, and pain interference. These symptoms worsened after restarting TKI therapy.12

0526FED-AVAHO-TKI_T1

TKI DISCONTINUATION

Electronic health record data were extracted using structured query language from the US Department of Veterans Affairs (VA) Corporate Data Warehouse (CDW). To be eligible for discontinuation, veterans had to be aged > 18 years, receive oncology care within a Veterans Integrated Services Network (VISN) 21 health care system (HCS) (VA Sierra Nevada HCS, VA Southern Nevada HCS, VA Central California HCS, VA Palo Alto HCS, VA Northern California HCS, and VA San Francisco HCS) or be a veteran referred to a community-based oncology practitioner. Patients had to have a documented diagnosis of chronic phase CML, have an active order for a TKI, be on TKI therapy for ≥ 3 years, and have a stable molecular response (BCR-ABL1 ≤ 0.01% on the International Scale for ≥ 2 years with ≥ 4 tests done ≥ 3 months apart) as of October 1, 2024. Veterans were excluded if they had a history of advanced accelerated phase CML, previous TKI discontinuation trials, nonadherence to the TKI, or if they did not want to consider TKI discontinuation.

This analysis evaluated the potential cost avoidance associated with TKI discontinuation. Cost avoidance was calculated using the average wholesale price of each TKI. Secondary objectives evaluated health outcomes of TKI discontinuation including CML relapse, reported AEs, long-term remission, and TKI withdrawal syndrome. Health outcomes were determined through chart review of AEs and clinic notes documented in the electronic health record during the study time frame.

Baseline information for eligible patients was collected, including age, sex, and race, and chart reviews were completed to evaluate reported AEs associated with therapy. Oncology clinical pharmacy practitioners (CPPs) at each VISN 21 facility were notified of eligible patients to facilitate discussion with oncologists and establish monitoring if therapy was discontinued. Following TKI discontinuation, health outcomes were evaluated, including CML relapse, changes in reported AEs, long-term remission, and TKI withdrawal syndrome. Descriptive statistics were used to analyze the baseline characteristics. Cost avoidance was calculated using the average wholesale price for each TKI. The number of tablets required to reach each patient’s individual dose was taken into consideration when determining the cost avoidance. A dashboard was created using the query from the CDW and was developed in Microsoft Power BI.

Preliminary Results

In FY 2024, VISN 21 had 3819 oncology patients. Twenty-four patients had taken a TKI for ≥ 3 years, 20 had a stable molecular response, and 15 had not previously attempted to discontinue their TKI (Figure 1). Fifteen veterans were eligible for therapy discontinuation for a total potential annual cost avoidance of $1.2 million (Figure 2). Most of the cost avoidance, $935,057 (78%), was attributed to 3 patients on nilotinib. The mean age of the population was 74 years. All patients were male, and 12 (80%) were White. (Table 2). At baseline, 11 patients (73%) were taking imatinib. One patient received oncology care from a community care clinician. All 15 patients decided to remain on therapy.

0526FED-AVAHO-TKI_F1
FIGURE 1. Flow Diagram for Study Participants
Abbreviations: CML, chronic myeloid leukemia; TKI, tyrosine kinase inhibitor;
VISN, Veterans Integrated Service Network.
0526FED-AVAHO-TKI_F2
FIGURE 2. Potential average yearly wholesale cost avoidance
for 15 patients at Veterans Integrated Services Network 21.
0526FED-AVAHO-TKI_T2

DISCUSSION

As a multisite quality improvement initiative, this project raised awareness of TKI therapy discontinuation in select patients with CML. It also sparked collaboration among oncology CPPs and clinicians and stimulated conversations about CML treatment. The development of the TKI discontinuation dashboard provides a population health management tool for CPPs and clinicians to identify eligible patients in the future.

Adherence to TKIs is crucial for disease control and survival in patients with CML. Patients are counseled that poor adherence to therapy may contribute to worsening disease or suboptimal response, the development of resistance, and greater health care costs.13 Therefore, it was a challenge for patients to understand and accept that they could stop TKI therapy after achieving a stable deep molecular response. Discussions with patients about the goal of therapy—suppressing the BCR-ABL oncogene, which they have achieved—could encourage patients to trial therapy discontinuation.

Only small cohort studies have been completed to evaluate the outcomes of therapy discontinuation. Much remains unknown regarding the optimal dose-reduction strategy and the minimum effective dose of each agent. Additionally, understanding the qualities of a good candidate for TKI discontinuation remains a barrier. A similar project was conducted in VISN 17. Five patients were counseled on TKI discontinuation; however, only 1 discontinued TKI therapy. Unfortunately, soon after discontinuing treatment, the patient had to restart therapy. Additional literature will enhance understanding of therapy discontinuation.

An unexpected finding of TKI discontinuation trials has been a reversible phenomenon known as TKI withdrawal syndrome.9 It can occur regardless of the TKI used and results in pruritus and new or worsening musculoskeletal pain within several weeks of TKI discontinuation in about 30% of patients. Symptoms may last several months and may require acetaminophen or nonsteroidal anti-inflammatory drugs for pain control.9,10,14

The potential cost avoidance of $1.2 million is an underestimation because VA contracts allow for greater cost savings. However, that information is confidential and therefore average wholesale price had to be used for this project. Most of the cost avoidance was due to 4 patients who could not tolerate imatinib and used nilotinib, which is more expensive.

Limitations

The small sample size presented some limitations. Of the 3819 oncology patients within VISN 21 in FY 2024, 186 received a TKI and only 15 were eligible for discontinuation. Additionally, challenges emerged when discussing discontinuation with community care clinicians and patients. Community care clinicians were difficult to contact, making it challenging to discuss the project with them. CPPs noted hesitancy among VA clinicians and patients to discontinue a medication for which adherence was continually emphasized.

Conclusions

Discussions about CML TKI discontinuation led to collaboration with the oncology care team and could lead to significant cost avoidance. Barriers to TKI discontinuation included patients’ concern for relapse, risk of discontinuation syndrome, the requirement for close monitoring, and clinician buy-in. Outcome studies are needed to gain a greater understanding of the benefits and risks of therapy discontinuation. In the future, evaluation of possible clinical and biological predictors of successful TKI discontinuation may be beneficial.

References
  1. Schiffer CA. BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia. N Engl J Med. 2007;357:258-265. doi:10.1056/NEJMct071828
  2. Hehlmann R, Hochhaus A, Baccarani M; European LeukemiaNet. Chronic myeloid leukaemia. Lancet. 2007;370:342-350. doi:10.1016/S0140-6736(07)61165-9
  3. Goldman JM, Melo JV. Chronic myeloid leukemia--advances in biology and new approaches to treatment. N Engl J Med. 2003;349:1451-1464. doi:10.1056/NEJMra020777
  4. Pasic I, Lipton JH. Current approach to the treatment of chronic myeloid leukaemia. Leuk Res. 2017;55:65-78. doi:10.1016/j.leukres.2017.01.005
  5. Rao KV, Iannucci A, Jabbour E. Current and future clinical strategies in the management of chronic myeloid leukemia. Pharmacotherapy. 2010;30:77S-101S. doi:10.1592/phco.30.pt2.77S
  6. Cortes J, Pavlovsky C, Saußele S. Chronic myeloid leukaemia. Lancet. 2021;398:1914-1926. doi:10.1016/S0140-6736(21)01204-6
  7. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Chronic myeloid leukemia. Version 1.2026. July 16, 2025. Accessed February 8, 2026. https://www.nccn.org /guidelines/guidelines-detail?id=1427
  8. Hochhaus A, Baccarani M, Silver RT, et al. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia. 2020;34:966-984. doi:10.1038/s41375-020-0776-2
  9. Saußele S, Richter J, Hochhaus A, Mahon F-X. The concept of treatment-free remission in chronic myeloid leukemia. Leukemia. 2016;30:1638-1647. doi:10.1038/leu.2016.115
  10. Atallah E, Sweet K. Treatment-free remission: the new goal in CML therapy. Curr Hematol Malig Rep. 2021;16:433-439. doi:10.1007/s11899-021-00653-1
  11. Hehlmann R. The new ELN recommendations for treating CML. J Clin Med. 2020;9:3671. doi:10.3390/jcm9113671
  12. Atallah E, Schiffer CA, Radich JP , et al. Assessment of outcomes after stopping tyrosine kinase inhibitors among patients with chronic myeloid leukemia: a non-randomized clinical trial. JAMA Oncol. 2021;7:42-50. doi:10.1001/jamaoncol.2020.5774
  13. Breccia M, Efficace F, Alimena G. Imatinib treatment in chronic myelogenous leukemia: what have we learned so far? Cancer Lett. 2011;300:115-121. doi:10.1016/j.canlet.2010.10.018
  14. Berman E. How I treat chronic-phase chronic myelogenous leukemia. Blood. 2022;139:3138-3147. doi:10.1182/blood.2021011722
References
  1. Schiffer CA. BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia. N Engl J Med. 2007;357:258-265. doi:10.1056/NEJMct071828
  2. Hehlmann R, Hochhaus A, Baccarani M; European LeukemiaNet. Chronic myeloid leukaemia. Lancet. 2007;370:342-350. doi:10.1016/S0140-6736(07)61165-9
  3. Goldman JM, Melo JV. Chronic myeloid leukemia--advances in biology and new approaches to treatment. N Engl J Med. 2003;349:1451-1464. doi:10.1056/NEJMra020777
  4. Pasic I, Lipton JH. Current approach to the treatment of chronic myeloid leukaemia. Leuk Res. 2017;55:65-78. doi:10.1016/j.leukres.2017.01.005
  5. Rao KV, Iannucci A, Jabbour E. Current and future clinical strategies in the management of chronic myeloid leukemia. Pharmacotherapy. 2010;30:77S-101S. doi:10.1592/phco.30.pt2.77S
  6. Cortes J, Pavlovsky C, Saußele S. Chronic myeloid leukaemia. Lancet. 2021;398:1914-1926. doi:10.1016/S0140-6736(21)01204-6
  7. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Chronic myeloid leukemia. Version 1.2026. July 16, 2025. Accessed February 8, 2026. https://www.nccn.org /guidelines/guidelines-detail?id=1427
  8. Hochhaus A, Baccarani M, Silver RT, et al. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia. 2020;34:966-984. doi:10.1038/s41375-020-0776-2
  9. Saußele S, Richter J, Hochhaus A, Mahon F-X. The concept of treatment-free remission in chronic myeloid leukemia. Leukemia. 2016;30:1638-1647. doi:10.1038/leu.2016.115
  10. Atallah E, Sweet K. Treatment-free remission: the new goal in CML therapy. Curr Hematol Malig Rep. 2021;16:433-439. doi:10.1007/s11899-021-00653-1
  11. Hehlmann R. The new ELN recommendations for treating CML. J Clin Med. 2020;9:3671. doi:10.3390/jcm9113671
  12. Atallah E, Schiffer CA, Radich JP , et al. Assessment of outcomes after stopping tyrosine kinase inhibitors among patients with chronic myeloid leukemia: a non-randomized clinical trial. JAMA Oncol. 2021;7:42-50. doi:10.1001/jamaoncol.2020.5774
  13. Breccia M, Efficace F, Alimena G. Imatinib treatment in chronic myelogenous leukemia: what have we learned so far? Cancer Lett. 2011;300:115-121. doi:10.1016/j.canlet.2010.10.018
  14. Berman E. How I treat chronic-phase chronic myelogenous leukemia. Blood. 2022;139:3138-3147. doi:10.1182/blood.2021011722
Issue
Federal Practitioner - 43(suppl 2)
Issue
Federal Practitioner - 43(suppl 2)
Page Number
S14-S17
Page Number
S14-S17
Publications
Publications
Topics
Article Type
Display Headline

Potential Tyrosine Kinase Inhibitor Therapy Discontinuation for Patients With Chronic Myeloid Leukemia in a VA Regional Network

Display Headline

Potential Tyrosine Kinase Inhibitor Therapy Discontinuation for Patients With Chronic Myeloid Leukemia in a VA Regional Network

Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
survey writer start date

Involving Concerned Significant Others in Firearm Suicide Prevention: Development of the Family FireArms Secure Storage Training Intervention

Article Type
Changed
Display Headline

Involving Concerned Significant Others in Firearm Suicide Prevention: Development of the Family FireArms Secure Storage Training Intervention

Veterans are at higher risk for suicide compared with civilian populations.1 Firearms are the most frequent cause of death in veteran deaths by suicide, likely because about 51% of veterans own ≥ 1 firearms and firearms are the most lethal and readily available mechanism.1-3 Unsecure firearm storage practices (eg, storing firearms unlocked, in an unsecure location, or loaded with ammunition) are associated with increased suicide risk.4 Conversely, secure firearm storage (ie, storing firearms locked and unloaded) is associated with lower suicide risk.5

A 2019 study of veterans who own firearms found that only 22.2% store all their firearms unloaded and locked, while 32.7% store ≥ 1 firearm unlocked and loaded, and 45.2% store firearms both unlocked and loaded or locked and unloaded. Only 6.3% of veterans strongly agreed that having a firearm at home increased suicide risk among household members; however, 77.2% indicated they would ensure a household member could not access firearms if they were concerned about their suicidal ideation.6

Another study found that 9.2% of veterans receive lethal means safety counseling from their US Department of Veterans Affairs (VA)-affiliated or non-VA health care professional.7 These data highlight a need to educate veterans about the increased risk for suicide associated with storing an unsecured firearm in the household and to connect this understanding to their values of service and protection of others, while simultaneously preparing them and their family members for a potential mental health crisis.

Consistent with the government’s public health approach to suicide prevention, prevention efforts should also enlist the participation of individuals outside health care.8 For example, prior research has found that family members are considered highly credible, and engaging them could expand the reach of lethal means safety conversations. A qualitative analysis of 29 veterans found that 17 (57%) said they preferred having a concerned significant other (CSO) (eg, spouse, adult friend, or relative) involved in their suicide prevention care, while 21 (72%) said they would prefer having a CSO assisting in the secure storage of firearms.9,10 Some veterans may be more amenable to a conversation about firearm access and suicide risk concerns initiated by a CSO rather than by a clinician, indicating the potential benefits of educating and involving CSOs in suicide prevention.11 Involving CSOs in secure firearm storage planning may also strengthen the veteran’s sense of social support, a key protective factor against suicidal ideation.12

CSO involvement in secure firearm storage can provide the following benefits: (1) helping the veteran create a secure storage plan, including developing approaches to secure storage; (2) understanding warning signs of suicide; (3) helping the veteran limit access to firearms during a suicidal crisis; (4) helping the veteran remember the secure storage plan; (5) helping the veteran connect with mental health services; and (6) enhancing social support. In most instances, CSOs are physically close to the veteran (eg, live in the same household) and have a greater practical ability to support and affect change with respect to changes in firearm storage practices.

This article describes the development of an intervention that incorporates CSO involvement in firearms safety efforts for veterans with guidance from VA mental health care practitioners (HCPs). The goal is to provide HCPs and other key stakeholders with a detailed description of the intervention and to suggest potential strategies for how to involve CSOs in suicide prevention.

This article follows the Guideline for Reporting Evidence-based Practice Educational interventions and Teaching checklist, which was developed to facilitate standardized reporting and replication for education interventions.13 Applicable portions of the checklist are outlined, with others (ie, incentives, planned/unplanned changes, attendance, and other outcomes) to be addressed in future research.

FFAST INTERVENTION

Training (FFAST) intervention promotes voluntary secure firearm storage, engages CSOs in veteran mental health care, and provides psychoeducation and skills to support crisis management. The intervention was developed for all veterans who do not securely store firearms.

Theory

The intervention incorporates motivational interviewing techniques, as ambivalence about changing firearm storage behaviors is common, particularly when veterans own firearms for safety or protection.6,14 Motivational interviewing is a collaborative approach that addresses a client’s ambivalence to change by eliciting and exploring the client’s own arguments related to change.14 An important aspect of developing this intervention was to ensure it would be culturally relevant to veteran firearm owners and their CSOs.15 Further, involvement of the CSO is intentional and meant to boost social support, a known buffering factor against suicide risk.12

Objectives

This intervention’s primary objective was for veteran participants to identify secure firearm storage practices and develop a plan for implementing them, including when a veteran or other household member experiences a mental health crisis. For CSOs, the primary objective is to learn how to help the veteran connect with mental health resources if needed and support secure firearm storage as necessary. The overall goal is to learn how to identify warning signs for suicide and how to respond to a mental health crisis through a collaborative process, including securing firearms in a crisis situation.

Materials, Educational Strategies, and Instructors

Training for delivering the intervention was provided via direct consultation with the developer of the intervention and manual. The manual contains pertinent background information to provide context for the intervention’s significance and rationale, including the role of firearms in suicides and current lethal means safety initiatives. It also describes the purpose and objective of each intervention component in detail in addition to providing a script for interventionists to follow to complete each objective.

Training materials for veterans and CSOs include a single Firearms Secure Storage Planning worksheet completed during the intervention, with which the interventionist guides participants through the creation of a secure firearm storage plan (Table). Educational strategies include psychoeducation and Socratic questioning (eg, questioning focused on guiding participants toward the intervention goals) delivered verbally by the interventionist.

0426FED-MH-FFAST-T1

The intervention is delivered in person or virtually during a single 90-minute session with a veteran and CSO. Veterans and CSOs work with the interventionist to complete collaborative activities during the session and have self-directive learning activities or homework.

The intervention has 4 primary components: (1) CSO involvement; (2) psychoeducation; (3) secure firearm storage; and (4) how to respond to a mental health crisis. Each CSO should have an established relationship with the veteran, be willing and able to be present during the intervention, and remain an encouraging support person for the veteran. The interventionist emphasizes that it is part of the VA mission for staff to care about the veteran, and that initiating such contact with a CSO is meant to prioritize veteran safety and the safety of their family. Psychoeducation on mental health symptoms, suicide warning signs, veteran suicide rates and lethal means, and the benefits of secure firearm storage, is incorporated in the intervention.

The secure firearm storage component consists of 7 subcomponents: (1) general lethal means secure storage; (2) warning signs; (3) dyad communication; (4) lethal means safety when symptoms emerge; (5) coping strategies; (6) social support; and (7) emergency contacts. A lethal means safety worksheet rooted in the Stanley and Brown suicide safety plan model and implemented in VA health care settings is used to facilitate discussions of secure storage (Appendix).16

0426FED-MH-FFAST-A1

CSOs typically have little or no suicidal crisis response training, yet they likely have more interaction with the veteran on a daily basis than HCPs, putting them in a vital position to identify a crisis early and connect the veteran with the proper care. The crisis component prepares the CSO and veteran to navigate a crisis scenario so they can practice their newly developed safety plan and increase their comfort in discussing mental health and suicidal crisis.

FICTIONAL CASE STUDY

Cole, aged 59 years, is a Persian Gulf War veteran and retired police officer. His medical history includes hypothyroidism, hypertension, type 2 diabetes mellitus, chronic posttraumatic stress disorder, major depressive disorder, and insomnia.

Cole's wife of > 30 years, Sheila, joined him for the FFAST intervention. They report having 4 firearms in the home, 3 of which are loaded but stored in a lockbox and 1 that Cole reports is kept on his person for protection. Cole reports passive suicidal ideation, but no plans or intent. When discussing warning signs that a mental health crisis is building, Cole describes feeling anxious, having a change in his speech patterns, and isolating himself. Sheila agrees, but also mentions that Cole is easily angered and becomes nonverbal. Cole and Sheila express difficulty communicating and appear to have a breakthrough moment when Cole says he does not like when Sheila repeats herself, as he feels like she is “poking” at him. Sheila shares concerns for his safety and that she only repeats herself because he refuses to talk.

Cole agrees to verbalize that he is safe but needs time to process his thoughts. Sheila agrees to give him space with a plan to revisit the conversation within an agreed upon timeline. When discussing an updated secure storage plan for their firearms when a mental health crisis is building, Cole commits to allowing Sheila to store the firearm currently on his person in their gun safe, with the ammunition stored separately, and to giving her the gun safe key. They agree to implement this practice until the mental health crisis has passed.

To mitigate a potential crisis, the interventionist discusses possible internal coping strategies for Cole, including writing, reading, walking the dog, listening to music, and baking. People and social settings that could provide distraction involve going to the gym, talking to his friend Carl or his daughter Kelly, and attending the men’s ministry at church. The intervention concludes by discussing professionals or agencies that Cole and Sheila could contact during a crisis. After the intervention, Cole and Sheila are asked to rate their likelihood of using the plan they established during the conversation on a scale of 0 to 10, with 0 being highly unlikely and 10 being extremely likely. Cole responds with 9 and Sheila responds with 10.

DISCUSSION

Lethal means safety remains a critical component of veteran suicide prevention. However, lethal means safety discussions are often implemented after suicide risk has been identified, which may be too late. Thus, having these conversations early and before a crisis may be imperative. Veterans have expressed a desire to have CSOs involved in their suicide prevention treatment, and CSOs can play a key role in recognizing risk factors during everyday life. The FFAST intervention addresses many of these gaps.

Having discussions in advance of a crisis allows veterans to consider an effective secure firearm storage plan outside of the context of a crisis. Including a CSO galvanizes another person to understand a veteran’s needs and assist with secure firearm storage, identify warning signs, and support them during a crisis. These discussions occur in a context where there is less pressure than during a crisis. Features that were more appealing to veterans and their CSOs were also incorporated, such as having the dyad build a plan that is conceptually similar to other public safety initiatives (eg, a fire safety plan, tornado plan, or hurricane plan). Previous research demonstrates that veterans appreciated the nonjudgmental approach and some preferred that clinicians approach the discussion of secure firearm storage within the context of general home and family safety.17 Additionally, this intervention can build on veterans’ prior military training in preparedness.

Other potential benefits associated with the FFAST intervention include creating an opportunity to strengthen communication between the veteran and CSO. While FFAST is intended to be used with all types of CSOs, this work is consistent with preliminary data from a couples-based suicide prevention study that indicated veterans and their partners reported increases in relationship functioning and marginal decreases in suicidal ideation.18 It is possible that communication strategies gained from the current intervention could improve veterans’ relationships with their CSOs, which are associated with a greater sense of social support and reduced suicide risk.12

The intervention is a brief, single session that may be appealing to veterans and CSOs with full schedules. Evidence suggests that even brief, single-session interventions have a significant impact on beliefs about secure firearm storage, knowledge of lethal means safety, and confidence in having secure firearm storage conversations.19 However, clinicians should be cautious when extrapolating from the findings of the current case example, which was a one-time intervention with no follow-up.

Future Directions

Pilot testing of the proposed intervention is underway, and future research will include feedback from veterans and CSOs, as well as feasibility and acceptability data collected during the pilot process. The pilot study uses a successive cohort design with an initial 2 sets of 5 veteran and CSO dyads, and subsequent funding has expanded the pilot study to include an additional 30 dyads. Qualitative interviews will be conducted separately with each veteran and CSO, and additional constructs such as feasibility, acceptability, barriers and facilitators to implementation, and changes in secure storage will be examined. This future research may provide a deeper understanding of the broader acceptability, feasibility, and satisfaction associated with a suicide prevention intervention focused on securing firearms and involving veterans and their CSOs. These data could be used to inform future implementation trials and inform the development of an implementation strategy. In the interim, the nature of the manual is summarized in the context of the urgency of suicide prevention in this at-risk population.

Conclusions

FFAST is a novel approach to veteran firearm suicide prevention. By involving CSOs and emphasizing mental health crisis preparedness between them and veterans, the dyad can work in association with HCPs to establish and exercise secure firearm storage practices as part of an at-home safety plan. Implementation of FFAST may be beneficial for all veterans, not only those who have been identified as being at high suicide risk.

References
  1. US Dept of Veterans Affairs Office of Suicide Prevention. 2024 national veteran suicide prevention annual report. December 2024. Accessed February 5, 2026. https://www.mentalhealth.va.gov/docs/data-sheets/2024/2024-Annual-Report-Part-2-of-2_508.pdf
  2. Fischer IC, Aunon FM, Nichter B, et al. Firearm ownership among a nationally representative sample of U.S. veterans. Am J Prev Med. 2023;65:1129-1133. doi:10.1016/j.amepre.2023.06.013
  3. Conner A, Azrael D, Miller M. Suicide case-fatality rates in the United States, 2007-2014: a nationwide population-based study. Ann Intern Med. 2019;171(12):885-895. doi:10.7326/M19-1324
  4. Dempsey CL, Benedek DM, Zuromski KL, et al. Association of firearm ownership, use, accessibility, and storage practices with suicide risk among US army soldiers. JAMA Netw Open. 2019;2:e195383. doi:10.1001/jamanetworkopen.2019.5383
  5. Butterworth SE, Daruwala SE, Anestis MD. Firearm storage and shooting experience: factors relevant to the practical capability for suicide. J Psychiatr Res. 2018;102:52-56. doi:10.1016/j.jpsychires.2018.03.010
  6. Simonetti JA, Azrael D, Miller M. Firearm storage practices and risk perceptions among a nationally representative sample of U.S. veterans with and without self-harm risk factors. Suicide Life Threat Behav. 2019;49:653-664. doi:10.1111/sltb.12463
  7. Simonetti JA, Azrael D, Zhang W, Miller M. Receipt of clinician-delivered firearm safety counseling among U.S. veterans: results from a 2019 national survey. Suicide Life Threat Behav. 2022;52:1121-1125. doi:10.1111/sltb.12906
  8. US Office of the Surgeon General. The surgeon general’s call to action to implement the national strategy for suicide prevention. January 2021. Accessed February 5, 2026. https://www.hhs.gov/sites/default/files/sprc-call-to-action.pdf
  9. DeBeer BB, Matthieu MM, Kittel JA, et al. Quality Improvement Evaluation of the Feasibility and Acceptability of Adding a Concerned Significant Other to Safety Planning for Suicide Prevention With Veterans. J Ment Health Couns. 2019;41:4-20. doi:10.17744/mehc.41.1.02
  10. DeBeer BB, Matthieu MM, Degutis LC, et al. Firearms lethal means safety among veterans: attitudes toward involving a concerned significant other. J Mil Veteran Fam Health. 2025;11:23-31.
  11. Monteith LL, Holliday R, Dorsey Holliman BA, et al. Understanding female veterans’ experiences and perspectives of firearms. J Clin Psychol. 2020;76:1736-1753. doi:10.1002/jclp.22952
  12. DeBeer BB, Kimbrel NA, Meyer EC, et al. Combined PTSD and depressive symptoms interact with post-deployment social support to predict suicidal ideation in Operation Enduring Freedom and Operation Iraqi Freedom veterans. Psychiatry Res. 2014;216:357-362. doi:10.1016/j.psychres.2014.02.010
  13. Phillips AC, Lewis LK, McEvoy MP, et al. Development and validation of the guideline for reporting evidence-based practice educational interventions and teaching (GREET). BMC Med Educ. 2016;16:237. doi:10.1186/s12909-016-0759-1
  14. Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. 3rd ed. Guilford Press; 2013.
  15. Khazanov GK, Keddem S, Hoskins K, et al. Stakeholder perceptions of lethal means safety counseling: a qualitative systematic review. Front Psychiatry. 2022;13:993415. doi:10.3389/fpsyt.2022.993415
  16. Stanley B, Brown GK, Karlin B, et al. US Dept of Veterans Affairs. Safety plan treatment manual to reduce suicide risk: veteran version. August 20, 2008. Accessed February 5, 2026. https://www.mentalhealth.va.gov/mentalhealth/docs/va_safety_planning_manual.doc
  17. Dobscha SK, Clark KD, Newell S, et al. Strategies for discussing firearms storage safety in primary care: veteran perspectives. J Gen Intern Med. 2021;36:1492-1502. doi:10.1007/s11606-020-06412-x
  18. Khalifian CE, Leifker FR, Knopp K, et al. Utilizing the couple relationship to prevent suicide: a preliminary examination of treatment for relationships and safety together. J Clin Psych. 2022;78:747-757. doi:10.1002/jclp.23251
  19. Walsh A, Friedman K, Morrissey BH, et al. Project Safe Guard: evaluating a lethal means safety intervention to reduce firearm suicide in the National Guard. Mil Med. 2024;189:510-516. doi:10.1093/milmed/usae172
  20. Beck AT. Beyond belief: a theory of modes, personality, and psychopathology. In: Salkovkis PM, ed. Frontiers of Cognitive Therapy. Guilford Press;1996:1-25.
  21. Rudd MD. The suicidal mode: a cognitive-behavioral model of suicidality. Suicide Life Threat Behav. 2000;30(1):18-33.
Article PDF
Author and Disclosure Information

Bryann B. DeBeer, PhDa,b; Alexis Blessing, PhDa,b; Monica Matthieu, PhDc,d; Joseph Simonetti, MD, MPHa,b; Elisa Borah, PhDe; Elizabeth Karras-Pilato, PhDf; Meredith Mealer, PhD, RNb; Joseph Mignogna, PhDa,b; Sandra B. Morissette, PhDg

Author affiliations
aRocky Mountain Mental Illness, Research, Education and Clinical Center (MIRECC) for Suicide Prevention, Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado
bUniversity of Colorado, Aurora
cSaint Louis University, Missouri
dCentral Arkansas Veterans Healthcare System, Little Rock
eThe University of Texas at Austin
fVISN 2 Center of Excellence for Suicide Prevention, Canandaigua, New York
gUniversity of Texas at San Antonio

Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies.

Ethics and consent
The Colorado Multiple Institutional Review Board and the Veterans Affairs Eastern Colorado Health Care Research & Development committee reviewed and provided ethical approval to conduct this nonhuman subjects project.

Funding
This work was funded by the Veterans Affairs Suicide Prevention Research Impact Network Pilot Award and funding from the Office of Suicide Prevention Health Sciences awarded to Dr. Bryann B. DeBeer. This work does not represent the views of the US Department of Veterans Affairs, the University of Colorado, the United States Government, or other affiliates.

Correspondence: Bryann DeBeer (bryann.debeer@va.gov)

Fed Pract. 2026;43(suppl 1). Published online April 18. doi:10.12788/fp.0695

Issue
Federal Practitioner 43(suppl 1)
Publications
Topics
Page Number
S1-S7
Sections
Author and Disclosure Information

Bryann B. DeBeer, PhDa,b; Alexis Blessing, PhDa,b; Monica Matthieu, PhDc,d; Joseph Simonetti, MD, MPHa,b; Elisa Borah, PhDe; Elizabeth Karras-Pilato, PhDf; Meredith Mealer, PhD, RNb; Joseph Mignogna, PhDa,b; Sandra B. Morissette, PhDg

Author affiliations
aRocky Mountain Mental Illness, Research, Education and Clinical Center (MIRECC) for Suicide Prevention, Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado
bUniversity of Colorado, Aurora
cSaint Louis University, Missouri
dCentral Arkansas Veterans Healthcare System, Little Rock
eThe University of Texas at Austin
fVISN 2 Center of Excellence for Suicide Prevention, Canandaigua, New York
gUniversity of Texas at San Antonio

Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies.

Ethics and consent
The Colorado Multiple Institutional Review Board and the Veterans Affairs Eastern Colorado Health Care Research & Development committee reviewed and provided ethical approval to conduct this nonhuman subjects project.

Funding
This work was funded by the Veterans Affairs Suicide Prevention Research Impact Network Pilot Award and funding from the Office of Suicide Prevention Health Sciences awarded to Dr. Bryann B. DeBeer. This work does not represent the views of the US Department of Veterans Affairs, the University of Colorado, the United States Government, or other affiliates.

Correspondence: Bryann DeBeer (bryann.debeer@va.gov)

Fed Pract. 2026;43(suppl 1). Published online April 18. doi:10.12788/fp.0695

Author and Disclosure Information

Bryann B. DeBeer, PhDa,b; Alexis Blessing, PhDa,b; Monica Matthieu, PhDc,d; Joseph Simonetti, MD, MPHa,b; Elisa Borah, PhDe; Elizabeth Karras-Pilato, PhDf; Meredith Mealer, PhD, RNb; Joseph Mignogna, PhDa,b; Sandra B. Morissette, PhDg

Author affiliations
aRocky Mountain Mental Illness, Research, Education and Clinical Center (MIRECC) for Suicide Prevention, Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado
bUniversity of Colorado, Aurora
cSaint Louis University, Missouri
dCentral Arkansas Veterans Healthcare System, Little Rock
eThe University of Texas at Austin
fVISN 2 Center of Excellence for Suicide Prevention, Canandaigua, New York
gUniversity of Texas at San Antonio

Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies.

Ethics and consent
The Colorado Multiple Institutional Review Board and the Veterans Affairs Eastern Colorado Health Care Research & Development committee reviewed and provided ethical approval to conduct this nonhuman subjects project.

Funding
This work was funded by the Veterans Affairs Suicide Prevention Research Impact Network Pilot Award and funding from the Office of Suicide Prevention Health Sciences awarded to Dr. Bryann B. DeBeer. This work does not represent the views of the US Department of Veterans Affairs, the University of Colorado, the United States Government, or other affiliates.

Correspondence: Bryann DeBeer (bryann.debeer@va.gov)

Fed Pract. 2026;43(suppl 1). Published online April 18. doi:10.12788/fp.0695

Article PDF
Article PDF

Veterans are at higher risk for suicide compared with civilian populations.1 Firearms are the most frequent cause of death in veteran deaths by suicide, likely because about 51% of veterans own ≥ 1 firearms and firearms are the most lethal and readily available mechanism.1-3 Unsecure firearm storage practices (eg, storing firearms unlocked, in an unsecure location, or loaded with ammunition) are associated with increased suicide risk.4 Conversely, secure firearm storage (ie, storing firearms locked and unloaded) is associated with lower suicide risk.5

A 2019 study of veterans who own firearms found that only 22.2% store all their firearms unloaded and locked, while 32.7% store ≥ 1 firearm unlocked and loaded, and 45.2% store firearms both unlocked and loaded or locked and unloaded. Only 6.3% of veterans strongly agreed that having a firearm at home increased suicide risk among household members; however, 77.2% indicated they would ensure a household member could not access firearms if they were concerned about their suicidal ideation.6

Another study found that 9.2% of veterans receive lethal means safety counseling from their US Department of Veterans Affairs (VA)-affiliated or non-VA health care professional.7 These data highlight a need to educate veterans about the increased risk for suicide associated with storing an unsecured firearm in the household and to connect this understanding to their values of service and protection of others, while simultaneously preparing them and their family members for a potential mental health crisis.

Consistent with the government’s public health approach to suicide prevention, prevention efforts should also enlist the participation of individuals outside health care.8 For example, prior research has found that family members are considered highly credible, and engaging them could expand the reach of lethal means safety conversations. A qualitative analysis of 29 veterans found that 17 (57%) said they preferred having a concerned significant other (CSO) (eg, spouse, adult friend, or relative) involved in their suicide prevention care, while 21 (72%) said they would prefer having a CSO assisting in the secure storage of firearms.9,10 Some veterans may be more amenable to a conversation about firearm access and suicide risk concerns initiated by a CSO rather than by a clinician, indicating the potential benefits of educating and involving CSOs in suicide prevention.11 Involving CSOs in secure firearm storage planning may also strengthen the veteran’s sense of social support, a key protective factor against suicidal ideation.12

CSO involvement in secure firearm storage can provide the following benefits: (1) helping the veteran create a secure storage plan, including developing approaches to secure storage; (2) understanding warning signs of suicide; (3) helping the veteran limit access to firearms during a suicidal crisis; (4) helping the veteran remember the secure storage plan; (5) helping the veteran connect with mental health services; and (6) enhancing social support. In most instances, CSOs are physically close to the veteran (eg, live in the same household) and have a greater practical ability to support and affect change with respect to changes in firearm storage practices.

This article describes the development of an intervention that incorporates CSO involvement in firearms safety efforts for veterans with guidance from VA mental health care practitioners (HCPs). The goal is to provide HCPs and other key stakeholders with a detailed description of the intervention and to suggest potential strategies for how to involve CSOs in suicide prevention.

This article follows the Guideline for Reporting Evidence-based Practice Educational interventions and Teaching checklist, which was developed to facilitate standardized reporting and replication for education interventions.13 Applicable portions of the checklist are outlined, with others (ie, incentives, planned/unplanned changes, attendance, and other outcomes) to be addressed in future research.

FFAST INTERVENTION

Training (FFAST) intervention promotes voluntary secure firearm storage, engages CSOs in veteran mental health care, and provides psychoeducation and skills to support crisis management. The intervention was developed for all veterans who do not securely store firearms.

Theory

The intervention incorporates motivational interviewing techniques, as ambivalence about changing firearm storage behaviors is common, particularly when veterans own firearms for safety or protection.6,14 Motivational interviewing is a collaborative approach that addresses a client’s ambivalence to change by eliciting and exploring the client’s own arguments related to change.14 An important aspect of developing this intervention was to ensure it would be culturally relevant to veteran firearm owners and their CSOs.15 Further, involvement of the CSO is intentional and meant to boost social support, a known buffering factor against suicide risk.12

Objectives

This intervention’s primary objective was for veteran participants to identify secure firearm storage practices and develop a plan for implementing them, including when a veteran or other household member experiences a mental health crisis. For CSOs, the primary objective is to learn how to help the veteran connect with mental health resources if needed and support secure firearm storage as necessary. The overall goal is to learn how to identify warning signs for suicide and how to respond to a mental health crisis through a collaborative process, including securing firearms in a crisis situation.

Materials, Educational Strategies, and Instructors

Training for delivering the intervention was provided via direct consultation with the developer of the intervention and manual. The manual contains pertinent background information to provide context for the intervention’s significance and rationale, including the role of firearms in suicides and current lethal means safety initiatives. It also describes the purpose and objective of each intervention component in detail in addition to providing a script for interventionists to follow to complete each objective.

Training materials for veterans and CSOs include a single Firearms Secure Storage Planning worksheet completed during the intervention, with which the interventionist guides participants through the creation of a secure firearm storage plan (Table). Educational strategies include psychoeducation and Socratic questioning (eg, questioning focused on guiding participants toward the intervention goals) delivered verbally by the interventionist.

0426FED-MH-FFAST-T1

The intervention is delivered in person or virtually during a single 90-minute session with a veteran and CSO. Veterans and CSOs work with the interventionist to complete collaborative activities during the session and have self-directive learning activities or homework.

The intervention has 4 primary components: (1) CSO involvement; (2) psychoeducation; (3) secure firearm storage; and (4) how to respond to a mental health crisis. Each CSO should have an established relationship with the veteran, be willing and able to be present during the intervention, and remain an encouraging support person for the veteran. The interventionist emphasizes that it is part of the VA mission for staff to care about the veteran, and that initiating such contact with a CSO is meant to prioritize veteran safety and the safety of their family. Psychoeducation on mental health symptoms, suicide warning signs, veteran suicide rates and lethal means, and the benefits of secure firearm storage, is incorporated in the intervention.

The secure firearm storage component consists of 7 subcomponents: (1) general lethal means secure storage; (2) warning signs; (3) dyad communication; (4) lethal means safety when symptoms emerge; (5) coping strategies; (6) social support; and (7) emergency contacts. A lethal means safety worksheet rooted in the Stanley and Brown suicide safety plan model and implemented in VA health care settings is used to facilitate discussions of secure storage (Appendix).16

0426FED-MH-FFAST-A1

CSOs typically have little or no suicidal crisis response training, yet they likely have more interaction with the veteran on a daily basis than HCPs, putting them in a vital position to identify a crisis early and connect the veteran with the proper care. The crisis component prepares the CSO and veteran to navigate a crisis scenario so they can practice their newly developed safety plan and increase their comfort in discussing mental health and suicidal crisis.

FICTIONAL CASE STUDY

Cole, aged 59 years, is a Persian Gulf War veteran and retired police officer. His medical history includes hypothyroidism, hypertension, type 2 diabetes mellitus, chronic posttraumatic stress disorder, major depressive disorder, and insomnia.

Cole's wife of > 30 years, Sheila, joined him for the FFAST intervention. They report having 4 firearms in the home, 3 of which are loaded but stored in a lockbox and 1 that Cole reports is kept on his person for protection. Cole reports passive suicidal ideation, but no plans or intent. When discussing warning signs that a mental health crisis is building, Cole describes feeling anxious, having a change in his speech patterns, and isolating himself. Sheila agrees, but also mentions that Cole is easily angered and becomes nonverbal. Cole and Sheila express difficulty communicating and appear to have a breakthrough moment when Cole says he does not like when Sheila repeats herself, as he feels like she is “poking” at him. Sheila shares concerns for his safety and that she only repeats herself because he refuses to talk.

Cole agrees to verbalize that he is safe but needs time to process his thoughts. Sheila agrees to give him space with a plan to revisit the conversation within an agreed upon timeline. When discussing an updated secure storage plan for their firearms when a mental health crisis is building, Cole commits to allowing Sheila to store the firearm currently on his person in their gun safe, with the ammunition stored separately, and to giving her the gun safe key. They agree to implement this practice until the mental health crisis has passed.

To mitigate a potential crisis, the interventionist discusses possible internal coping strategies for Cole, including writing, reading, walking the dog, listening to music, and baking. People and social settings that could provide distraction involve going to the gym, talking to his friend Carl or his daughter Kelly, and attending the men’s ministry at church. The intervention concludes by discussing professionals or agencies that Cole and Sheila could contact during a crisis. After the intervention, Cole and Sheila are asked to rate their likelihood of using the plan they established during the conversation on a scale of 0 to 10, with 0 being highly unlikely and 10 being extremely likely. Cole responds with 9 and Sheila responds with 10.

DISCUSSION

Lethal means safety remains a critical component of veteran suicide prevention. However, lethal means safety discussions are often implemented after suicide risk has been identified, which may be too late. Thus, having these conversations early and before a crisis may be imperative. Veterans have expressed a desire to have CSOs involved in their suicide prevention treatment, and CSOs can play a key role in recognizing risk factors during everyday life. The FFAST intervention addresses many of these gaps.

Having discussions in advance of a crisis allows veterans to consider an effective secure firearm storage plan outside of the context of a crisis. Including a CSO galvanizes another person to understand a veteran’s needs and assist with secure firearm storage, identify warning signs, and support them during a crisis. These discussions occur in a context where there is less pressure than during a crisis. Features that were more appealing to veterans and their CSOs were also incorporated, such as having the dyad build a plan that is conceptually similar to other public safety initiatives (eg, a fire safety plan, tornado plan, or hurricane plan). Previous research demonstrates that veterans appreciated the nonjudgmental approach and some preferred that clinicians approach the discussion of secure firearm storage within the context of general home and family safety.17 Additionally, this intervention can build on veterans’ prior military training in preparedness.

Other potential benefits associated with the FFAST intervention include creating an opportunity to strengthen communication between the veteran and CSO. While FFAST is intended to be used with all types of CSOs, this work is consistent with preliminary data from a couples-based suicide prevention study that indicated veterans and their partners reported increases in relationship functioning and marginal decreases in suicidal ideation.18 It is possible that communication strategies gained from the current intervention could improve veterans’ relationships with their CSOs, which are associated with a greater sense of social support and reduced suicide risk.12

The intervention is a brief, single session that may be appealing to veterans and CSOs with full schedules. Evidence suggests that even brief, single-session interventions have a significant impact on beliefs about secure firearm storage, knowledge of lethal means safety, and confidence in having secure firearm storage conversations.19 However, clinicians should be cautious when extrapolating from the findings of the current case example, which was a one-time intervention with no follow-up.

Future Directions

Pilot testing of the proposed intervention is underway, and future research will include feedback from veterans and CSOs, as well as feasibility and acceptability data collected during the pilot process. The pilot study uses a successive cohort design with an initial 2 sets of 5 veteran and CSO dyads, and subsequent funding has expanded the pilot study to include an additional 30 dyads. Qualitative interviews will be conducted separately with each veteran and CSO, and additional constructs such as feasibility, acceptability, barriers and facilitators to implementation, and changes in secure storage will be examined. This future research may provide a deeper understanding of the broader acceptability, feasibility, and satisfaction associated with a suicide prevention intervention focused on securing firearms and involving veterans and their CSOs. These data could be used to inform future implementation trials and inform the development of an implementation strategy. In the interim, the nature of the manual is summarized in the context of the urgency of suicide prevention in this at-risk population.

Conclusions

FFAST is a novel approach to veteran firearm suicide prevention. By involving CSOs and emphasizing mental health crisis preparedness between them and veterans, the dyad can work in association with HCPs to establish and exercise secure firearm storage practices as part of an at-home safety plan. Implementation of FFAST may be beneficial for all veterans, not only those who have been identified as being at high suicide risk.

Veterans are at higher risk for suicide compared with civilian populations.1 Firearms are the most frequent cause of death in veteran deaths by suicide, likely because about 51% of veterans own ≥ 1 firearms and firearms are the most lethal and readily available mechanism.1-3 Unsecure firearm storage practices (eg, storing firearms unlocked, in an unsecure location, or loaded with ammunition) are associated with increased suicide risk.4 Conversely, secure firearm storage (ie, storing firearms locked and unloaded) is associated with lower suicide risk.5

A 2019 study of veterans who own firearms found that only 22.2% store all their firearms unloaded and locked, while 32.7% store ≥ 1 firearm unlocked and loaded, and 45.2% store firearms both unlocked and loaded or locked and unloaded. Only 6.3% of veterans strongly agreed that having a firearm at home increased suicide risk among household members; however, 77.2% indicated they would ensure a household member could not access firearms if they were concerned about their suicidal ideation.6

Another study found that 9.2% of veterans receive lethal means safety counseling from their US Department of Veterans Affairs (VA)-affiliated or non-VA health care professional.7 These data highlight a need to educate veterans about the increased risk for suicide associated with storing an unsecured firearm in the household and to connect this understanding to their values of service and protection of others, while simultaneously preparing them and their family members for a potential mental health crisis.

Consistent with the government’s public health approach to suicide prevention, prevention efforts should also enlist the participation of individuals outside health care.8 For example, prior research has found that family members are considered highly credible, and engaging them could expand the reach of lethal means safety conversations. A qualitative analysis of 29 veterans found that 17 (57%) said they preferred having a concerned significant other (CSO) (eg, spouse, adult friend, or relative) involved in their suicide prevention care, while 21 (72%) said they would prefer having a CSO assisting in the secure storage of firearms.9,10 Some veterans may be more amenable to a conversation about firearm access and suicide risk concerns initiated by a CSO rather than by a clinician, indicating the potential benefits of educating and involving CSOs in suicide prevention.11 Involving CSOs in secure firearm storage planning may also strengthen the veteran’s sense of social support, a key protective factor against suicidal ideation.12

CSO involvement in secure firearm storage can provide the following benefits: (1) helping the veteran create a secure storage plan, including developing approaches to secure storage; (2) understanding warning signs of suicide; (3) helping the veteran limit access to firearms during a suicidal crisis; (4) helping the veteran remember the secure storage plan; (5) helping the veteran connect with mental health services; and (6) enhancing social support. In most instances, CSOs are physically close to the veteran (eg, live in the same household) and have a greater practical ability to support and affect change with respect to changes in firearm storage practices.

This article describes the development of an intervention that incorporates CSO involvement in firearms safety efforts for veterans with guidance from VA mental health care practitioners (HCPs). The goal is to provide HCPs and other key stakeholders with a detailed description of the intervention and to suggest potential strategies for how to involve CSOs in suicide prevention.

This article follows the Guideline for Reporting Evidence-based Practice Educational interventions and Teaching checklist, which was developed to facilitate standardized reporting and replication for education interventions.13 Applicable portions of the checklist are outlined, with others (ie, incentives, planned/unplanned changes, attendance, and other outcomes) to be addressed in future research.

FFAST INTERVENTION

Training (FFAST) intervention promotes voluntary secure firearm storage, engages CSOs in veteran mental health care, and provides psychoeducation and skills to support crisis management. The intervention was developed for all veterans who do not securely store firearms.

Theory

The intervention incorporates motivational interviewing techniques, as ambivalence about changing firearm storage behaviors is common, particularly when veterans own firearms for safety or protection.6,14 Motivational interviewing is a collaborative approach that addresses a client’s ambivalence to change by eliciting and exploring the client’s own arguments related to change.14 An important aspect of developing this intervention was to ensure it would be culturally relevant to veteran firearm owners and their CSOs.15 Further, involvement of the CSO is intentional and meant to boost social support, a known buffering factor against suicide risk.12

Objectives

This intervention’s primary objective was for veteran participants to identify secure firearm storage practices and develop a plan for implementing them, including when a veteran or other household member experiences a mental health crisis. For CSOs, the primary objective is to learn how to help the veteran connect with mental health resources if needed and support secure firearm storage as necessary. The overall goal is to learn how to identify warning signs for suicide and how to respond to a mental health crisis through a collaborative process, including securing firearms in a crisis situation.

Materials, Educational Strategies, and Instructors

Training for delivering the intervention was provided via direct consultation with the developer of the intervention and manual. The manual contains pertinent background information to provide context for the intervention’s significance and rationale, including the role of firearms in suicides and current lethal means safety initiatives. It also describes the purpose and objective of each intervention component in detail in addition to providing a script for interventionists to follow to complete each objective.

Training materials for veterans and CSOs include a single Firearms Secure Storage Planning worksheet completed during the intervention, with which the interventionist guides participants through the creation of a secure firearm storage plan (Table). Educational strategies include psychoeducation and Socratic questioning (eg, questioning focused on guiding participants toward the intervention goals) delivered verbally by the interventionist.

0426FED-MH-FFAST-T1

The intervention is delivered in person or virtually during a single 90-minute session with a veteran and CSO. Veterans and CSOs work with the interventionist to complete collaborative activities during the session and have self-directive learning activities or homework.

The intervention has 4 primary components: (1) CSO involvement; (2) psychoeducation; (3) secure firearm storage; and (4) how to respond to a mental health crisis. Each CSO should have an established relationship with the veteran, be willing and able to be present during the intervention, and remain an encouraging support person for the veteran. The interventionist emphasizes that it is part of the VA mission for staff to care about the veteran, and that initiating such contact with a CSO is meant to prioritize veteran safety and the safety of their family. Psychoeducation on mental health symptoms, suicide warning signs, veteran suicide rates and lethal means, and the benefits of secure firearm storage, is incorporated in the intervention.

The secure firearm storage component consists of 7 subcomponents: (1) general lethal means secure storage; (2) warning signs; (3) dyad communication; (4) lethal means safety when symptoms emerge; (5) coping strategies; (6) social support; and (7) emergency contacts. A lethal means safety worksheet rooted in the Stanley and Brown suicide safety plan model and implemented in VA health care settings is used to facilitate discussions of secure storage (Appendix).16

0426FED-MH-FFAST-A1

CSOs typically have little or no suicidal crisis response training, yet they likely have more interaction with the veteran on a daily basis than HCPs, putting them in a vital position to identify a crisis early and connect the veteran with the proper care. The crisis component prepares the CSO and veteran to navigate a crisis scenario so they can practice their newly developed safety plan and increase their comfort in discussing mental health and suicidal crisis.

FICTIONAL CASE STUDY

Cole, aged 59 years, is a Persian Gulf War veteran and retired police officer. His medical history includes hypothyroidism, hypertension, type 2 diabetes mellitus, chronic posttraumatic stress disorder, major depressive disorder, and insomnia.

Cole's wife of > 30 years, Sheila, joined him for the FFAST intervention. They report having 4 firearms in the home, 3 of which are loaded but stored in a lockbox and 1 that Cole reports is kept on his person for protection. Cole reports passive suicidal ideation, but no plans or intent. When discussing warning signs that a mental health crisis is building, Cole describes feeling anxious, having a change in his speech patterns, and isolating himself. Sheila agrees, but also mentions that Cole is easily angered and becomes nonverbal. Cole and Sheila express difficulty communicating and appear to have a breakthrough moment when Cole says he does not like when Sheila repeats herself, as he feels like she is “poking” at him. Sheila shares concerns for his safety and that she only repeats herself because he refuses to talk.

Cole agrees to verbalize that he is safe but needs time to process his thoughts. Sheila agrees to give him space with a plan to revisit the conversation within an agreed upon timeline. When discussing an updated secure storage plan for their firearms when a mental health crisis is building, Cole commits to allowing Sheila to store the firearm currently on his person in their gun safe, with the ammunition stored separately, and to giving her the gun safe key. They agree to implement this practice until the mental health crisis has passed.

To mitigate a potential crisis, the interventionist discusses possible internal coping strategies for Cole, including writing, reading, walking the dog, listening to music, and baking. People and social settings that could provide distraction involve going to the gym, talking to his friend Carl or his daughter Kelly, and attending the men’s ministry at church. The intervention concludes by discussing professionals or agencies that Cole and Sheila could contact during a crisis. After the intervention, Cole and Sheila are asked to rate their likelihood of using the plan they established during the conversation on a scale of 0 to 10, with 0 being highly unlikely and 10 being extremely likely. Cole responds with 9 and Sheila responds with 10.

DISCUSSION

Lethal means safety remains a critical component of veteran suicide prevention. However, lethal means safety discussions are often implemented after suicide risk has been identified, which may be too late. Thus, having these conversations early and before a crisis may be imperative. Veterans have expressed a desire to have CSOs involved in their suicide prevention treatment, and CSOs can play a key role in recognizing risk factors during everyday life. The FFAST intervention addresses many of these gaps.

Having discussions in advance of a crisis allows veterans to consider an effective secure firearm storage plan outside of the context of a crisis. Including a CSO galvanizes another person to understand a veteran’s needs and assist with secure firearm storage, identify warning signs, and support them during a crisis. These discussions occur in a context where there is less pressure than during a crisis. Features that were more appealing to veterans and their CSOs were also incorporated, such as having the dyad build a plan that is conceptually similar to other public safety initiatives (eg, a fire safety plan, tornado plan, or hurricane plan). Previous research demonstrates that veterans appreciated the nonjudgmental approach and some preferred that clinicians approach the discussion of secure firearm storage within the context of general home and family safety.17 Additionally, this intervention can build on veterans’ prior military training in preparedness.

Other potential benefits associated with the FFAST intervention include creating an opportunity to strengthen communication between the veteran and CSO. While FFAST is intended to be used with all types of CSOs, this work is consistent with preliminary data from a couples-based suicide prevention study that indicated veterans and their partners reported increases in relationship functioning and marginal decreases in suicidal ideation.18 It is possible that communication strategies gained from the current intervention could improve veterans’ relationships with their CSOs, which are associated with a greater sense of social support and reduced suicide risk.12

The intervention is a brief, single session that may be appealing to veterans and CSOs with full schedules. Evidence suggests that even brief, single-session interventions have a significant impact on beliefs about secure firearm storage, knowledge of lethal means safety, and confidence in having secure firearm storage conversations.19 However, clinicians should be cautious when extrapolating from the findings of the current case example, which was a one-time intervention with no follow-up.

Future Directions

Pilot testing of the proposed intervention is underway, and future research will include feedback from veterans and CSOs, as well as feasibility and acceptability data collected during the pilot process. The pilot study uses a successive cohort design with an initial 2 sets of 5 veteran and CSO dyads, and subsequent funding has expanded the pilot study to include an additional 30 dyads. Qualitative interviews will be conducted separately with each veteran and CSO, and additional constructs such as feasibility, acceptability, barriers and facilitators to implementation, and changes in secure storage will be examined. This future research may provide a deeper understanding of the broader acceptability, feasibility, and satisfaction associated with a suicide prevention intervention focused on securing firearms and involving veterans and their CSOs. These data could be used to inform future implementation trials and inform the development of an implementation strategy. In the interim, the nature of the manual is summarized in the context of the urgency of suicide prevention in this at-risk population.

Conclusions

FFAST is a novel approach to veteran firearm suicide prevention. By involving CSOs and emphasizing mental health crisis preparedness between them and veterans, the dyad can work in association with HCPs to establish and exercise secure firearm storage practices as part of an at-home safety plan. Implementation of FFAST may be beneficial for all veterans, not only those who have been identified as being at high suicide risk.

References
  1. US Dept of Veterans Affairs Office of Suicide Prevention. 2024 national veteran suicide prevention annual report. December 2024. Accessed February 5, 2026. https://www.mentalhealth.va.gov/docs/data-sheets/2024/2024-Annual-Report-Part-2-of-2_508.pdf
  2. Fischer IC, Aunon FM, Nichter B, et al. Firearm ownership among a nationally representative sample of U.S. veterans. Am J Prev Med. 2023;65:1129-1133. doi:10.1016/j.amepre.2023.06.013
  3. Conner A, Azrael D, Miller M. Suicide case-fatality rates in the United States, 2007-2014: a nationwide population-based study. Ann Intern Med. 2019;171(12):885-895. doi:10.7326/M19-1324
  4. Dempsey CL, Benedek DM, Zuromski KL, et al. Association of firearm ownership, use, accessibility, and storage practices with suicide risk among US army soldiers. JAMA Netw Open. 2019;2:e195383. doi:10.1001/jamanetworkopen.2019.5383
  5. Butterworth SE, Daruwala SE, Anestis MD. Firearm storage and shooting experience: factors relevant to the practical capability for suicide. J Psychiatr Res. 2018;102:52-56. doi:10.1016/j.jpsychires.2018.03.010
  6. Simonetti JA, Azrael D, Miller M. Firearm storage practices and risk perceptions among a nationally representative sample of U.S. veterans with and without self-harm risk factors. Suicide Life Threat Behav. 2019;49:653-664. doi:10.1111/sltb.12463
  7. Simonetti JA, Azrael D, Zhang W, Miller M. Receipt of clinician-delivered firearm safety counseling among U.S. veterans: results from a 2019 national survey. Suicide Life Threat Behav. 2022;52:1121-1125. doi:10.1111/sltb.12906
  8. US Office of the Surgeon General. The surgeon general’s call to action to implement the national strategy for suicide prevention. January 2021. Accessed February 5, 2026. https://www.hhs.gov/sites/default/files/sprc-call-to-action.pdf
  9. DeBeer BB, Matthieu MM, Kittel JA, et al. Quality Improvement Evaluation of the Feasibility and Acceptability of Adding a Concerned Significant Other to Safety Planning for Suicide Prevention With Veterans. J Ment Health Couns. 2019;41:4-20. doi:10.17744/mehc.41.1.02
  10. DeBeer BB, Matthieu MM, Degutis LC, et al. Firearms lethal means safety among veterans: attitudes toward involving a concerned significant other. J Mil Veteran Fam Health. 2025;11:23-31.
  11. Monteith LL, Holliday R, Dorsey Holliman BA, et al. Understanding female veterans’ experiences and perspectives of firearms. J Clin Psychol. 2020;76:1736-1753. doi:10.1002/jclp.22952
  12. DeBeer BB, Kimbrel NA, Meyer EC, et al. Combined PTSD and depressive symptoms interact with post-deployment social support to predict suicidal ideation in Operation Enduring Freedom and Operation Iraqi Freedom veterans. Psychiatry Res. 2014;216:357-362. doi:10.1016/j.psychres.2014.02.010
  13. Phillips AC, Lewis LK, McEvoy MP, et al. Development and validation of the guideline for reporting evidence-based practice educational interventions and teaching (GREET). BMC Med Educ. 2016;16:237. doi:10.1186/s12909-016-0759-1
  14. Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. 3rd ed. Guilford Press; 2013.
  15. Khazanov GK, Keddem S, Hoskins K, et al. Stakeholder perceptions of lethal means safety counseling: a qualitative systematic review. Front Psychiatry. 2022;13:993415. doi:10.3389/fpsyt.2022.993415
  16. Stanley B, Brown GK, Karlin B, et al. US Dept of Veterans Affairs. Safety plan treatment manual to reduce suicide risk: veteran version. August 20, 2008. Accessed February 5, 2026. https://www.mentalhealth.va.gov/mentalhealth/docs/va_safety_planning_manual.doc
  17. Dobscha SK, Clark KD, Newell S, et al. Strategies for discussing firearms storage safety in primary care: veteran perspectives. J Gen Intern Med. 2021;36:1492-1502. doi:10.1007/s11606-020-06412-x
  18. Khalifian CE, Leifker FR, Knopp K, et al. Utilizing the couple relationship to prevent suicide: a preliminary examination of treatment for relationships and safety together. J Clin Psych. 2022;78:747-757. doi:10.1002/jclp.23251
  19. Walsh A, Friedman K, Morrissey BH, et al. Project Safe Guard: evaluating a lethal means safety intervention to reduce firearm suicide in the National Guard. Mil Med. 2024;189:510-516. doi:10.1093/milmed/usae172
  20. Beck AT. Beyond belief: a theory of modes, personality, and psychopathology. In: Salkovkis PM, ed. Frontiers of Cognitive Therapy. Guilford Press;1996:1-25.
  21. Rudd MD. The suicidal mode: a cognitive-behavioral model of suicidality. Suicide Life Threat Behav. 2000;30(1):18-33.
References
  1. US Dept of Veterans Affairs Office of Suicide Prevention. 2024 national veteran suicide prevention annual report. December 2024. Accessed February 5, 2026. https://www.mentalhealth.va.gov/docs/data-sheets/2024/2024-Annual-Report-Part-2-of-2_508.pdf
  2. Fischer IC, Aunon FM, Nichter B, et al. Firearm ownership among a nationally representative sample of U.S. veterans. Am J Prev Med. 2023;65:1129-1133. doi:10.1016/j.amepre.2023.06.013
  3. Conner A, Azrael D, Miller M. Suicide case-fatality rates in the United States, 2007-2014: a nationwide population-based study. Ann Intern Med. 2019;171(12):885-895. doi:10.7326/M19-1324
  4. Dempsey CL, Benedek DM, Zuromski KL, et al. Association of firearm ownership, use, accessibility, and storage practices with suicide risk among US army soldiers. JAMA Netw Open. 2019;2:e195383. doi:10.1001/jamanetworkopen.2019.5383
  5. Butterworth SE, Daruwala SE, Anestis MD. Firearm storage and shooting experience: factors relevant to the practical capability for suicide. J Psychiatr Res. 2018;102:52-56. doi:10.1016/j.jpsychires.2018.03.010
  6. Simonetti JA, Azrael D, Miller M. Firearm storage practices and risk perceptions among a nationally representative sample of U.S. veterans with and without self-harm risk factors. Suicide Life Threat Behav. 2019;49:653-664. doi:10.1111/sltb.12463
  7. Simonetti JA, Azrael D, Zhang W, Miller M. Receipt of clinician-delivered firearm safety counseling among U.S. veterans: results from a 2019 national survey. Suicide Life Threat Behav. 2022;52:1121-1125. doi:10.1111/sltb.12906
  8. US Office of the Surgeon General. The surgeon general’s call to action to implement the national strategy for suicide prevention. January 2021. Accessed February 5, 2026. https://www.hhs.gov/sites/default/files/sprc-call-to-action.pdf
  9. DeBeer BB, Matthieu MM, Kittel JA, et al. Quality Improvement Evaluation of the Feasibility and Acceptability of Adding a Concerned Significant Other to Safety Planning for Suicide Prevention With Veterans. J Ment Health Couns. 2019;41:4-20. doi:10.17744/mehc.41.1.02
  10. DeBeer BB, Matthieu MM, Degutis LC, et al. Firearms lethal means safety among veterans: attitudes toward involving a concerned significant other. J Mil Veteran Fam Health. 2025;11:23-31.
  11. Monteith LL, Holliday R, Dorsey Holliman BA, et al. Understanding female veterans’ experiences and perspectives of firearms. J Clin Psychol. 2020;76:1736-1753. doi:10.1002/jclp.22952
  12. DeBeer BB, Kimbrel NA, Meyer EC, et al. Combined PTSD and depressive symptoms interact with post-deployment social support to predict suicidal ideation in Operation Enduring Freedom and Operation Iraqi Freedom veterans. Psychiatry Res. 2014;216:357-362. doi:10.1016/j.psychres.2014.02.010
  13. Phillips AC, Lewis LK, McEvoy MP, et al. Development and validation of the guideline for reporting evidence-based practice educational interventions and teaching (GREET). BMC Med Educ. 2016;16:237. doi:10.1186/s12909-016-0759-1
  14. Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. 3rd ed. Guilford Press; 2013.
  15. Khazanov GK, Keddem S, Hoskins K, et al. Stakeholder perceptions of lethal means safety counseling: a qualitative systematic review. Front Psychiatry. 2022;13:993415. doi:10.3389/fpsyt.2022.993415
  16. Stanley B, Brown GK, Karlin B, et al. US Dept of Veterans Affairs. Safety plan treatment manual to reduce suicide risk: veteran version. August 20, 2008. Accessed February 5, 2026. https://www.mentalhealth.va.gov/mentalhealth/docs/va_safety_planning_manual.doc
  17. Dobscha SK, Clark KD, Newell S, et al. Strategies for discussing firearms storage safety in primary care: veteran perspectives. J Gen Intern Med. 2021;36:1492-1502. doi:10.1007/s11606-020-06412-x
  18. Khalifian CE, Leifker FR, Knopp K, et al. Utilizing the couple relationship to prevent suicide: a preliminary examination of treatment for relationships and safety together. J Clin Psych. 2022;78:747-757. doi:10.1002/jclp.23251
  19. Walsh A, Friedman K, Morrissey BH, et al. Project Safe Guard: evaluating a lethal means safety intervention to reduce firearm suicide in the National Guard. Mil Med. 2024;189:510-516. doi:10.1093/milmed/usae172
  20. Beck AT. Beyond belief: a theory of modes, personality, and psychopathology. In: Salkovkis PM, ed. Frontiers of Cognitive Therapy. Guilford Press;1996:1-25.
  21. Rudd MD. The suicidal mode: a cognitive-behavioral model of suicidality. Suicide Life Threat Behav. 2000;30(1):18-33.
Issue
Federal Practitioner 43(suppl 1)
Issue
Federal Practitioner 43(suppl 1)
Page Number
S1-S7
Page Number
S1-S7
Publications
Publications
Topics
Article Type
Display Headline

Involving Concerned Significant Others in Firearm Suicide Prevention: Development of the Family FireArms Secure Storage Training Intervention

Display Headline

Involving Concerned Significant Others in Firearm Suicide Prevention: Development of the Family FireArms Secure Storage Training Intervention

Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
survey writer start date

Ask the Expert Geriatric Psychiatry: A VHA Email Consultation Program to Support Clinicians

Article Type
Changed
Display Headline

Ask the Expert Geriatric Psychiatry: A VHA Email Consultation Program to Support Clinicians

T he US Census Bureau projects that the number of older adults (aged ≥ 65 years) will exceed 49 million by 2030, and an estimated 20% (nearly 10 million) of this population will experience cognitive or mental health disorders.1,2 The mental health workforce is not equipped to address the specialized mental health care needs of many older adults.2,3 For example, geriatric psychiatrists specialize in the diagnosis and treatment of mental illness and cognitive disorders in the later stages of life, but their numbers are few and declining. Only 33.5% of geriatric psychiatry fellowship training slots were filled from 2017 to 2021, and only 62 fellows trained during the 2021-2022 academic year.4 Board-certified geriatric psychiatrists also tend to be concentrated in larger, urban, academically-affiliated medical centers, often leaving rural areas and smaller facilities without access, including facilities in the Veterans Health Administration (VHA).5

The VHA has been optimizing access to specialty geriatric mental health services via regional and national virtual consultation services. Seven of 19 Veterans Integrated Service Network (VISN) Clinical Resource Hubs (CRHs) have geriatric mental health teams.6 These provide interdisciplinary geriatric mental telehealth services, including geriatric psychiatry, for older veterans with complex care needs.7,8 Likewise, the VHA National Expert Consultation & Specialized Services-Mental Health (NEXCSS- MH, formerly known as the National Telemental Health Center) sponsors video teleconsultations with board-certified geriatric psychiatrists and an Ask the Expert email consultation program.

This article describes the Ask the Expert Geriatric Psychiatry email program (one of several similar programs at NEXCSS-MH), building upon a symposium presented at the American Association for Geriatric Psychiatry (AAGP) annual meeting in March 2022.9 The program was initiated in June 2021 as a result of discussions between the National Mental Health Director, Geriatric Mental Health in the VHA Office of Mental Health and Suicide Prevention (now known as the Office of Mental Health [OMH]), and National Telemental Health Center leadership. VHA board certified geriatric psychiatrists were recruited to serve as expert consultants and respond to email questions submitted by VHA clinicians regarding the psychiatric care of older adult veterans. The results of this program identify educational needs among clinical staff and may inform the development of program materials for a range of clinicians.

Program Description

The national geriatric mental health director recruited prospective experts and met with each to assess interest and qualifications, consulting with OMH psychiatrist leaders before making selections. Five experts were initially selected; 1 later stepped down and was replaced by another, who also stepped down. The experts were board certified in psychiatry and geriatric psychiatry and held a variety of local and national leadership positions, including geriatric psychiatry fellowship director, US Department of Veterans Affairs (VA) research and clinical leader, and various roles in the AAGP; some had received teaching awards.

Operations

The national geriatric mental health director announced the program in June 2021 to VHA mental health and geriatric program email groups with reminders sent every few months. The announcement included information about the types of questions appropriate to submit, including examples of general clinical management questions that did not share patient-specific protected health information, and clarified that experts would not be conducting chart reviews because the time required for detailed chart reviews was not feasible for volunteer experts to integrate into their otherwise full-time jobs at their respective VA medical centers. The announcement also included brief biographies of the experts.

The Figure describes the daily operations of the Ask the Expert Geriatric Psychiatry email consultation program. The NEXCSS- MH developed a Microsoft Outlook mailbox and group email address where clinicians from across the VHA could submit questions. The experts, as well as the national geriatric mental health director and NEXCSS-MH staff, had access to this mailbox to track and/or respond to questions. One expert volunteered to be the program’s primary mailbox coordinator. The coordinator checked the inbox daily and assigned each question to one of the experts on a rotating basis using the color-coding feature in Outlook. The other experts were advised to check the email account at least once weekly and reply to any assigned questions.

0426FED-MH-Consult-F1
FIGURE. Process for Answering Ask the Expert Geriatric Psychiatry Email Questions

Responding to a question entailed first determining whether the question was appropriate for the service. For example, if a question requested a chart review, the expert replied that experts could not provide chart reviews and requested that the question be reframed. Next, the expert often needed to define a specific clinical question from the information provided, as email questions often touched upon several topics. The expert provided personalized advice on diagnostic testing, nonpharmacologic treatment strategies, and/or pharmacologic treatment options. Experts also often attached relevant guidelines or review articles. The goal was to provide a response within 7 business days.

All email responses included a disclaimer indicating that the program was not intended for urgent or immediate medical advice and that the information provided was for VHA clinician education purposes only. The disclaimer explained that email communication did not establish a doctor-patient relationship between the expert and a specific veteran and that, if desired, a request for a clinical consultation could be submitted on a specific case (ie, a video teleconsultation).

Methods for Reviewing Questions

Descriptive statistics, including frequencies, means, and minimum and maximum ranges, were used to capture the number of questions the program received, type of requester, and length of time prior to response for emailed questions.9 Conventional content analysis procedures were used between January and October 2024 to analyze clinicians’ questions.10 Four subject matter experts (3 geriatric psychiatrists and 1 geropsychologist) served as coders, assigned in groups of 2 to review questions. Each coder independently reviewed assigned questions and identified preliminary themes. Themes were reviewed and revised using an iterative process during regular team meetings with coders to clarify and confirm interpretations. Discrepancies were discussed within team meetings to achieve consensus.

Questions received. Between February 2022 and December 2023, the program received 101 email questions. Requesters included 39 physicians, 17 nurse practitioners or physician assistants, 15 social workers, 14 psychologists, 9 nurses, 5 pharmacists, 1 dietitian, and 1 who was undetermined. Experts responded to the questions an average of 6 days after receipt (range, < 1-19); 73 responses (72%) met the 7-day goal.

Iterative changes to coded themes were made during group discussions. Multiple clinical questions were often posed within the same email. Initially, some coders identified themes solely based on reported symptoms; others identified themes based on reported and/or potential diagnostic conditions attributed to the symptom(s) described within the email. For example, some coders selected a primary theme of behavioral and psychological symptoms of dementia (BPSD) only if a behavior contributing to distress in the veteran or others was described, while others selected this theme when any psychiatric symptom (eg, psychosis) was present in the context of dementia. The group identified 1 primary theme per question based on the main clinical symptom or main concern presented. Co-occurring diagnostic conditions highlighted in the email requests were included as secondary themes, and each question could have > 1 secondary theme.

The most frequent requests related to clinical symptoms included questions about agitated behaviors, sleep and/or nightmares, and depression symptoms (Table 1). Twenty-seven of 33 email requests on agitated behaviors were related to a dementia diagnosis, as were several questions about sleep/nightmares, depression, psychosis/mania, and anxiety. Many diagnostic conditions were described in the email requests (Table 2). The most frequent condition was dementia, followed by a medical condition, depressive disorder, posttraumatic stress disorder, and/or serious mental illness.

0426FED-MH-Consult-T10426FED-MH-Consult-T2

Request for Feedback. In February 2022, an email request was sent to the 64 clinicians who asked email questions from the start of the program in June 2021 through December 2021. A second request included 11 clinicians who asked questions from January through February 2022. These requests were sent as part of preparations for the symposium on the program presented at the AAGP annual meeting in March 2022.9 In May 2024, feedback was requested from 37 clinicians who submitted questions from May 1, 2023, through May 15, 2024.

Requests for feedback included 6 closed-ended and 1 open-ended question: (1) Did the answer you received help inform clinical practice? (2) Did you receive a timely response? (3) What type of information was useful to you in addressing your question (ie, direct/specific answer to a clinical scenario, guidelines, articles, VA resources)? (4) Do you have access to a geriatric psychiatrist at your facility? (5) Are you likely to use Ask the Expert Geriatric Psychiatry in the future? (6) Would you use a geriatric psychiatry teleconsultation service? (7) Share suggestions for improvement. Frequencies of response selection were obtained for each question. Text responses to the open-ended question asking for suggestions for improvement were reviewed and summarized.

Responses

Thirty users responded to the feedback request (27% response rate). Respondents considered the answers received extremely (n = 14; 47%) or very much (n = 12; 40%) helpful for their clinical practice. Twenty-three respondents (77%) felt an answer was provided promptly, 7 respondents (23%) felt the answer was not timely but still useful, and none felt that the answer was too late. Respondents reported that the most useful type of information in addressing their questions was a direct/specific answer to a clinical scenario (n = 27; 90%), followed by guidelines (n = 12; 40%), articles (n = 7; 23%), and VA resources (n = 4; 13%).

Sixteen respondents (53%) reported that they rarely had ready access to a geriatric psychiatrist at their facility, 3 (10%) had access sometimes, 4 (14%) had access usually, 3 (10%) had access regularly, and 3 (10%) never had access. Twenty-seven respondents (90%) indicated they would be very likely to use the service again. If geriatric psychiatry teleconsultation and/or e-consultation were offered, many respondents indicated they would be extremely (n = 10; 33%) or very (n = 12; 40%) likely to use teleconsultation and/or e-consultation.

Suggestions for improvement included supporting experts to perform chart reviews for email questions, developing a template or consult form, holding a biweekly drop-in meeting to present questions to and discuss cases with a panel of experts, and providing further help addressing complex decisional capacity issues, delirium, and care or placement for veterans with severe behavioral issues in a rural setting.

Discussion

Although many older adults experience cognitive and mental health disorders that may benefit from management by a geriatric psychiatrist, the number of trained geriatric psychiatrists available is insufficient to allow for direct care for each patient. The Ask the Expert Geriatric Psychiatry email consultation program is one aspect of a multicomponent strategy within the VHA to increase access to specialty geriatric mental health services for veterans. A key advantage of the program is that it is not resource intensive. Experts can participate voluntarily, providing timely feedback to clinicians around the country while continuing other duties at their respective VA medical centers. Email replies to the experts’ answers elicited positive feedback on the program, include: “I found this service to be extremely helpful and I have shared the information they sent me with several other coworkers!”, “It was great!”, and “I endorsed the service to our VISN Rehabilitation and Extended Care group.”

The coding of primary and secondary themes from 101 email questions that were retained revealed the range and relative frequencies of clinical and administrative topics with which clinicians needed help. The most common (33%) theme was agitated behaviors. Nearly half of the questions (48%) were related to underlying dementia, and 29% were related to a patient’s medical comorbidities. These findings suggest that the expertise of a geriatric psychiatrist is particularly relevant when caring for older patients experiencing BPSD or patients with complex, overlapping psychiatric and medical conditions.

Despite a 27% response rate, participant feedback has been helpful. The program reached its intended audience of clinicians in rural areas and at smaller facilities with 53% of requesters reporting they rarely had access to a geriatric psychiatrist. Suggestions for improvement indicated that some clinicians desired additional support, including chart reviews, meetings with experts, and a video teleconsultation service (available through NEXCSS-MH).

Many clinicians without training in specialty geriatric mental health may require help with complex clinical presentations. For example, 39 clinicians who submitted questions to the program were physicians. Accreditation Council for Graduate Medical Education program requirements for general psychiatry residency include 4 weeks of geriatric psychiatry.11 The findings of this study suggest that this level of training may not be adequate to independently care for every patient who experiences dementia or multimorbidity. Several training and mentoring initiatives have been developed to address the professional development need for psychiatrists.12-14

The need for geriatric workforce development is significant across health care, including other mental health professions.15,16 The VHA Geriatric Scholars program trains rural primary care practitioners, psychologists, and psychiatrists.17,18 Likewise, consultative geriatric specialty support for primary care practitioners in rural areas is provided via the Geriatric Research Education and Clinical Center Connect program.19 The Ask the Expert Geriatric Psychiatry email program is an additional economical model to support clinician educational development and provide rapid educational responses to inform patient care.

Ask the Expert received fewer email questions than anticipated. Enhanced optimization may require more frequent and widespread announcements about the program. Clinical staff may not be aware of the program due to an overload of email communications. Likewise, it may be challenging for busy clinicians to take the time to seek consultation or recognize a potential gap in their knowledge or skills. Had more questions been submitted, the 5 volunteer experts may have had more difficulty addressing the demand. Feedback from this project may inform development of a frequently asked questions document to share with VHA teams and a drop-in office hour to pose clinical questions of geriatric psychiatry experts, as recommended by a clinician who participated in the program.

Limitations

Not all requesters were sent a request for feedback, and the response rate for the request for feedback was only 27%. As the program has evolved, it began sending a request for feedback immediately after answering each question, which may increase the odds of response. The goal of experts answering questions within 7 business days was met 72% of the time, likely an artifact of experts integrating question answering with many other duties. The mailbox coordinator has since provided email prompts to experts immediately upon being assigned a question with the goal of improving timeliness. The program did not include chart reviews or patient consultations, as neither was feasible for volunteer experts. The email consultation service is a single component of virtual consultative specialty geriatric mental health services within the VHA, including video consultations via NEXCSS-MH and regional geriatric mental health teams.

Conclusions

The need for specialty geriatric mental health services is increasing in the VHA and across the US. However, there are too few board-certified geriatric psychiatrists to provide direct patient care to all older adults with cognitive and mental health disorders. The VHA has leveraged telehealth to improve access to geriatric mental health care. The VHA Ask the Expert Geriatric Psychiatry email consultation program is a low-resource service which provides rapid feedback to clinicians nationwide on challenging clinical scenarios, many of which are dementia-related. Most users of the service who responded to requests for feedback reported that answers to their questions were helpful and timely. The email consultation program should continue to be supplemented by more comprehensive geriatric telemental health services for particularly complex cases to meet the needs of older veterans.

References
  1. 2023 population projections for the nation by age, sex, race, Hispanic origin and nativity. United States Census Bureau. November 9, 2023. Accessed December 11, 2025. https://www.census.gov/newsroom/press-kits/2023/population-projections.html
  2. National Academies of Sciences Engineering and Medicine. Addressing the rising mental health needs of an aging population: proceedings of a workshop. 2024. Accessed December 11, 2025. doi.org:10.17226/27340
  3. Institute of Medicine. The mental health and substance use workforce for older adults: in whose hands? The National Academies Press; 2012. Accessed December 11, 2025. doi:10.17226/13400
  4. American Psychiatric Association. 2022 resident/fellow census. November 2023. Accessed December 11, 2025. https://www.psychiatry.org/getmedia/d80438af-f760-40f3-9d33-f91309b09564/APA-Resident-Census-2022.pdf
  5. Juul D, Colenda CC, Lyness JM, et al. Subspecialty training and certification in geriatric psychiatry: a 25-year overview. Am J Geriatr Psychiatry. 2017;25:445-453. doi:10.1016/j.jagp.2016.12.018
  6. Jaske E, Wheat CL, Rubenstein LV, et al. Understanding how contingency staffing programs can support mental health services in the Veterans Health Administration. Telemed J E Health. 2024;30:1857-1865. doi:10.1089/tmj.2023.0573
  7. Gould CE, Carlson C, Alfaro AJ, et al. Supporting veterans, caregivers, and providers in rural regions with tele-geriatric psychiatry consultation: a mixed methods pilot study. Am J Geriatr Psychiatry. 2023;31:279-290. doi:10.1016/j.jagp.2023.01.005
  8. Gould CE, Paiko L, Carlson C, et al. Implementation of tele-geriatricmental healthcare for rural veterans: factors influencing care models. Front Health Serv. 2024;4:1221899. doi:10.3389/frhs.2024.1221899
  9. Padala P, Schultz S, Khatkhate G, et al. Ask the expert geriatric psychiatry: VA program to support clinicians. Am J Geriatr Psychiatry. 2022;30:S18. doi:10.1016/j.jagp.2022.01.279
  10. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15:1277-1288. doi:10.1177/1049732305276687
  11. Accreditation Council for Graduate Medical Education. Program requirements for graduate medical education in psychiatry. Revised September 3, 2025. Accessed December 11, 2025. https://www.acgme.org/globalassets/pfassets/programrequirements/2025-reformatted-requirements/400_psychiatry_2025_reformatted.pdf
  12. Fernandez J, Agarwal KS, Amspoker AB, et al. Outcomes from an interprofessional, dementia-focused, telementoring program: a brief report. Gerontol Geriatr Educ. 2024;45:601-606. doi:10.1080/02701960.2023.2253175
  13. Conroy ML, Garcia-Pittman EC, van Dyck LI, et al. The COVID-19 American Association for Geriatric Psychiatry (AAGP) online trainee curriculum: program evaluation and future directions. Am J Geriatr Psychiatry. 2025;33:308-314. doi:10.1016/j.jagp.2024.10.010
  14. Conroy ML, Garcia-Pittman EC, Ali H, et al. The COVID-19 AAGP online trainee curriculum: development and method of initial evaluation. Am J Geriatr Psychiatry. 2020;28:1004-1008. doi:10.1016/j.jagp.2020.06.003
  15. Flaherty E, Busby-Whitehead J, Potter J, et al. The geriatric workforce enhancement program: review of the coordinating center and examples of the GWEP in practice. Am J Geriatr Psychiatry. 2019;27:675-686. doi:10.1016/j.jagp.2019.04.010
  16. Hoge MA, Karel MJ, Zeiss AM, et al. Strengthening psychology’s workforce for older adults: implications of the Institute of Medicine’s report to Congress. Am Psychol. 2015;70:265-278. doi:10.1037/a0038927
  17. Kramer BJ, Creekmur B, Howe JL, et al. Veterans Affairs geriatric scholars program: enhancing existing primary care clinician skills in caring for older veterans. J Am Geriatr Soc. 2016;64:2343-2348. doi:10.1111/jgs.14382
  18. Gould CE, Rodriguez RL, Gregg JJ, et al. Preparing Veterans Health Administration psychologists to meet the complex needs of aging veterans. Fed Pract. 2024;41:S10-S15. doi:10.12788/fp.0466
  19. Pimentel CB, Gately M, Barczi SR, et al. GRECC Connect: Geriatrics telehealth to empower health care providers and improve management of older veterans in rural communities. Fed Pract. 2019;36:464-470.
Article PDF
Author and Disclosure Information

Brandon C. Yarns, MD, MSa,b; Kimberly J. Curyto, PhDc; Ruchi Aggarwal, MDd,e; Gauri Khatkhate, MDf,g; Prasad R. Padala, MD, MS, FACHEh,i; Michele J. Karel, PhD, ABPPj

Author affiliations
aVeterans Affairs Greater Los Angeles Healthcare System, California
bDavid Geffen School of Medicine at the University of California, Los Angeles
cVeterans Affairs Western New York Healthcare System, Batavia
dMichael E. DeBakey Department of Veterans Affairs Medical Center, Houston, Texas
eBaylor College of Medicine, Houston, Texas
fEdward Hines, Jr. Veterans Affairs Hospital, Illinois
gLoyola University Medical Center, Hines, Illinois
hCentral Arkansas Veterans Healthcare System, Little Rock
iBaptist Health University of Arkansas for Medical Sciences, Little Rock
jUS Department of Veterans Affairs Central Office, Washington, DC

Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article

Acknowledgments
The authors thank the service of prior experts in the Ask the Expert Geriatric Psychiatry program: Donovan Maust, MD, MS, and Rebecca Radue, MD. The authors also thank the administrative support received from Veterans Health Administration National Expert Consultation & Specialized Services — Mental Health.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies.

Ethics and consent
This report is a program description and does not involve human subjects research.

Funding
Brandon Yarns was supported by a Research Career Development Award from the US Department of Veterans Affairs (grant number IK2CX001884). Prasad Padala received research support from the Office of Research Development, Department of Veterans Affairs, the Alzheimer’s Association, and National Institutes of Health.

Correspondence: Brandon Yarns (byarns@mednet.ucla.edu)

Fed Pract. 2026;43(suppl 1). Published online April 18. doi:10.12788/fp.0679

Issue
Federal Practitioner 43(suppl 1)
Publications
Topics
Page Number
S1-S6
Sections
Author and Disclosure Information

Brandon C. Yarns, MD, MSa,b; Kimberly J. Curyto, PhDc; Ruchi Aggarwal, MDd,e; Gauri Khatkhate, MDf,g; Prasad R. Padala, MD, MS, FACHEh,i; Michele J. Karel, PhD, ABPPj

Author affiliations
aVeterans Affairs Greater Los Angeles Healthcare System, California
bDavid Geffen School of Medicine at the University of California, Los Angeles
cVeterans Affairs Western New York Healthcare System, Batavia
dMichael E. DeBakey Department of Veterans Affairs Medical Center, Houston, Texas
eBaylor College of Medicine, Houston, Texas
fEdward Hines, Jr. Veterans Affairs Hospital, Illinois
gLoyola University Medical Center, Hines, Illinois
hCentral Arkansas Veterans Healthcare System, Little Rock
iBaptist Health University of Arkansas for Medical Sciences, Little Rock
jUS Department of Veterans Affairs Central Office, Washington, DC

Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article

Acknowledgments
The authors thank the service of prior experts in the Ask the Expert Geriatric Psychiatry program: Donovan Maust, MD, MS, and Rebecca Radue, MD. The authors also thank the administrative support received from Veterans Health Administration National Expert Consultation & Specialized Services — Mental Health.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies.

Ethics and consent
This report is a program description and does not involve human subjects research.

Funding
Brandon Yarns was supported by a Research Career Development Award from the US Department of Veterans Affairs (grant number IK2CX001884). Prasad Padala received research support from the Office of Research Development, Department of Veterans Affairs, the Alzheimer’s Association, and National Institutes of Health.

Correspondence: Brandon Yarns (byarns@mednet.ucla.edu)

Fed Pract. 2026;43(suppl 1). Published online April 18. doi:10.12788/fp.0679

Author and Disclosure Information

Brandon C. Yarns, MD, MSa,b; Kimberly J. Curyto, PhDc; Ruchi Aggarwal, MDd,e; Gauri Khatkhate, MDf,g; Prasad R. Padala, MD, MS, FACHEh,i; Michele J. Karel, PhD, ABPPj

Author affiliations
aVeterans Affairs Greater Los Angeles Healthcare System, California
bDavid Geffen School of Medicine at the University of California, Los Angeles
cVeterans Affairs Western New York Healthcare System, Batavia
dMichael E. DeBakey Department of Veterans Affairs Medical Center, Houston, Texas
eBaylor College of Medicine, Houston, Texas
fEdward Hines, Jr. Veterans Affairs Hospital, Illinois
gLoyola University Medical Center, Hines, Illinois
hCentral Arkansas Veterans Healthcare System, Little Rock
iBaptist Health University of Arkansas for Medical Sciences, Little Rock
jUS Department of Veterans Affairs Central Office, Washington, DC

Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article

Acknowledgments
The authors thank the service of prior experts in the Ask the Expert Geriatric Psychiatry program: Donovan Maust, MD, MS, and Rebecca Radue, MD. The authors also thank the administrative support received from Veterans Health Administration National Expert Consultation & Specialized Services — Mental Health.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies.

Ethics and consent
This report is a program description and does not involve human subjects research.

Funding
Brandon Yarns was supported by a Research Career Development Award from the US Department of Veterans Affairs (grant number IK2CX001884). Prasad Padala received research support from the Office of Research Development, Department of Veterans Affairs, the Alzheimer’s Association, and National Institutes of Health.

Correspondence: Brandon Yarns (byarns@mednet.ucla.edu)

Fed Pract. 2026;43(suppl 1). Published online April 18. doi:10.12788/fp.0679

Article PDF
Article PDF

T he US Census Bureau projects that the number of older adults (aged ≥ 65 years) will exceed 49 million by 2030, and an estimated 20% (nearly 10 million) of this population will experience cognitive or mental health disorders.1,2 The mental health workforce is not equipped to address the specialized mental health care needs of many older adults.2,3 For example, geriatric psychiatrists specialize in the diagnosis and treatment of mental illness and cognitive disorders in the later stages of life, but their numbers are few and declining. Only 33.5% of geriatric psychiatry fellowship training slots were filled from 2017 to 2021, and only 62 fellows trained during the 2021-2022 academic year.4 Board-certified geriatric psychiatrists also tend to be concentrated in larger, urban, academically-affiliated medical centers, often leaving rural areas and smaller facilities without access, including facilities in the Veterans Health Administration (VHA).5

The VHA has been optimizing access to specialty geriatric mental health services via regional and national virtual consultation services. Seven of 19 Veterans Integrated Service Network (VISN) Clinical Resource Hubs (CRHs) have geriatric mental health teams.6 These provide interdisciplinary geriatric mental telehealth services, including geriatric psychiatry, for older veterans with complex care needs.7,8 Likewise, the VHA National Expert Consultation & Specialized Services-Mental Health (NEXCSS- MH, formerly known as the National Telemental Health Center) sponsors video teleconsultations with board-certified geriatric psychiatrists and an Ask the Expert email consultation program.

This article describes the Ask the Expert Geriatric Psychiatry email program (one of several similar programs at NEXCSS-MH), building upon a symposium presented at the American Association for Geriatric Psychiatry (AAGP) annual meeting in March 2022.9 The program was initiated in June 2021 as a result of discussions between the National Mental Health Director, Geriatric Mental Health in the VHA Office of Mental Health and Suicide Prevention (now known as the Office of Mental Health [OMH]), and National Telemental Health Center leadership. VHA board certified geriatric psychiatrists were recruited to serve as expert consultants and respond to email questions submitted by VHA clinicians regarding the psychiatric care of older adult veterans. The results of this program identify educational needs among clinical staff and may inform the development of program materials for a range of clinicians.

Program Description

The national geriatric mental health director recruited prospective experts and met with each to assess interest and qualifications, consulting with OMH psychiatrist leaders before making selections. Five experts were initially selected; 1 later stepped down and was replaced by another, who also stepped down. The experts were board certified in psychiatry and geriatric psychiatry and held a variety of local and national leadership positions, including geriatric psychiatry fellowship director, US Department of Veterans Affairs (VA) research and clinical leader, and various roles in the AAGP; some had received teaching awards.

Operations

The national geriatric mental health director announced the program in June 2021 to VHA mental health and geriatric program email groups with reminders sent every few months. The announcement included information about the types of questions appropriate to submit, including examples of general clinical management questions that did not share patient-specific protected health information, and clarified that experts would not be conducting chart reviews because the time required for detailed chart reviews was not feasible for volunteer experts to integrate into their otherwise full-time jobs at their respective VA medical centers. The announcement also included brief biographies of the experts.

The Figure describes the daily operations of the Ask the Expert Geriatric Psychiatry email consultation program. The NEXCSS- MH developed a Microsoft Outlook mailbox and group email address where clinicians from across the VHA could submit questions. The experts, as well as the national geriatric mental health director and NEXCSS-MH staff, had access to this mailbox to track and/or respond to questions. One expert volunteered to be the program’s primary mailbox coordinator. The coordinator checked the inbox daily and assigned each question to one of the experts on a rotating basis using the color-coding feature in Outlook. The other experts were advised to check the email account at least once weekly and reply to any assigned questions.

0426FED-MH-Consult-F1
FIGURE. Process for Answering Ask the Expert Geriatric Psychiatry Email Questions

Responding to a question entailed first determining whether the question was appropriate for the service. For example, if a question requested a chart review, the expert replied that experts could not provide chart reviews and requested that the question be reframed. Next, the expert often needed to define a specific clinical question from the information provided, as email questions often touched upon several topics. The expert provided personalized advice on diagnostic testing, nonpharmacologic treatment strategies, and/or pharmacologic treatment options. Experts also often attached relevant guidelines or review articles. The goal was to provide a response within 7 business days.

All email responses included a disclaimer indicating that the program was not intended for urgent or immediate medical advice and that the information provided was for VHA clinician education purposes only. The disclaimer explained that email communication did not establish a doctor-patient relationship between the expert and a specific veteran and that, if desired, a request for a clinical consultation could be submitted on a specific case (ie, a video teleconsultation).

Methods for Reviewing Questions

Descriptive statistics, including frequencies, means, and minimum and maximum ranges, were used to capture the number of questions the program received, type of requester, and length of time prior to response for emailed questions.9 Conventional content analysis procedures were used between January and October 2024 to analyze clinicians’ questions.10 Four subject matter experts (3 geriatric psychiatrists and 1 geropsychologist) served as coders, assigned in groups of 2 to review questions. Each coder independently reviewed assigned questions and identified preliminary themes. Themes were reviewed and revised using an iterative process during regular team meetings with coders to clarify and confirm interpretations. Discrepancies were discussed within team meetings to achieve consensus.

Questions received. Between February 2022 and December 2023, the program received 101 email questions. Requesters included 39 physicians, 17 nurse practitioners or physician assistants, 15 social workers, 14 psychologists, 9 nurses, 5 pharmacists, 1 dietitian, and 1 who was undetermined. Experts responded to the questions an average of 6 days after receipt (range, < 1-19); 73 responses (72%) met the 7-day goal.

Iterative changes to coded themes were made during group discussions. Multiple clinical questions were often posed within the same email. Initially, some coders identified themes solely based on reported symptoms; others identified themes based on reported and/or potential diagnostic conditions attributed to the symptom(s) described within the email. For example, some coders selected a primary theme of behavioral and psychological symptoms of dementia (BPSD) only if a behavior contributing to distress in the veteran or others was described, while others selected this theme when any psychiatric symptom (eg, psychosis) was present in the context of dementia. The group identified 1 primary theme per question based on the main clinical symptom or main concern presented. Co-occurring diagnostic conditions highlighted in the email requests were included as secondary themes, and each question could have > 1 secondary theme.

The most frequent requests related to clinical symptoms included questions about agitated behaviors, sleep and/or nightmares, and depression symptoms (Table 1). Twenty-seven of 33 email requests on agitated behaviors were related to a dementia diagnosis, as were several questions about sleep/nightmares, depression, psychosis/mania, and anxiety. Many diagnostic conditions were described in the email requests (Table 2). The most frequent condition was dementia, followed by a medical condition, depressive disorder, posttraumatic stress disorder, and/or serious mental illness.

0426FED-MH-Consult-T10426FED-MH-Consult-T2

Request for Feedback. In February 2022, an email request was sent to the 64 clinicians who asked email questions from the start of the program in June 2021 through December 2021. A second request included 11 clinicians who asked questions from January through February 2022. These requests were sent as part of preparations for the symposium on the program presented at the AAGP annual meeting in March 2022.9 In May 2024, feedback was requested from 37 clinicians who submitted questions from May 1, 2023, through May 15, 2024.

Requests for feedback included 6 closed-ended and 1 open-ended question: (1) Did the answer you received help inform clinical practice? (2) Did you receive a timely response? (3) What type of information was useful to you in addressing your question (ie, direct/specific answer to a clinical scenario, guidelines, articles, VA resources)? (4) Do you have access to a geriatric psychiatrist at your facility? (5) Are you likely to use Ask the Expert Geriatric Psychiatry in the future? (6) Would you use a geriatric psychiatry teleconsultation service? (7) Share suggestions for improvement. Frequencies of response selection were obtained for each question. Text responses to the open-ended question asking for suggestions for improvement were reviewed and summarized.

Responses

Thirty users responded to the feedback request (27% response rate). Respondents considered the answers received extremely (n = 14; 47%) or very much (n = 12; 40%) helpful for their clinical practice. Twenty-three respondents (77%) felt an answer was provided promptly, 7 respondents (23%) felt the answer was not timely but still useful, and none felt that the answer was too late. Respondents reported that the most useful type of information in addressing their questions was a direct/specific answer to a clinical scenario (n = 27; 90%), followed by guidelines (n = 12; 40%), articles (n = 7; 23%), and VA resources (n = 4; 13%).

Sixteen respondents (53%) reported that they rarely had ready access to a geriatric psychiatrist at their facility, 3 (10%) had access sometimes, 4 (14%) had access usually, 3 (10%) had access regularly, and 3 (10%) never had access. Twenty-seven respondents (90%) indicated they would be very likely to use the service again. If geriatric psychiatry teleconsultation and/or e-consultation were offered, many respondents indicated they would be extremely (n = 10; 33%) or very (n = 12; 40%) likely to use teleconsultation and/or e-consultation.

Suggestions for improvement included supporting experts to perform chart reviews for email questions, developing a template or consult form, holding a biweekly drop-in meeting to present questions to and discuss cases with a panel of experts, and providing further help addressing complex decisional capacity issues, delirium, and care or placement for veterans with severe behavioral issues in a rural setting.

Discussion

Although many older adults experience cognitive and mental health disorders that may benefit from management by a geriatric psychiatrist, the number of trained geriatric psychiatrists available is insufficient to allow for direct care for each patient. The Ask the Expert Geriatric Psychiatry email consultation program is one aspect of a multicomponent strategy within the VHA to increase access to specialty geriatric mental health services for veterans. A key advantage of the program is that it is not resource intensive. Experts can participate voluntarily, providing timely feedback to clinicians around the country while continuing other duties at their respective VA medical centers. Email replies to the experts’ answers elicited positive feedback on the program, include: “I found this service to be extremely helpful and I have shared the information they sent me with several other coworkers!”, “It was great!”, and “I endorsed the service to our VISN Rehabilitation and Extended Care group.”

The coding of primary and secondary themes from 101 email questions that were retained revealed the range and relative frequencies of clinical and administrative topics with which clinicians needed help. The most common (33%) theme was agitated behaviors. Nearly half of the questions (48%) were related to underlying dementia, and 29% were related to a patient’s medical comorbidities. These findings suggest that the expertise of a geriatric psychiatrist is particularly relevant when caring for older patients experiencing BPSD or patients with complex, overlapping psychiatric and medical conditions.

Despite a 27% response rate, participant feedback has been helpful. The program reached its intended audience of clinicians in rural areas and at smaller facilities with 53% of requesters reporting they rarely had access to a geriatric psychiatrist. Suggestions for improvement indicated that some clinicians desired additional support, including chart reviews, meetings with experts, and a video teleconsultation service (available through NEXCSS-MH).

Many clinicians without training in specialty geriatric mental health may require help with complex clinical presentations. For example, 39 clinicians who submitted questions to the program were physicians. Accreditation Council for Graduate Medical Education program requirements for general psychiatry residency include 4 weeks of geriatric psychiatry.11 The findings of this study suggest that this level of training may not be adequate to independently care for every patient who experiences dementia or multimorbidity. Several training and mentoring initiatives have been developed to address the professional development need for psychiatrists.12-14

The need for geriatric workforce development is significant across health care, including other mental health professions.15,16 The VHA Geriatric Scholars program trains rural primary care practitioners, psychologists, and psychiatrists.17,18 Likewise, consultative geriatric specialty support for primary care practitioners in rural areas is provided via the Geriatric Research Education and Clinical Center Connect program.19 The Ask the Expert Geriatric Psychiatry email program is an additional economical model to support clinician educational development and provide rapid educational responses to inform patient care.

Ask the Expert received fewer email questions than anticipated. Enhanced optimization may require more frequent and widespread announcements about the program. Clinical staff may not be aware of the program due to an overload of email communications. Likewise, it may be challenging for busy clinicians to take the time to seek consultation or recognize a potential gap in their knowledge or skills. Had more questions been submitted, the 5 volunteer experts may have had more difficulty addressing the demand. Feedback from this project may inform development of a frequently asked questions document to share with VHA teams and a drop-in office hour to pose clinical questions of geriatric psychiatry experts, as recommended by a clinician who participated in the program.

Limitations

Not all requesters were sent a request for feedback, and the response rate for the request for feedback was only 27%. As the program has evolved, it began sending a request for feedback immediately after answering each question, which may increase the odds of response. The goal of experts answering questions within 7 business days was met 72% of the time, likely an artifact of experts integrating question answering with many other duties. The mailbox coordinator has since provided email prompts to experts immediately upon being assigned a question with the goal of improving timeliness. The program did not include chart reviews or patient consultations, as neither was feasible for volunteer experts. The email consultation service is a single component of virtual consultative specialty geriatric mental health services within the VHA, including video consultations via NEXCSS-MH and regional geriatric mental health teams.

Conclusions

The need for specialty geriatric mental health services is increasing in the VHA and across the US. However, there are too few board-certified geriatric psychiatrists to provide direct patient care to all older adults with cognitive and mental health disorders. The VHA has leveraged telehealth to improve access to geriatric mental health care. The VHA Ask the Expert Geriatric Psychiatry email consultation program is a low-resource service which provides rapid feedback to clinicians nationwide on challenging clinical scenarios, many of which are dementia-related. Most users of the service who responded to requests for feedback reported that answers to their questions were helpful and timely. The email consultation program should continue to be supplemented by more comprehensive geriatric telemental health services for particularly complex cases to meet the needs of older veterans.

T he US Census Bureau projects that the number of older adults (aged ≥ 65 years) will exceed 49 million by 2030, and an estimated 20% (nearly 10 million) of this population will experience cognitive or mental health disorders.1,2 The mental health workforce is not equipped to address the specialized mental health care needs of many older adults.2,3 For example, geriatric psychiatrists specialize in the diagnosis and treatment of mental illness and cognitive disorders in the later stages of life, but their numbers are few and declining. Only 33.5% of geriatric psychiatry fellowship training slots were filled from 2017 to 2021, and only 62 fellows trained during the 2021-2022 academic year.4 Board-certified geriatric psychiatrists also tend to be concentrated in larger, urban, academically-affiliated medical centers, often leaving rural areas and smaller facilities without access, including facilities in the Veterans Health Administration (VHA).5

The VHA has been optimizing access to specialty geriatric mental health services via regional and national virtual consultation services. Seven of 19 Veterans Integrated Service Network (VISN) Clinical Resource Hubs (CRHs) have geriatric mental health teams.6 These provide interdisciplinary geriatric mental telehealth services, including geriatric psychiatry, for older veterans with complex care needs.7,8 Likewise, the VHA National Expert Consultation & Specialized Services-Mental Health (NEXCSS- MH, formerly known as the National Telemental Health Center) sponsors video teleconsultations with board-certified geriatric psychiatrists and an Ask the Expert email consultation program.

This article describes the Ask the Expert Geriatric Psychiatry email program (one of several similar programs at NEXCSS-MH), building upon a symposium presented at the American Association for Geriatric Psychiatry (AAGP) annual meeting in March 2022.9 The program was initiated in June 2021 as a result of discussions between the National Mental Health Director, Geriatric Mental Health in the VHA Office of Mental Health and Suicide Prevention (now known as the Office of Mental Health [OMH]), and National Telemental Health Center leadership. VHA board certified geriatric psychiatrists were recruited to serve as expert consultants and respond to email questions submitted by VHA clinicians regarding the psychiatric care of older adult veterans. The results of this program identify educational needs among clinical staff and may inform the development of program materials for a range of clinicians.

Program Description

The national geriatric mental health director recruited prospective experts and met with each to assess interest and qualifications, consulting with OMH psychiatrist leaders before making selections. Five experts were initially selected; 1 later stepped down and was replaced by another, who also stepped down. The experts were board certified in psychiatry and geriatric psychiatry and held a variety of local and national leadership positions, including geriatric psychiatry fellowship director, US Department of Veterans Affairs (VA) research and clinical leader, and various roles in the AAGP; some had received teaching awards.

Operations

The national geriatric mental health director announced the program in June 2021 to VHA mental health and geriatric program email groups with reminders sent every few months. The announcement included information about the types of questions appropriate to submit, including examples of general clinical management questions that did not share patient-specific protected health information, and clarified that experts would not be conducting chart reviews because the time required for detailed chart reviews was not feasible for volunteer experts to integrate into their otherwise full-time jobs at their respective VA medical centers. The announcement also included brief biographies of the experts.

The Figure describes the daily operations of the Ask the Expert Geriatric Psychiatry email consultation program. The NEXCSS- MH developed a Microsoft Outlook mailbox and group email address where clinicians from across the VHA could submit questions. The experts, as well as the national geriatric mental health director and NEXCSS-MH staff, had access to this mailbox to track and/or respond to questions. One expert volunteered to be the program’s primary mailbox coordinator. The coordinator checked the inbox daily and assigned each question to one of the experts on a rotating basis using the color-coding feature in Outlook. The other experts were advised to check the email account at least once weekly and reply to any assigned questions.

0426FED-MH-Consult-F1
FIGURE. Process for Answering Ask the Expert Geriatric Psychiatry Email Questions

Responding to a question entailed first determining whether the question was appropriate for the service. For example, if a question requested a chart review, the expert replied that experts could not provide chart reviews and requested that the question be reframed. Next, the expert often needed to define a specific clinical question from the information provided, as email questions often touched upon several topics. The expert provided personalized advice on diagnostic testing, nonpharmacologic treatment strategies, and/or pharmacologic treatment options. Experts also often attached relevant guidelines or review articles. The goal was to provide a response within 7 business days.

All email responses included a disclaimer indicating that the program was not intended for urgent or immediate medical advice and that the information provided was for VHA clinician education purposes only. The disclaimer explained that email communication did not establish a doctor-patient relationship between the expert and a specific veteran and that, if desired, a request for a clinical consultation could be submitted on a specific case (ie, a video teleconsultation).

Methods for Reviewing Questions

Descriptive statistics, including frequencies, means, and minimum and maximum ranges, were used to capture the number of questions the program received, type of requester, and length of time prior to response for emailed questions.9 Conventional content analysis procedures were used between January and October 2024 to analyze clinicians’ questions.10 Four subject matter experts (3 geriatric psychiatrists and 1 geropsychologist) served as coders, assigned in groups of 2 to review questions. Each coder independently reviewed assigned questions and identified preliminary themes. Themes were reviewed and revised using an iterative process during regular team meetings with coders to clarify and confirm interpretations. Discrepancies were discussed within team meetings to achieve consensus.

Questions received. Between February 2022 and December 2023, the program received 101 email questions. Requesters included 39 physicians, 17 nurse practitioners or physician assistants, 15 social workers, 14 psychologists, 9 nurses, 5 pharmacists, 1 dietitian, and 1 who was undetermined. Experts responded to the questions an average of 6 days after receipt (range, < 1-19); 73 responses (72%) met the 7-day goal.

Iterative changes to coded themes were made during group discussions. Multiple clinical questions were often posed within the same email. Initially, some coders identified themes solely based on reported symptoms; others identified themes based on reported and/or potential diagnostic conditions attributed to the symptom(s) described within the email. For example, some coders selected a primary theme of behavioral and psychological symptoms of dementia (BPSD) only if a behavior contributing to distress in the veteran or others was described, while others selected this theme when any psychiatric symptom (eg, psychosis) was present in the context of dementia. The group identified 1 primary theme per question based on the main clinical symptom or main concern presented. Co-occurring diagnostic conditions highlighted in the email requests were included as secondary themes, and each question could have > 1 secondary theme.

The most frequent requests related to clinical symptoms included questions about agitated behaviors, sleep and/or nightmares, and depression symptoms (Table 1). Twenty-seven of 33 email requests on agitated behaviors were related to a dementia diagnosis, as were several questions about sleep/nightmares, depression, psychosis/mania, and anxiety. Many diagnostic conditions were described in the email requests (Table 2). The most frequent condition was dementia, followed by a medical condition, depressive disorder, posttraumatic stress disorder, and/or serious mental illness.

0426FED-MH-Consult-T10426FED-MH-Consult-T2

Request for Feedback. In February 2022, an email request was sent to the 64 clinicians who asked email questions from the start of the program in June 2021 through December 2021. A second request included 11 clinicians who asked questions from January through February 2022. These requests were sent as part of preparations for the symposium on the program presented at the AAGP annual meeting in March 2022.9 In May 2024, feedback was requested from 37 clinicians who submitted questions from May 1, 2023, through May 15, 2024.

Requests for feedback included 6 closed-ended and 1 open-ended question: (1) Did the answer you received help inform clinical practice? (2) Did you receive a timely response? (3) What type of information was useful to you in addressing your question (ie, direct/specific answer to a clinical scenario, guidelines, articles, VA resources)? (4) Do you have access to a geriatric psychiatrist at your facility? (5) Are you likely to use Ask the Expert Geriatric Psychiatry in the future? (6) Would you use a geriatric psychiatry teleconsultation service? (7) Share suggestions for improvement. Frequencies of response selection were obtained for each question. Text responses to the open-ended question asking for suggestions for improvement were reviewed and summarized.

Responses

Thirty users responded to the feedback request (27% response rate). Respondents considered the answers received extremely (n = 14; 47%) or very much (n = 12; 40%) helpful for their clinical practice. Twenty-three respondents (77%) felt an answer was provided promptly, 7 respondents (23%) felt the answer was not timely but still useful, and none felt that the answer was too late. Respondents reported that the most useful type of information in addressing their questions was a direct/specific answer to a clinical scenario (n = 27; 90%), followed by guidelines (n = 12; 40%), articles (n = 7; 23%), and VA resources (n = 4; 13%).

Sixteen respondents (53%) reported that they rarely had ready access to a geriatric psychiatrist at their facility, 3 (10%) had access sometimes, 4 (14%) had access usually, 3 (10%) had access regularly, and 3 (10%) never had access. Twenty-seven respondents (90%) indicated they would be very likely to use the service again. If geriatric psychiatry teleconsultation and/or e-consultation were offered, many respondents indicated they would be extremely (n = 10; 33%) or very (n = 12; 40%) likely to use teleconsultation and/or e-consultation.

Suggestions for improvement included supporting experts to perform chart reviews for email questions, developing a template or consult form, holding a biweekly drop-in meeting to present questions to and discuss cases with a panel of experts, and providing further help addressing complex decisional capacity issues, delirium, and care or placement for veterans with severe behavioral issues in a rural setting.

Discussion

Although many older adults experience cognitive and mental health disorders that may benefit from management by a geriatric psychiatrist, the number of trained geriatric psychiatrists available is insufficient to allow for direct care for each patient. The Ask the Expert Geriatric Psychiatry email consultation program is one aspect of a multicomponent strategy within the VHA to increase access to specialty geriatric mental health services for veterans. A key advantage of the program is that it is not resource intensive. Experts can participate voluntarily, providing timely feedback to clinicians around the country while continuing other duties at their respective VA medical centers. Email replies to the experts’ answers elicited positive feedback on the program, include: “I found this service to be extremely helpful and I have shared the information they sent me with several other coworkers!”, “It was great!”, and “I endorsed the service to our VISN Rehabilitation and Extended Care group.”

The coding of primary and secondary themes from 101 email questions that were retained revealed the range and relative frequencies of clinical and administrative topics with which clinicians needed help. The most common (33%) theme was agitated behaviors. Nearly half of the questions (48%) were related to underlying dementia, and 29% were related to a patient’s medical comorbidities. These findings suggest that the expertise of a geriatric psychiatrist is particularly relevant when caring for older patients experiencing BPSD or patients with complex, overlapping psychiatric and medical conditions.

Despite a 27% response rate, participant feedback has been helpful. The program reached its intended audience of clinicians in rural areas and at smaller facilities with 53% of requesters reporting they rarely had access to a geriatric psychiatrist. Suggestions for improvement indicated that some clinicians desired additional support, including chart reviews, meetings with experts, and a video teleconsultation service (available through NEXCSS-MH).

Many clinicians without training in specialty geriatric mental health may require help with complex clinical presentations. For example, 39 clinicians who submitted questions to the program were physicians. Accreditation Council for Graduate Medical Education program requirements for general psychiatry residency include 4 weeks of geriatric psychiatry.11 The findings of this study suggest that this level of training may not be adequate to independently care for every patient who experiences dementia or multimorbidity. Several training and mentoring initiatives have been developed to address the professional development need for psychiatrists.12-14

The need for geriatric workforce development is significant across health care, including other mental health professions.15,16 The VHA Geriatric Scholars program trains rural primary care practitioners, psychologists, and psychiatrists.17,18 Likewise, consultative geriatric specialty support for primary care practitioners in rural areas is provided via the Geriatric Research Education and Clinical Center Connect program.19 The Ask the Expert Geriatric Psychiatry email program is an additional economical model to support clinician educational development and provide rapid educational responses to inform patient care.

Ask the Expert received fewer email questions than anticipated. Enhanced optimization may require more frequent and widespread announcements about the program. Clinical staff may not be aware of the program due to an overload of email communications. Likewise, it may be challenging for busy clinicians to take the time to seek consultation or recognize a potential gap in their knowledge or skills. Had more questions been submitted, the 5 volunteer experts may have had more difficulty addressing the demand. Feedback from this project may inform development of a frequently asked questions document to share with VHA teams and a drop-in office hour to pose clinical questions of geriatric psychiatry experts, as recommended by a clinician who participated in the program.

Limitations

Not all requesters were sent a request for feedback, and the response rate for the request for feedback was only 27%. As the program has evolved, it began sending a request for feedback immediately after answering each question, which may increase the odds of response. The goal of experts answering questions within 7 business days was met 72% of the time, likely an artifact of experts integrating question answering with many other duties. The mailbox coordinator has since provided email prompts to experts immediately upon being assigned a question with the goal of improving timeliness. The program did not include chart reviews or patient consultations, as neither was feasible for volunteer experts. The email consultation service is a single component of virtual consultative specialty geriatric mental health services within the VHA, including video consultations via NEXCSS-MH and regional geriatric mental health teams.

Conclusions

The need for specialty geriatric mental health services is increasing in the VHA and across the US. However, there are too few board-certified geriatric psychiatrists to provide direct patient care to all older adults with cognitive and mental health disorders. The VHA has leveraged telehealth to improve access to geriatric mental health care. The VHA Ask the Expert Geriatric Psychiatry email consultation program is a low-resource service which provides rapid feedback to clinicians nationwide on challenging clinical scenarios, many of which are dementia-related. Most users of the service who responded to requests for feedback reported that answers to their questions were helpful and timely. The email consultation program should continue to be supplemented by more comprehensive geriatric telemental health services for particularly complex cases to meet the needs of older veterans.

References
  1. 2023 population projections for the nation by age, sex, race, Hispanic origin and nativity. United States Census Bureau. November 9, 2023. Accessed December 11, 2025. https://www.census.gov/newsroom/press-kits/2023/population-projections.html
  2. National Academies of Sciences Engineering and Medicine. Addressing the rising mental health needs of an aging population: proceedings of a workshop. 2024. Accessed December 11, 2025. doi.org:10.17226/27340
  3. Institute of Medicine. The mental health and substance use workforce for older adults: in whose hands? The National Academies Press; 2012. Accessed December 11, 2025. doi:10.17226/13400
  4. American Psychiatric Association. 2022 resident/fellow census. November 2023. Accessed December 11, 2025. https://www.psychiatry.org/getmedia/d80438af-f760-40f3-9d33-f91309b09564/APA-Resident-Census-2022.pdf
  5. Juul D, Colenda CC, Lyness JM, et al. Subspecialty training and certification in geriatric psychiatry: a 25-year overview. Am J Geriatr Psychiatry. 2017;25:445-453. doi:10.1016/j.jagp.2016.12.018
  6. Jaske E, Wheat CL, Rubenstein LV, et al. Understanding how contingency staffing programs can support mental health services in the Veterans Health Administration. Telemed J E Health. 2024;30:1857-1865. doi:10.1089/tmj.2023.0573
  7. Gould CE, Carlson C, Alfaro AJ, et al. Supporting veterans, caregivers, and providers in rural regions with tele-geriatric psychiatry consultation: a mixed methods pilot study. Am J Geriatr Psychiatry. 2023;31:279-290. doi:10.1016/j.jagp.2023.01.005
  8. Gould CE, Paiko L, Carlson C, et al. Implementation of tele-geriatricmental healthcare for rural veterans: factors influencing care models. Front Health Serv. 2024;4:1221899. doi:10.3389/frhs.2024.1221899
  9. Padala P, Schultz S, Khatkhate G, et al. Ask the expert geriatric psychiatry: VA program to support clinicians. Am J Geriatr Psychiatry. 2022;30:S18. doi:10.1016/j.jagp.2022.01.279
  10. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15:1277-1288. doi:10.1177/1049732305276687
  11. Accreditation Council for Graduate Medical Education. Program requirements for graduate medical education in psychiatry. Revised September 3, 2025. Accessed December 11, 2025. https://www.acgme.org/globalassets/pfassets/programrequirements/2025-reformatted-requirements/400_psychiatry_2025_reformatted.pdf
  12. Fernandez J, Agarwal KS, Amspoker AB, et al. Outcomes from an interprofessional, dementia-focused, telementoring program: a brief report. Gerontol Geriatr Educ. 2024;45:601-606. doi:10.1080/02701960.2023.2253175
  13. Conroy ML, Garcia-Pittman EC, van Dyck LI, et al. The COVID-19 American Association for Geriatric Psychiatry (AAGP) online trainee curriculum: program evaluation and future directions. Am J Geriatr Psychiatry. 2025;33:308-314. doi:10.1016/j.jagp.2024.10.010
  14. Conroy ML, Garcia-Pittman EC, Ali H, et al. The COVID-19 AAGP online trainee curriculum: development and method of initial evaluation. Am J Geriatr Psychiatry. 2020;28:1004-1008. doi:10.1016/j.jagp.2020.06.003
  15. Flaherty E, Busby-Whitehead J, Potter J, et al. The geriatric workforce enhancement program: review of the coordinating center and examples of the GWEP in practice. Am J Geriatr Psychiatry. 2019;27:675-686. doi:10.1016/j.jagp.2019.04.010
  16. Hoge MA, Karel MJ, Zeiss AM, et al. Strengthening psychology’s workforce for older adults: implications of the Institute of Medicine’s report to Congress. Am Psychol. 2015;70:265-278. doi:10.1037/a0038927
  17. Kramer BJ, Creekmur B, Howe JL, et al. Veterans Affairs geriatric scholars program: enhancing existing primary care clinician skills in caring for older veterans. J Am Geriatr Soc. 2016;64:2343-2348. doi:10.1111/jgs.14382
  18. Gould CE, Rodriguez RL, Gregg JJ, et al. Preparing Veterans Health Administration psychologists to meet the complex needs of aging veterans. Fed Pract. 2024;41:S10-S15. doi:10.12788/fp.0466
  19. Pimentel CB, Gately M, Barczi SR, et al. GRECC Connect: Geriatrics telehealth to empower health care providers and improve management of older veterans in rural communities. Fed Pract. 2019;36:464-470.
References
  1. 2023 population projections for the nation by age, sex, race, Hispanic origin and nativity. United States Census Bureau. November 9, 2023. Accessed December 11, 2025. https://www.census.gov/newsroom/press-kits/2023/population-projections.html
  2. National Academies of Sciences Engineering and Medicine. Addressing the rising mental health needs of an aging population: proceedings of a workshop. 2024. Accessed December 11, 2025. doi.org:10.17226/27340
  3. Institute of Medicine. The mental health and substance use workforce for older adults: in whose hands? The National Academies Press; 2012. Accessed December 11, 2025. doi:10.17226/13400
  4. American Psychiatric Association. 2022 resident/fellow census. November 2023. Accessed December 11, 2025. https://www.psychiatry.org/getmedia/d80438af-f760-40f3-9d33-f91309b09564/APA-Resident-Census-2022.pdf
  5. Juul D, Colenda CC, Lyness JM, et al. Subspecialty training and certification in geriatric psychiatry: a 25-year overview. Am J Geriatr Psychiatry. 2017;25:445-453. doi:10.1016/j.jagp.2016.12.018
  6. Jaske E, Wheat CL, Rubenstein LV, et al. Understanding how contingency staffing programs can support mental health services in the Veterans Health Administration. Telemed J E Health. 2024;30:1857-1865. doi:10.1089/tmj.2023.0573
  7. Gould CE, Carlson C, Alfaro AJ, et al. Supporting veterans, caregivers, and providers in rural regions with tele-geriatric psychiatry consultation: a mixed methods pilot study. Am J Geriatr Psychiatry. 2023;31:279-290. doi:10.1016/j.jagp.2023.01.005
  8. Gould CE, Paiko L, Carlson C, et al. Implementation of tele-geriatricmental healthcare for rural veterans: factors influencing care models. Front Health Serv. 2024;4:1221899. doi:10.3389/frhs.2024.1221899
  9. Padala P, Schultz S, Khatkhate G, et al. Ask the expert geriatric psychiatry: VA program to support clinicians. Am J Geriatr Psychiatry. 2022;30:S18. doi:10.1016/j.jagp.2022.01.279
  10. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15:1277-1288. doi:10.1177/1049732305276687
  11. Accreditation Council for Graduate Medical Education. Program requirements for graduate medical education in psychiatry. Revised September 3, 2025. Accessed December 11, 2025. https://www.acgme.org/globalassets/pfassets/programrequirements/2025-reformatted-requirements/400_psychiatry_2025_reformatted.pdf
  12. Fernandez J, Agarwal KS, Amspoker AB, et al. Outcomes from an interprofessional, dementia-focused, telementoring program: a brief report. Gerontol Geriatr Educ. 2024;45:601-606. doi:10.1080/02701960.2023.2253175
  13. Conroy ML, Garcia-Pittman EC, van Dyck LI, et al. The COVID-19 American Association for Geriatric Psychiatry (AAGP) online trainee curriculum: program evaluation and future directions. Am J Geriatr Psychiatry. 2025;33:308-314. doi:10.1016/j.jagp.2024.10.010
  14. Conroy ML, Garcia-Pittman EC, Ali H, et al. The COVID-19 AAGP online trainee curriculum: development and method of initial evaluation. Am J Geriatr Psychiatry. 2020;28:1004-1008. doi:10.1016/j.jagp.2020.06.003
  15. Flaherty E, Busby-Whitehead J, Potter J, et al. The geriatric workforce enhancement program: review of the coordinating center and examples of the GWEP in practice. Am J Geriatr Psychiatry. 2019;27:675-686. doi:10.1016/j.jagp.2019.04.010
  16. Hoge MA, Karel MJ, Zeiss AM, et al. Strengthening psychology’s workforce for older adults: implications of the Institute of Medicine’s report to Congress. Am Psychol. 2015;70:265-278. doi:10.1037/a0038927
  17. Kramer BJ, Creekmur B, Howe JL, et al. Veterans Affairs geriatric scholars program: enhancing existing primary care clinician skills in caring for older veterans. J Am Geriatr Soc. 2016;64:2343-2348. doi:10.1111/jgs.14382
  18. Gould CE, Rodriguez RL, Gregg JJ, et al. Preparing Veterans Health Administration psychologists to meet the complex needs of aging veterans. Fed Pract. 2024;41:S10-S15. doi:10.12788/fp.0466
  19. Pimentel CB, Gately M, Barczi SR, et al. GRECC Connect: Geriatrics telehealth to empower health care providers and improve management of older veterans in rural communities. Fed Pract. 2019;36:464-470.
Issue
Federal Practitioner 43(suppl 1)
Issue
Federal Practitioner 43(suppl 1)
Page Number
S1-S6
Page Number
S1-S6
Publications
Publications
Topics
Article Type
Display Headline

Ask the Expert Geriatric Psychiatry: A VHA Email Consultation Program to Support Clinicians

Display Headline

Ask the Expert Geriatric Psychiatry: A VHA Email Consultation Program to Support Clinicians

Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
survey writer start date

Accelerated Unified Protocol for Transdiagnostic Treatment of Anxiety Disorders in a VHA System

Article Type
Changed
Display Headline

Accelerated Unified Protocol for Transdiagnostic Treatment of Anxiety Disorders in a VHA System

Cognitive behavioral therapy (CBT) is supported as an effective treatment for depression by clinical practice guidelines from the US Department of Veterans Affairs (VA) and US Department of Defense.1-3 Despite research supporting the use of evidence-based CBT for anxiety, mood, and emotional disorders, patient access to these interventions is limited.4 One barrier to CBT for anxiety, mood, and emotional disorders is the traditional use of single-disorder protocols (SDPs) to separately treat each disorder (eg, major depression, generalized anxiety disorder, panic disorder).

Use of SDPs places a high burden on clinicians, requiring them to learn and competently implement multiple different manualized interventions for each anxiety, mood, or emotional disorder encountered in practice.4 It is common for individuals who present with an anxiety, mood, or emotional disorder to experience co-occurring disorders.5 Traditional SDP-based CBT may require multiple SDPs to address co-occurring disorders, extending time in treatment and increasing training burden. There is evidence that even when an SDP is used, co-occurring difficulties may decrease in intensity.6 Thus, evidence-based CBT for 1 presenting concern may positively affect co-occurring difficulties that are not the primary treatment target.6

Unified Protocol (UP) is a transdiagnostic CBT intervention for anxiety and mood disorders. UP targets emotional experiences (eg, negative affect and emotional distress) that are present in multiple anxiety, depression, and emotional disorders. UP is organized into 8 modules and uses interventions present in other CBT SDPs, such as teaching objective assessment methods to clients, motivational enhancement and goal setting, emotion psychoeducation, mindful awareness, cognitive reframing, and exposure principles as mechanisms of change (Table 1).4 UP is an ideal intervention for addressing a number of anxiety, mood, and emotional disorders as well as addressing cooccurring disorders within the same course of treatment.

0426FED-MH-Anxiety-T1

UP has been compared to SDPs; studies illustrate that UP is equivalent to SDPs at the end of treatment and at 6 months posttreatment.4,7 Additionally, patients who received UP experienced symptom reduction for multiple co-occurring disorders.7 Furthermore, patients were less likely to drop out of UP when compared with SDPs.4

Studies have reported positive impacts on affective disorders with UP. A 2019 meta-analysis found significant reductions in depression and anxiety-related disorders.8 Additionally, UP has been shown to be effective when delivered in person and via telehealth.9,10 UP has also been successfully used in veterans.11 While traditional models of UP (1-2 sessions weekly) have a lower dropout rate than SDPs, UP and CBT dropout rates still leave room for improvement.12-14 Specifically, rates of attrition from SDP CBT and transdiagnostic CBT protocols range from 9% to 35%, and dropout reduces the likelihood of attaining a full therapeutic dose of any course of CBT. Notably, accelerated delivery of CBT (ie, ≥ 3 sessions/wk) has been shown to reduce risk of dropout.14,15

Veterans are at increased risk for suicide, and anxiety and mood disorders are associated with increased risk of suicide attempt and death.16,17 Very few veterans who could benefit from high-quality CBT interventions, whether SDP or UP, are able to access them. Only 6.3% of veterans received ≥1 session of an evidence-based CBT SDP for posttraumatic stress disorder (PTSD) at 6 clinics evaluated in 2010.18

We identified 2 strategies to increase access to and completion of an evidence-based CBT course. First, the use of transdiagnostic UP instead of SDPs reduced burden on therapists and allowed them to address presenting and co-occurring disorders within the same course of care. Second, the use of an accelerated model of service delivery reduced dropout risk. Training clinicians to deliver UP is efficient and cost-effective, considering clinicians use core strategies that can be tailored and flexibly applied to a range of emotional difficulties. Thus, implementing UP may decrease barriers to receiving an optimal dose of an evidence-based CBT delivered with fidelity in a time- and cost-efficient manner.4 Two studies have found no evidence of differences in outcomes between UP and SDPs, suggesting that training and supervising clinicians in a single transdiagnostic UP intervention may prepare them to treat heterogeneous and co-occurring anxiety, mood, and emotional disorders with less burden than learning multiple SDPs.7,19

Delivering UP in an accelerated or massed format (≥4 sessions/wk) instead of the traditional spaced model (1 session/wk) has empirical support but has not been widely implemented. This approach, sometimes referred to as a UP-intensive outpatient program (UP-IOP) or UP-intensive outpatient track (UP-IOT), has been shown to be feasible, acceptable, and effective, with increased completion rates compared with traditional UP delivery (1-2 sessions/wk).20-22

Ragsdale et al describe a 2-week IOP with multiple treatment tracks, including a general track.20 The general track includes massed UP and additional standard services, including case management, wellness services, family services, and a single session effective behaviors group. Additional augmentation services are available when clinically indicated (eg, repetitive transcranial magnetic stimulation, transcranial direct current stimulation, psychoeducation, motivational interviewing, relapse prevention). In other words, this was an UP-IOP.20

Thompson-Brenner et al described a successful implementation of massed UP applied in intensive treatment settings, such as residential and day-hospital programs, for eating disorders. Patients reported improvements in 3 UP targets: experiential avoidance, mindfulness, and anxiety.21 Watkins et al evaluated a 2-week IOP using CBT for comorbid substance use and mental health disorders, including prolonged exposure, UP, and relapse prevention for substance use disorders. Participants were post-9/11 veterans and activeduty personnel. Results indicated that UP reduced PTSD and depressive symptoms following treatment. Furthermore, the retention rate (91%) was higher than retention in outpatient treatment (39%-65%), supporting the IOP model as a strategy to reduce dropout.22

Massed psychotherapy has been extended to IOP programs for PTSD treatment within the Veterans Health Administration (VHA). Yamokoski et al found that patients who completed an IOP that included massed CBT for PTSD had high retention, high satisfaction, and significant reduction in self-reported co-occurring depression symptoms. The authors also found that this model of care could be implemented and sustained within a VHA facility using minimal staffing resources.23

The UP-IOP models described by Ragsdale et al and Watkins et al included massed UP as the primary evidence-based practice (EBP) with adjunctive groups (eg, wellness and educational groups and access to complementary interventions such as mindfulness and yoga); they found that adding these groups increased retention and patient- reported satisfaction (ie, UP-IOP).20,22 The addition of wellness education alongside a primary EBP aligns with the VHA focus on whole health well-being and wellness. This includes understanding factors that motivate a patient toward health and well-being, providing health education, and offering access to complementary interventions such as mindfulness.24

Dryden et al described the whole health transformation within VHA as a proactive approach to addressing both employee and patient wellness. Their research found that the whole health model promoted wellbeing in patients and staff and these improvements were sustained during the COVID-19 pandemic. Dryden et al also noted that virtual technologies facilitated continued whole health implementation.25

The literature illustrates that (1) massed UP can be delivered with complementary education and wellness offerings that may increase retention and satisfaction by enriching treatment (eg, delivering UP-IOP); (2) whole health, including wellness education and complementary interventions (eg, mindfulness, motivational enhancement), promotes well-being in patients and clinicians; and (3) whole health education and complementary interventions can be delivered virtually.

IVET

Health Care Need

Veterans Affairs Pacific Islands Health Care System (VAPIHCS) provides medical services to veterans in the Hawaiian Islands, American Samoa, Guam, and Saipan spanning nearly 4000 miles across the Pacific Ocean. Prior to implementation of this program, veterans who received care at VAPIHCS had little to no access to UP in outpatient settings and no access to UP in residential settings. Access to UP depended on the presence of a therapist trained in UP within a given clinic and was geographically limited to the location of the UP-trained therapist. The limited outpatient access to UP was restricted to the traditional UP delivery model (eg, about 1 session/wk); thus, there was no access to accelerated UP for veterans served at VAPIHCS. In the fiscal year prior to implementation of the massed UP program, > 1000 VAPIHCS veterans had been diagnosed with obsessive-compulsive related disorder or anxiety. A massed-UP program with weekly rolling admissions would support access to UP for more veterans over 12 months, and the virtual treatment modality would reduce barriers for diverse and underserved veterans, making care more equitable and inclusive.

Successful implementation and sustainment of an EBP prompted the establishment of this UP program. In 2022, VAPIHCS launched the Intensive Virtual Evidence- Based Psychotherapy Team (iVET) for treatment of PTSD. This clinic and associated EBP project demonstrated that massed (≥3 individual sessions/wk) of prolonged exposure (PE) therapy, delivered virtually to a geographically diverse veteran population with PTSD, resulted in significant reductions in PTSD, depression, and anxiety symptoms and substance use risk factors, with very high retention rates. The iVET for PTSD program was feasible, acceptable, and effective, with veterans reporting significant improvement in quality of life and high satisfaction with their mental health services.15 Given the known benefits of transdiagnostic UP treatment (vs SDPs), the need for accelerated UP, and success with accelerated PE, our goal was to spread the EBP of massed (≥3 sessions/ wk) virtual psychotherapy to other presenting problems (eg, anxiety disorders with or without co-occurring unipolar depression) using transdiagnostic UP.

Program Description

The program implemented within outpatient mental health services at VAPIHCS was iVET for the treatment of anxiety with or without co-occurring depression. The program model consists of an accelerated course of UP and whole health education provided via VA Video Connect (VVC), the VA video telehealth platform. iVET is a 2- to 4-week program and consists of 3 parts: (1) massed individual UP for transdiagnostic treatment of anxiety and co-occurring depression, (2) group whole health and wellness classes, and (3) individual health coaching to address personal wellness goals. Programming is offered over 10-hour days to increase access across multiple time zones, especially to allow participation from Guam and Saipan.

When a patient is referred to iVET, the first contact is a video (or telephone) appointment with a registered nurse (RN) for a screening session. The screening session is designed to provide education about the program (including interventions, time commitment, and resources required for participation). Following education, the RN completes a safety screening, including screening for suicidal ideation and risk, as well as intimate partner violence risk. If urgent safety concerns are present, a licensed social worker or psychologist joins the screening to complete further risk assessment and address any safety concerns.

Following screening, patients are scheduled for a VVC telehealth intake with a licensed therapist (social worker or psychologist) to complete a diagnostic interview. Patients are sent a secure link to complete a measurement-based care (MBC) battery of self-report measures, including assessments of demographics, anxiety symptoms, depression symptoms, substance use, psychological flexibility, quality of life, and satisfaction with mental health care. The results of the diagnostic interview and self-report measures are discussed with the patient during the intake session to plan next steps and support shared decision-making. This initial VVC intake not only allows for fit assessment but also serves to troubleshoot technical difficulties with the virtual platforms.

Notably, there are minimal exclusion criteria for participation in iVET. These include active unmanaged psychosis or manic symptoms, recent suicidal crises (attempt within 8 weeks), active nonsuicidal self-injury (within 8 weeks), and moderate to severe cognitive impairment. Following intake, patients are scheduled to begin their course of care with iVET. Upon completion of intake, patients receive program materials for individual and group classes and are told they will receive email links for all VVC telehealth appointments. Patients are admitted to the iVET on a rolling basis, thereby increasing access compared with closed group and/or cohort models of care.

Patients receiving iVET attend 2 to 4 telehealth appointments daily and complete exercises between sessions. The primary iVET for Anxiety program EBP intervention is a massed or accelerated individual course of UP, which includes 8 primary components: assessment, goals and motivation, understanding emotions, mindful emotion awareness, cognitive flexibility, countering emotional behaviors, understanding and confronting physical sensations, and emotional exposures. UP is delivered in 4 to 8 individual sessions weekly (60-90 minutes each), allowing completion of the full UP protocol with fidelity in 2 to 4 weeks. In addition to primary EBP intervention, patients participate in 4 group sessions weekly (50 minutes each) of a whole health and wellness education class and have access to 1 individual health coaching session weekly (30- 60 minutes) to set wellness goals and receive coaching. During iVET, patients are invited to complete MBC batteries of self-report measures assessing anxiety symptoms, depression symptoms, substance use, psychological flexibility, quality of life, and satisfaction with mental health care at sessions 1, 5, 9, 13, and the final UP session. Following discharge from the iVET, patients are offered 1-, 3-, and 6-month individual postdischarge check-up sessions with a therapist, during which they are invited to complete MBC measures and review relapse prevention and maintenance of treatment gains. Likewise, patients are offered 1-, 3-, and 6-month individual postdischarge check-up sessions with an RN focused on maintaining wellness gains.

The iVET for Anxiety staff has 3 therapists (psychologists or social workers) and 1 RN. Additionally, the iVET for Anxiety is supported by a program manager and a program support assistant who support 2 programs total (the iVET for Anxiety plus another mental health program). The primary cost of the program is staff salary. Additional resources included computer equipment for staff and supplies (eg, printed materials for patients and office supplies). Due to the virtual environment of care, iVET staff telework and do not require physical space within VAPIHCS.

Outcomes

Veterans receiving iVET for Anxiety are invited to complete MBC multiple times, including pretreatment, during UP treatment (sessions 1, 5, 9, 13, and the final session), and posttreatment (1, 3, and 6 months). MBC measures include self-reported demographics; a 2-item measure of satisfaction with mental health services; the Acceptance and Action Questionnaire II,26 the Brief Addiction Monitor-Intensive Outpatient Program, 27 the Generalized Anxiety Disorder-7,28 the Patient Health Questionnaire (PHQ-9),29 and the Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form.30

Forty-two veterans completed the iVET for Anxiety program, with a retention rate of 87.5% completing . 16 sessions of massed UP (Table 2). Veterans reported reduced anxiety (P < .001), depression (P < .001), and substance use risk (P < .001). Veterans experienced improved acceptance of emotional experiences (P < .001) and quality of life (P < .001), based on paired sample t tests comparing session 1 vs final session scores on the self-reported measures. Veterans also reported high satisfaction with mental health care in iVET for Anxiety.

0426FED-MH-Anxiety-T2

Veterans experienced reduced thoughts of death or suicidal ideation (SI) based on responses to item 9 of PHQ-9. When SI was categorically analyzed (presence vs absence) using PHQ-9 item 9, there was an association observed between absence of SI and completion of a course of massed UP that does not appear to be due to chance, (X2 [1, N = 42) = 3.94; P = .047). In addition, veterans who completed the program showed a significant decrease in SI severity measured continuously (range, 0-3) on PHQ-9 item 9 (P < .05) (Table 3).

0426FED-MH-Anxiety-T3

Future Directions

The aim of this program is to see sustained patient outcomes as iVET continues to serve more veterans. Another line of inquiry is longer- term follow-up, given that long-term follow- up was not addressed in this project. We also hope that the accelerated model of care can be applied to treatment of other presenting concerns (eg, relationship difficulties, insomnia). Expansion of accelerated mental health treatment into other federal and nonfederal health care settings is another area worthy of future inquiry. Exploration of staff satisfaction and burnout related to providing accelerated UP is another important future direction. Relatedly, assessment of the staff burden to learn 1 transdiagnostic EBP vs learning multiple SDPs is another future direction. Likewise, exploration of institutional benefits of investment in transdiagnostic training, supervision, and consultation for UP vs multiple SDPs may be important. These areas could also result in insightful, beneficial evidence of the effectiveness of massed UP to add to the existing literature.

Conclusions

UP for transdiagnostic treatment of anxiety, depressive, and emotional disorders has demonstrated reduced suffering and improved functioning and is supported by multiple clinical practice guidelines.1-4 Federal practitioners are positioned to improve access to this intervention, thereby reducing pain and improving lives. Indeed, it is crucial to envision a future state in which access to UP for a range of anxiety and depressive disorders is improved and broad, retention rates are dramatically improved, and clinicians providing UP do not experience the high burden and burnout associated with needing to learn and implement a variety of SDPs. Development of these programs, or similar tracks within existing programs, that provide massed or accelerated UP for transdiagnostic treatment of a range of anxiety and depressive disorders with virtual delivery options, is imperative to advance improved care for patients and clinicians.

Federal health care settings treating patients with anxiety and depression, such as those within the US Department of Defense, Indian Health Services, Bureau of Prisons, and VHA, are positioned to implement programs like iVET. Moreover, at the institutional level, investment in training and supervision in the transdiagnostic UP as opposed to multiple SDPs warrants consideration. We believe this model of care has great merit and foresee a future where all patients seeking treatment for anxiety and depression have the option to complete an accelerated or massed course of transdiagnostic care with UP if they so desire. Our experiences with iVET illustrate the feasibility, acceptability, and sustainability of such programs without requiring substantial staffing and financial resources.

References
  1. US Department of Veterans Affairs, US Department of Defense. VA/DoD clinical practice guideline for the management of major depressive disorder. Version 4. 2022. Accessed February 1, 2026. https://www.healthquality.va.gov/guidelines/MH/mdd/VADoDMDDCPGFinal508.pdf
  2. American Psychological Association. Clinical practice guideline for the treatment of depression across three age cohorts. February 2019. Accessed February 4, 2026. https://www.apa.org/depression-guideline/guideline.pdf
  3. Katzman MA, Bleau P, Blier P, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive compulsive disorders. BMC Psychiatry. 2014;14:S1. doi:10.1186/1471-244X-14-S1-S1
  4. Barlow DH, Farchione TJ, Bullis JR, et al. The unified protocol for transdiagnostic treatment of emotional disorders compared with diagnosis-specific protocols for anxiety disorders: a randomized clinical trial. JAMA Psychiatry. 2017;74:875-884. doi:10.1001/jamapsychiatry.2017.2164
  5. Calkins AW, et al. Comorbidity of anxiety and depression. In: Ressler KJ, Pine DS, Rothbaum BO, eds. Anxiety Disorders, Primer On. Oxford Academic; 2015. https://doi.org/10.1093/med/9780199395125.003.0021
  6. Manber R, Edinger JD, Gress JL, et al. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep. 2008;31:489-495. doi:10.1093/sleep/31.4.489
  7. Steele SJ, Farchione TJ, Cassiello-Robbins C, et al. Efficacy of the Unified Protocol for transdiagnostic treatment of comorbid psychopathology accompanying emotional disorders compared to treatments targeting single disorders. J Psychiatr Res. 2018;104:211-216. doi:10.1016/j.jpsychires.2018.08.005
  8. Sakiris N, Berle D. A systematic review and meta-analysis of the Unified Protocol as a transdiagnostic emotion regulation based intervention. Clin Psychol Rev. 2019;72:101751. doi:10.1016/j.cpr.2019.101751
  9. Cassiello-Robbins C, Rosenthal MZ, Ammirati RJ. Delivering transdiagnostic treatment over telehealth during the COVID-19 pandemic: application of the unified protocol. Cogn Behav Pract. 2021;28:555-572. doi:10.1016/j.cbpra.2021.04.007
  10. Meyer EC, Coe E, Pennington ML, et al. The unified protocol for transdiagnostic treatment of emotional disorders delivered to firefighters via videoconferencing: pilot outcomes highlighting improvements in alcohol use disorder and posttraumatic stress disorder symptoms. Cogn Behav Pract. 2024;31:215-229. doi:10.1016/j.cbpra.2022.08.004
  11. Varkovitzky RL, Sherrill AM, Reger GM. Effectiveness of the unified protocol for transdiagnostic treatment of emotional disorders among veterans with posttraumatic stress disorder: a pilot study. Behav Modif. 2018;42:210-230. doi:10.1177/0145445517724539
  12. Oliveira JT, Sousa I, Ribeiro AP, et al. Premature termination of the unified protocol for the transdiagnostic treatment of emotional disorders: The role of ambivalence towards change. Clin Psychol Psychother. 2022;29:1089-1100. doi:10.1002/cpp.2694
  13. Schaeuffele C, Homeyer S, Perea L, et al. The unified protocol as an internet-based intervention for emotional disorders: Randomized controlled trial. PLoS One. 2022;17:e0270178. doi:10.1371/journal.pone.0270178
  14. Bentley KH, Cohen ZD, Kim T, et al. The nature, timing, and symptom trajectories of dropout from transdiagnostic and single-diagnosis cognitive-behavioral therapy for anxiety disorders. Behav Ther. 2021;52:1364-1376. doi:10.1016/j.beth.2021.03.007
  15. Aosved AC, Brown TB, Bell JC, et al. Accelerated prolonged exposure therapy for posttraumatic stress disorder in a Veterans Health Administration system. Fed Pract. 2025;42:S6-S11. doi:10.12788/fp.0568
  16. Nepon J, Belik SL, Bolton J, et al. The relationship between anxiety disorders and suicide attempts: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Depress Anxiety. 2010;27:791-798. doi:10.1002/da.20674
  17. Shiner B, D’Avolio LW, Nguyen TM, et al. Measuring use of evidence based psychotherapy for posttraumatic stress disorder. Adm Policy Ment Health. 2013;40:311-318. doi:10.1007/s10488-012-0421-0
  18. Nichter B, Stein MB, Monteith LL, et al. Risk factors for suicide attempts among U.S. military veterans: A 7-year population-based, longitudinal cohort study. Suicide Life Threat Behav. 2022;52:303-316. doi:10.1111/sltb.12822
  19. McHugh RK, Barlow DH. The dissemination and implementation of evidence-based psychological treatments. A review of current efforts. Am Psychol. 2010;65:73-84. doi:10.1037/a0018121
  20. Ragsdale KA, Nichols AA, Mehta M, et al. Comorbid treatment of traumatic brain injury and mental health disorders. NeuroRehabilitation. 2024;55:375-384. doi:10.3233/NRE-230235
  21. Thompson-Brenner H, Brooks GE, Boswell JF, et al. Evidence-based implementation practices applied to the intensive treatment of eating disorders: summary of research and illustration of principles using a case example. Clin Psychol Sci Pract. 2018;25:e12221. doi:10.1111/cpsp.12221
  22. Watkins LE, Patton SC, Drexler K, et al. Clinical effectiveness of an intensive outpatient program for integrated treatment of comorbid substance abuse and mental health disorders. Cog Behav Pract. 2023;30:354-366.
  23. Yamokoski C, Flores H, Facemire V, et al. Feasibility of an intensive outpatient treatment program for post-traumatic stress disorder within the veterans health care administration. Psychol Serv. 2023;20:506-515. doi:10.1037/ser0000628
  24. Gaudet T, Kligler B. Whole health in the whole system of the Veterans Administration: how will we know we have reached this future state?. J Altern Complement Med. 2019;25:S7-S11. doi:10.1089/acm.2018.29061.gau
  25. Dryden EM, Bolton RE, Bokhour BG, et al. Leaning into whole health: sustaining system transformation while supporting patients and employees during COVID-19. Glob Adv Health Med. 2021;10:21649561211021047. doi:10.1177/21649561211021047
  26. Bond FW, Hayes SC, Baer RA, et al. Preliminary psychometric properties of the Acceptance and Action Questionnaire-II: a revised measure of psychological inflexibility and experiential avoidance. Behav Ther. 2011;42:676-688. doi:10.1016/j.beth.2011.03.007
  27. Cacciola JS, Alterman AI, Dephilippis D, et al. Development and initial evaluation of the Brief Addiction Monitor (BAM). J Subst Abuse Treat. 2013;44:256-263. doi:10.1016/j.jsat.2012.07.013
  28. Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092-1097. doi:10.1001/archinte.166.10.1092
  29. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606-613. doi:10.1046/j.1525-1497.2001.016009606.x
  30. Stevanovic D. Quality of life enjoyment and satisfaction questionnaire-short form for quality of life assessments in clinical practice: a psychometric study. J Psychiatr Ment Health Nurs. 2011;18:744-750. doi:10.1111/j.1365-2850.2011.01735.x
Article PDF
Author and Disclosure Information

Allison C. Aosved, PhD, ABPPa,b; Marissa Sia, PsyD, MAa; Jodi C. Bell, PsyDa; Theresa B. Brown, PsyDa; Hsin-Tine "Tina" Liu-Tom, PhD, CSACa

Author affiliations
aVeterans Affairs Pacific Islands Health Care System, Honolulu, Hawaii
bThrive Psychology LLC, Honolulu, Hawaii

Author disclosures
The authors report no actual or potential conflicts of interest regarding this article.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies.

Ethics and consent
Veteran participation in iVET was voluntary and optional. Participants engaged in routine informed consent practices utilized for all veterans receiving mental health care at VAPIHCS. The development of iVET was an Evidence Based Practice (EBP) Council approved project at VAPIHCS and, as such, it is not considered research and is exempt from Institutional Review Board review. The project was approved by the council on December 26, 2023, and Chief of Staff on December 29, 2023. The project final report was submitted to the EBP Council on February 28, 2025, and the project remains in the sustainment phase.

Acknowledgments
The authors thank iVET colleagues Chelsea Briggs, Maria Cabrera, Janver Fudolig, Bernadette Furtado, Christine Kindler, Mukul Khandelwal, Gaudencia Palomo-Burns, Kanani Racimo. Collaborators outside of iVET, including David Bernstein, Judy Carlson, Shiloh Jordan, Scott Masters, Dennis Perez, Sheila Rauch, Andrew Sherrill, and Cynthia Yamokoski provided valuable contributions including, but not limited to, administrative support, service delivery, mentorship, consultation, and sponsorship that was instrumental for the development of the iVET.

Correspondence: Allison Aosved (dr.a@thrivepsychologyllc.com)

Fed Pract. 2026;43(suppl 1). Published online April 15. doi:10.12788/fp.0687

Issue
Federal Practitioner 43(suppl 1)
Publications
Topics
Page Number
S1-S7
Sections
Author and Disclosure Information

Allison C. Aosved, PhD, ABPPa,b; Marissa Sia, PsyD, MAa; Jodi C. Bell, PsyDa; Theresa B. Brown, PsyDa; Hsin-Tine "Tina" Liu-Tom, PhD, CSACa

Author affiliations
aVeterans Affairs Pacific Islands Health Care System, Honolulu, Hawaii
bThrive Psychology LLC, Honolulu, Hawaii

Author disclosures
The authors report no actual or potential conflicts of interest regarding this article.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies.

Ethics and consent
Veteran participation in iVET was voluntary and optional. Participants engaged in routine informed consent practices utilized for all veterans receiving mental health care at VAPIHCS. The development of iVET was an Evidence Based Practice (EBP) Council approved project at VAPIHCS and, as such, it is not considered research and is exempt from Institutional Review Board review. The project was approved by the council on December 26, 2023, and Chief of Staff on December 29, 2023. The project final report was submitted to the EBP Council on February 28, 2025, and the project remains in the sustainment phase.

Acknowledgments
The authors thank iVET colleagues Chelsea Briggs, Maria Cabrera, Janver Fudolig, Bernadette Furtado, Christine Kindler, Mukul Khandelwal, Gaudencia Palomo-Burns, Kanani Racimo. Collaborators outside of iVET, including David Bernstein, Judy Carlson, Shiloh Jordan, Scott Masters, Dennis Perez, Sheila Rauch, Andrew Sherrill, and Cynthia Yamokoski provided valuable contributions including, but not limited to, administrative support, service delivery, mentorship, consultation, and sponsorship that was instrumental for the development of the iVET.

Correspondence: Allison Aosved (dr.a@thrivepsychologyllc.com)

Fed Pract. 2026;43(suppl 1). Published online April 15. doi:10.12788/fp.0687

Author and Disclosure Information

Allison C. Aosved, PhD, ABPPa,b; Marissa Sia, PsyD, MAa; Jodi C. Bell, PsyDa; Theresa B. Brown, PsyDa; Hsin-Tine "Tina" Liu-Tom, PhD, CSACa

Author affiliations
aVeterans Affairs Pacific Islands Health Care System, Honolulu, Hawaii
bThrive Psychology LLC, Honolulu, Hawaii

Author disclosures
The authors report no actual or potential conflicts of interest regarding this article.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies.

Ethics and consent
Veteran participation in iVET was voluntary and optional. Participants engaged in routine informed consent practices utilized for all veterans receiving mental health care at VAPIHCS. The development of iVET was an Evidence Based Practice (EBP) Council approved project at VAPIHCS and, as such, it is not considered research and is exempt from Institutional Review Board review. The project was approved by the council on December 26, 2023, and Chief of Staff on December 29, 2023. The project final report was submitted to the EBP Council on February 28, 2025, and the project remains in the sustainment phase.

Acknowledgments
The authors thank iVET colleagues Chelsea Briggs, Maria Cabrera, Janver Fudolig, Bernadette Furtado, Christine Kindler, Mukul Khandelwal, Gaudencia Palomo-Burns, Kanani Racimo. Collaborators outside of iVET, including David Bernstein, Judy Carlson, Shiloh Jordan, Scott Masters, Dennis Perez, Sheila Rauch, Andrew Sherrill, and Cynthia Yamokoski provided valuable contributions including, but not limited to, administrative support, service delivery, mentorship, consultation, and sponsorship that was instrumental for the development of the iVET.

Correspondence: Allison Aosved (dr.a@thrivepsychologyllc.com)

Fed Pract. 2026;43(suppl 1). Published online April 15. doi:10.12788/fp.0687

Article PDF
Article PDF

Cognitive behavioral therapy (CBT) is supported as an effective treatment for depression by clinical practice guidelines from the US Department of Veterans Affairs (VA) and US Department of Defense.1-3 Despite research supporting the use of evidence-based CBT for anxiety, mood, and emotional disorders, patient access to these interventions is limited.4 One barrier to CBT for anxiety, mood, and emotional disorders is the traditional use of single-disorder protocols (SDPs) to separately treat each disorder (eg, major depression, generalized anxiety disorder, panic disorder).

Use of SDPs places a high burden on clinicians, requiring them to learn and competently implement multiple different manualized interventions for each anxiety, mood, or emotional disorder encountered in practice.4 It is common for individuals who present with an anxiety, mood, or emotional disorder to experience co-occurring disorders.5 Traditional SDP-based CBT may require multiple SDPs to address co-occurring disorders, extending time in treatment and increasing training burden. There is evidence that even when an SDP is used, co-occurring difficulties may decrease in intensity.6 Thus, evidence-based CBT for 1 presenting concern may positively affect co-occurring difficulties that are not the primary treatment target.6

Unified Protocol (UP) is a transdiagnostic CBT intervention for anxiety and mood disorders. UP targets emotional experiences (eg, negative affect and emotional distress) that are present in multiple anxiety, depression, and emotional disorders. UP is organized into 8 modules and uses interventions present in other CBT SDPs, such as teaching objective assessment methods to clients, motivational enhancement and goal setting, emotion psychoeducation, mindful awareness, cognitive reframing, and exposure principles as mechanisms of change (Table 1).4 UP is an ideal intervention for addressing a number of anxiety, mood, and emotional disorders as well as addressing cooccurring disorders within the same course of treatment.

0426FED-MH-Anxiety-T1

UP has been compared to SDPs; studies illustrate that UP is equivalent to SDPs at the end of treatment and at 6 months posttreatment.4,7 Additionally, patients who received UP experienced symptom reduction for multiple co-occurring disorders.7 Furthermore, patients were less likely to drop out of UP when compared with SDPs.4

Studies have reported positive impacts on affective disorders with UP. A 2019 meta-analysis found significant reductions in depression and anxiety-related disorders.8 Additionally, UP has been shown to be effective when delivered in person and via telehealth.9,10 UP has also been successfully used in veterans.11 While traditional models of UP (1-2 sessions weekly) have a lower dropout rate than SDPs, UP and CBT dropout rates still leave room for improvement.12-14 Specifically, rates of attrition from SDP CBT and transdiagnostic CBT protocols range from 9% to 35%, and dropout reduces the likelihood of attaining a full therapeutic dose of any course of CBT. Notably, accelerated delivery of CBT (ie, ≥ 3 sessions/wk) has been shown to reduce risk of dropout.14,15

Veterans are at increased risk for suicide, and anxiety and mood disorders are associated with increased risk of suicide attempt and death.16,17 Very few veterans who could benefit from high-quality CBT interventions, whether SDP or UP, are able to access them. Only 6.3% of veterans received ≥1 session of an evidence-based CBT SDP for posttraumatic stress disorder (PTSD) at 6 clinics evaluated in 2010.18

We identified 2 strategies to increase access to and completion of an evidence-based CBT course. First, the use of transdiagnostic UP instead of SDPs reduced burden on therapists and allowed them to address presenting and co-occurring disorders within the same course of care. Second, the use of an accelerated model of service delivery reduced dropout risk. Training clinicians to deliver UP is efficient and cost-effective, considering clinicians use core strategies that can be tailored and flexibly applied to a range of emotional difficulties. Thus, implementing UP may decrease barriers to receiving an optimal dose of an evidence-based CBT delivered with fidelity in a time- and cost-efficient manner.4 Two studies have found no evidence of differences in outcomes between UP and SDPs, suggesting that training and supervising clinicians in a single transdiagnostic UP intervention may prepare them to treat heterogeneous and co-occurring anxiety, mood, and emotional disorders with less burden than learning multiple SDPs.7,19

Delivering UP in an accelerated or massed format (≥4 sessions/wk) instead of the traditional spaced model (1 session/wk) has empirical support but has not been widely implemented. This approach, sometimes referred to as a UP-intensive outpatient program (UP-IOP) or UP-intensive outpatient track (UP-IOT), has been shown to be feasible, acceptable, and effective, with increased completion rates compared with traditional UP delivery (1-2 sessions/wk).20-22

Ragsdale et al describe a 2-week IOP with multiple treatment tracks, including a general track.20 The general track includes massed UP and additional standard services, including case management, wellness services, family services, and a single session effective behaviors group. Additional augmentation services are available when clinically indicated (eg, repetitive transcranial magnetic stimulation, transcranial direct current stimulation, psychoeducation, motivational interviewing, relapse prevention). In other words, this was an UP-IOP.20

Thompson-Brenner et al described a successful implementation of massed UP applied in intensive treatment settings, such as residential and day-hospital programs, for eating disorders. Patients reported improvements in 3 UP targets: experiential avoidance, mindfulness, and anxiety.21 Watkins et al evaluated a 2-week IOP using CBT for comorbid substance use and mental health disorders, including prolonged exposure, UP, and relapse prevention for substance use disorders. Participants were post-9/11 veterans and activeduty personnel. Results indicated that UP reduced PTSD and depressive symptoms following treatment. Furthermore, the retention rate (91%) was higher than retention in outpatient treatment (39%-65%), supporting the IOP model as a strategy to reduce dropout.22

Massed psychotherapy has been extended to IOP programs for PTSD treatment within the Veterans Health Administration (VHA). Yamokoski et al found that patients who completed an IOP that included massed CBT for PTSD had high retention, high satisfaction, and significant reduction in self-reported co-occurring depression symptoms. The authors also found that this model of care could be implemented and sustained within a VHA facility using minimal staffing resources.23

The UP-IOP models described by Ragsdale et al and Watkins et al included massed UP as the primary evidence-based practice (EBP) with adjunctive groups (eg, wellness and educational groups and access to complementary interventions such as mindfulness and yoga); they found that adding these groups increased retention and patient- reported satisfaction (ie, UP-IOP).20,22 The addition of wellness education alongside a primary EBP aligns with the VHA focus on whole health well-being and wellness. This includes understanding factors that motivate a patient toward health and well-being, providing health education, and offering access to complementary interventions such as mindfulness.24

Dryden et al described the whole health transformation within VHA as a proactive approach to addressing both employee and patient wellness. Their research found that the whole health model promoted wellbeing in patients and staff and these improvements were sustained during the COVID-19 pandemic. Dryden et al also noted that virtual technologies facilitated continued whole health implementation.25

The literature illustrates that (1) massed UP can be delivered with complementary education and wellness offerings that may increase retention and satisfaction by enriching treatment (eg, delivering UP-IOP); (2) whole health, including wellness education and complementary interventions (eg, mindfulness, motivational enhancement), promotes well-being in patients and clinicians; and (3) whole health education and complementary interventions can be delivered virtually.

IVET

Health Care Need

Veterans Affairs Pacific Islands Health Care System (VAPIHCS) provides medical services to veterans in the Hawaiian Islands, American Samoa, Guam, and Saipan spanning nearly 4000 miles across the Pacific Ocean. Prior to implementation of this program, veterans who received care at VAPIHCS had little to no access to UP in outpatient settings and no access to UP in residential settings. Access to UP depended on the presence of a therapist trained in UP within a given clinic and was geographically limited to the location of the UP-trained therapist. The limited outpatient access to UP was restricted to the traditional UP delivery model (eg, about 1 session/wk); thus, there was no access to accelerated UP for veterans served at VAPIHCS. In the fiscal year prior to implementation of the massed UP program, > 1000 VAPIHCS veterans had been diagnosed with obsessive-compulsive related disorder or anxiety. A massed-UP program with weekly rolling admissions would support access to UP for more veterans over 12 months, and the virtual treatment modality would reduce barriers for diverse and underserved veterans, making care more equitable and inclusive.

Successful implementation and sustainment of an EBP prompted the establishment of this UP program. In 2022, VAPIHCS launched the Intensive Virtual Evidence- Based Psychotherapy Team (iVET) for treatment of PTSD. This clinic and associated EBP project demonstrated that massed (≥3 individual sessions/wk) of prolonged exposure (PE) therapy, delivered virtually to a geographically diverse veteran population with PTSD, resulted in significant reductions in PTSD, depression, and anxiety symptoms and substance use risk factors, with very high retention rates. The iVET for PTSD program was feasible, acceptable, and effective, with veterans reporting significant improvement in quality of life and high satisfaction with their mental health services.15 Given the known benefits of transdiagnostic UP treatment (vs SDPs), the need for accelerated UP, and success with accelerated PE, our goal was to spread the EBP of massed (≥3 sessions/ wk) virtual psychotherapy to other presenting problems (eg, anxiety disorders with or without co-occurring unipolar depression) using transdiagnostic UP.

Program Description

The program implemented within outpatient mental health services at VAPIHCS was iVET for the treatment of anxiety with or without co-occurring depression. The program model consists of an accelerated course of UP and whole health education provided via VA Video Connect (VVC), the VA video telehealth platform. iVET is a 2- to 4-week program and consists of 3 parts: (1) massed individual UP for transdiagnostic treatment of anxiety and co-occurring depression, (2) group whole health and wellness classes, and (3) individual health coaching to address personal wellness goals. Programming is offered over 10-hour days to increase access across multiple time zones, especially to allow participation from Guam and Saipan.

When a patient is referred to iVET, the first contact is a video (or telephone) appointment with a registered nurse (RN) for a screening session. The screening session is designed to provide education about the program (including interventions, time commitment, and resources required for participation). Following education, the RN completes a safety screening, including screening for suicidal ideation and risk, as well as intimate partner violence risk. If urgent safety concerns are present, a licensed social worker or psychologist joins the screening to complete further risk assessment and address any safety concerns.

Following screening, patients are scheduled for a VVC telehealth intake with a licensed therapist (social worker or psychologist) to complete a diagnostic interview. Patients are sent a secure link to complete a measurement-based care (MBC) battery of self-report measures, including assessments of demographics, anxiety symptoms, depression symptoms, substance use, psychological flexibility, quality of life, and satisfaction with mental health care. The results of the diagnostic interview and self-report measures are discussed with the patient during the intake session to plan next steps and support shared decision-making. This initial VVC intake not only allows for fit assessment but also serves to troubleshoot technical difficulties with the virtual platforms.

Notably, there are minimal exclusion criteria for participation in iVET. These include active unmanaged psychosis or manic symptoms, recent suicidal crises (attempt within 8 weeks), active nonsuicidal self-injury (within 8 weeks), and moderate to severe cognitive impairment. Following intake, patients are scheduled to begin their course of care with iVET. Upon completion of intake, patients receive program materials for individual and group classes and are told they will receive email links for all VVC telehealth appointments. Patients are admitted to the iVET on a rolling basis, thereby increasing access compared with closed group and/or cohort models of care.

Patients receiving iVET attend 2 to 4 telehealth appointments daily and complete exercises between sessions. The primary iVET for Anxiety program EBP intervention is a massed or accelerated individual course of UP, which includes 8 primary components: assessment, goals and motivation, understanding emotions, mindful emotion awareness, cognitive flexibility, countering emotional behaviors, understanding and confronting physical sensations, and emotional exposures. UP is delivered in 4 to 8 individual sessions weekly (60-90 minutes each), allowing completion of the full UP protocol with fidelity in 2 to 4 weeks. In addition to primary EBP intervention, patients participate in 4 group sessions weekly (50 minutes each) of a whole health and wellness education class and have access to 1 individual health coaching session weekly (30- 60 minutes) to set wellness goals and receive coaching. During iVET, patients are invited to complete MBC batteries of self-report measures assessing anxiety symptoms, depression symptoms, substance use, psychological flexibility, quality of life, and satisfaction with mental health care at sessions 1, 5, 9, 13, and the final UP session. Following discharge from the iVET, patients are offered 1-, 3-, and 6-month individual postdischarge check-up sessions with a therapist, during which they are invited to complete MBC measures and review relapse prevention and maintenance of treatment gains. Likewise, patients are offered 1-, 3-, and 6-month individual postdischarge check-up sessions with an RN focused on maintaining wellness gains.

The iVET for Anxiety staff has 3 therapists (psychologists or social workers) and 1 RN. Additionally, the iVET for Anxiety is supported by a program manager and a program support assistant who support 2 programs total (the iVET for Anxiety plus another mental health program). The primary cost of the program is staff salary. Additional resources included computer equipment for staff and supplies (eg, printed materials for patients and office supplies). Due to the virtual environment of care, iVET staff telework and do not require physical space within VAPIHCS.

Outcomes

Veterans receiving iVET for Anxiety are invited to complete MBC multiple times, including pretreatment, during UP treatment (sessions 1, 5, 9, 13, and the final session), and posttreatment (1, 3, and 6 months). MBC measures include self-reported demographics; a 2-item measure of satisfaction with mental health services; the Acceptance and Action Questionnaire II,26 the Brief Addiction Monitor-Intensive Outpatient Program, 27 the Generalized Anxiety Disorder-7,28 the Patient Health Questionnaire (PHQ-9),29 and the Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form.30

Forty-two veterans completed the iVET for Anxiety program, with a retention rate of 87.5% completing . 16 sessions of massed UP (Table 2). Veterans reported reduced anxiety (P < .001), depression (P < .001), and substance use risk (P < .001). Veterans experienced improved acceptance of emotional experiences (P < .001) and quality of life (P < .001), based on paired sample t tests comparing session 1 vs final session scores on the self-reported measures. Veterans also reported high satisfaction with mental health care in iVET for Anxiety.

0426FED-MH-Anxiety-T2

Veterans experienced reduced thoughts of death or suicidal ideation (SI) based on responses to item 9 of PHQ-9. When SI was categorically analyzed (presence vs absence) using PHQ-9 item 9, there was an association observed between absence of SI and completion of a course of massed UP that does not appear to be due to chance, (X2 [1, N = 42) = 3.94; P = .047). In addition, veterans who completed the program showed a significant decrease in SI severity measured continuously (range, 0-3) on PHQ-9 item 9 (P < .05) (Table 3).

0426FED-MH-Anxiety-T3

Future Directions

The aim of this program is to see sustained patient outcomes as iVET continues to serve more veterans. Another line of inquiry is longer- term follow-up, given that long-term follow- up was not addressed in this project. We also hope that the accelerated model of care can be applied to treatment of other presenting concerns (eg, relationship difficulties, insomnia). Expansion of accelerated mental health treatment into other federal and nonfederal health care settings is another area worthy of future inquiry. Exploration of staff satisfaction and burnout related to providing accelerated UP is another important future direction. Relatedly, assessment of the staff burden to learn 1 transdiagnostic EBP vs learning multiple SDPs is another future direction. Likewise, exploration of institutional benefits of investment in transdiagnostic training, supervision, and consultation for UP vs multiple SDPs may be important. These areas could also result in insightful, beneficial evidence of the effectiveness of massed UP to add to the existing literature.

Conclusions

UP for transdiagnostic treatment of anxiety, depressive, and emotional disorders has demonstrated reduced suffering and improved functioning and is supported by multiple clinical practice guidelines.1-4 Federal practitioners are positioned to improve access to this intervention, thereby reducing pain and improving lives. Indeed, it is crucial to envision a future state in which access to UP for a range of anxiety and depressive disorders is improved and broad, retention rates are dramatically improved, and clinicians providing UP do not experience the high burden and burnout associated with needing to learn and implement a variety of SDPs. Development of these programs, or similar tracks within existing programs, that provide massed or accelerated UP for transdiagnostic treatment of a range of anxiety and depressive disorders with virtual delivery options, is imperative to advance improved care for patients and clinicians.

Federal health care settings treating patients with anxiety and depression, such as those within the US Department of Defense, Indian Health Services, Bureau of Prisons, and VHA, are positioned to implement programs like iVET. Moreover, at the institutional level, investment in training and supervision in the transdiagnostic UP as opposed to multiple SDPs warrants consideration. We believe this model of care has great merit and foresee a future where all patients seeking treatment for anxiety and depression have the option to complete an accelerated or massed course of transdiagnostic care with UP if they so desire. Our experiences with iVET illustrate the feasibility, acceptability, and sustainability of such programs without requiring substantial staffing and financial resources.

Cognitive behavioral therapy (CBT) is supported as an effective treatment for depression by clinical practice guidelines from the US Department of Veterans Affairs (VA) and US Department of Defense.1-3 Despite research supporting the use of evidence-based CBT for anxiety, mood, and emotional disorders, patient access to these interventions is limited.4 One barrier to CBT for anxiety, mood, and emotional disorders is the traditional use of single-disorder protocols (SDPs) to separately treat each disorder (eg, major depression, generalized anxiety disorder, panic disorder).

Use of SDPs places a high burden on clinicians, requiring them to learn and competently implement multiple different manualized interventions for each anxiety, mood, or emotional disorder encountered in practice.4 It is common for individuals who present with an anxiety, mood, or emotional disorder to experience co-occurring disorders.5 Traditional SDP-based CBT may require multiple SDPs to address co-occurring disorders, extending time in treatment and increasing training burden. There is evidence that even when an SDP is used, co-occurring difficulties may decrease in intensity.6 Thus, evidence-based CBT for 1 presenting concern may positively affect co-occurring difficulties that are not the primary treatment target.6

Unified Protocol (UP) is a transdiagnostic CBT intervention for anxiety and mood disorders. UP targets emotional experiences (eg, negative affect and emotional distress) that are present in multiple anxiety, depression, and emotional disorders. UP is organized into 8 modules and uses interventions present in other CBT SDPs, such as teaching objective assessment methods to clients, motivational enhancement and goal setting, emotion psychoeducation, mindful awareness, cognitive reframing, and exposure principles as mechanisms of change (Table 1).4 UP is an ideal intervention for addressing a number of anxiety, mood, and emotional disorders as well as addressing cooccurring disorders within the same course of treatment.

0426FED-MH-Anxiety-T1

UP has been compared to SDPs; studies illustrate that UP is equivalent to SDPs at the end of treatment and at 6 months posttreatment.4,7 Additionally, patients who received UP experienced symptom reduction for multiple co-occurring disorders.7 Furthermore, patients were less likely to drop out of UP when compared with SDPs.4

Studies have reported positive impacts on affective disorders with UP. A 2019 meta-analysis found significant reductions in depression and anxiety-related disorders.8 Additionally, UP has been shown to be effective when delivered in person and via telehealth.9,10 UP has also been successfully used in veterans.11 While traditional models of UP (1-2 sessions weekly) have a lower dropout rate than SDPs, UP and CBT dropout rates still leave room for improvement.12-14 Specifically, rates of attrition from SDP CBT and transdiagnostic CBT protocols range from 9% to 35%, and dropout reduces the likelihood of attaining a full therapeutic dose of any course of CBT. Notably, accelerated delivery of CBT (ie, ≥ 3 sessions/wk) has been shown to reduce risk of dropout.14,15

Veterans are at increased risk for suicide, and anxiety and mood disorders are associated with increased risk of suicide attempt and death.16,17 Very few veterans who could benefit from high-quality CBT interventions, whether SDP or UP, are able to access them. Only 6.3% of veterans received ≥1 session of an evidence-based CBT SDP for posttraumatic stress disorder (PTSD) at 6 clinics evaluated in 2010.18

We identified 2 strategies to increase access to and completion of an evidence-based CBT course. First, the use of transdiagnostic UP instead of SDPs reduced burden on therapists and allowed them to address presenting and co-occurring disorders within the same course of care. Second, the use of an accelerated model of service delivery reduced dropout risk. Training clinicians to deliver UP is efficient and cost-effective, considering clinicians use core strategies that can be tailored and flexibly applied to a range of emotional difficulties. Thus, implementing UP may decrease barriers to receiving an optimal dose of an evidence-based CBT delivered with fidelity in a time- and cost-efficient manner.4 Two studies have found no evidence of differences in outcomes between UP and SDPs, suggesting that training and supervising clinicians in a single transdiagnostic UP intervention may prepare them to treat heterogeneous and co-occurring anxiety, mood, and emotional disorders with less burden than learning multiple SDPs.7,19

Delivering UP in an accelerated or massed format (≥4 sessions/wk) instead of the traditional spaced model (1 session/wk) has empirical support but has not been widely implemented. This approach, sometimes referred to as a UP-intensive outpatient program (UP-IOP) or UP-intensive outpatient track (UP-IOT), has been shown to be feasible, acceptable, and effective, with increased completion rates compared with traditional UP delivery (1-2 sessions/wk).20-22

Ragsdale et al describe a 2-week IOP with multiple treatment tracks, including a general track.20 The general track includes massed UP and additional standard services, including case management, wellness services, family services, and a single session effective behaviors group. Additional augmentation services are available when clinically indicated (eg, repetitive transcranial magnetic stimulation, transcranial direct current stimulation, psychoeducation, motivational interviewing, relapse prevention). In other words, this was an UP-IOP.20

Thompson-Brenner et al described a successful implementation of massed UP applied in intensive treatment settings, such as residential and day-hospital programs, for eating disorders. Patients reported improvements in 3 UP targets: experiential avoidance, mindfulness, and anxiety.21 Watkins et al evaluated a 2-week IOP using CBT for comorbid substance use and mental health disorders, including prolonged exposure, UP, and relapse prevention for substance use disorders. Participants were post-9/11 veterans and activeduty personnel. Results indicated that UP reduced PTSD and depressive symptoms following treatment. Furthermore, the retention rate (91%) was higher than retention in outpatient treatment (39%-65%), supporting the IOP model as a strategy to reduce dropout.22

Massed psychotherapy has been extended to IOP programs for PTSD treatment within the Veterans Health Administration (VHA). Yamokoski et al found that patients who completed an IOP that included massed CBT for PTSD had high retention, high satisfaction, and significant reduction in self-reported co-occurring depression symptoms. The authors also found that this model of care could be implemented and sustained within a VHA facility using minimal staffing resources.23

The UP-IOP models described by Ragsdale et al and Watkins et al included massed UP as the primary evidence-based practice (EBP) with adjunctive groups (eg, wellness and educational groups and access to complementary interventions such as mindfulness and yoga); they found that adding these groups increased retention and patient- reported satisfaction (ie, UP-IOP).20,22 The addition of wellness education alongside a primary EBP aligns with the VHA focus on whole health well-being and wellness. This includes understanding factors that motivate a patient toward health and well-being, providing health education, and offering access to complementary interventions such as mindfulness.24

Dryden et al described the whole health transformation within VHA as a proactive approach to addressing both employee and patient wellness. Their research found that the whole health model promoted wellbeing in patients and staff and these improvements were sustained during the COVID-19 pandemic. Dryden et al also noted that virtual technologies facilitated continued whole health implementation.25

The literature illustrates that (1) massed UP can be delivered with complementary education and wellness offerings that may increase retention and satisfaction by enriching treatment (eg, delivering UP-IOP); (2) whole health, including wellness education and complementary interventions (eg, mindfulness, motivational enhancement), promotes well-being in patients and clinicians; and (3) whole health education and complementary interventions can be delivered virtually.

IVET

Health Care Need

Veterans Affairs Pacific Islands Health Care System (VAPIHCS) provides medical services to veterans in the Hawaiian Islands, American Samoa, Guam, and Saipan spanning nearly 4000 miles across the Pacific Ocean. Prior to implementation of this program, veterans who received care at VAPIHCS had little to no access to UP in outpatient settings and no access to UP in residential settings. Access to UP depended on the presence of a therapist trained in UP within a given clinic and was geographically limited to the location of the UP-trained therapist. The limited outpatient access to UP was restricted to the traditional UP delivery model (eg, about 1 session/wk); thus, there was no access to accelerated UP for veterans served at VAPIHCS. In the fiscal year prior to implementation of the massed UP program, > 1000 VAPIHCS veterans had been diagnosed with obsessive-compulsive related disorder or anxiety. A massed-UP program with weekly rolling admissions would support access to UP for more veterans over 12 months, and the virtual treatment modality would reduce barriers for diverse and underserved veterans, making care more equitable and inclusive.

Successful implementation and sustainment of an EBP prompted the establishment of this UP program. In 2022, VAPIHCS launched the Intensive Virtual Evidence- Based Psychotherapy Team (iVET) for treatment of PTSD. This clinic and associated EBP project demonstrated that massed (≥3 individual sessions/wk) of prolonged exposure (PE) therapy, delivered virtually to a geographically diverse veteran population with PTSD, resulted in significant reductions in PTSD, depression, and anxiety symptoms and substance use risk factors, with very high retention rates. The iVET for PTSD program was feasible, acceptable, and effective, with veterans reporting significant improvement in quality of life and high satisfaction with their mental health services.15 Given the known benefits of transdiagnostic UP treatment (vs SDPs), the need for accelerated UP, and success with accelerated PE, our goal was to spread the EBP of massed (≥3 sessions/ wk) virtual psychotherapy to other presenting problems (eg, anxiety disorders with or without co-occurring unipolar depression) using transdiagnostic UP.

Program Description

The program implemented within outpatient mental health services at VAPIHCS was iVET for the treatment of anxiety with or without co-occurring depression. The program model consists of an accelerated course of UP and whole health education provided via VA Video Connect (VVC), the VA video telehealth platform. iVET is a 2- to 4-week program and consists of 3 parts: (1) massed individual UP for transdiagnostic treatment of anxiety and co-occurring depression, (2) group whole health and wellness classes, and (3) individual health coaching to address personal wellness goals. Programming is offered over 10-hour days to increase access across multiple time zones, especially to allow participation from Guam and Saipan.

When a patient is referred to iVET, the first contact is a video (or telephone) appointment with a registered nurse (RN) for a screening session. The screening session is designed to provide education about the program (including interventions, time commitment, and resources required for participation). Following education, the RN completes a safety screening, including screening for suicidal ideation and risk, as well as intimate partner violence risk. If urgent safety concerns are present, a licensed social worker or psychologist joins the screening to complete further risk assessment and address any safety concerns.

Following screening, patients are scheduled for a VVC telehealth intake with a licensed therapist (social worker or psychologist) to complete a diagnostic interview. Patients are sent a secure link to complete a measurement-based care (MBC) battery of self-report measures, including assessments of demographics, anxiety symptoms, depression symptoms, substance use, psychological flexibility, quality of life, and satisfaction with mental health care. The results of the diagnostic interview and self-report measures are discussed with the patient during the intake session to plan next steps and support shared decision-making. This initial VVC intake not only allows for fit assessment but also serves to troubleshoot technical difficulties with the virtual platforms.

Notably, there are minimal exclusion criteria for participation in iVET. These include active unmanaged psychosis or manic symptoms, recent suicidal crises (attempt within 8 weeks), active nonsuicidal self-injury (within 8 weeks), and moderate to severe cognitive impairment. Following intake, patients are scheduled to begin their course of care with iVET. Upon completion of intake, patients receive program materials for individual and group classes and are told they will receive email links for all VVC telehealth appointments. Patients are admitted to the iVET on a rolling basis, thereby increasing access compared with closed group and/or cohort models of care.

Patients receiving iVET attend 2 to 4 telehealth appointments daily and complete exercises between sessions. The primary iVET for Anxiety program EBP intervention is a massed or accelerated individual course of UP, which includes 8 primary components: assessment, goals and motivation, understanding emotions, mindful emotion awareness, cognitive flexibility, countering emotional behaviors, understanding and confronting physical sensations, and emotional exposures. UP is delivered in 4 to 8 individual sessions weekly (60-90 minutes each), allowing completion of the full UP protocol with fidelity in 2 to 4 weeks. In addition to primary EBP intervention, patients participate in 4 group sessions weekly (50 minutes each) of a whole health and wellness education class and have access to 1 individual health coaching session weekly (30- 60 minutes) to set wellness goals and receive coaching. During iVET, patients are invited to complete MBC batteries of self-report measures assessing anxiety symptoms, depression symptoms, substance use, psychological flexibility, quality of life, and satisfaction with mental health care at sessions 1, 5, 9, 13, and the final UP session. Following discharge from the iVET, patients are offered 1-, 3-, and 6-month individual postdischarge check-up sessions with a therapist, during which they are invited to complete MBC measures and review relapse prevention and maintenance of treatment gains. Likewise, patients are offered 1-, 3-, and 6-month individual postdischarge check-up sessions with an RN focused on maintaining wellness gains.

The iVET for Anxiety staff has 3 therapists (psychologists or social workers) and 1 RN. Additionally, the iVET for Anxiety is supported by a program manager and a program support assistant who support 2 programs total (the iVET for Anxiety plus another mental health program). The primary cost of the program is staff salary. Additional resources included computer equipment for staff and supplies (eg, printed materials for patients and office supplies). Due to the virtual environment of care, iVET staff telework and do not require physical space within VAPIHCS.

Outcomes

Veterans receiving iVET for Anxiety are invited to complete MBC multiple times, including pretreatment, during UP treatment (sessions 1, 5, 9, 13, and the final session), and posttreatment (1, 3, and 6 months). MBC measures include self-reported demographics; a 2-item measure of satisfaction with mental health services; the Acceptance and Action Questionnaire II,26 the Brief Addiction Monitor-Intensive Outpatient Program, 27 the Generalized Anxiety Disorder-7,28 the Patient Health Questionnaire (PHQ-9),29 and the Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form.30

Forty-two veterans completed the iVET for Anxiety program, with a retention rate of 87.5% completing . 16 sessions of massed UP (Table 2). Veterans reported reduced anxiety (P < .001), depression (P < .001), and substance use risk (P < .001). Veterans experienced improved acceptance of emotional experiences (P < .001) and quality of life (P < .001), based on paired sample t tests comparing session 1 vs final session scores on the self-reported measures. Veterans also reported high satisfaction with mental health care in iVET for Anxiety.

0426FED-MH-Anxiety-T2

Veterans experienced reduced thoughts of death or suicidal ideation (SI) based on responses to item 9 of PHQ-9. When SI was categorically analyzed (presence vs absence) using PHQ-9 item 9, there was an association observed between absence of SI and completion of a course of massed UP that does not appear to be due to chance, (X2 [1, N = 42) = 3.94; P = .047). In addition, veterans who completed the program showed a significant decrease in SI severity measured continuously (range, 0-3) on PHQ-9 item 9 (P < .05) (Table 3).

0426FED-MH-Anxiety-T3

Future Directions

The aim of this program is to see sustained patient outcomes as iVET continues to serve more veterans. Another line of inquiry is longer- term follow-up, given that long-term follow- up was not addressed in this project. We also hope that the accelerated model of care can be applied to treatment of other presenting concerns (eg, relationship difficulties, insomnia). Expansion of accelerated mental health treatment into other federal and nonfederal health care settings is another area worthy of future inquiry. Exploration of staff satisfaction and burnout related to providing accelerated UP is another important future direction. Relatedly, assessment of the staff burden to learn 1 transdiagnostic EBP vs learning multiple SDPs is another future direction. Likewise, exploration of institutional benefits of investment in transdiagnostic training, supervision, and consultation for UP vs multiple SDPs may be important. These areas could also result in insightful, beneficial evidence of the effectiveness of massed UP to add to the existing literature.

Conclusions

UP for transdiagnostic treatment of anxiety, depressive, and emotional disorders has demonstrated reduced suffering and improved functioning and is supported by multiple clinical practice guidelines.1-4 Federal practitioners are positioned to improve access to this intervention, thereby reducing pain and improving lives. Indeed, it is crucial to envision a future state in which access to UP for a range of anxiety and depressive disorders is improved and broad, retention rates are dramatically improved, and clinicians providing UP do not experience the high burden and burnout associated with needing to learn and implement a variety of SDPs. Development of these programs, or similar tracks within existing programs, that provide massed or accelerated UP for transdiagnostic treatment of a range of anxiety and depressive disorders with virtual delivery options, is imperative to advance improved care for patients and clinicians.

Federal health care settings treating patients with anxiety and depression, such as those within the US Department of Defense, Indian Health Services, Bureau of Prisons, and VHA, are positioned to implement programs like iVET. Moreover, at the institutional level, investment in training and supervision in the transdiagnostic UP as opposed to multiple SDPs warrants consideration. We believe this model of care has great merit and foresee a future where all patients seeking treatment for anxiety and depression have the option to complete an accelerated or massed course of transdiagnostic care with UP if they so desire. Our experiences with iVET illustrate the feasibility, acceptability, and sustainability of such programs without requiring substantial staffing and financial resources.

References
  1. US Department of Veterans Affairs, US Department of Defense. VA/DoD clinical practice guideline for the management of major depressive disorder. Version 4. 2022. Accessed February 1, 2026. https://www.healthquality.va.gov/guidelines/MH/mdd/VADoDMDDCPGFinal508.pdf
  2. American Psychological Association. Clinical practice guideline for the treatment of depression across three age cohorts. February 2019. Accessed February 4, 2026. https://www.apa.org/depression-guideline/guideline.pdf
  3. Katzman MA, Bleau P, Blier P, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive compulsive disorders. BMC Psychiatry. 2014;14:S1. doi:10.1186/1471-244X-14-S1-S1
  4. Barlow DH, Farchione TJ, Bullis JR, et al. The unified protocol for transdiagnostic treatment of emotional disorders compared with diagnosis-specific protocols for anxiety disorders: a randomized clinical trial. JAMA Psychiatry. 2017;74:875-884. doi:10.1001/jamapsychiatry.2017.2164
  5. Calkins AW, et al. Comorbidity of anxiety and depression. In: Ressler KJ, Pine DS, Rothbaum BO, eds. Anxiety Disorders, Primer On. Oxford Academic; 2015. https://doi.org/10.1093/med/9780199395125.003.0021
  6. Manber R, Edinger JD, Gress JL, et al. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep. 2008;31:489-495. doi:10.1093/sleep/31.4.489
  7. Steele SJ, Farchione TJ, Cassiello-Robbins C, et al. Efficacy of the Unified Protocol for transdiagnostic treatment of comorbid psychopathology accompanying emotional disorders compared to treatments targeting single disorders. J Psychiatr Res. 2018;104:211-216. doi:10.1016/j.jpsychires.2018.08.005
  8. Sakiris N, Berle D. A systematic review and meta-analysis of the Unified Protocol as a transdiagnostic emotion regulation based intervention. Clin Psychol Rev. 2019;72:101751. doi:10.1016/j.cpr.2019.101751
  9. Cassiello-Robbins C, Rosenthal MZ, Ammirati RJ. Delivering transdiagnostic treatment over telehealth during the COVID-19 pandemic: application of the unified protocol. Cogn Behav Pract. 2021;28:555-572. doi:10.1016/j.cbpra.2021.04.007
  10. Meyer EC, Coe E, Pennington ML, et al. The unified protocol for transdiagnostic treatment of emotional disorders delivered to firefighters via videoconferencing: pilot outcomes highlighting improvements in alcohol use disorder and posttraumatic stress disorder symptoms. Cogn Behav Pract. 2024;31:215-229. doi:10.1016/j.cbpra.2022.08.004
  11. Varkovitzky RL, Sherrill AM, Reger GM. Effectiveness of the unified protocol for transdiagnostic treatment of emotional disorders among veterans with posttraumatic stress disorder: a pilot study. Behav Modif. 2018;42:210-230. doi:10.1177/0145445517724539
  12. Oliveira JT, Sousa I, Ribeiro AP, et al. Premature termination of the unified protocol for the transdiagnostic treatment of emotional disorders: The role of ambivalence towards change. Clin Psychol Psychother. 2022;29:1089-1100. doi:10.1002/cpp.2694
  13. Schaeuffele C, Homeyer S, Perea L, et al. The unified protocol as an internet-based intervention for emotional disorders: Randomized controlled trial. PLoS One. 2022;17:e0270178. doi:10.1371/journal.pone.0270178
  14. Bentley KH, Cohen ZD, Kim T, et al. The nature, timing, and symptom trajectories of dropout from transdiagnostic and single-diagnosis cognitive-behavioral therapy for anxiety disorders. Behav Ther. 2021;52:1364-1376. doi:10.1016/j.beth.2021.03.007
  15. Aosved AC, Brown TB, Bell JC, et al. Accelerated prolonged exposure therapy for posttraumatic stress disorder in a Veterans Health Administration system. Fed Pract. 2025;42:S6-S11. doi:10.12788/fp.0568
  16. Nepon J, Belik SL, Bolton J, et al. The relationship between anxiety disorders and suicide attempts: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Depress Anxiety. 2010;27:791-798. doi:10.1002/da.20674
  17. Shiner B, D’Avolio LW, Nguyen TM, et al. Measuring use of evidence based psychotherapy for posttraumatic stress disorder. Adm Policy Ment Health. 2013;40:311-318. doi:10.1007/s10488-012-0421-0
  18. Nichter B, Stein MB, Monteith LL, et al. Risk factors for suicide attempts among U.S. military veterans: A 7-year population-based, longitudinal cohort study. Suicide Life Threat Behav. 2022;52:303-316. doi:10.1111/sltb.12822
  19. McHugh RK, Barlow DH. The dissemination and implementation of evidence-based psychological treatments. A review of current efforts. Am Psychol. 2010;65:73-84. doi:10.1037/a0018121
  20. Ragsdale KA, Nichols AA, Mehta M, et al. Comorbid treatment of traumatic brain injury and mental health disorders. NeuroRehabilitation. 2024;55:375-384. doi:10.3233/NRE-230235
  21. Thompson-Brenner H, Brooks GE, Boswell JF, et al. Evidence-based implementation practices applied to the intensive treatment of eating disorders: summary of research and illustration of principles using a case example. Clin Psychol Sci Pract. 2018;25:e12221. doi:10.1111/cpsp.12221
  22. Watkins LE, Patton SC, Drexler K, et al. Clinical effectiveness of an intensive outpatient program for integrated treatment of comorbid substance abuse and mental health disorders. Cog Behav Pract. 2023;30:354-366.
  23. Yamokoski C, Flores H, Facemire V, et al. Feasibility of an intensive outpatient treatment program for post-traumatic stress disorder within the veterans health care administration. Psychol Serv. 2023;20:506-515. doi:10.1037/ser0000628
  24. Gaudet T, Kligler B. Whole health in the whole system of the Veterans Administration: how will we know we have reached this future state?. J Altern Complement Med. 2019;25:S7-S11. doi:10.1089/acm.2018.29061.gau
  25. Dryden EM, Bolton RE, Bokhour BG, et al. Leaning into whole health: sustaining system transformation while supporting patients and employees during COVID-19. Glob Adv Health Med. 2021;10:21649561211021047. doi:10.1177/21649561211021047
  26. Bond FW, Hayes SC, Baer RA, et al. Preliminary psychometric properties of the Acceptance and Action Questionnaire-II: a revised measure of psychological inflexibility and experiential avoidance. Behav Ther. 2011;42:676-688. doi:10.1016/j.beth.2011.03.007
  27. Cacciola JS, Alterman AI, Dephilippis D, et al. Development and initial evaluation of the Brief Addiction Monitor (BAM). J Subst Abuse Treat. 2013;44:256-263. doi:10.1016/j.jsat.2012.07.013
  28. Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092-1097. doi:10.1001/archinte.166.10.1092
  29. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606-613. doi:10.1046/j.1525-1497.2001.016009606.x
  30. Stevanovic D. Quality of life enjoyment and satisfaction questionnaire-short form for quality of life assessments in clinical practice: a psychometric study. J Psychiatr Ment Health Nurs. 2011;18:744-750. doi:10.1111/j.1365-2850.2011.01735.x
References
  1. US Department of Veterans Affairs, US Department of Defense. VA/DoD clinical practice guideline for the management of major depressive disorder. Version 4. 2022. Accessed February 1, 2026. https://www.healthquality.va.gov/guidelines/MH/mdd/VADoDMDDCPGFinal508.pdf
  2. American Psychological Association. Clinical practice guideline for the treatment of depression across three age cohorts. February 2019. Accessed February 4, 2026. https://www.apa.org/depression-guideline/guideline.pdf
  3. Katzman MA, Bleau P, Blier P, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive compulsive disorders. BMC Psychiatry. 2014;14:S1. doi:10.1186/1471-244X-14-S1-S1
  4. Barlow DH, Farchione TJ, Bullis JR, et al. The unified protocol for transdiagnostic treatment of emotional disorders compared with diagnosis-specific protocols for anxiety disorders: a randomized clinical trial. JAMA Psychiatry. 2017;74:875-884. doi:10.1001/jamapsychiatry.2017.2164
  5. Calkins AW, et al. Comorbidity of anxiety and depression. In: Ressler KJ, Pine DS, Rothbaum BO, eds. Anxiety Disorders, Primer On. Oxford Academic; 2015. https://doi.org/10.1093/med/9780199395125.003.0021
  6. Manber R, Edinger JD, Gress JL, et al. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep. 2008;31:489-495. doi:10.1093/sleep/31.4.489
  7. Steele SJ, Farchione TJ, Cassiello-Robbins C, et al. Efficacy of the Unified Protocol for transdiagnostic treatment of comorbid psychopathology accompanying emotional disorders compared to treatments targeting single disorders. J Psychiatr Res. 2018;104:211-216. doi:10.1016/j.jpsychires.2018.08.005
  8. Sakiris N, Berle D. A systematic review and meta-analysis of the Unified Protocol as a transdiagnostic emotion regulation based intervention. Clin Psychol Rev. 2019;72:101751. doi:10.1016/j.cpr.2019.101751
  9. Cassiello-Robbins C, Rosenthal MZ, Ammirati RJ. Delivering transdiagnostic treatment over telehealth during the COVID-19 pandemic: application of the unified protocol. Cogn Behav Pract. 2021;28:555-572. doi:10.1016/j.cbpra.2021.04.007
  10. Meyer EC, Coe E, Pennington ML, et al. The unified protocol for transdiagnostic treatment of emotional disorders delivered to firefighters via videoconferencing: pilot outcomes highlighting improvements in alcohol use disorder and posttraumatic stress disorder symptoms. Cogn Behav Pract. 2024;31:215-229. doi:10.1016/j.cbpra.2022.08.004
  11. Varkovitzky RL, Sherrill AM, Reger GM. Effectiveness of the unified protocol for transdiagnostic treatment of emotional disorders among veterans with posttraumatic stress disorder: a pilot study. Behav Modif. 2018;42:210-230. doi:10.1177/0145445517724539
  12. Oliveira JT, Sousa I, Ribeiro AP, et al. Premature termination of the unified protocol for the transdiagnostic treatment of emotional disorders: The role of ambivalence towards change. Clin Psychol Psychother. 2022;29:1089-1100. doi:10.1002/cpp.2694
  13. Schaeuffele C, Homeyer S, Perea L, et al. The unified protocol as an internet-based intervention for emotional disorders: Randomized controlled trial. PLoS One. 2022;17:e0270178. doi:10.1371/journal.pone.0270178
  14. Bentley KH, Cohen ZD, Kim T, et al. The nature, timing, and symptom trajectories of dropout from transdiagnostic and single-diagnosis cognitive-behavioral therapy for anxiety disorders. Behav Ther. 2021;52:1364-1376. doi:10.1016/j.beth.2021.03.007
  15. Aosved AC, Brown TB, Bell JC, et al. Accelerated prolonged exposure therapy for posttraumatic stress disorder in a Veterans Health Administration system. Fed Pract. 2025;42:S6-S11. doi:10.12788/fp.0568
  16. Nepon J, Belik SL, Bolton J, et al. The relationship between anxiety disorders and suicide attempts: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Depress Anxiety. 2010;27:791-798. doi:10.1002/da.20674
  17. Shiner B, D’Avolio LW, Nguyen TM, et al. Measuring use of evidence based psychotherapy for posttraumatic stress disorder. Adm Policy Ment Health. 2013;40:311-318. doi:10.1007/s10488-012-0421-0
  18. Nichter B, Stein MB, Monteith LL, et al. Risk factors for suicide attempts among U.S. military veterans: A 7-year population-based, longitudinal cohort study. Suicide Life Threat Behav. 2022;52:303-316. doi:10.1111/sltb.12822
  19. McHugh RK, Barlow DH. The dissemination and implementation of evidence-based psychological treatments. A review of current efforts. Am Psychol. 2010;65:73-84. doi:10.1037/a0018121
  20. Ragsdale KA, Nichols AA, Mehta M, et al. Comorbid treatment of traumatic brain injury and mental health disorders. NeuroRehabilitation. 2024;55:375-384. doi:10.3233/NRE-230235
  21. Thompson-Brenner H, Brooks GE, Boswell JF, et al. Evidence-based implementation practices applied to the intensive treatment of eating disorders: summary of research and illustration of principles using a case example. Clin Psychol Sci Pract. 2018;25:e12221. doi:10.1111/cpsp.12221
  22. Watkins LE, Patton SC, Drexler K, et al. Clinical effectiveness of an intensive outpatient program for integrated treatment of comorbid substance abuse and mental health disorders. Cog Behav Pract. 2023;30:354-366.
  23. Yamokoski C, Flores H, Facemire V, et al. Feasibility of an intensive outpatient treatment program for post-traumatic stress disorder within the veterans health care administration. Psychol Serv. 2023;20:506-515. doi:10.1037/ser0000628
  24. Gaudet T, Kligler B. Whole health in the whole system of the Veterans Administration: how will we know we have reached this future state?. J Altern Complement Med. 2019;25:S7-S11. doi:10.1089/acm.2018.29061.gau
  25. Dryden EM, Bolton RE, Bokhour BG, et al. Leaning into whole health: sustaining system transformation while supporting patients and employees during COVID-19. Glob Adv Health Med. 2021;10:21649561211021047. doi:10.1177/21649561211021047
  26. Bond FW, Hayes SC, Baer RA, et al. Preliminary psychometric properties of the Acceptance and Action Questionnaire-II: a revised measure of psychological inflexibility and experiential avoidance. Behav Ther. 2011;42:676-688. doi:10.1016/j.beth.2011.03.007
  27. Cacciola JS, Alterman AI, Dephilippis D, et al. Development and initial evaluation of the Brief Addiction Monitor (BAM). J Subst Abuse Treat. 2013;44:256-263. doi:10.1016/j.jsat.2012.07.013
  28. Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092-1097. doi:10.1001/archinte.166.10.1092
  29. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606-613. doi:10.1046/j.1525-1497.2001.016009606.x
  30. Stevanovic D. Quality of life enjoyment and satisfaction questionnaire-short form for quality of life assessments in clinical practice: a psychometric study. J Psychiatr Ment Health Nurs. 2011;18:744-750. doi:10.1111/j.1365-2850.2011.01735.x
Issue
Federal Practitioner 43(suppl 1)
Issue
Federal Practitioner 43(suppl 1)
Page Number
S1-S7
Page Number
S1-S7
Publications
Publications
Topics
Article Type
Display Headline

Accelerated Unified Protocol for Transdiagnostic Treatment of Anxiety Disorders in a VHA System

Display Headline

Accelerated Unified Protocol for Transdiagnostic Treatment of Anxiety Disorders in a VHA System

Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
survey writer start date